Patent Grant
8722663
The present invention relates to a heterocyclic compound.
Since the clinical use of nitrogen mustard as an anticancer agent in the 1940s for the first time in the world, numerous anticancer drugs have ever been developed. Actually, for example, antimetabolites such as 5-fluorouracil, antitumor antibiotics such as adriamycin, platinum complex such as cisplatin, and plant-derived carcinostatics such as vindesine have been subjected to clinical use.
However, most of these carcinostatics have significant side effects such as digestive disorders, myelosuppression and alopecia since they are cytotoxic also to normal cells. Due to the side effects, their range of application is limited. In addition, the therapeutic effects themselves are partial and short, in most cases.
Developments of new carcinostatics in place of these has been made; however, satisfactory results have not yet been obtained. Patent Documents 1, 2, 3 and 4 disclose that certain kinds of compounds have fibrosing inhibitory actions, antitumor actions and STAT3/5 activation inhibitory actions, respectively. However, it is not known whether the specific compounds of the present invention have an antitumor effect.
An object of the present invention is therefore to provide a compound which has an antitumor effect with less side effects, and excellent safety.
The present inventors intensively conducted studies with the view to attaining the aforementioned object. As a result, they found that a compound represented by the general formula (1) below and a salt thereof have an excellent anti-proliferative activity with less side effects, and excellent safety, and therefore they are useful as a medical drug for treating or preventing various cancer types. Examples of the cancer include sex-steroid hormone related cancer (for example, prostate cancer, breast cancer, ovarian cancer, uterine cancer, testicular cancer) and solid cancer (for example, lung cancer, colon cancer, bladder cancer, thyroid cancer, esophageal cancer, liver cancer). The present invention has been achieved based on the finding.
More specifically, the present invention provides a heterocyclic compound shown in the following items:
wherein
R1 and R2 are each independently aryl or unsaturated heterocyclic ring, each of which is optionally substituted with one or more substituents,
A is lower alkylene,
Ring X is optionally substituted arylene,
E is bond or lower alkenylene,
the partial structural formula:
is optionally substituted heterocycloalkylene containing one or more nitrogen atoms, one of which is attached to the adjacent carbonyl group,
G is —NH-G2-, —N(lower alkyl)-G2-, —NH—CH2-G2-, —N(lower alkyl)-CH2-G2- or —CH2-G2-,
wherein G2 of said G binds to R2,
G2-R2 is bond-R2, phenylene-G3-R2, phenylene-G4-O—R2, phenylene-G5-NH—R2, phenylene-G6-N(lower alkyl)-R2 or quinolinediyl-O—R2, wherein the phenylene of said phenylene-G3-R2, phenylene-G4-O—R2, phenylene-G5-NH—R2 and phenylene-G6-N(lower alkyl)-R2 is optionally substituted with one or more substituents selected from the group consisting of halogen and lower alkyl,
G3-R2 is bond-R2, —O-lower alkylene-R2, lower alkylene-O-lower alkylene-R2 or —O-lower alkylene-CO—R2,
G4-O— is bond-O—, lower alkylene-O—, lower alkenylene-O—, —O-lower alkylene-O— or —CO-lower alkylene-O—,
G5 and G6 are each lower alkylene.
R1 is phenyl, pyridyl, benzothiazolyl or thiazolyl, each of which is optionally substituted with one or more substituents,
the partial structural formula:
is the following formula:
wherein R3 and R4 are the same or different, and are each independently hydrogen, halogen, lower alkyl or lower alkoxy,
the partial structural formula:
is piperazinediyl, piperidinediyl, pyrrolidinediyl, diazepanediyl or oxadiazepanediyl, each of which is optionally substituted with one or more substituents, and
R2 is:
(i) aryl which may be substituted with one or more substituents selected from the group consisting of halogen, cyano, nitro, methylenedioxy, trimethylene, tetramethylene, pyrrolyl, lower alkyl carbonyl, lower alkyl sulfonyl, lower alkyl which may be substituted with one or more halogen, lower alkoxy which may be substituted with one or more halogen, cyclo lower alkyl, lower alkoxy lower alkyl, lower alkenyl, hydroxy lower alkenyl, lower alkoxy lower alkenyl, hydroxy lower alkyl, amino which may be substituted with one or more lower alkyl, and hydroxy lower alkoxy,
(ii) unsaturated heterocyclic ring which may be substituted with one or more substituents selected from the group consisting of halogen, lower alkyl which may be substituted with one or more halogen, and lower alkoxy.
R1 is the following formula:
wherein R5 and R6 are the same or different, and are each independently hydrogen, halogen, cyano, nitro, lower alkoxy which may be substituted with one or more halogen, or lower alkyl which may be substituted with one or more halogen,
the partial structural formula:
is the following formula:
and,
the partial structural formula:
is the following formula:
wherein R7 is hydrogen or lower alkyl.
R2 is:
(i) phenyl which may be substituted with one or more substituents selected from the group consisting of halogen, cyano, nitro, methylenedioxy, trimethylene, tetramethylene, pyrrolyl, lower alkyl carbonyl, lower alkyl sulfonyl, lower alkyl which may be substituted with one or more halogen, lower alkoxy which may be substituted with one or more halogen, cyclo lower alkyl, lower alkoxy lower alkyl, lower alkenyl, hydroxy lower alkenyl, lower alkoxy lower alkenyl, hydroxy lower alkyl, amino which may be substituted with one or more lower alkyl, and hydroxy lower alkoxy,
(ii) naphtyl,
(iii) pyridyl which may be substituted with one or more substituents selected from the group consisting of halogen, lower alkyl which may be substituted with one or more halogen, and lower alkoxy,
(iv) benzoxazolyl which may be substituted with one or more halogen,
(v) benzothiazolyl which may be substituted with one or more lower alkyl, or
(vi) quinolyl.
G is —NH-G2-, —N(lower alkyl)-CH2-G2- or —CH2-G2-,
wherein G2 of said G binds to R2,
G2-R2 is phenylene-G3-R2, phenylene-G4-O—R2, phenylene-G5-NH—R2, phenylene-G6-N(lower alkyl)-R2 or quinolinediyl-O—R2, wherein the phenylene of said phenylene-G3-R2, phenylene-G4-O—R2, phenylene-G5-NH—R2 and phnylene-G6-N(lower alkyl)-R2 is optionally substituted with one or more substituents selected from the group consisting of halogen and lower alkyl.
Specific examples of individual groups shown in the general formula (1) are as follows.
Examples of the “lower alkoxy” include linear or branched alkoxy groups having 1 to 6 carbon atoms and cycloalkylalkoxy groups having 4 to 7 carbon atoms such as methoxy, ethoxy, propoxy, isopropoxy, cyclopropylmethoxy, butoxy, tert-butoxy, pentyloxy, and hexyloxy groups.
Examples of the “lower alkyl” include linear or branched alkyl groups having 1 to 6 carbon atoms such as methyl, ethyl, propyl, isopropyl, 2,2-dimethylpropyl, 1-ethylpropyl, butyl, isobutyl, tert-butyl, isopentyl, pentyl, cyclopropylmethyl, and hexyl groups.
Examples of the “cyclo lower alkyl” include cyclo alkyl groups having 3 to 6 carbon atoms such as cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl.
Examples of the “halogen” are fluorine, chlorine, bromine, and iodine.
Examples of the “lower alkylene” include linear or branched alkylene groups having 1 to 6 carbon atoms, such as methylene, ethylene, 1-methylethylene, 2-methylethylene, trimethylene, 2-methyltrimethylene, 2,2 dimethyltrimethylene, 1-methyltrimethylene, methylmethylene, ethylmethylene, dimethylmethylene, tetramethylene, pentamethylene, and hexamethylene.
Examples of the “lower alkenylene” include linear or branched alkenylene group having 1 to 3 double bonds and 2 to 6 carbon atoms such as vinylene, 1-methylvinylene, 2-methylvinylene, 1,2-dimethylvinylene, 1-propenylene, 1-methyl-1-propenylene, 2-methyl-1-propenylene, 2-propenylene, 2-butenylene, 1-butenylene, 3-butenylene, 2-pentenylene, 1-pentenylene, 3-pentenylene, 4-pentenylene, 1,3-butadienylene, 1,3-pentadienylene, 2-penten-4-ynylene, 2-hexenylene, 1-hexenylene, 5-hexenylene, 3-hexenylene, 4-hexenylene, 3,3-dimethyl-1-propenylene, 2-ethyl-1-propenylene, 1,3,5-hexatrienylene, 1,3-hexadienylene, and 1,4-hexadienylene.
Examples of the “unsaturated heterocyclic ring” include unsaturated monocyclic or bicyclic heterocyclic ring containing at least one hetero atom selected from among oxygen, sulfur and nitrogen. Examples of preferable unsaturated heterocyclic ring include the following (a) to (i):
(a) unsaturated 3 to 8-membered, preferably 5 or 6-membered heteromonocyclic ring containing 1 to 4 nitrogen atoms, for example, pyrrolyl, pyrrolinyl, imidazolyl, pyrazolyl, pyridyl, and its N-oxide, tetrahydropyridyl (e.g., 1,2,3,6-tetrahydropyridyl), pyrimidinyl, pyrazinyl, pyridazinyl, triazolyl (e.g., 4H-1,2,4-triazolyl, 1H-1,2,3-triazolyl, 2H-1,2,3-triazolyl, etc.), tetrazolyl (e.g., 1H-tetrazolyl, 2H-tetrazolyl, etc.), dihydrotriazinyl (e.g., 4,5-dihydro-1,2,4-triazinyl, 2,5-dihydro-1,2,4-triazinyl, etc.), etc.;
(b) unsaturated condensed 7 to 12-membered heterocyclic rings containing 1 to 3 oxygen atoms, for example, benzofuranyl, dihydrobenzofuranyl(e.g. 2,3-dihydrobenzo[b]furanyl, etc.), chromanyl, benzodioxanyl (e.g., 1,4-benzodioxanyl, etc.), benzodioxolyl (benzo[1,3]dioxolyl, etc.), etc.;
(c) unsaturated condensed 7 to 12-membered heterocyclic rings containing 1 to 5 nitrogen atoms, for example, decahydroquinolyl, indolyl, dihydroindolyl (e.g., 2,3-dihydroindolyl, etc.), isoindolyl, indolizinyl, benzimidazolyl, dihydrobenzimidazolyl (e.g., 2,3-dihydro-1H-benzo[d]imidazolyl, etc.), quinolyl, dihydroquinolyl (e.g. 1,4-dihydroquinolyl, 1,2-dihydroquinolyl, etc.), tetrahydroquinolyl (1,2,3,4-tetrahydroquinolyl, etc.), isoquinolyl, dihydroisoquinolyl (e.g., 3,4-dihydro-1H-isoquinolyl, 1,2-dihydroisoquinolyl, etc.), tetrahydroisoquinolyl (e.g., 1,2,3,4-tetrahydro-1H-isoquinolyl, 5,6,7,8-tetrahydroisoquinolyl, etc.), carbostyril, dihydrocarbostyril (e.g., 3,4-dihydrocarbostyril, etc.), indazolyl, benzotriazolyl (e.g. benzo[d][1,2,3]triazolyl, etc.), tetrazolopyridyl, tetrazolopyridazinyl (e.g., tetrazolo[1,5-b]pyridazinyl, etc.), dihydrotriazolopyridazinyl, imidazopyridyl (e.g., imidazo[1,2-a]pyridyl, imidazo[4,5-c]pyridyl, imidazo[1,5-a]pyridyl, etc.), naphthyridinyl, cinnolinyl, quinoxalinyl, quinazolinyl, pyrazolopyridyl (e.g., pyrazolo[2,3-a]pyridyl, etc.), tetrahydropyridoindolyl (e.g., 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indolyl, etc.), etc.;
(d) unsaturated 3 to 8-membered, preferably 5 or 6-membered heteromonocyclic rings containing 1 to 2 oxygen atoms and 1 to 3 nitrogen atoms, for example, oxazolyl, isoxazolyl, oxadiazolyl (e.g., 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,5-oxadiazolyl, etc.), etc.;
(e) unsaturated condensed 7 to 12-membered heterocyclic rings containing 1 to 2 oxygen atoms and 1 to 3 nitrogen atoms, for example, benzoxazolyl, benzoxadiazolyl, benzisoxazolyl, dihydrobenzoxazinyl (e.g., 2,3-dihydrobenz-1,4-oxazinyl, etc.), furopyridyl (e.g., furo[2,3-c]pyridyl, 6,7-dihydrofuro[2,3-c]pyridyl, furo[3,2-c]pyridyl, 4,5-dihydrofuro[3,2-c]pyridyl, furo[2,3-b]pyridyl, 6,7-dihydrofuro[2,3-b]pyridyl, etc.), furopyrrolyl (e.g., furo[3,2-b]pyrrolyl etc.), etc.;
(f) unsaturated 3 to 8-membered, preferably 5 or 6-membered heteromonocyclic rings containing 1 to 2 sulfur atoms and 1 to 3 nitrogen atoms, for example, thiazolyl, thiazolinyl, thiadiazolyl (e.g., 1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl, 1,2,3-thiadiazolyl, etc.), isothiazolyl , etc.;
(g) unsaturated 3 to 8-membered, preferably 5 or 6-membered heteromonocyclic rings containing a sulfur atom, for example, thienyl, etc.;
(h) unsaturated condensed 7 to 12-membered heterocyclic rings containing 1 to 3 sulfur atoms, for example, benzothienyl (e.g. benzo[b]thienyl, etc.);
(i) unsaturated condensed 7 to 12-membered heterocyclic groups containing 1 to 2 sulfur atoms and 1 to 3 nitrogen atoms, for example, benzothiazolyl, benzothiadiazolyl, thienopyridyl (e.g., thieno[2,3-c]pyridyl, 6,7-dihydrothieno[2,3-c]pyridyl, thieno[3,2-c]pyridyl, 4,5-dihydrothieno[3,2-c]pyridyl, thieno[2,3-b]pyridyl, 6,7-dihydrothieno[2,3-b]pyridyl, 4,5,6,7-tetrahydrothieno[2,3-c]pyridyl, etc.), imidazothiazolyl (e.g., imidazo[2,1-b]thiazolyl, etc.), dihydroimidazothiazolyl (e.g., 2,3-dihydroimidazo[2,1-b]thiazolyl, etc.), thienopyrazinyl (e.g., thieno[2,3-b]pyrazinyl, etc.), etc.; and the like.
The term “heterocycloalkylene” refers to the bivalent group derived from heterocyclyl (including substituted heterocyclyl).
Examples of heterocycloalkylene which contains one or more nitrogen atoms and optionally contains another hetero atom include the following (j) to (m):
(j) 3 to 8-membered, preferably 5 to 7-membered, heterocycloalkylene containing 1 to 4 nitrogen atoms, for example, azetidinediyl, pyrrolidinediyl, imidazolidinediyl, piperidinediyl, pyrazolidinediyl, piperazinediyl, azepanediyl, 1,4-diazepandiyl, etc.;
(k) 3 to 8-membered, preferably 5 or 6-membered heterocycloalkylene containing 1 to 2 oxygen atoms and 1 to 3 nitrogen atoms, for example, morpholinediyl, oxadiazepanediyl, etc
(l) 3 to 8-membered, preferably 5 or 6-heterocycloalkylene containing 1 to 2 sulfur atoms and 1 to 3 nitrogen atoms, for example, thiazolidinediyl, etc.; and the like.
Examples of “aryl” include monocyclic or polycyclic aryl, such as phenyl and naphthyl.
Examples of the “arylene” include monocyclic or polycyclic arylene such as phenylene, naphthalenediyl, anthracenediyl, indenediyl, phenanthrenediyl, azulenediyl, heptalenediyl etc., in which preferred are (C6-14)arylene such as phenylene, naphthalenediyl, etc.
Table 1 lists abbreviations used throughout the specification.
Methods for producing compounds according to the present invention will be described below.
The compound of the present invention represented by the general formula (1) or its salt can be readily produced by persons skilled in the art using technical knowledge, based on the EXAMPLES of the present specification. For example, the compound (1) or its salt can be produced according to the processes shown in the following reaction formulae.
wherein R1, R2, Ring X, Ring Y, A, E and G are the same as described above, and Xa is a leaving group.
Examples of the leaving group for Xa include halogen (e.g., fluorine, chlorine, bromine, iodine), optionally halogenated C1-6 alkylsulfonyloxy (e.g., methanesulfonyloxy, ethanesulfonyloxy, trichloromethanesulfonyloxy, trifluoromethanesulfonyloxy, etc.), arylsulfonyloxy (e.g., C6-10 arylsulfonyloxy (e.g., phenylsulfonyloxy, naphthylsulfonyloxy) optionally substituted by 1 to 3 substituents selected from the group of C1-6 alkyl group (e.g., methyl, ethyl, etc.), C1-6 alkoxy (e.g., methoxy, ethoxy, etc.) and a nitro group), and the like. Specific examples include phenylsulfonyloxy, m-nitrophenylsulfonyloxy, p-toluenesulfonyloxy and the like, acyloxy (e.g., trichloroacetoxy, trifluoroacetoxy and the like) and the like.
The reaction of the compound (2) with the compound (3) is carried out by the known palladium- and copper-catalyzed cross-coupling, etc. For example, the reaction can be carried out in a solvent (e.g., toluene, THF, DMF, NMP and DMSO), in the presence of transition metal compound (e.g., Pd(OAc)2, Pd2(dba)3 and copper iodide), a basic compound (e.g., sodium tert-butoxide, K3PO4 and Cs2CO3), and if necessary a phosphine (e.g., xantphos, BINAP, tetrafluoroborate, N,N′-dimethylethylenediamine, and L-proline).
The reaction is carried out typically at −30 to 200° C., and preferably at about 0 to 180° C., and is generally completed in about 5 minutes to 80 hours.
The compound (2) and the compound (3) can be easily obtained as a commercial product, and also can be produced according to a method known per se or similar manner to EXAMPLES as mentioned below.
wherein R1, R2, Ring X, Ring Y, A, E and G are the same as described above.
Known reactions for producing an amide bond may be applied to the reaction of the compound (4) with the compound (5). Specific methods thereof include: (i) a mixed acid anhydride method, in which Carboxylic Acid (4) is reacted with an alkyl halocarboxylate to form a mixed acid anhydride, which is then reacted with Amine (5); (ii) an active ester method, in which Carboxylic Acid (4) is converted to an activated ester such as a phenyl ester, p-nitrophenyl ester, N-hydroxysuccinimide ester, or 1-hydroxybenzotriazole ester, or to an activated amide with benzoxazoline-2-thione, and the activated ester or amide is reacted with Amine (5); (iii) a carbodiimide method, in which Carboxylic Acid (4) is subjected to a condensation reaction with Amine (5) in the presence of an activating agent such as DCC, WSC, or carbonyldiimidazole; and (iv) other methods, for example, a method in which Carboxylic Acid (4) is converted to a carboxylic anhydride using a dehydrating agent such as acetic anhydride, and the carboxylic anhydride is reacted with Amine (5), a method in which an ester of Carboxylic Acid (4) with a lower (C1-6) alcohol is reacted with Amine (5) at a high pressure and a high temperature, and a method in which an acid halide of Carboxylic Acid (4), i.e., a carboxylic acid halide, is reacted with Amine (5).
Generally, the mixed acid anhydride method (i) is performed in a solvent, in the presence or absence of a basic compound. Any solvents used for conventional mixed acid anhydride methods are usable. Specific examples of usable solvents include halogenated hydrocarbons such as chloroform, dichloromethane, dichloroethane, and carbon tetrachloride; aromatic hydrocarbons such as benzene, toluene, and xylene; ethers such as Et2O, diisopropyl ether, THF, and dimethoxyethane; esters such as methyl acetate, AcOEt, and isopropyl acetate; aprotic polar solvents such as DMF, DMSO, and hexamethylphosphoric triamide; and mixtures thereof.
Examples of usable basic compounds include organic bases such as Et3N, trimethylamine, pyridine, dimethylaniline, DIPEA, dimethylaminopyridine, N-methylmorpholine, DBN, DBU and DABCO; inorganic bases, for example, carbonates such as sodium carbonate, potassium carbonate, sodium hydrogencarbonate, and potassium hydrogencarbonate; metal hydroxides such as sodium hydroxide, potassium hydroxide, and calcium hydroxide; potassium hydride; sodium hydride; potassium; sodium; sodium amide; and metal alcoholates such as sodium methoxide and sodium ethoxide.
Examples of alkyl halocarboxylates usable in the mixed acid anhydride method include methyl chloroformate, methyl bromoformate, ethyl chloroformate, ethyl bromoformate, and isobutyl chloroformate. In this method, Carboxylic Acid (4), an alkyl halocarboxylate, and Amine (5) are preferably used in equimolar amounts, but each of the alkyl halocarboxylate and Carboxylic Acid (4) can also be used in an amount of about 1 to about 1.5 moles per mole of Amine (5).
The reaction is typically performed at about −20 to about 150° C., and preferably at about 10 to about 50° C., typically for about 5 minutes to about 30 hours.
Method (iii), in which a condensation reaction is performed in the presence of an activating agent, can be performed in a suitable solvent in the presence or absence of a basic compound. Solvents and basic compounds usable in this method include those mentioned hereinafter as solvents and basic compounds usable in the method in which a carboxylic acid halide is reacted with Amine (5) mentioned above as one of the other methods (iv). A suitable amount of activating agent is typically at least 1 mole, and preferably 1 to 5 moles per mole of Compound (5). When WSC is used as an activating agent, the addition of 1-hydroxybenzotriazol to the reaction system allows the reaction to proceed advantageously. The reaction is typically performed at about −20 to about 180° C., and preferably at about 0 to about 150° C., and is typically completed in about 5 minutes to about 90 hours.
When the method in which a carboxylic acid halide is reacted with Amine (5), mentioned above as one of the other methods (iv), is employed, the reaction is performed in the presence of a basic compound in a suitable solvent.
Examples of usable basic compounds include a wide variety of known basic compounds, such as those for use in the method (i).
In addition to those usable in the mixed acid anhydride method, usable solvents include alcohols such as MeOH, EtOH, 2-propanol, propanol, butanol, 3-methoxy-1-butanol, ethyl cellosolve, and methyl cellosolve; acetonitrile; pyridine; acetone; and water.
The ratio of the carboxylic acid halide to Amine (5) is not limited, and can be suitably selected from a wide range. It is typically suitable to use, for example, at least about 1 mole, and preferably about 1 to about 5 moles of the carboxylic acid halide per mole of Amine (5).
The reaction is typically performed at about −20 to about 180° C., and preferably at about 0 to about 150° C., and is typically completed in about 5 minutes to about 30 hours.
The amide bond formation reaction shown in Reaction Formula 2 can also be performed by reacting Carboxylic Acid (4) with Amine (5) in the presence of a phosphorus compound serving as a condensing agent, such as triphenylphosphine, diphenylphosphinyl chloride, phenyl-N-phenylphosphoramide chloridate, diethyl chlorophosphate, diethyl cyanophosphate, diphenylphosphoric azide, bis(2-oxo-3-oxazolidinyl)phosphinic chloride, or the like.
The reaction is performed in the presence of a solvent and a basic compound usable for the method in which a carboxylic acid halide is reacted with Amine (5), typically at about −20 to about 150° C., and preferably at about 0 to about 100° C., and is typically completed in about 5 minutes to about 30 hours. It is suitable to use each of the condensing agent and Carboxylic Acid (4) in amounts of at least about 1 mole, and preferably about 1 to about 2 moles, per mole of Amine (5).
The compound (4) and the compound (5) can be easily obtained as a commercial product, and also can be produced according to a method known per se or similar manner to EXAMPLES as mentioned below.
wherein R1, R2, Ring X, A, E and G2 are the same as described above,
Examples of the leaving group for Xb include those recited for a leaving group Xa.
Examples of the “optionally substituted heterocycloalkylene containing at least two nitrogen atoms” include imidazolidinediyl, pyrazolidinediyl, piperazinediyl, 1,4-diazepandiyl, oxadiazepanediyl, each of which is optionally substituted with one or more lower alkyl, and the like.
(i) When R8 is formyl, the reaction between the compound (6) and the compound (7) is performed, for example, in a suitable solvent or without using any solvent, in the presence of a reducing agent.
Examples of usable solvents include water; lower (C1-6) alcohols such as MeOH, EtOH, isopropanol, butanol, tert-butanol, and ethylene glycol; aliphatic acids such as formic acid, and acetic acid; ethers such as Et2O, THF, dioxane, monoglyme, and diglyme; aromatic hydrocarbons such as benzene, toluene, and xylene; halogenated hydrocarbons such as dichloromethane, dichloroethane, chloroform, and carbon tetrachloride; acetonitrile; and mixtures thereof.
Examples of reducing agents include aliphatic acids such as formic acid; aliphatic acid alkali metal salts such as sodium formate; hydride reducing agents such as sodium borohydride, sodium cyanoborohydride, NaBH(OAc)3, sodium trimethoxyborohydride, lithium aluminium hydride, and mixtures thereof, or mixtures of aliphatic acids or aliphatic acid alkali metal salts with hydride reducing agents; and catalytic hydrogenation reducing agents such as palladium black, palladium on carbon, platinum oxide, platinum black, and Raney nickel.
When an aliphatic acid such as formic acid, or an aliphatic acid alkali metal salt such as sodium formate is used as a reducing agent, a suitable reaction temperature is typically about room temperature to about 200° C., and preferably about 50 to about 150° C. The reaction is typically completed in about 10 minutes to about 10 hours. Preferably, the aliphatic acid or aliphatic acid alkali metal salt is used in large excess relative to the compound (6).
When a hydride reducing agent is used, a suitable reaction temperature is typically about −80 to about 100° C., and preferably about −80 to about 70° C. The reaction is typically completed in about 30 minutes to about 100 hours. The hydride reducing agent is typically used in an amount of about 1 to about 20 moles, and preferably about 1 to about 10 moles, per mole of the compound of (6). Particularly when lithium aluminium hydride is used as a hydride reducing agent, it is preferable to use as a solvent an ether such as Et2O, THF, dioxane, monoglyme, or diglyme; or an aromatic hydrocarbon such as benzene, toluene, or xylene. To the reaction system may be added an amine such as trimethylamine, Et3N, or DIPEA; or a molecular sieve such as MS-3A or MS-4A.
When a catalytic hydrogenation reducing agent is used, the reaction is typically performed at about −30 to about 100° C., and preferably at about 0 to about 60° C., in a hydrogen atmosphere at typically about atmospheric pressure to about 20 atm, and preferably at about atmospheric pressure to about 10 atm, or in the presence of a hydrogen donor such as formic acid, ammonium formate, cyclohexene, or hydrazine hydrate. The reaction is typically completed in about 1 to about 12 hours. The catalytic hydrogenation reducing agent is typically used in an amount of about 0.1 to about 40 wt %, and preferably about 1 to about 20 wt %, based on the compound (6).
In the reaction of the compound of (6) and the compound (7), the compound (7) is typically used in an amount of at least 1 mole, and preferably 1 to 5 moles, per mole of the compound (7).
The compound (6) may also be a hydrated compound wherein a water molecule is attached to a carbonyl group.
(ii) When R8 is —CH2-Xb, the reaction of the compound (6) with the compound (7) can be performed in a general inert solvent or without using any solvent, in the presence or absence of a basic compound and/or catalyst.
Examples of inert solvents include water; ethers such as dioxane, THF, Et2O, diethylene glycol dimethyl ether, and ethylene glycol dimethyl ether; aromatic hydrocarbons such as benzene, toluene, and xylene; halogenated hydrocarbons such as dichloromethane, dichloroethane, chloroform, and carbon tetrachloride; lower (C1-6) alcohols such as MeOH, EtOH, and isopropanol; ketones such as acetone and methyl ethyl ketone; polar solvents such as DMF, DMSO, hexamethylphosphoric triamide, and acetonitrile; and mixtures thereof.
A wide variety of known basic compounds can be used as the basic compound. Examples of such basic compounds include inorganic bases, for example, alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, cesium hydroxide, and lithium hydroxide; alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, lithium carbonate, lithium hydrogencarbonate, sodium hydrogencarbonate, and potassium hydrogencarbonate; alkali metals such as sodium and potassium; sodium amide; sodium hydride; and potassium hydride; and organic bases, for example, alkali metal alcoholates such as sodium methoxide, sodium ethoxide, potassium methoxide, and potassium ethoxide; Et3N; DIPEA; tripropylamine; pyridine; quinoline; DBN; DBU; and DABCO. These basic compounds can be used singly or in a combination of two or more.
Examples of the catalyst include palladium compounds such as palladium acetate, bis(tributyltin)/bis(dibenzylideneacetone)palladium, copper iodide/2,2′-bipyridyl, bis (dibenzylideneacetone)palladium, copper iodide/bis(triphenylphosphine)palladium dichloride, tris(dibenzylideneacetone)dipalladium, R-tris(dibenzylideneacetone)-dipalladium, S-tris(dibenzylideneacetone)dipalladium, palladium(II) acetate, [1,1′-bis(diphenylphosphino)-ferrocene]dichloropalladium(II), and Pd(PPh3)4.
Additives (ligands etc.) can be used together with the catalyst. Examples of the additive include compounds such as BINAP, and 2,2-bis(diphenylimidazolidinyliden), xanthene compounds such as 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene, and borates such as tri-tert-butylphosphine tetrafluoroborate, and a mixture thereof.
The above reaction may be performed by adding to the reaction system, as required, an alkali metal iodide serving as a reaction accelerator, such as potassium iodide or sodium iodide.
The compound (6) is typically used in an amount of at least 0.5 moles, and preferably about 0.5 to about 10 moles, per mole of the compound (6).
The amount of basic compound is typically 0.5 to 10 moles, and preferably 0.5 to 6 moles, per mole of the compound (6).
The catalyst is appropriately used in a typical catalytic amount, preferably 0.0001 to 1 moles, and more preferably 0.001 to 0.5 moles, per mole of the compound (6).
The reaction is typically performed at a temperature of 0 to 250° C., and preferably 0 to 200° C., and is typically completed in about 1 to about 80 hours.
The compound (6) and the compound (7) can be easily obtained as a commercial product, and also can be produced according to a method known per se or similar manner to EXAMPLES as mentioned below.
wherein R1, R2, R8, Ring X, Ring Y, A, E and G2 are the same as described above, R9 is hydrogen or lower alkyl.
The reaction of the compound (8) with the compound (7) can be performed under the same reaction conditions as those for the reaction of the compound (6) with the compound (7) shown in Reaction Formula 3 above.
The compound (8) can be easily obtained as a commercial product, and also can be produced according to a method known per se or similar manner to EXAMPLES as mentioned below.
wherein R1, R2, Ring X, Ring Y, A, E and G are the same as described above, Xc is hydroxy or a leaving group.
Examples of the leaving group for Xc include those recited for leaving group Xa. (i) When Xc is leaving group, the reaction of the compound (9) with the compound (10) is carried out in an appropriate solvent or with no solvent in the presence or absence of a basic compound.
Examples of the inert solvent used include aromatic hydrocarbons such as benzene, toluene, and xylene, ethers such as Et2O, THF, dioxane, monoglyme, and diglyme, halogenated hydrocarbons such as dichloromethane, dichloroethane, chloroform, and carbon tetrachloride, lower alcohols such as MeOH, EtOH, 2-propanol, butanol, tert-butanol, and ethylene glycol, fatty acids such as acetic acid, esters such as AcOEt and methyl acetate, ketones such as acetone and methyl ethyl ketone, acetonitrile, pyridine, DMSO, DMF, NMP, and hexamethylphosphoric acid triamide, and a mixture thereof.
Examples of the basic compound include carbonates such as sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, and cesium carbonate, metal hydroxides such as sodium hydroxide, potassium hydroxide, and calcium hydroxide, sodium hydride, potassium hydride, potassium, sodium, sodium amide, metal alcoholates such as sodium methoxide, sodium ethoxide, and sodium n-butoxide, and organic bases such as pyridine, imidazole, DIPEA, dimethylaminopyridine, Et3N, trimethylamine, dimethylaniline, N-methylmorpholine, DBN, DBU, and DABCO, and a mixture thereof.
When the reaction is carried out in the presence of a basic compound, the basic compound is used in an amount typically equimolar to the compound (9), and preferably 1 to 10 times of the compound (9) on a molar basis
The compound (10) is used in an amount typically at least equimolar to the compound (9), and preferably 1 to 10 times of the compound (9) on a molar basis.
The reaction is carried out typically at −30 to 200° C., and preferably at about 0 to 180° C., and is generally completed in about 5 minutes to 80 hours.
To this reaction system, an alkali metal halide such as sodium iodide or potassium iodide may be added, and a phase-transfer catalyst may be added.
Examples of the phase-transfer catalyst include quaternary ammonium salts substituted with a group selected from the group consisting of a linear or branched alkyl group having 1 to 18 carbon atoms, a phenyl alkyl group of which alkyl moiety is a linear or branched alkyl group having 1 to 6 carbon atoms and a phenyl group, such as tetrabutylammonium chloride, tetrabutylammonium bromide, tetrabutylammonium fluoride, tetrabutylammonium iodide, tetrabutylammonium hydroxide, tetrabutylammonium hydrogensulfite, tributylmethylammonium chloride, tributylbenzylammonium chloride, tetrapentylammonium chloride, tetrapentylammonium bromide, tetrahexylammonium chloride, benzyldimethyloctylammonium chloride, methyltrihexylammonium chloride, benzyldimethyloctadecanylammonium chloride, methyltridecanylammonium chloride, benzyltripropylammonium chloride, benzyltriethylammonium chloride, phenyltriethylammonium chloride, tetraethylammonium chloride, tetramethylammonium chloride; phosphonium salts substituted with a linear or branched alkyl group having 1 to 18 carbon atoms such as tetrabutylphosphonium chloride; and pyridinium salts substituted with a linear or branched alkyl group having 1 to 18 carbon atoms such as 1-dodecanylpyridinium chloride. These phase-transfer catalysts are used singly or in a combination of two or more.
Typically the phase-transfer catalyst is used in an amount of 0.1 to 1 times of the compound (9), and preferably 0.1 to 0.5 times of the compound (9). (ii) When Xc is hydroxy, the reaction of the compound (9) with the compound (10) is carried out in an appropriate solvent in the presence of a condensation agent.
Specific examples of the solvent include halogenated hydrocarbons such as chloroform, dichloromethane, dichloroethane, and carbon tetrachloride, aromatic hydrocarbons such as benzene, toluene and xylene, ethers such as Et2O, diisopropyl ether, THF, and dimethoxyethane, esters such as methyl acetate, AcOEt, and isopropyl acetate, and aprotic polar solvents such as DMF, DMSO, and hexamethylphosphoric acid triamide, and a mixture thereof.
Examples of the condensation agent used include a mixture of an azocarboxylate (such as diethyl azocarboxylate) with a phosphorus compound (such as triphenylphosphine).
The condensation agent is appropriately used in an amount typically at least equimolar to the compound (9), and preferably 1 to 2 times of the compound (9) on a molar basis.
The compound (9) is appropriately used in an amount typically at least equimolar to the compound (9), and preferably 1 to 2 times of the compound (9) on a molar basis.
The above described reaction favorably proceeds typically at 0 to 200° C., preferably at around 0 to 150° C. and is, in general, completed in around 1 to 10 hours.
The compound (9) and the compound (10) can be easily obtained as a commercial product, and also can be produced according to a method known per se or similar manner to EXAMPLES as mentioned below.
The compounds obtained by the above Processes 1 to 5 can be successively prepared by a conventional method within the scope of the compound (1).
In addition, compounds in the form in which a solvate (for example, a hydrate, ethanolate, etc.) was added to the starting material compounds and object compounds shown in each of the reaction formulae are included in each of the formulae.
The compound (1) according to the present invention includes stereoisomers and optical isomers.
The starting material compounds and object compounds represented by each of the reaction formulae can be used in an appropriate salt form.
Each of the object compounds obtained according to the above reaction formulae can be isolated and purified from the reaction mixture by, for example, after cooling the reaction mixture, performing an isolation procedure such as filtration, concentration, extraction, etc., to separate a crude reaction product, and then subjecting the crude reaction product to a general purification procedure such as column chromatography, recrystallization, etc.
Among the compounds of the present invention, those having a basic group or groups can easily form salts with common pharmaceutically acceptable acids. Examples of such acids include hydrochloric acid, hydrobromic acid, nitric acid, sulfuric acid, phosphoric acid and other inorganic acids, methansulfonic acid, p-toluenesulfonic acid, acetic acid, citric acid, tartaric acid, maleic acid, fumaric acid, malic acid, lactic acid and other organic acids, etc.
Among the compounds of the present invention, those having an acidic group or groups can easily form salts by reacting with pharmaceutically acceptable basic compounds. Examples of such basic compounds include sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogencarbonate, potassium hydrogencarbonate, etc.
In the compound of the present invention, one or more atoms can be substituted with one or more isotopic atoms. Examples of the isotopic atoms include deuterium (2H), tritium (3H), 13C, 14N, 18O, etc.
The following is an explanation of pharmaceutical preparations comprising the compound of the present invention as an active ingredient. Such pharmaceutical preparations are obtained by formulating the compound of the present invention into general pharmaceutical preparations, using typically employed diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrants, surfactants, lubricants, etc.
The form of such pharmaceutical preparations can be selected from various forms according to the purpose of therapy. Typical examples include tablets, pills, powders, solutions, suspensions, emulsions, granules, capsules, suppositories, injections (solutions, suspensions, etc.) and the like.
To form tablets, any of various known carriers can be used, including, for example, lactose, white sugar, sodium chloride, glucose, urea, starch, calcium carbonate, kaolin, crystalline cellulose and other excipients; water, EtOH, propanol, simple syrup, glucose solutions, starch solutions, gelatin solutions, carboxymethylcellulose, shellac, methylcellulose, potassium phosphate, polyvinylpyrrolidone and other binders; dry starch, sodium alginate, agar powder, laminaran powder, sodium hydrogencarbonate, calcium carbonate, aliphatic acid esters of polyoxyethylenesorbitan, sodium laurylsulfate, stearic acid monoglyceride, starch, lactose and other disintegrants; white sugar, stearin, cacao butter, hydrogenated oils and other disintegration inhibitors; quaternary ammonium base, sodium lauryl sulfate and other absorption promoters; glycerin, starch and other wetting agents; starch, lactose, kaolin, bentonite, colloidal silicic acid and other adsorbents; purified talc, stearates, boric acid powder, polyethylene glycol and other lubricants; etc.
Such tablets may be coated with general coating materials as required, to prepare, for example, sugar-coated tablets, gelatin-coated tablets, enteric-coated tablets, film-coated tablets, double- or multi-layered tablets, etc. To form pills, any of various known carriers can be used, including, for example, glucose, lactose, starch, cacao butter, hydrogenated vegetable oils, kaolin, talc and other excipients; gum arabic powder, tragacanth powder, gelatin, EtOH and other binders; laminaran, agar and other disintegrants; etc.
To form suppositories, any of various known carriers can be used, including, for example, polyethylene glycol, cacao butter, higher alcohols, esters of higher alcohols, gelatin, semisynthetic glycerides, etc.
To form an injection, a solution, emulsion or suspension is sterilized and preferably made isotonic with blood. Any of various known widely used diluents can be employed to prepare the solution, emulsion or suspension. Examples of such diluents include water, EtOH, propylene glycol, ethoxylated isostearyl alcohol, polyoxylated isostearyl alcohol, aliphatic acid esters of polyoxyethylene sorbitan, etc. In this case, the pharmaceutical preparation may contain sodium chloride, glucose or glycerin in an amount sufficient to prepare an isotonic solution, and may contain general solubilizers, buffers, analgesic agents, etc., and further, if necessary, coloring agents, preservatives, flavors, sweetening agents, etc., and/or other medicines.
The proportion of the compound of the present invention in the pharmaceutical preparation is not limited and can be suitably selected from a wide range. It is typically preferable that the pharmaceutical preparation contain the compound of the present invention in a proportion of 1 to 70 wt. %.
The route of administration of the pharmaceutical preparation according to the present invention is not limited, and the preparation can be administered by a route suitable for the form of the preparation, the patient's age and sex, the conditions of the disease, and other conditions.
For example, tablets, pills, solutions, suspensions, emulsions, granules and capsules are administered orally.
Injections are intravenously administered singly or as mixed with general injection transfusions such as glucose solutions, amino acid solutions or the like, or singly administered intramuscularly, intracutaneously, subcutaneously or intraperitoneally, as required. Suppositories are administered intrarectally.
The dosage of the pharmaceutical preparation is suitably selected according to the method of use, the patient's age and sex, the severity of the disease, and other conditions, and is typically about 0.001 to about 100 mg/kg body weight/day, and preferably 0.001 to 50 mg/kg body weight/day, in single or divided doses.
Manufacturing examples of compounds used in the invention are shown below, being followed by the Pharmacological Test results of these compounds.
To a 1,2-dichloroethane (15 mL) solution of 4-(2-{[tert-butyl(dimethyl)silyl]-oxy}ethyl)benzaldehyde (0.70 g) and tert-butyl piperazine-1-carboxylate (0.52 g) was added NaBH(OAc)3 (0.83 g) at 0° C. The resultant mixture was stirred at room temperature for 66 hours. To the reaction mixture was added saturated aqueous NaHCO3, and extracted with CH2Cl2. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous MgSO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=9/1 to 2/1) to afford tert-butyl 4-[4-(2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)benzyl]piperazine-1-carboxylate (0.96 g) as a colorless oil.
1H-NMR (CDCl3) δ: −0.02 (6H, s), 0.86 (9H, s), 1.45 (9H, s), 2.36 (4H, t, J=4.9 Hz), 2.80 (2H, t, J=6.9 Hz), 3.41 (4H, t, J=4.9 Hz), 3.47 (2H, s), 3.79 (2H, t, J=6.9 Hz), 7.15 (2H, d, J=7.9 Hz), 7.22 (2H, d, J=7.9 Hz).
The following compounds were produced in the same manner as in Reference Example 1 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.39-2.41 (4H, m), 3.41-3.43 (4H, m), 3.53 (2H, s), 7.20-7.28 (3H, m).
1H-NMR (CDCl3) δ: 1.30-1.45 (2H, m), 1.46 (9H, s), 1.80-1.90 (1H, m), 1.98-2.05 (2H, m), 2.92 (2H, t, J=11.9 Hz), 2.95-3.08 (1H, m), 3.35-3.51 (2H, m), 3.75-3.91 (3H, m), 3.95-4.11 (2H, m), 6.52-6.60 (2H, m), 7.00-7.08 (2H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 1.65 (1H, brs), 1.86-1.93 (2H, m), 2.37 (4H, t, J=5.0 Hz), 2.70 (2H, t, J=7.7 Hz), 3.42 (4H, t, J=5.0 Hz), 3.47 (2H, s), 3.68 (2H, t, J=6.2 Hz), 7.15 (2H, d, J=8.1 Hz), 7.23 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38-2.40 (4H, m), 3.43-3.45 (6H, m), 6.85-6.92 (2H, m), 7.02 (1H, d, J=11.7 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=5.0 Hz), 3.39 (3H, s), 3.42 (4H, t, J=5.0 Hz), 3.49 (2H, s), 4.09 (2H, dd, J=6.1, 1.5 Hz), 6.27 (1H, dt, J=16.1, 6.1 Hz), 6.60 (1H, d, J=16.1 Hz), 7.26 (2H, d, J=8.3 Hz), 7.34 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.35 (4H, t, J=4.9 Hz), 2.43 (3H, s), 3.41 (4H, t, J=4.9 Hz), 3.43 (2H, s), 5.24 (2H, s), 6.87-6.90 (2H, m), 7.19-7.23 (2H, m), 7.28-7.31 (2H, m), 7.89-7.92 (2H, m).
1H-NMR (CDCl3) or 1.46 (9H, s), 2.41-2.43 (4H, m), 3.44-3.45 (4H, m), 3.55 (2H, s), 7.31-7.47 (5H, m), 7.52-7.61 (4H, m).
1H-NMR (CDCl3) δ: 1.46 (9H, s), 2.38-2.39 (4H, m), 3.42-3.43 (4H, m), 3.48 (2H, s), 6.92-6.95 (4H, m), 7.26-7.29 (4H, m).
1H-NMR (CDCl3) δ: 1.25 (6H, d, J=6.8 Hz), 1.46 (9H, s), 2.36-2.40 (4H, m), 2.87-2.93 (1H, m), 3.42-3.43 (4H, m), 3.47 (2H, s), 6.94 (4H, dd, J=8.5, 2.2 Hz), 7.18 (2H, d, J=8.5 Hz), 7.25 (2H, d, J=9.3 Hz).
To a solution of (4-bromobenzyloxy)(tert-butyl)dimethylsilane (3.080 g) in THF (20 mL) were added Mg (0.288 g) and I2 (cat) at room temperature under an Ar atmosphere. The mixture was heated at 50° C. for 1 hour, and then cooled to room temperature. To the mixture was added 1,2-epoxypropane (0.77 mL) at room temperature under an Ar atmosphere, and the mixture was stirred at room temperature for 14.5 hours, and then heated at 50° C. for 1 hour, and then cooled to room temperature. To the mixture was added saturated aqueous NH4Cl, and the mixture was extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=2/1) to afford 1-[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)phenyl]propan-2-ol (1.485 g) as a colorless oil.
1H-NMR (CDCl3) δ: 0.10 (6H, s), 0.94 (9H, s), 1.25 (3H, d, J=6.1 Hz), 1.48 (1H, d, J=3.7 Hz), 2.67 (1H, dd, J=13.6, 8.1 Hz), 2.79 (1H, dd, J=13.6, 4.8 Hz), 3.99-4.03 (1H, m), 4.72 (2H, s), 7.18 (2H, d, J=8.3 Hz), 7.28 (2H, d, J=8.3 Hz).
The following compounds were produced in the same manner as in Reference Example 11 using appropriate starting materials.
1H-NMR (CDCl3) δ: 0.10 (6H, s), 0.94 (9H, s), 1.35 (1H, t, J=6.0 Hz), 2.33 (3H, s), 2.88 (2H, t, J=6.8 Hz), 3.80-3.85 (2H, m), 4.68 (2H, s), 7.09-7.14 (3H, m).
1H-NMR (CDCl3) δ: 1.24 (6H, t, J=7.0 Hz), 1.25 (3H, d, J=6.1 Hz), 1.49 (1H, brs), 2.69 (1H, dd, J=13.6, 7.9 Hz), 2.79 (1H, dd, J=13.6, 4.6 Hz), 3.50-3.67 (4H, m), 4.02 (1H, brs), 5.48 (1H, s), 7.21 (2H, d, J=8.3 Hz), 7.42 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 0.10 (6H, s), 0.94 (9H, s), 1.35 (1H, t, J=6.1 Hz), 2.26 (3H, s), 2.83 (2H, t, J=6.5 Hz), 3.82-3.87 (2H, m), 4.68 (2H, s), 7.00 (1H, d, J=1.5 Hz), 7.05 (1H, dd, J=7.6, 1.5 Hz), 7.35 (1H, d, J=7.6 Hz).
To a THF (8 mL) solution of tert-butyl 4-[4-(2-{[tert-butyl(dimethyl)silyl]oxy}-ethyl)benzyl]piperazine-1-carboxylate (0.96 g) was added 1.0 M solution of TBAF in THF (2.32 mL) at 0° C. The resultant mixture was stirred at room temperature for 2.5 hours. After cooling to 0° C., the reaction mixture was diluted with AcOEt and water. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous MgSO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (CH2Cl2/MeOH=40/1) to afford tert-butyl 4-[4-(2-hydroxyethyl)benzyl]piperazine-1-carboxylate (0.55 g) as a colorless oil.
1H-NMR (DMSO-d6) δ: 1.38 (9H, s), 2.28 (4H, t, J=4.9 Hz), 2.69 (2H, t, J=6.9 Hz), 3.29 (4H, t, J=4.9 Hz), 3.42 (2H, s), 3.54-3.62 (2H, m), 4.60 (1H, t, J=5.3 Hz), 7.13-7.20 (4H, m).
The following compounds were produced in the same manner as in Reference Example 15 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.28 (3H, d, J=6.1 Hz), 1.56 (1H, t, J=6.0 Hz), 2.27 (3H, s), 2.81 (1H, dd, J=13.7, 6.6 Hz), 3.07 (1H, dd, J=13.7, 6.0 Hz), 4.47-4.55 (1H, m), 4.66 (2H, d, J=6.0 Hz), 6.79 (2H, dt, J=9.0, 2.4 Hz), 7.06 (2H, d, J=8.1 Hz), 7.23 (2H, d, J=8.1 Hz), 7.29 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.55 (1H, t, J=5.9 Hz), 2.28 (3H, s), 2.38 (3H, s), 3.09 (2H, t, J=7.3 Hz), 4.11 (2H, t, J=7.3 Hz), 4.64 (2H, d, J=5.9 Hz), 6.79 (2H, dt, J=9.2, 2.6 Hz), 7.07 (2H, dt, J=9.2, 2.6 Hz), 7.15-7.23 (3H, m).
1H-NMR (CDCl3) δ: 1.61 (1H, brs), 2.29 (3H, s), 2.35 (3H, s), 4.65 (2H, d, J=5.6 Hz), 4.69 (2H, dd, J=5.8, 1.6 Hz), 6.30 (1H, dt, J=15.9, 5.8 Hz), 6.87 (2H, dt, J=9.2, 2.6 Hz), 6.92 (1H, d, J=15.9 Hz), 7.09 (2H, d, J=8.1 Hz), 7.16-7.17 (2H, m), 7.47 (1H, d, J=8.5 Hz).
1H-NMR (CDCl3) δ: 1.48 (1H, t, J=5.7 Hz), 2.29 (3H, s), 2.35 (3H, s), 4.67 (2H, dd, J=5.8, 1.5 Hz), 4.69 (2H, d, J=5.7 Hz), 6.41 (1H, dt, J=16.1, 5.8 Hz), 6.69 (1H, dt, J=16.1, 1.5 Hz), 6.86 (2H, dt, J=9.3, 2.6 Hz), 7.09 (2H, dd, J=8.7, 0.6 Hz), 7.23-7.25 (2H, m), 7.31 (1H, d, J=7.6 Hz).
To a THF (40 mL) solution of tert-butyl 4-[4-(2-hydroxyethyl)benzyl]piperazine-1-carboxylate (4.74 g) and p-cresol (1.76 g) were added triphenylphosphine (4.27 g) and 2.2 M solution of DEAD in toluene (7.40 mL) at 0° C. After stirring at room temperature for 85 hours, the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=3/1 to 1/2), then the concentrated eluate was diluted with CH2Cl2, and washed with 5 M NaOH and saturated aqueous NaCl, dried over anhydrous MgSO4, and concentrated under reduced pressure to give tert-butyl 4-{4-[2-(4-methylphenoxy)ethyl]benzyl}piperazine-1-carboxylate as a yellow solid (3.87 g).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.26 (3H, s), 2.37 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=6.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 4.14 (2H, t, J=6.9 Hz), 6.79 (2H, d, J=8.2 Hz), 7.06 (2H, d, J=8.2 Hz), 7.20-7.27 (4H, m).
The following compounds were produced in the same manner as in Reference Example 20 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37 (4H, t, J=4.9 Hz), 3.05 (2H, t, J=6.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 3.76 (3H, s), 4.11 (2H, t, J=6.9 Hz), 6.79-6.86 (4H, m), 7.20-7.27 (4H, m).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.9 Hz), 1.45 (9H, s), 2.37 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.9 Hz), 3.06 (2H, t, J=6.9 Hz), 3.42 (4H, t, J=6.9 Hz), 3.48 (2H, s), 4.14 (2H, t, J=6.9 Hz), 6.81-6.85 (2H, m), 7.11-7.14 (2H, m), 7.20-7.26 (4H, m).
1H-NMR (CDCl3) δ: 1.29 (6H, d, J=5.9 Hz), 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=6.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 4.14 (2H, t, J=6.9 Hz), 4.41 (1H, septet, J=5.9 Hz), 6.81 (4H, s), 7.19-7.30 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.36-2.39 (4H, m), 3.04-3.09 (2H, m), 3.40-3.44 (4H, m), 3.48 (2H, s), 4.10-4.16 (2H, m), 6.81 (2H, d, J=9.2 Hz), 7.18-7.28 (6H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37 (4H, t, J=5.0 Hz), 3.07 (2H, t, J=6.9 Hz), 3.40-3.44 (4H, m), 3.48 (2H, s), 4.13 (2H, t, J=6.9 Hz), 6.77 (2H, d, J=8.9 Hz), 7.22 (2H, d, J=8.2 Hz), 7.26 (2H, d, J=8.2 Hz), 7.35 (2H, d, J=8.9 Hz).
1H-NMR (CDCl3) δ: 1.38 (3H, t, J=6.9 Hz), 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.05 (2H, t, J=6.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 3.96 (2H, q, J=6.9 Hz), 4.14 (2H, t, J=6.9 Hz), 6.81 (4H, s), 7.20-7.30 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=6.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.14 (2H, t, J=6.9 Hz), 6.73-6.83 (1H, m), 6.85-6.95 (2H, m), 7.12-7.32 (5H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.10 (2H, t, J=6.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.50 (2H, s), 4.21 (2H, t, J=6.9 Hz), 6.94 (2H, d, J=8.9 Hz), 7.20-7.29 (4H, m), 7.57 (2H, d, J=8.9 Hz).
1H-NMR (CDCl3) δ: 1.40 (3H, t, J=6.9 Hz), 1.45 (9H, s), 2.38 (4H, t, J=4.6 Hz), 3.07 (2H, t, J=6.9 Hz), 3.42 (4H, t, J=4.6 Hz), 3.48 (2H, s), 4.00 (2H, q, J=6.9 Hz), 4.14 (2H, t, J=6.9 Hz), 6.43-6.54 (3H, m), 7.15 (1H, t, J=8.2 Hz), 7.20-7.30 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.31 (3H, s), 2.38 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.44 (4H, t, J=4.9 Hz), 3.48 (2H, s), 4.15 (2H, t, J=6.9 Hz), 6.69-6.76 (3H, m), 7.15 (1H, t, J=7.6 Hz), 7.22-7.27 (4H, m).
1H-NMR (CDCl3) δ: 1.23 (6H, d, J=6.9 Hz), 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 2.86 (1H, septet, J=6.9 Hz), 3.08 (2H, t, J=7.3 Hz), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.16 (2H, t, J=7.3 Hz), 6.67-6.85 (3H, m), 7.19 (1H, d, J=7.6 Hz), 7.23-7.30 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.18 (3H, s), 2.22 (3H, s), 2.38 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=7.3 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 4.13 (2H, t, J=7.3 Hz), 6.63 (1H, dd, J=8.2, 2.6 Hz), 6.71 (1H, d, J=2.6 Hz), 7.01 (1H, d, J=8.2 Hz), 7.20-7.30 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.3 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 3.78 (3H, s), 4.15 (2H, t, J=7.3 Hz), 6.43-6.55 (3H, m), 7.16 (1H, t, J=8.2 Hz), 7.20-7.30 (4H, m).
1H-NMR (CDCl3) δ: 1.29 (9H, s), 1.45 (9H, s), 2.37 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=6.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 4.15 (2H, t, J=6.9 Hz), 6.86-6.80 (2H, m), 7.31-7.24 (6H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 4.12 (2H, t, J=7.1 Hz), 6.66 (2H, d, J=6.9 Hz), 7.20-7.27 (4H, m), 7.53 (2H, d, J=6.9 Hz).
1H-NMR (CDCl3) δ: 0.91 (3H, t, J=7.3 Hz), 1.26-1.40 (2H, m), 1.45 (9H, s), 1.50-1.61 (2H, m), 2.38 (4H, t, J=5.1 Hz), 2.54 (2H, t, J=7.6 Hz), 3.07 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=5.1 Hz), 3.48 (2H, s), 4.14 (2H, t, J=7.1 Hz), 6.78-6.84 (2H, m), 7.04-7.10 (2H, m), 7.21-7.27 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.01 (3H, s), 3.11 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.23 (2H, t, J=7.1 Hz), 7.01 (2H, d, J=8.9 Hz), 7.21-7.29 (4H, m), 7.84 (2H, d, J=8.9 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.19 (3H, s), 2.37 (4H, t, J=4.9 Hz), 3.10 (2H, t, J=6.8 Hz), 3.42 (4H, t, J=5.1 Hz), 3.48 (2H, s), 4.16 (2H, t, J=6.8 Hz), 6.77-6.86 (2H, m), 7.08-7.15 (2H, m), 7.25 (4H, s).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37 (4H, t, J=4.9 Hz), 3.04 (2H, t, J=6.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 4.08 (2H, t, J=6.9 Hz), 5.90 (2H, s), 6.31 (1H, dd, J=8.6, 2.3 Hz), 6.47 (1H, d, J=2.3 Hz), 6.68 (1H, d, J=8.6 Hz), 7.20-7.27 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37-2.38 (4H, m), 3.14 (2H, t, J=6.9 Hz), 3.41-3.43 (4H, m), 3.49 (2H, s), 4.21 (2H, t, J=6.9 Hz), 6.85-6.91 (2H, m), 7.15-7.36 (6H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.11 (3H, s), 2.25 (3H, s), 2.37-2.38 (4H, m), 3.09 (2H, t, J=6.8 Hz), 3.41-3.42 (4H, m), 3.48 (2H, s), 4.14 (2H, t, J=6.8 Hz), 6.68 (1H, d, J=8.3 Hz), 6.76 (1H, d, J=7.8 Hz), 7.02 (1H, t, J=7.8 Hz), 7.21-7.27 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.27 (6H, s), 2.36-2.40 (4H, m), 3.06 (2H, t, J=7.1 Hz), 3.40-3.45 (4H, m), 3.48 (2H, s), 4.13 (2H, t, J=7.1 Hz), 6.53 (2H, s), 6.59 (1H, s), 7.23-7.28 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37-2.38 (4H, m), 3.14 (2H, t, J=6.8 Hz), 3.41-3.44 (4H, m), 3.48 (2H, s), 4.26 (2H, t, J=6.8 Hz), 7.03 (1H, d, J=2.4 Hz), 7.25-7.32 (5H, m), 7.36 (1H, dd, J=9.3, 2.4 Hz), 7.94-8.01 (2H, m), 8.73 (1H, d, J=3.4 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37-2.39 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.42-3.43 (4H, m), 3.49 (2H, s), 4.12 (2H, t, J=7.0 Hz), 6.74 (1H, dd, J=8.9, 2.8 Hz), 6.98 (1H, d, J=2.9 Hz), 7.21-7.31 (5H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.21 (3H, d, J=1.7 Hz), 2.37 (4H, t, J=4.9 Hz), 3.04 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=4.9 Hz), 3.47 (2H, s), 4.08 (2H, t, J=7.1 Hz), 6.61-6.69 (2H, m), 6.86 (1H, t, J=9.0 Hz), 7.20-7.26 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.01-2.08 (2H, m), 2.36 (4H, t, J=4.9 Hz), 2.80-2.86 (4H, m), 3.05 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=4.9 Hz), 3.46 (2H, s), 4.12 (2H, t, J=7.1 Hz), 6.67 (1H, dd, J=8.1, 2.4 Hz), 6.77 (1H, s), 7.08 (1H, d, J=8.1 Hz), 7.22-7.25 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 1.74-1.77 (4H, m), 2.37 (4H, t, J=4.9 Hz), 2.68-2.71 (4H, m), 3.05 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=4.9 Hz), 3.47 (2H, s), 4.12 (2H, t, J=7.1 Hz), 6.59-6.61 (1H, m), 6.66 (1H, dd, J=8.3, 2.7 Hz), 6.95 (1H, d, J=8.3 Hz), 7.22-7.25 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.36 (4H, brs), 3.12 (2H, t, J=7.1 Hz), 3.42 (4H, brs), 3.46 (2H, s), 4.24 (2H, t, J=7.1 Hz), 7.10-7.15 (2H, m), 7.25-7.32 (5H, m), 7.40 (1H, t, J=7.0 Hz), 7.66-7.74 (3H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 2.55 (3H, s), 3.11 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.22 (2H, t, J=7.1 Hz), 6.92 (2H, d, J=8.3 Hz), 7.22-7.28 (4H, m), 7.92 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.09 (2H, t, J=6.8 Hz), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.19 (2H, t, J=6.8 Hz), 7.08 (1H, dd, J=8.5, 3.2 Hz), 7.22 (2H, d, J=7.8 Hz), 7.27 (2H, d, J=7.8 Hz), 7.34 (1H, d, J=8.5 Hz), 8.04 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.36 (4H, t, J=5.0 Hz), 3.07 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=5.0 Hz), 3.47 (2H, s), 4.51 (2H, t, J=7.1 Hz), 6.71 (1H, d, J=8.5 Hz), 6.81-6.85 (1H, m), 7.24 (4H, s), 7.51-7.55 (1H, m), 8.13 (1H, dd, J=5.1, 1.2 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37 (4H, t, J=4.9 Hz), 3.05 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=4.9 Hz), 3.47 (2H, s), 4.47 (2H, t, J=7.1 Hz), 6.66 (1H, d, J=8.8 Hz), 7.20-7.27 (4H, m), 7.48 (1H, dd, J=8.8, 2.7 Hz), 8.07 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=5.0 Hz), 3.09 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=5.0 Hz), 3.49 (2H, s), 4.20 (2H, t, J=7.1 Hz), 7.14-7.28 (6H, m), 8.03 (1H, d, J=2.4 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37 (4H, t, J=5.0 Hz), 3.05 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=5.0 Hz), 3.47 (2H, s), 4.47 (2H, t, J=7.1 Hz), 6.63 (1H, dd, J=8.8, 0.7 Hz), 7.20-7.26 (4H, m), 7.61 (1H, dd, J=8.8, 2.7 Hz), 8.16 (1H, t, J=1.2 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, brs), 3.06 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=5.0 Hz), 3.48 (2H, s), 3.87 (3H, s), 4.19 (2H, t, J=7.1 Hz), 6.66 (1H, d, J=9.0 Hz), 7.17-7.27 (5H, m), 7.79 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.46 (9H, s), 2.32 (4H, brs), 3.04 (2H, t, J=7.1 Hz), 3.41-3.44 (6H, m), 4.02 (2H, t, J=7.1 Hz), 6.56 (1H, d, J=8.3 Hz), 7.00 (1H, dd, J=8.3, 2.0 Hz), 7.08-7.12 (2H, m), 7.16-7.21 (3H, m).
1H-NMR (CDCl3) δ: 1.46 (9H, s), 2.32 (4H, t, J=5.0 Hz), 2.99 (2H, t, J=7.6 Hz), 3.41 (4H, t, J=5.0 Hz), 3.44 (2H, s), 4.12 (2H, t, J=7.6 Hz), 6.89 (1H, d, J=7.8 Hz), 7.08-7.15 (3H, m), 7.19-7.23 (3H, m), 7.36-7.38 (1H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 2.79 (3H, s), 3.11 (2H, t, J=7.0 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 4.23 (2H, t, J=7.0 Hz), 6.97 (1H, dd, J=8.8, 2.4 Hz), 7.23-7.28 (4H, m), 7.45 (1H, d, J=2.4 Hz), 7.63 (1H d, J=8.8 Hz).
1H-NMR (CDCl3) δ: −0.01 (6H, s), 0.87 (9H, s), 1.45 (9H, s), 2.38-2.39 (4H, m), 2.75 (2H, t, J=7.2 Hz), 3.07 (2H, t, J=7.1 Hz), 3.41-3.43 (4H, m), 3.48 (2H, s), 3.75 (2H, t, J=7.2 Hz), 4.14 (2H, t, J=7.1 Hz), 6.81 (2H, d, J=8.5 Hz), 7.10 (2H, d, J=8.5 Hz), 7.23-7.25 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.41-2.44 (4H, m), 3.42-3.43 (4H, m), 3.59 (2H, s), 5.00 (2H, s), 6.87-7.00 (4H, m), 7.12 (1H, d, J=10.5 Hz), 7.15 (1H, d, J=8.1 Hz), 7.36-7.40 (1H, m).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=5.9 Hz), 1.46 (9H, s), 2.36-2.40 (4H, m), 3.42-3.43 (4H, m), 3.49 (2H, s), 4.40-4.45 (1H, m), 5.05 (2H, s), 6.83 (2H, d, J=9.3 Hz), 6.90 (2H, d, J=9.0 Hz), 7.08 (1H, d, J=1.7 Hz), 7.11 (1H, s), 7.43 (1H, t, J=7.7 Hz).
1H-NMR (CDCl3) δ: 1.46 (9H, s), 2.38-2.39 (4H, m), 3.42-3.44 (4H, m), 3.50 (2H, s), 5.06 (2H, s), 6.90-7.00 (4H, m), 7.11 (2H, d, J=9.0 Hz), 7.42 (1H, t, J=7.6 Hz).
1H-NMR (CDCl3) δ: 0.93 (3H, t, J=7.3 Hz), 1.46 (9H, s), 1.57-1.64 (2H, m), 2.36-2.40 (4H, m), 2.52-2.54 (2H, m), 3.42-3.43 (4H, m), 3.49 (2H, s), 5.08 (2H, s), 6.90 (2H, d, J=8.3 Hz), 7.10 (4H, d, J=8.5 Hz), 7.44 (1H, t, J=7.6 Hz).
1H-NMR (CDCl3) δ: 1.24 (6H, d, J=6.8 Hz), 2.36 (4H, t, J=4.9 Hz), 2.77-2.86 (2H, m), 2.91 (1H, septet, J=6.8 Hz), 3.41 (4H, t, J=4.9 Hz), 3.46 (2H, s), 3.93-4.03 (2H, m), 7.07-7.12 (4H, m), 7.12-7.24 (4H, m), 7.40-7.52 (2H, m), 7.55-7.65 (2H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.36 (4H, t, J=4.9 Hz), 2.77-2.86 (2H, m), 3.42 (4H, t, J=4.9 Hz), 3.46 (2H, s), 3.96-4.04 (2H, m), 6.06-7.05 (2H, m), 7.08 (2H, d, J=8.1 Hz), 7.01-7.18 (2H, m), 7.20 (2H, d, J=7.8 Hz), 7.43-7.54 (2H, m), 7.58-7.72 (2H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.36 (4H, t, J=4.9 Hz), 2.77-2.86 (2H, m), 3.42 (4H, t, J=4.9 Hz), 3.46 (2H, s), 3.81 (3H, s), 3.93-4.00 (2H, m), 6.79-6.86 (2H, m), 7.06-7.12 (4H, m), 7.20 (2H, d, J=8.1 Hz), 7.43-7.52 (2H, m), 7.56-7.66 (2H, m).
1H-NMR (CDCl3) δ: 1.24 (6H, d, J=6.8 Hz), 1.27-1.38 (2H, m), 1.46 (9H, s), 1.96-2.07 (2H, m), 2.67-2.75 (2H, m), 2.83-2.98 (3H, m), 333-3.47 (2H, m), 3.87-3.95 (2H, m), 3.96-4.12 (2H, m), 6.48-6.55 (2H, m), 6.92-6.98 (2H, m), 7.07-7.12 (2H, m), 7.14-7.19 (2H, m), 7.41-7.53 (2H, m), 7.54-7.66 (2H, m).
1H-NMR (CDCl3) δ: 1.26-1.38 (2H, m), 1.46 (9H, s), 1.98-2.07 (2H, m), 2.27 (3H, s), 2.86-3.00 (4H, m), 3.35-3.45 (2H, m), 3.95-4.12 (4H, m), 6.53-6.59 (2H, m), 6.75-6.83 (2H, m), 7.00-7.11 (4H, m).
1H-NMR (CDCl3) δ: 1.25-1.39 (2H, m), 1.46 (9H, s), 1.98-2.08 (2H, m), 2.86-3.00 (4H, m), 3.35-3.53 (2H, m), 3.95-4.15 (4H, m), 6.54-6.60 (2H, m), 6.79-6.85 (2H, m), 6.90-7.00 (2H, m), 7.04-7.11 (2H, m).
1H-NMR (CDCl3) δ: 3.04-3.09 (2H, m), 3.80 (3H, s), 4.19-4.24 (2H, m), 6.87 (2H, d, J=8.6 Hz), 6.99 (2H, d, J=8.6 Hz), 7.20 (2H, d, J=8.6 Hz), 7.82 (2H, d, J=8.6 Hz), 9.87 (1H, brs).
1H-NMR (CDCl3) δ: 2.33 (3H, s), 3.09 (2H, t, J=7.3 Hz), 4.23 (2H, t, J=7.3 Hz), 6.95-7.04 (2H, m), 7.10-7.22 (4H, m), 7.77-7.88 (2H, m), 9.87 (1H, s).
1H-NMR (CDCl3) δ: 1.25 (6H, d, J=6.9 Hz), 2.89 (1H, septet, J=6.9 Hz), 3.09 (2H, t, J=7.3 Hz), 4.23 (2H, t, J=7.3 Hz), 6.95-7.04 (2H, m), 7.13-7.27 (4H, m), 7.77-7.86 (2H, m), 9.87 (1H, s).
1H-NMR (CDCl3) δ: 2.04-2.17 (2H, m), 2.90 (2H, t, J=7.7 Hz), 3.92 (2H, t, J=6.1 Hz), 6.79-6.86 (2H, m), 6.92-7.01 (2H, m), 7.38 (2H, d, J=8.1 Hz), 7.81 (2H, d, J=8.2 Hz), 9.98 (1H, s).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.06-2.17 (2H, m), 2.81-2.93 (3H, m), 3.95 (2H, t, J=6.1 Hz), 6.82 (2H, d, J=8.7 Hz), 7.14 (2H, d, J=8.4 Hz), 7.38 (2H, d, J=8.1 Hz), 7.81 (2H, d, J=8.2 Hz), 9.98 (1H, s).
1H-NMR (CDCl3) δ: 4.79 (2H, dd, J=5.5, 1.6 Hz), 6.55 (1H, dt, J=15.8, 5.5 Hz), 6.80 (1H, d, J=15.8), 7.00-7.03 (2H, m), 7.55-7.63 (4H, m), 7.85-7.87 (2H, m), 10.00 (1H, s).
1H-NMR (CDCl3) δ: 3.02 (2H, t, J=6.6 Hz), 4.10 (2H, t, J=6.6 Hz), 6.76-6.84 (2H, m), 6.90-7.00 (2H, m), 7.13-7.16 (2H, m), 7.40-7.44 (2H, m).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.9 Hz), 2.85 (1H, septet, J=6.9 Hz), 3.03 (2H, t, J=6.9 Hz), 4.13 (2H, t, J=6.9 Hz), 6.77-6.85 (2H, m), 7.09-7.20 (4H, m), 7.38-7.47 (2H, m).
1H-NMR (CDCl3) δ: 3.02 (2H, t, J=6.9 Hz), 3.76 (3H, s), 4.10 (2H, t, J=6.8 Hz), 6.82 (4H, s), 7.14-7.17 (2H, m), 7.41-7.44 (2H, m).
1H-NMR (CDCl3) δ: 2.28 (3H, s), 3.03 (2H, t, J=6.9 Hz), 4.12 (2H, t, J=6.9 Hz), 6.73-6.83 (2H, m), 7.07 (2H, d, J=8.2 Hz), 7.15 (2H, d, J=8.6 Hz), 7.43 (2H, d, J=8.9 Hz).
1H-NMR (CDCl3) δ: 1.38 (3H, t, J=6.9 Hz), 3.01 (2H, t, J=6.9 Hz), 3.97 (2H, q, J=6.9 Hz), 4.09 (2H, t, J=6.9 Hz), 6.81 (4H, s), 7.15 (2H, d, J=8.2 Hz), 7.42 (2H, d, J=8.2 Hz).
1H-NMR (CDCl3) δ: 1.37 (3H, d, J=7.1 Hz), 2.27 (3H, s), 3.14-3.23 (1H, m), 3.92 (1H, dd, J=9.2, 7.2 Hz), 4.00 (1H, dd, J=9.2, 6.3 Hz), 6.76 (2H, d, J=8.5 Hz), 7.05 (2H, d, J=8.5 Hz), 7.16 (2H, d, J=8.5 Hz), 7.44 (2H, d, J=8.5 Hz).
1H-NMR (CDCl3) δ: 2.10 (3H, d, J=1.2 Hz), 2.29 (3H, s), 4.68-4.70 (2H, m), 6.02-6.06 (1H, m), 6.84 (2H, dt, J=9.3, 2.5 Hz), 7.09 (2H, d, J=8.7 Hz), 7.29 (2H, dt, J=9.0, 2.3 Hz), 7.44 (2H, dt, J=9.0, 2.3 Hz).
1H-NMR (CDCl3) δ: 3.07 (2H, t, J=6.7 Hz), 4.12 (2H, t, J=6.7 Hz), 6.79 (2H, d, J=9.0 Hz), 7.17-7.21 (5H, m).
1H-NMR (CDCl3) δ: 0.09 (6H, s), 0.93 (9H, s), 1.26 (3H, d, J=6.1 Hz), 2.27 (3H, s), 2.77 (1H, dd, J=13.6, 6.8 Hz), 3.08 (1H, dd, J=13.6, 5.7 Hz), 4.46-4.54 (1H, m), 4.71 (2H, s), 6.79 (2H, d, J=8.3 Hz), 7.06 (2H, d, J=8.3 Hz), 7.19 (2H, d, J=8.1 Hz), 7.24 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 0.10 (6H, s), 0.94 (9H, s), 2.28 (3H, s), 2.36 (3H, s), 3.08 (2H, t, J=7.6 Hz), 4.09 (2H, t, J=7.6 Hz), 4.69 (2H, s), 6.79 (2H, dt, J=9.3, 2.6 Hz), 7.05-7.12 (4H, m), 7.18 (1H, d, J=8.5 Hz).
1H-NMR (CDCl3) δ: 0.09 (6H, s), 0.94 (9H, s), 2.29 (3H, s), 2.34 (3H, s), 4.67-4.69 (4H, m), 6.28 (1H, dt, J=15.9, 5.7 Hz), 6.87 (2H, dt, J=9.1, 2.5 Hz), 6.92 (1H, d, J=15.9 Hz), 7.08-7.13 (4H, m), 7.44 (1H, d, J=7.8 Hz).
1H-NMR (CDCl3) δ: 0.09 (6H, s), 0.93 (9H, s), 2.25 (3H, s), 2.28 (3H, s), 4.65 (2H, dd, J=6.1, 1.2 Hz), 4.68 (2H, s), 6.38 (1H, dt, J=16.1, 6.1 Hz), 6.67 (1H, d, J=16.1 Hz), 6.85 (2H, d, J=8.8 Hz), 7.08 (2H, d, J=8.8 Hz), 7.17 (1H, brs), 7.22 (1H, dd, J=7.9, 1.3 Hz), 7.35 (1H, d, J=7.9 Hz).
1H-NMR (CDCl3) δ: 1.23 (6H, t, J=7.1 Hz), 2.29 (3H, s), 3.49-3.65 (4H, m), 4.67 (2H, dd, J=5.9, 1.5 Hz), 5.49 (1H, s), 6.42 (1H, dt, J=16.0, 5.9 Hz), 6.72 (1H, dt, J=16.0, 1.5 Hz), 6.86 (2H, dt, J=9.3, 2.5 Hz), 7.09 (2H, d, J=8.3 Hz), 7.39 (2H, d, J=8.5 Hz), 7.43 (2H, d, J=8.5 Hz).
1H-NMR (CDCl3) δ: 1.24 (6H, t, J=7.1 Hz), 3.49-3.65 (4H, m), 4.66 (2H, dd, J=5.9, 1.5 Hz), 5.49 (1H, s), 6.40 (1H, dt, J=16.1, 5.9 Hz), 6.72 (1H, d, J=16.1 Hz), 6.87-6.92 (2H, m), 6.95-7.00 (2H, m), 7.40 (2H, d, J=8.3 Hz), 7.44 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 1.23 (6H, t, J=7.1 Hz), 3.49-3.65 (4H, m), 4.70 (2H, dd, J=5.8, 1.5 Hz), 5.49 (1H, s), 6.43 (1H, dt, J=16.0, 5.8 Hz), 6.73 (1H, d, J=16.0 Hz), 6.94-6.98 (3H, m), 7.27 (2H, m), 7.39-7.45 (4H, m).
1H-NMR (CDCl3) δ: 1.23 (6H, t, J=7.1 Hz), 3.49-3.65 (4H, m), 3.77 (3H, s), 4.65 (2H, dd, J=5.9, 1.3 Hz), 5.49 (1H, s), 6.41 (1H, dt, J=15.9, 5.9 Hz), 6.72 (1H, d, J=15.9 Hz), 6.82-6.92 (4H, m), 7.38-7.44 (4H, m).
1H-NMR (CDCl3) δ: 1.23 (6H, t, J=7.1 Hz), 2.25 (3H, s), 3.49-3.64 (4H, m), 4.97 (2H, dd, J=6.1, 1.5 Hz), 5.49 (1H, s), 6.47 (1H, dt, J=16.0, 6.0 Hz), 6.69-6.75 (2H, m), 7.38-7.44 (5H, m), 7.96-7.97 (1H, m).
1H-NMR (CDCl3) δ: 1.24 (6H, t, J=7.1 Hz), 3.50-3.65 (4H, m), 4.73 (2H, dd, J=5.9, 1.5 Hz), 5.50 (1H, s), 6.37 (1H, dt, J=16.0, 5.9 Hz), 6.74 (1H, d, J=16.0 Hz), 7.24 (2H, d, J=1.9 Hz), 7.40 (2H, d, J=8.3 Hz), 7.45 (2H, d, J=8.3 Hz), 8.12 (1H, t, J=1.9 Hz).
1H-NMR (CDCl3) δ: 1.23 (6H, t, J=7.1 Hz), 3.48-3.64 (4H, m), 4.96 (2H, d, J=6.1 Hz), 5.49 (1H, s), 6.43 (1H, dt, J=15.9, 6.1 Hz), 6.69-6.74 (2H, m), 7.38-7.44 (4H, m), 7.65 (1H, ddd, J=8.8, 2.4, 0.7 Hz), 8.20 (1H, d, J=2.4 Hz).
1H-NMR (CDCl3) δ: 1.22-1.25 (12H, m), 2.81-2.92 (1H, m), 3.49-3.65 (4H, m), 4.68 (2H, dd, J=5.7, 1.2 Hz), 5.49 (1H, s), 6.42 (1H, dt, J=16.0, 5.7 Hz), 6.72 (1H, d, J=16.0 Hz), 6.89 (2H, dt, J=9.4, 2.5 Hz), 7.15 (2H, dt, J=9.4, 2.5 Hz), 7.39-7.44 (4H, m).
1H-NMR (CDCl3) δ: 1.23 (6H, t, J=7.1 Hz), 2.25 (3H, s), 3.49-3.64 (4H, m), 4.97 (2H, dd, J=6.1, 1.5 Hz), 5.49 (1H, s), 6.47 (1H, dt, J=16.0, 6.0 Hz), 6.69-6.75 (2H, m), 7.38-7.44 (5H, m), 7.96-7.97 (1H, m).
1H-NMR (CDCl3) δ: 1.24 (6H, t, J=7.1 Hz), 2.07-2.14 (2H, m), 2.82 (2H, t, J=7.7 Hz), 3.50-3.66 (4H, m), 3.96 (2H, t, J=6.3 Hz), 5.48 (1H, s), 6.88-6.96 (3H, m), 7.21 (2H, d, J=8.1 Hz), 7.25-7.31 (2H, m), 7.39 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.27 (6H, t, J=7.1 Hz), 2.10-2.17 (2H, m), 2.84 (2H, t, J=7.6 Hz), 3.52-3.69 (4H, m), 4.00 (2H, t, J=6.2 Hz), 5.50 (1H, s), 7.17-7.26 (4H, m), 7.43 (2H, d, J=8.1 Hz), 8.07 (1H, dd, J=3.1, 0.6 Hz).
1H-NMR (CDCl3) δ: 1.24 (6H, t, J=7.1 Hz), 1.96 (3H, d, J=1.2 Hz), 2.29 (3H, s), 3.50-3.67 (4H, m), 4.54 (2H, s), 5.50 (1H, s), 6.62 (1H, brs), 6.87 (2H, dt, J=9.1, 2.4 Hz), 7.09 (2H, d, J=8.3 Hz), 7.29 (2H, d, J=8.3 Hz), 7.44 (2H, d, J=8.3 Hz).
tert-Butyl 4-[4-(2-hydroxyethyl)benzyl]piperazine-1-carboxylate (1.44 g), 2-hydroxy-5-methylpyridine (0.737 g), tri-n-butylphosphine (1.76 mL), 1,1′-(azodicarbonyl)-dipiperidine (1.70 g), and THF (16.5 mL) were mixed in a 20 mL process vial. The vial was sealed, and the reaction mixture was heated with microwaves to 55 ° C. for 10 minutes. The reaction mixture was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt =10/1 to 3/10) to give tert-butyl 4-(4-{2-[(5-methylpyridin-2-yl)oxy]ethyl}benzyl)piperazine-1-carboxylate as a pale yellow amorphous (1.01 g).
1H-NMR (CDC13) δ: 1.45 (9H, s), 2.22 (3H, s), 2.37 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=7.1 Hz), 3.42 (4H, t, J =4.9 Hz), 3.47 (2H, s), 4.46 (2H, t, J=7.1 Hz), 6.63 (1H, d, J=8.3 Hz), 7.22-7.24 (4H, m), 7.36 (1H, dd, J=8.5, 2.4 Hz), 7.93 (1H, s).
The following compound was produced in the same manner as in Reference Example 100 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.39 (4H, t, J=4.9 Hz), 2.48 (3H, s), 3.08 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.18 (2H, t, J=7.1 Hz), 7.05-7.11 (2H, m), 7.20-7.22 (2H, m), 7.24-7.26 (2H, m), 8.16 (1H, d, J=2.7 Hz).
To a toluene (99 mL) solution of 4-bromo-2-fluorobenzaldehyde (10.00 g) was added ethylene glycol (3.30 mL) and toluenesulfonic acid (849 mg), then the resultant mixture was refluxed for 8 hours. The mixture was poured into saturated aqueous NaHCO3, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=99/1 to 95/5) to afford 2-(4-bromo-2-fluorophenyl)-1,3-dioxolane as a colorless oil (11.046 g).
1H-NMR (CDCl3) δ: 4.02-4.06 (2H, m), 4.11-4.15 (2H, m), 6.03 (1H, s), 7.25-7.32 (2H, m), 7.40-7.42 (1H, m).
To a THF (40 mL) solution of 2-(4-bromo-2-fluorophenyl)-1,3-dioxolane (3.29 g) was added Mg (406 mg) and I2 (135 mg), then the resultant mixture was refluxed for 5 hours. After cooling to 0° C., the reaction mixture was added ethylene oxide (12.5 mL, 1.1 M in THF), then the resultant mixture was stirred at 50° C. for 3 hours. The reaction mixture was added ethylene oxide (12.5 mL, 1.1 M in THF), the resultant mixture was stirred at 50° C. over night. The mixture was poured into saturated aqueous NH4Cl, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=99/1 to 4/1) to afford a colorless oil. To a THF (10 mL) solution of that colorless oil and PPh3 (857 mg) and alpha,alpha,alpha-trifluoro-p-cresol (530 mg) were added DEAD (1.486 mL, 2.2 M in toluene) at 0° C., then the resultant mixture was stirred at room temperature over night. The reaction mixture was evaporated, to the residue was added n-hexane/AcOEt (4/1), then the mixture was filtered, and the filtrate was evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/0 to 9/1) to afford 2-(2-fluoro-4-{2-[4-(trifluoromethyl)phenoxy]ethyl}phenyl)-1,3-dioxolane as a colorless oil (0.552 g).
1H-NMR (CDCl3) δ: 3.11 (2H, t, J=6.7 Hz), 4.03-4.21 (6H, m), 6.07 (1H, s), 6.93 (2H, d, J=8.5 Hz), 7.01 (1H, d, J=11.0 Hz), 7.08 (1H, d, J=7.8 Hz), 7.46-7.54 (3H, m).
tert-Butyl 4-{4-[2-(4-iodophenoxy)ethyl]benzyl}piperazine-1-carboxylate (209 mg), potassium cyclopropyltrifluoroborate (86 mg), Pd(OAc)2 (6 mg), di(1-adamantyl)-n-butyl-phosphine (13 mg), Cs2CO3 (391 mg), and toluene/water (10:1) (3.3 mL) were mixed in a 5 mL process vial. The vial was sealed, and the reaction mixture was heated with microwaves to 130° C. for 1 hour. After filtration through a Celite pad, the solvent was removed under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/0 to 0/1) to give tert-butyl 4-{4-[2-(4-cyclopropylphenoxy)ethyl]benzyl}piperazine-1-carboxylate as a pale yellow solid (40 mg).
1H-NMR (CDCl3) δ: 0.57-0.62 (2H, m), 0.85-0.90 (2H, m), 1.45 (9H, s), 1.81-1.86 (1H, m), 2.37 (4H, t, J=5.0 Hz), 3.06 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=5.0 Hz), 3.47 (2H, s), 4.13 (2H, t, J=7.1 Hz), 6.78-6.81 (2H, m), 6.97-7.00 (2H, m), 7.21-7.26 (4H, m).
To a THF (100 mL) solution of 1-bromo-4-[2-(4-fluorophenoxy)ethyl]benzene (3.05 g) was added 1.6 M solution of n-BuLi in n-hexane (6.80 mL) dropwise at −70° C. under an argon atmosphere. After stirring for 30 minutes, DMF (1.20 mL) was slowly added at −70° C. The resultant mixture was stirred and slowly warmed to −40° C. for 3 hours. The reaction mixture was quenched by addition of saturated aqueous NH4Cl, and extracted with AcOEt. The organic layer was washed with water, saturated aqueous NaCl, dried over anhydrous MgSO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=9/1 to 1/1) to afford 4-[2-(4-fluorophenoxy)ethyl]benzaldehyde as a light yellow solid (1.63 g).
1H-NMR (DMSO-d6) δ: 3.13 (2H, t, J=6.6 Hz), 4.22 (2H, t, J=6.6 Hz), 6.90-6.98 (2H, m), 7.05-7.15 (2H, m), 7.56 (2H, d, J=8.2 Hz), 7.86 (2H, d, J=8.2 Hz), 9.98 (1H, s).
The following compounds were produced in the same manner as in Reference Example 105 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.24 (6H, d, J=6.9 Hz), 2.85 (1H, septet, J=6.9 Hz), 3.16 (2H, t, J=6.6 Hz), 4.20 (2H, t, J=6.6 Hz), 6.77-6.88 (2H, m), 7.08-7.17 (2H, m), 7.42-7.49 (2H, m), 7.79-7.87 (2H, m), 9.99 (1H, s).
1H-NMR (CDCl3) δ: 3.15 (2H, t, J=6.8 Hz), 3.76 (3H, s), 4.17 (2H, t, J=6.8 Hz), 6.81 (4H, s), 7.45 (2H, d, J=7.9 Hz), 7.82-7.84 (2H, m), 9.99 (1H, s).
1H-NMR (CDCl3) δ: 2.28 (3H, s), 3.16 (2H, t, J=6.6 Hz), 4.19 (2H, t, J=6.9 Hz), 6.78 (2H, d, J=8.6 Hz), 7.07 (2H, d, J=8.2 Hz), 7.45 (2H, d, J=7.9 Hz), 7.83 (2H, d, J=8.2 Hz), 9.99 (1H, s).
1H-NMR (CDCl3) δ: 1.38 (3H, t, J=6.9 Hz), 3.15 (2H, t, J=6.9 Hz), 3.97 (2H, q, J=6.9 Hz), 4.17 (2H, t, J=6.9 Hz), 6.81 (4H, s), 7.45 (2H, d, J=8.2 Hz), 7.83 (2H, d, J=8.2 Hz), 9.99 (1H, s).
1H-NMR (CDCl3) δ: 1.42 (3H, d, J=7.1 Hz), 2.27 (3H, s), 3.27-3.36 (1H, m), 4.01 (1H, dd, J=9.2, 6.7 Hz), 4.07 (1H, dd, J=9.2, 6.7 Hz), 6.76 (2H, d, J=8.5 Hz), 7.06 (2H, d, J=8.5 Hz), 7.45 (2H, d, J=8.2 Hz), 7.84 (2H, dt, J=8.2, 1.7 Hz), 9.99 (1H, s).
1H-NMR (CDCl3) δ: 2.16 (3H, d, J=1.0 Hz), 2.30 (3H, s), 4.73-4.75 (2H, m), 6.17-6.21 (1H, m), 6.85 (2H, dt, J=9.1, 2.4 Hz), 7.10 (2H, d, J=8.3 Hz), 7.58 (2H, dt, J=8.5, 1.8 Hz), 7.84 (2H, dt, J=8.5, 1.8 Hz), 10.00 (1H, s).
1H-NMR (CDCl3) δ: 3.20 (2H, t, J=6.6 Hz), 4.19 (2H, t, J=6.6 Hz), 6.80 (2H, d, J=8.8 Hz), 7.22 (2H, d, J=8.8 Hz), 7.48-7.49 (1H, m), 7.56 (1H, d, J=9.8 Hz), 7.63 (1H, d, J=7.6 Hz), 9.96 (1H, d, J=1.5 Hz).
To a THF (44 mL) solution of tert-butyl 4-(4-bromo-2-fluorobenzyl)piperazine-1-carboxylate (8.445 g) was added slowly n-BuLi (11.31 mL, 2.6 M in hexane) at −78° C., then the resultant mixture was stirred for 0.5 hour. To the mixture was added slowly DMF (1.927 mL) at −78° C. After stirring for 1 hour at −78° C., then the mixture was stirred at room temperature over night. The mixture was poured into saturated aqueous NH4Cl, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=9/1 to 2/1) to afford a colorless oil. To a MeOH (13 mL) solution of that colorless oil was added NaBH4 (0.200 g) at 0° C., then the resultant mixture was stirred for 5 hours. To the reaction mixture was added saturated aqueous NaHCO3, and extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=3/1 to 1/1) to afford tert-butyl 4-[2-fluoro-4-(hydroxymethyl)benzyl]piperazine-1-carboxylate as a colorless oil (0.500 g).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 1.70-1.80 (1H, m), 2.41-2.42 (4H, m), 3.42-3.43 (4H, m), 3.58 (2H, s), 4.69 (2H, s), 7.06-7.12 (2H, m), 7.33-7.37 (1H, m).
To a THF (53 mL) solution of tert-butyl 4-(4-bromo-2-fluorobenzyl)piperazine-1-carboxylate (5.331 g) was added slowly n-BuLi (11.48 mL, 2.6 M in hexane) at −78° C., then the resultant mixture was stirred for 0.5 hour. To the mixture was added slowly DMF (1.681 mL) at −78° C., then the resultant mixture was stirred for 2 hours. The mixture was poured into saturated aqueous NH4Cl, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=95/5 to 67/33) to afford a colorless oil. To a CH2Cl2 (25 mL) solution of that colorless oil and tert-butyl 1-piperazinecarboxylate (3.42 g) were added NaBH(OAc)3 (5.310 g) at 0° C. The resultant mixture was stirred at room temperature over night. To the reaction mixture was added saturated aqueous NaHCO3, and extracted with CH2Cl2. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous MgSO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=67/33 to 33/67) to afford a colorless oil. To a THF (25 mL) solution of that colorless oil was added TBAF (25.05 mL, 1.0 M in THF) at 0° C. The resultant mixture was stirred at room temperature for 1 hour. After cooling to 0° C., the reaction mixture was diluted with AcOEt and water. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=67/33 to 1/4) to afford tert-butyl 4-[3-fluoro-4-(hydroxymethyl)benzyl]piperazine-1-carboxylate as a colorless oil (2.303 g).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 1.78-1.80 (1H, m), 2.37-2.38 (4H, m), 3.42-3.43 (4H, m), 3.49 (2H, s), 4.74 (2H, s), 7.05-7.10 (2H, m), 7.33-7.38 (1H, m).
To a solution of {4-[2-(4-methylphenoxy)propyl]phenyl}methanol (0.725 g) in THF (20 mL) were added CCl4 (2.3 mL) and PPh3 (1.640 g) at room temperature under an Ar atmosphere. The mixture was heated at reflux for 6.5 hours, and then cooled to room temperature, and evaporated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=5/1) to afford 1-[4-(chloromethyl)phenyl]propan-2-yl 4-methylphenyl ether (0.696 g) as a colorless oil.
1H-NMR (CDCl3) δ: 1.28 (3H, d, J=6.1 Hz), 2.27 (3H, s), 2.81 (1H, dd, J=13.7, 6.6 Hz), 3.07 (1H, dd, J=13.7, 6.1 Hz), 4.47-4.55 (1H, m), 4.57 (2H, s), 6.78 (2H, dt, J=9.1, 2.5 Hz), 7.06 (2H, d, J=8.5 Hz), 7.23 (2H, d, J=8.3 Hz), 7.31 (2H, d, J=8.3 Hz).
The following compounds were produced in the same manner as in Reference Example 115 using appropriate starting materials.
1H-NMR (CDCl3) δ: 2.28 (3H, s), 2.37 (3H, s), 3.09 (2H, t, J=7.3 Hz), 4.11 (2H, t, J=7.3 Hz), 4.55 (2H, s), 6.79 (2H, dt, J=9.2, 2.6 Hz), 7.07 (2H, dd, J=8.8, 0.5 Hz), 7.16-7.23 (3H, m).
1H-NMR (CDCl3) δ: 2.37 (3H, s), 3.09 (2H, t, J=7.2 Hz), 4.09 (2H, t, J=7.2 Hz), 4.55 (2H, s), 6.79-6.84 (2H, m), 6.92-6.99 (2H, m), 7.17-7.22 (3H, m).
1H-NMR (CDCl3) δ: 2.29 (3H, s), 2.34 (3H, s), 4.55 (2H, s), 4.69 (2H, dd, J=5.9, 1.5 Hz), 6.30 (1H, dt, J=15.9, 5.9 Hz), 6.86 (2H, dt, J=9.3, 2.5 Hz), 6.91 (1H, d, J=15.9 Hz), 7.09 (2H, d, J=8.8 Hz), 7.17-7.20 (2H, m), 7.46 (1H, d, J=7.8 Hz).
1H-NMR (CDCl3) δ: 2.29 (3H, s), 2.42 (3H, s), 4.60 (2H, s), 4.67 (2H, dd, J=5.7, 1.6 Hz), 6.41 (1H, dt, J=16.0, 5.7 Hz), 6.68 (1H, d, J=16.0 Hz), 6.85 (2H, dt, J=9.2, 2.4 Hz), 7.09 (2H, d, J=8.8 Hz), 7.21-7.35 (3H, m).
1H-NMR (CDCl3) δ: 2.28 (3H, s), 2.42 (3H, s), 3.04 (2H, t, J=7.2 Hz), 4.13 (2H, t, J=7.2 Hz), 4.60 (2H, s), 6.79 (2H, dt, J=9.3, 2.6 Hz), 7.06-7.12 (4H, m), 7.24 (1H, brs).
To a CH3CN (250 mL) solution of piperazine-1-carboxylic acid tert-butyl ester (19.8 g) and alpha,alpha-dichloro-p-xylene (18.6 g) was added DIPEA (18.5 mL) under a N2 atmosphere, then the resultant mixture was stirred at room temperature for 3 days. The reaction mixture was poured into saturated aqueous NaHCO3 (600 mL) and extracted with AcOEt (900 mL). The organic layer was washed with saturated aqueous NaCl (300 mL), dried over anhydrous MgSO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=3/1) to afford tert-butyl 4-[4-(chloromethyl)benzyl]piperazine-1-carboxylate (16.3 g) as a white powder.
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.36-2.39 (4H, m), 3.40-3.44 (4H, m), 3.50 (2H, s), 4.58 (2H, s), 7.26-7.36 (4H, m).
The following compounds were produced in the same manner as in Reference Example 121 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.28 (3H, d, J=6.1 Hz), 1.45 (9H, s), 2.27 (3H, s), 2.36 (4H, t, J=4.9 Hz), 2.78 (1H, dd, J=13.7, 6.7 Hz), 3.06 (1H, dd, J=13.7, 6.1 Hz), 3.41 (4H, t, J=4.9 Hz), 3.47 (2H, s), 4.47-4.54 (1H, m), 6.77 (2H, dt, J=9.4, 2.6 Hz), 7.05 (2H, dd, J=8.7, 0.6 Hz), 7.18 (2H, d, J=8.3 Hz), 7.22 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.28 (3H, s), 2.35 (3H, s), 2.38 (4H, t, J=5.0 Hz), 3.08 (2H, t, J=7.4 Hz), 3.41-3.46 (6H, m), 4.10 (2H, t, J=7.4 Hz), 6.79 (2H, dt, J=9.1, 2.4 Hz), 7.05-7.11 (4H, m), 7.16 (1H, d, J=7.6 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.35 (3H, s), 2.37 (4H, t, J=5.0 Hz), 3.07 (2H, t, J=7.3 Hz), 3.42 (4H, t, J=5.0 Hz), 3.45 (2H, s), 4.09 (2H, t, J=7.3 Hz), 6.79-6.85 (2H, m), 6.92-6.99 (2H, m), 7.09-7.17 (3H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.28 (3H, s), 2.34 (3H, s), 2.37 (4H, t, J=4.9 Hz), 3.03 (2H, t, J=7.2 Hz), 3.39 (4H, t, J=4.9 Hz), 3.43 (2H, s), 4.13 (2H, t, J=7.2 Hz), 6.80 (2H, dt, J=9.2, 2.5 Hz), 6.98-7.07 (4H, m), 7.17 (1H, d, J=7.6 Hz).
To a solution of tert-butyl 4-[4-(chloromethyl)benzyl]piperazine-1-carboxylate (4.00 g) in DMF (25 mL) were added 4-isopropoxyphenol (2.81 g) and K2CO3 (3.40 g) at room temperature, then the reaction mixture was stirred for 2 days. The reaction mixture was diluted with H2O, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=3/1 to 1/1) to afford tert-butyl 4-(4-{[4-(propan-2-yloxy)phenoxy]methyl}benzyl)piperazine-1-carboxylate as a colorless solid (5.42 g).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=5.9 Hz), 1.45 (9H, s), 2.39 (4H, t, J=4.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.51 (2H, s), 4.42 (1H, septet, J=5.9 Hz), 4.99 (2H, s), 6.80-6.96 (4H, m), 7.29-7.43 (4H, m).
The following compounds were produced in the same manner as in Reference Example 126 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.51 (2H, s), 5.01 (2H, s), 6.86-6.93 (2H, m), 7.20-7.26 (2H, m), 7.31-7.39 (4H, m).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 2.86 (1H, septet, J=6.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.51 (2H, s), 5.01 (2H, s), 6.89-6.94 (2H, m), 7.13-7.17 (2H, m), 7.32 (2H, d, J=8.2 Hz), 7.38 (2H, d, J=8.2 Hz).
1H-NMR (CDCl3) δ: 1.46 (9H, s), 2.39 (4H, t, J=5.0 Hz), 3.43 (4H, t, J=5.0 Hz), 3.52 (2H, s), 5.06 (2H, s), 6.31-6.33 (2H, m), 6.99-7.04 (4H, m), 7.31 (2H, d, J=8.9 Hz), 7.35 (2H, d, J=8.2 Hz), 7.40 (2H, d, J=8.2 Hz).
1H-NMR (DMSO-d6) δ: 1.39 (9H, s), 2.29 (4H, t, J=4.9 Hz), 3.28-3.31 (4H, m), 3.47 (2H, s), 5.05 (2H, s), 6.98-7.05 (2H, m), 7.07-7.15 (2H, m), 7.31 (2H, d, J=7.9 Hz), 7.39 (2H, d, J=7.9 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.51 (2H, s), 3.77 (3H, s), 4.99 (2H, s), 6.75-6.96 (4H, m), 7.29-7.43 (4H, m).
1H-NMR (CDCl3) δ: 1.38 (3H, t, J=6.9 Hz), 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.51 (2H, s), 3.97 (2H, q, J=6.9 Hz), 4.99 (2H, s), 6.70-6.95 (4H, m), 7.28-7.43 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.51 (2H, s), 4.96 (2H, s), 5.91 (2H, s), 6.39 (1H, dd, J=8.6, 2.3 Hz), 6.56 (1H, d, J=2.3 Hz), 6.70 (1H, d, J=8.6 Hz), 7.30-7.38 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.35 (4H, t, J=5.3 Hz), 3.35-3.48 (6H, m), 5.20 (2H, s), 6.83-6.93 (2H, m), 7.12-7.27 (4H, m), 8.00-8.10 (2H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.36 (4H, t, J=4.9 Hz), 3.41 (4H, t, J=4.9 Hz), 3.44 (2H, s), 4.25-4.30 (4H, m), 6.84-6.90 (4H, m), 7.21-7.26 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.29 (3H, s), 2.36 (4H, brs), 3.41 (4H, t, J=4.9 Hz), 3.45 (2H, s), 4.30 (4H, s), 6.85 (2H, d, J=8.5 Hz), 6.90 (2H, d, J=8.5 Hz), 7.09 (2H, d, J=8.5 Hz), 7.22 (2H, d, J=8.5 Hz).
1H-NMR (CDCl3) δ: 1.38 (3H, t, J=7.0 Hz), 1.45 (9H, s), 2.35 (4H, t, J=4.9 Hz), 3.41 (4H, t, J=4.9 Hz), 3.43 (2H, s), 3.97 (2H, q, J=7.0 Hz), 4.24-4.28 (4H, m), 6.81-6.90 (6H, m), 7.20-7.22 (2H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.35 (4H, t, J=4.9 Hz), 3.40-3.43 (6H, m), 3.74 (3H, s), 4.23-4.27 (4H, m), 6.81-6.84 (2H, m), 6.86-6.90 (4H, m), 7.21 (2H, d, J=8.8 Hz).
1H-NMR (CDCl3) δ: 1.29 (3H, t, J=7.2 Hz), 1.45 (9H, s), 1.57 (6H, s), 2.34-2.37 (4H, m), 3.41-3.43 (6H, m), 4.25 (2H, q, J=7.2 Hz), 6.91-6.92 (2H, m), 7.07 (1H, d, J=12.2 Hz).
1H-NMR (CDCl3) δ: 1.42 (3H, t, J=7.1 Hz), 2.28 (3H, s), 4.42 (2H, q, J=7.1 Hz), 5.23 (2H, s), 6.82-6.86 (2H, m), 7.06-7.10 (2H, m), 8.04-8.06 (2H, m), 8.14-8.16 (2H, m).
To a DMF (10 mL) solution of tert-butyl 4-[4-(2-hydroxyethyl)benzyl]piperazine-1-carboxylate (1.000 g) was added NaH (112 mg, 60% in mineral oil) at 0° C., then the resultant mixture was stirred for 1 hour. To the mixture was added 2-fluoro-6-methylpyridine (0.419 mL), then the resultant mixture was stirred at 70° C. over night. The mixture was poured into water, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=4/1 to 1/1) to afford tert-butyl 4-(4-{2-[(6-methylpyridin-2-yl)oxy]ethyl}benzyl)piperazine-1-carboxylate as a pale yellow amorphous powder (350 mg).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37-2.38 (4H, m), 2.42 (3H, s), 3.06 (2H, t, J=7.2 Hz), 3.41-3.42 (4H, m), 3.48 (2H, s), 4.48 (2H, t, J=7.2 Hz), 6.50 (1H, d, J=8.1 Hz), 6.69 (1H, d, J=7.1 Hz), 7.24-7.26 (4H, m), 7.42-7.44 (1H, m).
The following compounds were produced in the same manner as in Reference Example 141 using appropriate starting materials.
1H-NMR (DMSO-d6) δ: 1.38 (9H, s), 2.29 (4H, t, J=4.9 Hz), 3.30 (4H, t, J=4.9 Hz), 3.46 (2H, s), 4.50 (2H, s), 4.50 (2H, s), 7.14-7.22 (2H, m), 7.25-7.33 (4H, m), 7.36-7.42 (2H, m).
1H-NMR (CDCl3) δ: 1.25 (6H, d, J=6.9 Hz), 1.45 (9H, s), 2.37 (4H, t, J=4.9 Hz), 2.91 (1H, septet, J=6.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.50 (2H, s), 4.53 (2H, s), 4.53 (2H, s), 7.20-7.34 (8H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37 (4H, t, J=5.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=5.1 Hz), 3.48 (2H, s), 4.57 (2H, t, J=7.1 Hz), 6.80 (1H, d, J=8.9 Hz), 7.21-7.27 (4H, m), 7.75 (1H, dd, J=8.9, 2.5 Hz), 8.42 (1H, brs).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.11-3.14 (2H, m), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, brs), 4.24-4.27 (2H, m), 6.94 (2H, d, J=9.3 Hz), 7.23 (2H, d, J=8.3 Hz), 7.28 (2H, d, J=8.8 Hz), 8.19 (2H, d, J=9.3 Hz).
To a dioxane (10 mL) solution of 4-bromo-2-chlorophenol (207 mg) were added n-butyl acrylate (0.158 mL), N-methyldicyclohexylamine (0.236 mL), tri-tert-butylphosphonium tetrafluoroborate (12 mg), and tris(dibenzylideneacetone)dipalladium (0) (18 mg) under a N2 atmosphere. The resultant mixture was refluxed over night. After cooling, the reaction mixture was filtered off on Celite, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=4/1 to 2/1) to afford butyl (E)-3-(3-chloro-4-hydroxyphenyl)prop-2-enoate (244 mg) as a colorless oil.
1H-NMR (CDCl3) δ: 0.96 (3H, t, J=7.8 Hz), 1.36-1.49 (2H, m), 1.62-1.74 (2H, m), 4.20 (2H, t, J=6.9 Hz), 5.84 (1H, s), 6.31 (1H, d, J=15.6 Hz), 7.02 (1H, d, J=8.2 Hz), 7.36 (1H, dd, J=8.7, 2.3 Hz), 7.52 (1H, d, J=1.8 Hz), 7.55 (1H, d, J=16.0 Hz).
The following compounds were produced in the same manner as in Reference Example 146 using appropriate starting materials.
1H-NMR (CDCl3) δ: 0.96 (3H, t, J=7.3 Hz), 1.42-1.46 (2H, m), 1.63-1.73 (2H, m), 2.26 (3H, s), 4.20 (2H, t, J=6.6 Hz), 5.01 (1H, s), 6.29 (1H, d, J=16.2 Hz), 6.77 (1H, d, J=8.2 Hz), 7.25-7.32 (2H, m), 7.60 (1H, d, J=16.2 Hz).
1H-NMR (CDCl3) δ: 0.96 (3H, t, J=7.3 Hz), 1.37-1.50 (2H, m), 1.64-1.74 (2H, m), 2.38 (3H, s), 4.21 (2H, t, J=6.6 Hz), 5.41-5.44 (1H, m), 6.26 (1H, d, J=15.8 Hz), 6.67-6.71 (2H, m), 7.47-7.50 (1H, m), 7.91 (1H, d, J=15.8 Hz).
1H-NMR (CDCl3) δ: 0.96 (3H, t, J=7.3 Hz), 1.39-1.48 (2H, m), 1.65-1.72 (2H, m), 4.20 (2H, t, J=6.6 Hz), 5.51 (1H, s), 6.30 (1H, d, J=16.1 Hz), 6.99-7.03 (1H, m), 7.21-7.29 (2H, m), 7.57 (1H, d, J=16.1 Hz).
1H-NMR (CDCl3) δ: 0.10 (6H, s), 0.95 (9H, s), 0.97 (3H, t, J=8.1 Hz), 1.40-1.49 (2H, m), 1.66-1.73 (2H, m), 2.43 (3H, s), 4.21 (2H, t, J=6.6 Hz), 4.71 (2H, s), 6.35 (1H, d, J=15.9 Hz), 7.15-7.18 (2H, m), 7.53 (1H, d, J=7.8 Hz), 7.96 (1H, d, J=15.9 Hz).
1H-NMR (CDCl3) δ: 0.11 (6H, s), 0.95 (9H, s), 0.97 (3H, t, J=7.2 Hz), 1.39-1.49 (2H, m), 1.65-1.72 (2H, m), 2.27 (3H, s), 4.20 (2H, t, J=6.7 Hz), 4.70 (2H, s), 6.41 (1H, d, J=16.1 Hz), 7.29 (1H, brs), 7.37 (1H, dd, J=7.9, 1.6 Hz), 7.45 (1H, d, J=7.9 Hz), 7.65 (1H, d, J=16.1 Hz).
To a DMF (30 mL) solution of 2-chloro-4-bromo-6-methylphenol (4.90 g) were added 2-chloro-5-nitropyridine (3.58 g) and K2CO3 (3.12 g) at room temperature. After stirring at 50° C. for 3 hours, the solvent was removed under reduced pressure. To the residue was added water, and extracted with AcOEt. The organic layer was washed with water, saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure to give 2-(4-bromo-2-chloro-6-methylphenoxy)-5-nitropyridine as a brown solid (7.59 g).
1H-NMR (CDCl3) δ: 2.17 (3H, s), 7.16 (1H, d, J=8.8 Hz), 7.36-7.37 (1H, m), 7.48-7.49 (1H, m), 8.53 (1H, dd, J=8.8, 2.8 Hz), 8.98 (1H, d, J=2.8 Hz).
The following compounds were produced in the same manner as in Reference Example 152 using appropriate starting materials.
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.38-1.52 (2H, m), 1.65-1.75 (2H, m), 2.18 (3H, s), 4.22 (2H, q, J=6.6 Hz), 6.42 (1H, d, J=15.8 Hz), 7.07-7.11 (2H, m), 7.43-7.48 (2H, m), 7.67 (1H, d, J=16.2 Hz), 8.48-8.53 (1H, m), 9.02 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.36 (3H, t, J=7.1 Hz), 3.78 (3H, s), 4.28 (2H, q, J=7.2 Hz), 6.42 (1H, d, J=16.1 Hz), 7.09 (1H, d, J=9.3 Hz), 7.16-7.22 (3H, m), 7.68 (1H, d, J=16.1 Hz), 8.49 (1H, dd, J=9.0, 2.7 Hz), 9.00 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 3.87 (6H, s), 7.17 (1H, d, J=9.0 Hz), 7.24 (2H, s), 8.50 (1H, dd, J=9.0, 2.7 Hz), 8.96 (1H, d, J=2.7 Hz), 9.96 (1H, brs).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.38-1.51 (2H, m), 1.63-1.76 (2H, m), 2.46 (3H, s), 4.22 (2H, t, J=6.9 Hz), 6.36 (1H, d, J=15.8 Hz), 7.00-7.08 (3H, m), 7.62-7.66 (1H, m), 7.94 (1H, d, J=15.8 Hz), 8.50 (1H, dd, J=8.9, 2.6 Hz), 9.05 (1H, d, J=2.6 Hz).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=6.9 Hz), 2.97 (1H, septet, J=6.9 Hz), 3.97 (3H, s), 7.10-7.22 (3H, m), 7.24-7.34 (2H, m), 7.81 (1H, d, J=8.9 Hz), 8.19 (1H, d, J=8.9 Hz), 8.20 (1H, dd, J=8.9, 2.0 Hz), 8.51 (1H, d, J=2.0 Hz).
1H-NMR (CDCl3) δ: 3.85 (3H, s), 3.97 (3H, s), 6.92-7.01 (2H, m), 7.12 (1H, d, J=8.6 Hz), 7.15-7.22 (2H, m), 7.79 (1H, d, J=8.9 Hz), 8.18 (1H, d, J=8.9 Hz), 8.21 (1H, dd, J=8.9, 2.0 Hz), 8.50 (1H, d, J=1.6 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.38-1.51 (2H, m), 1.66-1.76 (2H, m), 4.23 (2H, t, J=6.8 Hz), 6.44 (1H, d, J=16.1 Hz), 7.17 (1H, d, J=9.8 Hz), 7.26 (1H, d, J=8.3 Hz), 7.51 (1H, dd, J=8.3, 2.0 Hz), 7.64 (1H, d, J=16.1 Hz), 7.67 (1H, d, J=2.0 Hz), 8.54 (1H, dd, J=8.8, 2.4 Hz), 9.00 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.40-1.49 (2H, m), 1.67-1.74 (2H, m), 4.23 (2H, t, J=6.8 Hz), 6.42 (1H, d, J=15.6 Hz), 7.17 (1H, d, J=9.3 Hz), 7.27 (1H, t, J=8.1 Hz), 7.37-7.41 (2H, m), 7.64 (1H, d, J=16.1 Hz), 8.54 (1H, dd, J=9.0, 2.7 Hz), 9.01 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.46 (3H, t, J=7.1 Hz), 4.46 (2H, q, J=7.2 Hz), 7.14 (1H, dd, J=9.0, 0.5 Hz), 7.36 (1H, dd, J=8.9, 2.3 Hz), 7.67 (1H, d, J=2.4 Hz), 7.86 (1H, d, J=8.8 Hz), 8.04 (1H, d, J=9.0 Hz), 8.11 (1H, dd, J=8.7, 1.6 Hz), 8.53 (1H, dd, J=9.0, 2.7 Hz), 8.65 (1H, d, J=0.5 Hz), 9.05 (1H, dd, J=2.9, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.18 (6H, s), 7.15 (1H, d, J=9.0 Hz), 7.69 (2H, s), 8.54 (1H, dd, J=9.0, 2.7 Hz), 8.98 (1H, d, J=2.7 Hz), 9.98 (1H, brs).
1H-NMR (CDCl3) δ: 2.11 (3H, s), 7.09 (1H, d, J=9.0 Hz), 7.20 (1H, s), 7.56 (1H, s), 8.51 (1H, dd, J=9.0, 2.9 Hz), 9.01 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.40 (3H, s), 7.11-7.14 (2H, m), 7.67 (1H, s), 8.52 (1H, dd, J=9.0, 2.7 Hz), 9.00 (1H, d, J=2.7 Hz).
To a THF (39 mL) suspension of LiAlH4 (0.15 g) was slowly added methyl 2-(4-methoxyphenoxy)quinoline-6-carboxylate (1.22 g) at 0° C., then the resultant mixture was stirred over night at room temperature. The reaction mixture was acidified with 6 M aqueous HCl, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure to afford [2-(4-methoxyphenoxy)quinolin-6-yl]methanol (1.11 g) as a pale yellow amorphous powder.
1H-NMR (CDCl3) δ: 1.89 (1H, brs), 3.84 (3H, s), 4.84 (2H, s), 6.91-6.99 (2H, m), 7.05 (1H, d, J=8.6 Hz), 7.13-7.22 (2H, m), 7.59 (1H, dd, J=8.6, 2.0 Hz), 7.73 (1H, brs), 7.78 (1H, d, J=8.6 Hz), 8.08 (1H, d, J=8.6 Hz).
The following compounds were produced in the same manner as in Reference Example 165 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.29 (6H, d, J=6.9 Hz), 1.65 (1H, brs), 2.96 (1H, septet, J=6.9 Hz), 4.84 (2H, s), 7.05 (1H, d, J=8.9 Hz), 7.13-7.20 (2H, m), 7.24-7.31 (2H, m), 7.60 (1H, dd, J=8.6, 2.0 Hz), 7.71-7.75 (1H, m), 7.80 (1H, d, J=8.9 Hz), 8.08 (1H, d, J=8.9 Hz).
1H-NMR (CDCl3) δ: 1.63 (1H, t, J=5.4 Hz), 2.29 (3H, s), 2.77 (1H, d, J=2.6 Hz), 3.97 (1H, dd, J=9.8, 9.0 Hz), 4.08 (1H, dd, J=9.8, 3.2 Hz), 4.72 (2H, d, J=5.4 Hz), 5.12 (1H, dt, J=9.0, 2.6 Hz), 6.80-6.83 (2H, m), 7.06-7.10 (2H, m), 7.40 (2H, d, J=8.1 Hz), 7.46 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.29 (6H, s), 1.46 (9H, s), 2.33-2.37 (5H, m), 3.43-3.44 (6H, m), 3.58-3.60 (2H, m), 6.99-7.01 (2H, m), 7.10 (1H, d, J=11.2 Hz).
To a solution of (E)-ethyl 3-(4-(diethoxymethyl)phenyl)acrylate (1.400 g) in toluene (10 mL) was added DIBAH (1 M solution in toluene) (10 mL) at −20° C. under an Ar atmosphere. The mixture was stirred at −20° C. for 1 hour. To the mixture was added MeOH, and then the mixture was heated to room temperature. To the mixture was added water, and the mixture was extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/1) to afford (E)-3-[4-(diethoxymethyl)phenyl]prop-2-en-1-ol (1.120 g) as a colorless oil.
1H-NMR (CDCl3) δ: 1.24 (6H, t, J=7.1 Hz), 1.42 (1H, t, J=6.0 Hz), 3.49-3.65 (4H, m), 4.33 (2H, td, J=6.0, 1.5 Hz), 5.49 (1H, s), 6.38 (1H, dt, J=16.1, 6.0 Hz), 6.62 (1H, dt, J=16.1, 1.5 Hz), 7.38 (2H, dd, J=6.6, 1.8 Hz), 7.43 (2H, dd, J=6.6, 1.8 Hz).
The following compounds were produced in the same manner as in Reference Example 169 using appropriate starting materials.
1H-NMR (CDCl3) δ: 0.10 (6H, s), 0.94 (9H, s), 1.42 (1H, t, J=6.0 Hz), 2.35 (3H, s), 4.32-4.36 (2H, m), 4.69 (2H, s), 6.25 (1H, dt, J=15.9, 5.8 Hz), 6.81 (1H, d, J=15.9 Hz), 7.10-7.13 (2H, m), 7.42 (1H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 0.10 (6H, s), 0.94 (9H, s), 1.40-1.43 (1H, m), 2.26 (3H, s), 4.30-4.33 (2H, m), 4.69 (2H, s), 6.34 (1H, dt, J=15.9, 5.9 Hz), 6.58 (1H, dt, J=15.9, 1.3 Hz), 7.16 (1H, d, J=1.7 Hz), 7.22 (1H, dd, J=8.1, 1.7 Hz), 7.36 (1H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.24 (6H, t, J=7.0 Hz), 1.50 (1H, t, J=6.1 Hz), 1.90 (3H, d, J=1.0 Hz), 3.51-3.67 (4H, m), 4.19 (2H, d, J=6.1 Hz), 5.50 (1H, s), 6.52 (1H, brs), 7.28 (2H, d, J=8.3 Hz), 7.44 (2H, d, J=8.3 Hz).
To a CH2Cl2 (38 mL) solution of [2-(4-methoxyphenoxy)quinolin-6-yl]methanol (1.11 g) and iodobenzene diacetate (1.33 g) was added 2,2,6,6-tetramethyl-1-piperidinyloxy radical (61.0 mg), then the resultant mixture was stirred over night at room temperature. The reaction mixture was quenched by addition of saturated aqueous Na2S2O3 and NaHCO3, and extracted with CH2Cl2. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=10/1 to 5/1) to afford 2-(4-methoxyphenoxy)quinoline-6-carbaldehyde (1.08 g) as a colorless solid.
1H-NMR (CDCl3) δ: 3.86 (3H, s), 6.92-7.02 (2H, m), 7.13-7.23 (3H, m), 7.85 (1H, d, J=8.6 Hz), 8.08 (1H, dd, J=8.6, 1.6 Hz), 8.23 (1H, d, J=8.9 Hz), 8.26 (1H, d, J=2.0 Hz), 10.13 (1H, s).
The following compounds were produced in the same manner as in Reference Example 173 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=6.9 Hz), 2.98 (1H, septet, J=6.9 Hz), 7.14-7.22 (3H, m), 7.27-734 (2H, m), 7.88 (1H, d, J=8.6 Hz), 8.09 (1H, dd, J=8.6, 2.0 Hz), 8.24 (1H, d, J=8.9 Hz), 8.27 (1H, d, J=2.0 Hz), 10.13 (1H, s).
1H-NMR (CDCl3) δ: 2.28 (3H, s), 5.23 (2H, s), 6.82-6.85 (2H, m), 7.07-7.10 (2H, m), 7.98-8.01 (2H, m), 8.13-8.16 (2H, m), 10.11 (1H, s).
To a solution of 1-(diethoxymethyl)-4-[(E)-3-(4-methylphenoxy)prop-1-en-1-yl]benzene (1.270 g) in THF (20 mL) was added 6 M HCl (4 mL) at room temperature. The mixture was stirred at room temperature for 0.5 hour. To the mixture was added 5 M NaOH (4 mL), and the mixture was evaporated under reduced pressure. To the residue was added saturated aqueous NaHCO3, and the mixture was extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure to afford 4-[(E)-3-(4-methylphenoxy)prop-1-en-1-yl]benzaldehyde (0.942 g) as a colorless solid.
1H-NMR (CDCl3) δ: 2.30 (3H, s), 4.72 (2H, dd, J=5.4, 1.8 Hz), 6.58 (1H, dt, J=16.2, 5.4 Hz), 6.80 (1H, dt, J=16.2, 1.8 Hz), 6.86 (2H, dt, J=9.2, 2.4 Hz), 7.10 (2H, d, J=8.3 Hz), 7.55 (2H, d, J=8.3 Hz), 7.84 (2H, dt, J=8.3, 1.7 Hz), 9.99 (1H, s).
The following compounds were produced in the same manner as in Reference Example 176 using appropriate starting materials.
1H-NMR (CDCl3) δ: 4.70 (2H, dd, J=5.4, 1.7 Hz), 6.56 (1H, dt, J=16.3, 5.4 Hz), 6.79 (1H, dt, J=16.3, 1.7 Hz), 6.88-6.93 (2H, m), 6.97-7.03 (2H, m), 7.56 (2H, d, J=8.3 Hz), 7.85 (2H, dt, J=8.3, 1.7 Hz), 9.99 (1H, s).
1H-NMR (CDCl3) δ: 4.75 (2H, dd, J=5.4, 1.7 Hz), 6.59 (1H, dt, J=16.1, 5.4 Hz), 6.81 (1H, d, J=16.1 Hz), 6.95-7.00 (3H, m), 7.29-7.39 (2H, m), 7.56 (2H, d, J=8.3 Hz), 7.83-7.86 (2H, m), 9.99 (1H, s).
1H-NMR (CDCl3) δ: 3.78 (3H, s), 4.69 (2H, dd, J=5.4, 1.5 Hz), 6.59 (1H, dt, J=16.1, 5.4 Hz), 6.79 (1H, d, J=16.1 Hz), 6.83-6.93 (4H, m), 7.55 (2H, d, J=8.3 Hz), 7.83-7.85 (2H, m), 9.99 (1H, s).
1H-NMR (CDCl3) δ: 1.23 (6H, d, J=7.1 Hz), 2.82-2.93 (1H, m), 4.72 (2H, dd, J=5.3, 1.7 Hz), 6.58 (1H, dt, J=16.1, 5.3 Hz), 6.80 (1H, d, J=16.1 Hz), 6.88-6.92 (2H, m), 7.15-7.18 (2H, m), 7.56 (2H, d, J=8.2 Hz), 7.84 (2H, d, J=8.2 Hz), 9.99 (1H, s).
1H-NMR (CDCl3) δ: 4.78 (2H, dd, J=5.3, 1.6 Hz), 6.53 (1H, dt, J=16.1, 5.3 Hz), 6.80 (1H, d, J=16.1 Hz), 7.25 (2H, d, J=2.0 Hz), 7.56 (2H, d, J=8.1 Hz), 7.85-7.87 (2H, m), 8.13 (1H, t, J=1.8 Hz), 10.00 (1H, s).
1H-NMR (CDCl3) δ: 5.01 (2H, dd, J=5.7, 1.3 Hz), 6.60 (1H, dt, J=15.9, 5.7 Hz), 6.72-6.79 (2H, m), 7.55 (2H, d, J=8.2 Hz), 7.68 (1H, dd, J=8.8, 2.4 Hz), 7.84 (2H, d, J=8.2 Hz), 8.21 (1H, d, J=2.4 Hz), 9.99 (1H, s).
1H-NMR (CDCl3) δ: 2.26 (3H, s), 5.02 (2H, dd, J=5.6, 1.5 Hz), 6.63 (1H, dt, J=16.0, 5.6 Hz), 6.72 (1H, d, J=8.6 Hz), 6.78 (1H, d, J=16.0 Hz), 7.42 (1H, ddd, J=8.6, 2.5, 0.5 Hz), 7.55 (2H, d, J=8.3 Hz), 7.83 (2H, dt, J=8.3, 1.7 Hz), 7.96-7.97 (1H, m), 9.98 (1H, s).
1H-NMR (CDCl3) δ: 1.68 (1H, brs), 4.39 (2H, s), 6.53 (1H, dt, J=15.9, 5.3 Hz), 6.70 (1H, dt, J=15.9, 1.7 Hz), 7.53 (2H, d, J=8.2 Hz), 7.83 (2H, dt, J=8.2, 1.7 Hz), 9.98 (1H, s).
1H-NMR (CDCl3) δ: 1.56-1.58 (1H, m), 2.13-2.15 (2H, m), 2.91 (2H, t, J=7.6 Hz), 3.97 (2H, t, J=6.1 Hz), 6.87-6.91 (2H, m), 6.93-6.96 (1H, m), 7.26-7.31 (2H, m), 7.38 (2H, d, J=8.2 Hz), 7.81 (2H, d, J=8.2 Hz), 9.98 (1H, s).
1H-NMR (CDCl3) δ: 2.12-2.19 m), 2.91 (2H, t, J=7.6 Hz), 4.00 (2H, t, J=6.1 Hz), 7.16 (1H, J=8.8, 3.0 Hz), 7.22 (1H, d, J=8.8 Hz), 7.37 (2H, d, J=8.0 Hz), 7.82 (2H, d, J=8.0 Hz), 8.04 (1H, d, J=3.0 Hz), 9.98 (1H, s).
1H-NMR (CDCl3) δ: 1.99 (3H, d, J=1.2 Hz), 2.30 (3H, s), 4.56 (2H, s), 6.68 (1H, brs), 6.87 (2H, dt, J=9.2, 2.6 Hz), 7.10 (2H, dd, J=8.7, 0.6 Hz), 7.45 (2H, d, J=8.3 Hz), 7.85 (2H, dt, J=8.3, 1.7 Hz), 9.99 (1H, s).
To a solution of 3-[4-(diethoxymethyl)phenyl]propan-1-01 (3.00 g), p-cresol (1.63 g), and triphenylphosphine (4.95 g) in THF (25 mL) was added 2.2 M solution of DEAD in toluene (8.58 mL). After stirring at room temperature for 2 hours, to the reaction mixture was added H2O, and extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/0 to 9/1) to afford a colorless oil (0.751 g). To a solution of that colorless oil (0.751 g) in THF (30 mL) was added 6 M aqueous HCl (0.492 mL). After stirring at room temperature for 1 hour, to the reaction mixture was added 5 M aqueous NaOH, and the solvent was removed under reduced pressure. To the residue was added saturated aqueous NaHCO3, and extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=9/1 to 4/1) to afford 4-[3-(4-methylphenoxy)propyl]benzaldehyde as a colorless oil (0.497 g).
1H-NMR (CDCl3) δ: 2.08-2.15 (2H, m), 2.29 (3H, s), 2.90 (2H, t, J=7.6 Hz), 3.94 (2H, t, J=6.1 Hz), 6.79 (2H, dt, J=9.2, 2.4 Hz), 7.06-7.10 (2H, m), 7.38 (2H, d, J=8.1 Hz), 7.81 (2H, dt, J=8.1, 1.7 Hz), 9.98 (1H, s).
The following compounds were produced in the same manner as in Reference Example 188 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.54 (1H, brs), 2.38 (3H, s), 3.09 (2H, t, J=7.3 Hz), 4.09 (2H, t, J=7.3 Hz), 4.65 (2H, s), 6.79-6.84 (2H, m), 6.92-6.99 (2H, m), 7.15-7.23 (3H, m).
1H-NMR (CDCl3) δ: 1.30 (3H, d, J=6.1 Hz), 2.94 (1H, dd, J=13.8, 5.6 Hz), 3.11 (1H, dd, J=13.8, 6.7 Hz), 4.46-4.54 (1H, m), 6.76-6.81 (2H, m), 6.91-6.97 (2H, m), 7.41 (2H, d, J=8.3 Hz), 7.82 (2H, d, J=8.3 Hz), 9.98 (1H, s).
1H-NMR (CDCl3) δ: 1.46 (1H, brs), 2.28 (3H, s), 2.36 (3H, s), 3.04 (2H, t, J=7.2 Hz), 4.13 (2H, t, J=7.2 Hz), 4.68 (2H, d, J=4.9 Hz), 6.79 (2H, dt, J=9.2, 2.6 Hz), 7.07 (2H, dd, J=8.8, 0.7 Hz), 7.11-7.13 (2H, m), 7.29 (1H, d, J=7.3 Hz).
The following compounds were produced in the same manner as in Reference Example 1 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.35 (4H, t, J=5.0 Hz), 3.00-3.05 (2H, m), 3.39-3.43 (4H, m), 3.48 (2H, s), 3.79 (3H, s), 4.09-4.14 (2H, m), 6.84 (2H, d, J=8.6 Hz), 6.85 (2H, d, J=8.6 Hz), 7.20 (4H, d, J=8.6 Hz).
1H-NMR (CDCl3) δ: 1.44 (9H, s), 2.30-2.38 (7H, m), 3.04 (2H, t, J=7.3 Hz), 3.36-3.45 (6H, m), 4.13 (2H, t, J=7.3 Hz), 6.79-6.88 (2H, m), 7.08-7.25 (6H, m).
1H-NMR (CDCl3) δ: 1.24 (6H, d, J=6.9 Hz), 1.45 (9H, s), 2.35 (4H, t, J=4.9 Hz), 2.89 (1H, septet, J=6.9 Hz), 3.06 (2H, t, J=7.3 Hz), 3.36-3.47 (6H, m), 4.15 (2H, t, J=7.3 Hz), 6.79-6.88 (2H, m), 7.15-7.25 (6H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=6.9 Hz), 3.41 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.14 (2H t, J=6.9 Hz), 6.77-6.87 (2H, m), 6.90-7.00 (2H, m), 7.22 (2H, d, J=8.2 Hz), 7.26 (2H, d, J=8.2 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.03-2.13 (2H, m), 2.37 (4H, t, J=5.0 Hz), 2.79 (2H, t, J=7.6 Hz), 3.42 (4H, t, J=5.1 Hz), 3.48 (2H, s), 3.92 (2H, t, J=6.3 Hz), 6.78-6.87 (2H, m), 6.91-7.01 (2H, m), 7.15 (2H, d, J=8.2 Hz), 7.23 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 1.45 (9H, s), 2.03-2.13 (2H, m), 2.37 (4H, t, J=5.0 Hz), 2.79 (2H, t, J=7.6 Hz), 2.80-2.93 (1H, m), 3.42 (4H, t, J=5.0 Hz), 3.47 (2H, s), 3.94 (2H, t, J=6.3 Hz), 6.83 (2H, d, J=8.7 Hz), 7.13 (2H, d, J=8.4 Hz), 7.16 (2H, d, J=8.2 Hz), 7.22 (2H, d, J=8.2 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.41 (4H, t, J=4.6 Hz), 3.44 (4H, t, J=4.6 Hz), 3.63 (2H, s), 3.85 (3H, s), 6.91-6.99 (2H, m), 7.04 (1H, d, J=8.6 Hz), 7.12-7.22 (2H, m), 7.60 (1H, dd, J=8.6, 2.0 Hz), 7.63-7.68 (1H, m), 7.75 (1H, d, J=8.2 Hz), 8.06 (1H, d, J=8.9 Hz).
1H-NMR (CDCl3) δ: 1.29 (6H, d, J=6.9 Hz), 1.45 (9H, s), 2.42 (4H, t, J=4.9 Hz), 2.96 (1H, septet, J=6.9 Hz), 3.44 (4H, t, J=4.6 Hz), 3.64 (2H, s), 7.04 (1H, d, J=8.6 Hz), 7.12-7.20 (2H, m), 7.22-7.31 (2H, m), 7.55-7.68 (2H, m), 7.78 (1H, d, J=8.6 Hz), 8.07 (1H, d, J=8.9 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 1.45-1.46 (9H, m), 1.75-1.88 (2H, m), 2.58-2.66 (4H, m), 2.85 (1H, septet, J=6.8 Hz), 3.07 (2H, t, J=7.1 Hz), 3.42-3.51 (4H, m), 3.62 (2H, s), 4.14 (2H, t, J=7.1 Hz), 6.81-6.85 (2H, m), 7.11-7.14 (2H, m), 7.21-7.27 (4H, m).
1H-NMR (CDCl3) δ: 1.39 (3H, d, J=6.8 Hz), 1.45 (9H, s), 2.27 (3H, s), 2.38 (4H, t, J=5.0 Hz), 3.16-3.25 (1H, m), 3.42 (4H, t, J=5.0 Hz), 3.48 (2H, s), 3.91 (1H, dd, J=9.3, 7.8 Hz), 4.05 (1H, dd, J=9.3, 6.0 Hz), 6.78 (2H, dt, J=9.2, 2.6 Hz), 7.05 (2H, dd, J=8.7, 0.6 Hz), 7.23 (2H, d, J=8.3 Hz), 7.26 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 2.77-2.89 (3H, m), 2.89 (3H, s), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 3.49-3.58 (2H, m), 6.66-6.71 (2H, m), 7.08-7.14 (2H, m), 7.14-7.19 (2H, m), 7.21-7.26 (2H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37 (4H, t, J=4.9 Hz), 2.81 (2H, t, J=7.8 Hz), 2.86 (3H, s), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 3.48-3.55 (2H, m), 6.60-6.69 (2H, m), 6.90-6.98 (2H, m), 7.13 (2H, d, J=7.8 Hz), 7.23 (2H, d, J=7.8 Hz).
1H-NMR (CDCl3) δ: 1.46 (9H, s), 2.28 (3H, s), 2.39 (4H, t, J=5.0 Hz), 3.44 (4H, t, J=5.0 Hz), 3.56 (2H, s), 5.22 (2H, s), 6.83-6.86 (2H, m), 7.06-7.10 (2H, m), 7.46 (2H, d, J=8.3 Hz), 7.95-7.98 (2H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.29 (3H, s), 2.37 (4H, t, J=4.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.67 (2H, dd, J=5.8, 1.5 Hz), 6.40 (1H, dt, J=16.0, 5.8 Hz), 6.71 (1H, d, J=16.0 Hz), 6.86 (2H, dt, J=9.3, 2.5 Hz), 7.09 (2H, d, J=8.3 Hz), 7.27 (2H, d, J=8.1 Hz), 7.36 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38-2.39 (4H, m), 2.86 (6H, s), 3.05 (2H, t, J=7.1 Hz), 3.42-3.43 (4H, m), 3.48 (2H, s), 4.12 (2H, t, J=7.1 Hz), 6.73 (2H, d, J=9.0 Hz), 6.83 (2H, d, J=9.0 Hz), 7.22-7.23 (4H, m).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 1.45 (9H, s), 1.67-1.72 (1H, m), 1.98-2.03 (1H, m), 2.80-2.87 (1H, m), 3.03-3.07 (2.5H, m), 3.12-3.16 (0.5H, m), 3.32-3.59 (5H, m), 3.73-3.76 (2H, m), 4.12 (2H, t, J=7.1 Hz), 6.79-6.83 (2H, m), 7.09-7.13 (2H, m), 7.21-7.25 (4H, m).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=7.1 Hz), 1.46 (9H, s), 1.81-1.86 (1H, m), 2.04-2.10 (1H, m), 2.13 (3H, s), 2.80-2.87 (1H, m), 2.98-3.00 (1H, m), 3.06 (2H, t, J=7.1 Hz), 3.18-3.23 (2H, m), 3.43-3.65 (3.5H, m), 3.69-3.72 (0.5H, m), 4.13 (2H, t, J=7.1 Hz), 6.80-6.84 (2H, m), 7.09-7.12 (2H, m), 7.22-7.25 (4H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37 (4H, t, J=4.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.70 (2H, dd, J=5.8, 1.5 Hz), 6.41 (1H, dt, J=15.9, 5.8 Hz), 6.72 (1H, d, J=15.9 Hz), 6.94-6.97 (3H, m), 7.26-7.32 (4H, m), 7.36 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=5.0 Hz), 3.42 (4H, t, J=5.0 Hz), 3.50 (2H, s), 4.75 (2H, dd, J=5.9, 1.5 Hz), 6.36 (1H, dt, J=16.1, 5.9 Hz), 6.72 (1H, d, J=16.1 Hz), 6.98-7.02 (2H, m), 7.29 (2H, d, J=8.2 Hz), 7.36 (2H, d, J=8.2 Hz), 7.58-7.61 (2H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37 (4H, t, J=4.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 3.77 (3H, s), 4.65 (2H, dd, J=5.8, 1.2 Hz), 6.39 (1H, dt, J=15.9, 5.8 Hz), 6.70 (1H, d, J=15.9 Hz), 6.82-6.92 (4H, m), 7.27 (2H, d, J=7.6 Hz), 7.36 (2H, d, J=7.6 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.48 (4H, t, J=5.0 Hz), 3.53 (2H, s), 3.65-3.75 (4H, m), 4.66 (2H, dd, J=5.9, 1.3 Hz), 5.96 (1H, brs), 6.39 (1H, dt, J=15.9, 5.9 Hz), 6.70-6.79 (3H, m), 6.88-6.92 (2H, m), 6.95-7.00 (2H, m), 7.22-7.26 (3H, m), 7.29 (2H, d, J=8.3 Hz), 7.38 (2H, d, J=8.3 Hz), 7.59 (1H, d, J=15.1 Hz), 7.72 (1H, dd, J=3.1, 0.6 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.66 (2H, dd, J=5.7, 1.5 Hz), 6.38 (1H, dt, J=16.0, 5.7 Hz), 6.71 (1H, d, J=16.0 Hz), 6.87-6.92 (2H, m), 6.95-7.01 (2H, m), 7.28 (2H, d, J=8.2 Hz), 7.36 (2H, d, J=8.2 Hz).
1H-NMR (CDCl3) δ: 1.28 (3H, d, J=6.1 Hz), 1.45 (9H, s), 2.37 (4H, t, J=5.0 Hz), 2.80 (1H, dd, J=13.7, 6.6 Hz), 3.04 (1H, dd, J=13.7, 6.1 Hz), 3.42 (4H, t, J=5.0 Hz), 3.47 (2H, s), 4.42-4.50 (1H, m), 6.77-6.82 (2H, m), 6.90-6.96 (2H, m), 7.18 (2H, d, J=8.1 Hz), 7.23 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.23 (6H, d, J=6.8 Hz), 2.37 (4H, t, J=4.8 Hz), 2.81-2.92 (1H, m), 3.42 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.67 (2H, dd, J=5.7, 1.2 Hz), 6.40 (1H, dt, J=16.0, 5.7 Hz), 6.71 (1H, d, J=16.0 Hz), 6.87-6.91 (2H, m), 7.13-7.16 (2H, m), 7.26-7.28 (2H, m), 7.36 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 1.46 (9H, s), 2.38 (4H, t, J=5.0 Hz), 3.42 (4H, t, J=5.0 Hz), 3.50 (2H, s), 4.73 (2H, dd, J=5.9, 1.5 Hz), 6.35 (1H, dt, J=16.0, 5.9 Hz), 6.73 (1H, d, J=16.0 Hz), 7.24 (2H, d, J=1.9 Hz), 7.29 (2H, d, J=8.1 Hz), 7.36 (2H, d, J=8.1 Hz), 8.12 (1H, t, J=1.9 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=5.0 Hz), 2.49 (3H, s), 3.42 (4H, t, J=5.0 Hz), 3.49 (2H, s), 4.72 (2H, dd, J=5.9, 1.5 Hz), 6.38 (1H, dt, J=15.9, 5.9 Hz), 6.72 (1H, d, J=15.9 Hz), 7.07 (1H, d, J=8.5 Hz), 7.16 (1H, dd, J=8.5, 2.8 Hz), 7.28 (2H, d, J=8.1 Hz), 7.36 (2H, d, J=8.1 Hz), 8.25 (1H, d, J=2.8 Hz).
1H-NMR (CDCl3) δ: 2.25 (3H, s), 2.38 (4H, brs), 3.48-3.49 (6H, m), 4.24 (1H, t, J=6.8 Hz), 4.42 (2H, d, J=6.8 Hz), 4.97 (2H, dd, J=6.1, 1.5 Hz), 6.46 (1H, dt, J=16.0, 6.0 Hz), 6.70-6.74 (2H, m), 7.26-7.32 (4H, m), 7.37-7.42 (5H, m), 7.56 (2H, dd, J=7.3, 0.7 Hz), 7.76 (2H, d, J=7.6 Hz), 7.96-7.97 (1H, m).
1H-NMR (CDCl3) δ: 2.38 (4H, s), 3.49-3.50 (6H, m), 4.24 (1H, t, J=6.7 Hz), 4.43 (2H, d, J=6.7 Hz), 4.97 (2H, dd, J=6.2, 1.5 Hz), 6.44 (1H, dt, J=16.0, 6.2 Hz), 6.70-6.74 (2H, m), 7.28-7.32 (4H, m), 7.37-7.42 (4H, m), 7.57 (2H, dd, J=7.3, 0.7 Hz), 7.66 (1H, dd, J=8.8, 2.6 Hz), 7.76 (2H, d, J=7.3 Hz), 8.21 (1H, dd, J=2.6, 0.7 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 1.63 (1H, brs), 2.38 (4H, t, J=5.0 Hz), 3.42 (4H, t, J=5.0 Hz), 3.49 (2H, s), 4.32 (2H, d, J=5.6 Hz), 6.36 (1H, dt, J=15.9, 5.6 Hz), 6.61 (1H, d, J=15.9 Hz), 7.25-7.27 (2H, m), 7.34 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) 1.45 (9H, s), 2.06-2.13 (2H, m), 2.37 (4H, t, J=5.0 Hz), 2.80 (2H, t, J=7.7 Hz), 3.42 (4H, t, J=5.0 Hz), 3.47 (2H, s), 3.97 (2H, t, J=6.3 Hz), 6.88-6.95 (3H, m), 7.16 (2H, d, J=8.1 Hz), 7.22 (2H, d, J=8.1 Hz), 7.25-7.30 (2H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.08-2.15 (2H, m), 2.37 (4H, t, J=5.0 Hz), 2.79 (2H, t, J=7.6 Hz), 3.42 (4H, t, J=5.0 Hz), 3.48 (2H, s), 3.98 (2H, t, J=6.2 Hz), 7.14-7.18 (3H, m), 7.21-7.25 (3H, m), 8.04 (1H, dd, J=3.1, 0.6 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.37-2.38 (4H, m), 3.10 (2H, t, J=7.0 Hz), 3.42-3.43 (4H, m), 3.47 (2H, s), 4.14 (2H, t, J=7.0 Hz), 6.81 (2H, d, J=8.8 Hz), 7.03-7.05 (2H, m), 7.20-7.23 (3H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.06-2.11 (2H, m), 2.28 (3H, s), 2.37 (4H, t, J=5.0 Hz), 2.79 (2H, t, J=7.7 Hz), 3.42 (4H, t, J=5.0 Hz), 3.47 (2H, s), 3.93 (2H, t, J=6.3 Hz), 6.79 (2H, dt, J=9.2, 2.6 Hz), 7.05-7.08 (2H, m), 7.16 (2H, d, J=8.2 Hz), 7.22 (2H, d, J=8.2 Hz).
To a THF (10 mL) solution of 2-(2-fluoro-4-{2-[4-(trifluoromethyl)phenoxy]-ethyl}phenyl)-1,3-dioxolane (0.552 g) was added 6 M HCl (0.775 mL) at 0° C., then the resultant mixture was room temperature for 5 hours. The reaction mixture was evaporated to afford a pale yellow oil. To a CH2Cl2 (15 mL) solution of that pale yellow oil and tert-Butyl 1-piperazinecarboxylate (0.375 g) were added NaB(OAc)3 (0.657 g) at 0° C. The resultant mixture was stirred at room temperature for 3 days. To the reaction mixture was added saturated aqueous NaHCO3, and extracted with CH2Cl2. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous MgSO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=9/1 to 4/1) to afford tert-butyl 4-(2-fluoro-4-{2-[4-(trifluoromethyl)phenoxy]ethyl}benzyl)piperazine-1-carboxylate as a colorless oil (0.511 g).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.41-2.42 (4H, m), 3.09 (2H, t, J=6.7 Hz), 3.42-3.43 (4H, m), 3.57 (2H, s), 4.20 (2H, t, J=6.7 Hz), 6.93-7.04 (4H, m), 7.29-7.31 (1H, m), 7.53 (2H, d, J=8.5 Hz).
To a solution of tert-butyl 4-[4-(2-{(4-methoxyphenyl)[(2-nitrophenyl)sulfonyl]-amino}ethyl)benzyl]piperazine-1-carboxylate in DMF (35 mL) was added mercaptoacetic acid (1.35 mL) and LiOH (1.63 g) at room temperature, then the reaction mixture was stirred over night. The reaction mixture was added mercaptoacetic acid (1.35 mL) and LiOH (1.63 g), and stirred for 5 hours. The reaction mixture was diluted with H2O, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/1 to 1/2) to afford tert-butyl 4-(4-{2-[(4-methoxyphenyl)amino]ethyl}benzyl)piperazine-1-carboxylate as a pale yellow amorphous (5.96 g).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 2.85-2.93 (2H, m), 3.45 (2H, t, J=7.1
Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 3.75 (3H, s), 6.55-6.61 (2H, m), 6.75-6.81 (2H, m), 7.16 (2H, d, J=8.1 Hz), 7.23-7.30 (2H, m).
The following compounds were produced in the same manner as in Reference Example 226 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.20 (6H, d, J=6.8 Hz), 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 2.80 (1H, septet, J=6.8 Hz), 2.90 (2H, t, J=6.8 Hz), 3.37 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 3.57 (1H, brs), 6.52-6.59 (2H, m), 7.01-7.08 (2H, m), 7.14-7.21 (2H, m), 7.22-7.28 (2H, m).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 2.88 (2H, t, J=7.1 Hz), 3.34 (2H, t, J=7.1 Hz), 3.42 (4H, t, J=4.9 Hz), 3.48 (2H, s), 6.49-6.57 (2H, m), 6.82-6.92 (2H, m), 7.13-7.20 (2H, m), 7.22-7.27 (2H, m).
1H-NMR (CDCl3) δ: 1.20 (6H, d, J=6.8 Hz), 1.25-1.39 (2H, m), 1.47 (9H, s), 1.98-2.08 (2H, m), 2.75-2.84 (3H, m), 2.92 (2H, t, J=11.5 Hz), 3.31 (2H, t, J=6.8 Hz), 3.35-3.60 (3H, m), 3.95-4.10 (2H, m), 6.52-6.60 (4H, m), 7.00-7.09 (4H, m).
To a solution of 3-[4-(diethoxymethyl)phenyl]propan-1-ol (2.27 g), 5-hydroxy-2-methylpyridine (1.25 g), and triphenylphosphine (3.00 g) in THF (19 mL) was added 2.2 M solution of DEAD in toluene (5.20 mL). After stirring at room temperature for 1 hour, to the reaction mixture was added H2O, and extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=17/3 to 13/7) to afford a colorless oil (3.86 g). To a solution of that colorless oil (3.86 g) in THF (50 mL) was added 6 M aqueous HCl (1.59 mL). After stirring at room temperature for 30 minutes, to the reaction mixture was added 5 M aqueous NaOH, and the solvent was removed under reduced pressure. To the residue was added saturated aqueous NaHCO3, and extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=3/1 to 13/7) to afford a colorless oil (2.93 g). To a solution of that colorless oil (2.93 g) in (CH2Cl)2 (95 mL) was added tert-butyl piperazine-1-carboxylate (1.95 g) and NaBH(OAc)3 (4.45 g). After stirring at room temperature for 37 hours, to the reaction mixture was added saturated aqueous NaHCO3, and extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=3/1 to 1/1) to afford tert-butyl 4-(4-{3-[(6-methylpyridin-3-yl)oxy]propyl}benzyl)piperazine-1-carboxylate as a colorless oil (1.37 g).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.06-2.13 (2H, m), 2.37 (4H, t, J=5.0 Hz), 2.49 (3H, s), 2.79 (2H, t, J=7.7 Hz), 3.42 (4H, t, J=5.0 Hz), 3.47 (2H, s), 3.97 (2H, t, J=6.3 Hz), 7.04 (1H, d, J=8.4 Hz), 7.09 (1H, dd, J=8.4, 2.9 Hz), 7.15 (2H, d, J=8.2 Hz), 7.23 (2H, d, J=8.2 Hz), 8.18 (1H, dd, J=2.9, 0.7 Hz).
To an EtOH (25 mL) solution of tert-butyl 4-{4-[2-(4-fluorophenoxy)ethyl]-benzyl}piperazine-1-carboxylate (2.36 g) was added 6 M HCl (9.49 mL) at room temperature. After stirring at 40° C. for 3 hours, the solvent was removed under reduced pressure. The resulting precipitate was collected by filtration, and dissolved in water. The solution was alkalified with 5 M NaOH, and extracted with CH2Cl2. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous MgSO4, and concentrated under reduced pressure to afford 1-{4-[2-(4-fluorophenoxy)ethyl]benzyl}piperazine as a colorless oil (1.47 g).
1H-NMR (CDCl3) δ: 1.67 (1H, brs), 2.41 (4H, m), 2.88 (4H, t, J=4.6 Hz), 3.06 (2H, t, J=6.9 Hz), 3.47 (2H, s), 4.12 (2H, t, J=6.9 Hz), 6.78-6.86 (2H, m), 6.90-7.00 (2H, m), 7.21 (2H, d, J=7.9 Hz), 7.27 (2H, d, J=7.9 Hz).
The following compounds were produced in the same manner as in Reference Example 231 using appropriate starting materials.
1H-NMR (CDCl3) δ: 2.38 (4H, brs), 2.52 (1H, brs), 2.87 (4H, t, J=5.0 Hz), 3.00-3.05 (2H, m), 3.41 (2H, s), 3.79 (3H, s), 4.12 (2H, t, J=7.3 Hz), 6.84 (2H, d, J=8.6 Hz), 6.85 (2H, d, J=8.6 Hz), 7.18-7.21 (4H, m).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 1.68 (1H, brs), 2.41 (4H, m), 2.81-2.90 (5H, m), 3.49 (2H, s), 5.01 (2H, s), 6.88-6.93 (2H, m), 7.13-7.17 (2H, m), 7.33 (2H, d, J=8.2 Hz), 7.38 (2H, d, J=8.2 Hz).
1H-NMR (CDCl3) δ: 2.41 (4H, brs), 2.87-2.90 (4H, m), 3.50 (2H, s), 5.06 (2H, s), 6.31-6.32 (2H, m), 6.99-7.03 (4H, m), 7.30 (2H, d, J=8.9 Hz), 7.35 (2H, d, J=8.9 Hz), 7.39 (2H, d, J=8.6 Hz).
1H-NMR (DMSO-d6) δ: 2.26-2.28 (5H, m), 2.67 (4H, t, J=4.6 Hz), 3.41 (2H, s), 5.04 (2H, s), 6.98-7.05 (2H, m), 7.07-7.15 (2H, m), 7.29 (2H, d, J=7.9 Hz), 7.38 (2H, d, J=7.9 Hz).
1H-NMR (DMSO-d6) δ: 2.26-2.36 (5H, m), 2.67 (4H, t, J=4.9 Hz), 3.40 (2H, s), 4.49 (2H, s), 4.49 (2H, s), 7.14-7.21 (2H, m), 7.24-7.31 (4H, m), 7.36-7.42 (2H, m).
1H-NMR (CDCl3) δ: 1.24 (6H, d, J=6.9 Hz), 1.71-1.78 (1H, m), 2.41 (4H, brs), 2.86-2.96 (5H, m), 3.48 (2H, s), 4.53 (2H, s), 4.53 (2H, s), 7.20-7.31 (8H, m).
1H-NMR (CDCl3) δ: 1.74 (1H, brs), 2.41 (4H, m), 2.89 (4H, t, J=4.9 Hz), 3.05 (2H, t, J=7.3 Hz), 3.47 (2H, s), 3.76 (3H, s), 4.11 (2H, t, J=7.3 Hz), 6.79-6.85 (4H, m), 7.20-7.28 (4H, m).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.9 Hz), 1.68 (1H, brs), 2.41 (4H, m), 2.79-2.90 (5H, m), 3.06 (2H, t, J=6.9 Hz), 3.46 (2H, s), 4.14 (2H, t, J=6.9 Hz), 6.80-6.85 (2H, m), 7.10-7.14 (2H, m), 7.20-7.27 (4H, m).
1H-NMR (CDCl3) δ: 1.67 (1H, brs), 2.28 (3H, s), 2.41 (4H, brs), 2.88 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=6.9 Hz), 3.47 (2H, s), 4.13 (2H, t, J=6.9 Hz), 6.79 (2H, d, J=8.6 Hz), 7.06 (2H, d, J=8.6 Hz), 7.20-7.28 (4H, m).
1H-NMR (CDCl3) δ: 2.42 (4H, brs), 2.52 (1H, brs), 2.90 (4H, t, J=5.0 Hz), 3.03-3.08 (2H, m), 3.47 (2H, s), 4.09-4.14 (2H, m), 6.85 (2H, d, J=9.2 Hz), 7.17-7.22 (4H, m), 7.26 (2H, d, J=8.2 Hz).
1H-NMR (CDCl3) δ: 2.44-2.45 (4H, m), 2.91 (4H, t, J=5.0 Hz), 3.03-3.09 (2H, m), 3.47 (2H, s), 4.09-4.14 (2H, m), 6.74-6.78 (2H, m), 7.21 (2H, d, J=7.9 Hz), 7.26 (2H, d, J=7.9 Hz), 7.33-7.36 (2H, m).
1H-NMR (CDCl3) δ: 2.41 (4H, brs), 2.89 (4H, t, J=4.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.47 (2H, s), 4.57 (2H, t, J=7.1 Hz), 6.80 (1H, d, J=8.6 Hz), 7.20-7.29 (4H, m), 7.75 (1H, dd, J=9.2, 2.6 Hz), 8.41-8.43 (1H, m).
1H-NMR (CDCl3) δ: 1.59 (1H, brs), 2.31 (3H, s), 2.34-2.47 (4H, m), 2.88 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.3 Hz), 3.47 (2H, s), 4.14 (2H, t, J=7.3 Hz), 6.66-6.79 (3H, m), 7.10-7.30 (5H, m).
1H-NMR (CDCl3) δ: 1.23 (6H, d, J=6.9 Hz), 1.61 (1H, brs), 2.30-2.50 (4H, m), 2.77-2.96 (5H, m), 3.08 (2H, t, J=7.3 Hz), 3.47 (2H, s), 4.16 (2H, t, J=7.3 Hz), 6.71 (1H, dd, J=8.2, 2.6 Hz), 6.75-6.85 (2H, m), 7.14-7.31 (5H, m).
1H-NMR (CDCl3) δ: 1.85 (1H, brs), 2.30-2.58 (4H, m), 2.88 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.3 Hz), 3.47 (2H, s), 3.77 (3H, s), 4.14 (2H, t, J=7.3 Hz), 6.44-6.54 (3H, m), 7.16 (1H, t, J=8.2 Hz), 7.20-7.30 (4H, m).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.22 (3H, s), 2.82-2.55 (4H, m), 2.90 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=7.3 Hz), 3.47 (2H, s), 4.12 (2H, t, J=7.3 Hz), 6.64 (1H, dd, J=8.2, 2.6 Hz), 6.71 (1H, d, J=2.6 Hz), 7.01 (1H, d, J=8.2 Hz), 7.15-7.30 (4H, m).
1H-NMR (CDCl3) δ: 1.29 (9H, s), 1.76 (1H, s), 2.40 (4H, brs), 2.88 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=6.9 Hz), 3.46 (2H, s), 4.14 (2H, t, J=6.9 Hz), 6.80-6.86 (2H, m), 7.20-7.31 (6H, m).
1H-NMR (CDCl3) δ: 1.45 (1H, s), 2.03-2.13 (2H, m), 2.41 (4H, brs), 2.78 (2H, t, J=7.6 Hz), 2.88 (4H, t, J=4.9 Hz), 3.46 (2H, s), 3.92 (2H, t, J=6.3 Hz), 6.79-6.86 (2H, m), 6.91-7.00 (2H, m), 7.15 (2H, d, J=8.1 Hz), 7.24 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 1.45 (1H, s), 2.03-2.13 (2H, m), 2.41 (4H, brs), 2.78 (2H, t, J=7.6 Hz), 2.80-2.90 (1H, m), 2.88 (4H, t, J=4.9 Hz), 3.46 (2H, s), 3.94 (2H, t, J=6.3 Hz), 6.83 (2H, d, J=8.7 Hz), 7.13 (2H, d, J=8.7 Hz), 7.15 (2H, d, J=8.2 Hz), 7.23 (2H, d, J=8.1 Hz).
1H-NMR (DMSO-c4) δ: 2.22 (3H, s), 3.04 (2H, t, J=6.6 Hz), 3.01-3.80 (8H, m), 4.16 (2H, t, J=6.8 Hz), 4.33 (2H, s), 6.82 (2H, d, J=8.6 Hz), 7.07 (2H, d, J=8.6 Hz), 7.40 (2H, d, J=7.9 Hz), 7.57 (2H, d, J=7.6 Hz), 9.67 (1H, s), 12.14 (1H, s).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47 (4H, s), 2.74 (1H, s), 2.94 (4H, t, J=4.8 Hz), 3.09 (2H, t, J=6.8 Hz), 3.48 (2H, s), 4.16 (2H, t, J=6.4 Hz), 6.77-6.86 (2H, m), 7.09-7.15 (2H, m), 7.25 (4H, s).
1H-NMR (CDCl3) δ: 0.91 (3H, t, J=7.3 Hz), 1.26-1.40 (2H, m), 1.50-1.61 (2H, m), 2.40 (4H, s), 2.54 (2H, t, J=7.7 Hz), 2.88 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=7.1 Hz), 3.46 (2H, s), 4.13 (2H, t, J=7.1 Hz), 6.78-6.83 (2H, m), 7.04-7.10 (2H, m), 7.20-7.28 (4H, m).
1H-NMR (DMSO-d6) δ: 3.05 (2H, t, J=6.6 Hz), 3.12-3.60 (8H, m), 4.19 (2H, t, J=6.6 Hz), 4.31 (2H, s), 6.90-6.98 (2H, m), 7.06-7.15 (2H, m), 7.41 (2H, d, J=7.9 Hz), 7.56 (2H, d, J=7.9 Hz), 9.56 (1H, brs), 12.01 (1H, brs).
1H-NMR (CDCl3) δ: 1.59 (1H, brs), 2.40 (4H, m), 2.88 (4H, t, J=4.9 Hz), 3.04 (2H, t, J=6.9
Hz), 3.46 (2H, s), 4.08 (2H, t, J=6.9 Hz), 5.90 (2H, s), 6.31 (1H, dd, J=8.6, 2.6 Hz), 6.48 (1H, d, J=2.6 Hz), 6.68 (1H, d, J=8.6 Hz), 7.20 (2H, d, J=8.2 Hz), 7.27 (2H, d, J=8.2 Hz).
1H-NMR (DMSO-d6) δ: 3.09 (2H, t, J=6.3 Hz), 3.34-3.52 (10H, m), 4.22-4.34 (2H, m), 6.93 (1H, t, J=7.6 Hz), 7.14 (1H, d, J=7.9 Hz), 7.24-7.31 (1H, m), 7.38-7.46 (3H, m), 7.56 (2H, d, J=6.9 Hz), 9.61 (2H, s).
1H-NMR (DMSO-d6) δ: 2.75 (2H, t, J=6.9 Hz), 2.92-3.42 (7H, m), 3.62 (2H, t, J=6.9 Hz), 4.11-4.45 (4H, m), 7.29 (2H, d, J=7.3 Hz), 7.52 (2H, d, J=5.0 Hz), 9.85 (2H, s), 12.20 (1H, s).
1H-NMR (DMSO-d6) δ: 2.01 (3H, s), 2.18 (3H, s), 3.08 (2H, t, J=6.3 Hz), 3.21-3.55 (8H, m), 4.15 (2H, t, J=6.3 Hz), 4.33 (2H, s), 6.73 (1H, d, J=7.3 Hz), 6.78 (1H, d, J=8.3 Hz), 7.01 (1H, t, J=7.8 Hz), 7.42 (2H, d, J=7.8 Hz), 7.57 (2H, d, J=6.8 Hz), 9.65 (2H, s), 12.07 (1H, s).
1H-NMR (DMSO-d6) δ: 2.21 (6H, s), 3.04 (2H, t, J=6.3 Hz), 3.22-3.59 (8H, m), 4.15 (2H, t, J=6.6 Hz), 4.35 (2H, s), 6.53-6.57 (3H, m), 7.40 (2H, d, J=7.8 Hz), 7.59 (2H, d, J=7.8 Hz), 9.80 (2H, s), 12.00-12.31 (1H, m).
1H-NMR (DMSO-d6) δ: 1.29 (3H, t, J=6.8 Hz), 2.90-3.80 (10H, m), 3.98 (2H, q, J=6.8 Hz), 4.19 (2H, t, J=6.8 Hz), 4.35 (2H, brs), 6.44-6.54 (3H, m), 7.15 (1H, t, J=8.1 Hz), 7.41 (2H, d, J=7.8 Hz), 7.57 (2H, d, J=6.6 Hz), 9.65 (1H, brs), 12.11 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.20 (2H, t, J=6.6 Hz), 3.31-3.86 (8H, m), 4.38 (2H, s), 4.43 (2H, t, J=6.6 Hz), 7.48 (2H, d, J=8.3 Hz), 7.59 (2H, dd, J=33.2, 7.8 Hz), 7.73-7.80 (2H, m), 7.97 (1H, dd, J=8.1, 5.1 Hz), 8.31 (1H, d, J=9.3 Hz), 8.92 (1H, d, J=7.8 Hz), 9.08 (1H, d, J=4.4 Hz), 9.86 (2H, s), 12.27 (1H, s).
1H-NMR (CDCl3) δ: 2.75 (4H, t, J=4.9 Hz), 3.12 (2H, t, J=6.8 Hz), 3.20-3.22 (4H, m), 3.55 (2H, s), 4.26 (2H, t, J=6.8 Hz), 6.94 (2H, d, J=9.2 Hz), 7.24 (4H, brs), 8.18 (2H, d, J=9.5 Hz).
1H-NMR (CDCl3) δ: 1.68 (1H, brs), 2.41 (4H, brs), 2.88 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.96 (2H, s), 5.91 (2H, s), 6.39 (1H, dd, J=8.5, 2.4 Hz), 6.56 (1H, d, J=2.4 Hz), 6.70 (1H, d, J=8.5 Hz), 7.30-7.39 (4H, m).
1H-NMR (DMSO-d6) δ: 3.07 (2H, t, J=6.5 Hz), 3.23-3.56 (8H, m), 4.26 (2H, t, J=6.6 Hz), 4.36 (2H, s), 6.97 (1H, dd, J=8.9, 2.6 Hz), 7.25 (1H, d, J=2.4 Hz), 7.41 (2H, d, J=7.8 Hz), 7.51 (1H, d, J=9.0 Hz), 7.61 (2H, d, J=7.6 Hz), 9.92 (2H, s), 12.28 (1H, s).
1H-NMR (DMSO-d6) δ: 2.19 (3H, d, J=2.0 Hz), 3.04 (2H, t, J=6.9 Hz), 3.11-3.61 (8H, m), 4.16 (2H, t, J=6.9 Hz), 4.34 (2H, brs), 6.72-6.77 (1H, m), 6.85 (1H, dd, J=6.2, 3.1 Hz), 7.00-7.04 (1H, m), 7.40 (2H, d, J=8.1 Hz), 7.57 (2H, d, J=6.1 Hz), 9.65 (2H, brs), 12.11 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.26 (3H, s), 3.06 (2H, t, J=6.6 Hz), 3.10-3.60 (8H, m), 4.18 (2H, t, J=6.8 Hz), 4.34 (2H, s), 6.71-6.75 (3H, m), 7.15 (1H, t, J=7.6 Hz), 7.41 (2H, d, J=7.8 Hz), 7.57 (2H, d, J=7.3 Hz), 9.63 (1H, s), 12.10 (1H, s).
1H-NMR (DMSO-d6) δ: 2.95-3.61 (10H, m), 4.26-4.33 (4H, m), 7.00-7.07 (4H, m), 7.33-7.37 (2H, m), 7.54 (2H, brs), 9.53 (2H, brs), 11.87 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.26-3.40 (8H, m), 4.35 (2H, s), 7.09 (4H, dd, J=8.4, 5.5 Hz), 7.47 (2H, d, J=8.8 Hz), 7.66 (2H, d, J=8.1 Hz), 9.71 (2H, s), 12.12 (1H, s).
1H-NMR (DMSO-d6) δ: 2.23 (3H, s), 2.93-3.60 (10H, m), 4.27-4.33 (4H, m), 6.85-6.88 (2H, m), 7.08-7.14 (4H, m), 7.54-7.56 (2H, m), 9.59 (2H, brs), 11.92 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.67-1.70 (4H, m), 2.61-2.66 (4H, m), 3.03 (2H, t, J=6.7 Hz), 3.29-3.45 (8H, m), 4.14 (2H, t, J=6.7 Hz), 4.34 (2H, brs), 6.58-6.61 (1H, m), 6.65 (1H, dd, J=8.3, 2.7 Hz), 6.93 (1H, d, J=8.5 Hz), 7.40 (2H, d, J=8.1 Hz), 7.56-7.58 (2H, m), 9.65 (2H, brs), 12.10 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.94-1.99 (2H, m), 2.76-2.80 (4H, m), 3.04 (2H, t, J=6.6 Hz), 3.29-3.44 (8H, m), 4.16 (2H, t, J=6.6 Hz), 4.34 (2H, brs), 6.67 (1H, dd, J=8.2, 2.3 Hz), 6.80 (1H, d, J=2.0 Hz), 7.08 (1H, d, J=8.1 Hz), 7.40 (2H, d, J=7.3 Hz), 7.58 (2H, d, J=7.8 Hz), 9.76 (2H, brs), 12.17 (1H, brs).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 1.70-1.79 (3H, m), 2.63-2.69 (4H, m), 2.81-2.91 (3H, m), 2.96 (2H, t, J=6.1 Hz), 3.07 (2H, t, J=7.1 Hz), 3.63 (2H, s), 4.14 (2H, t, J=7.1 Hz), 6.81-6.85 (2H, m), 7.11-7.13 (2H, m), 7.22 (2H, d, J=8.1 Hz), 7.28 (2H, d, J=8.1 Hz).
1H-NMR (DMSO-d6) δ: 3.20-3.58 (8H, m), 4.40 (2H, s), 7.40 (1H, t, J=7.2 Hz), 7.49 (2H, t, J=7.6 Hz), 7.68-7.78 (6H, m), 9.78 (2H, s), 12.31 (1H, s).
1H-NMR (DMSO-d6) δ: 1.21 (6H, d, J=6.8 Hz), 2.85-2.96 (1H, m), 3.16-3.48 (8H, m), 4.33 (2H, s), 6.98 (2H, d, J=8.5 Hz), 7.02 (2H, d, J=8.5 Hz), 7.29 (2H, d, J=8.3 Hz), 7.61-7.62 (2H, m), 9.69 (2H, s), 12.07 (1H, s).
1H-NMR (DMSO-d6) δ: 3.13-3.71 (10H, m), 4.32-4.35 (4H, m), 7.15 (1H, dd, J=8.9, 2.6 Hz), 7.32-7.36 (2H, m), 7.43-7.47 (3H, m), 7.61 (2H, d, J=7.1 Hz), 7.79-7.83 (3H, m), 9.73 (2H, brs), 12.18 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.08 (2H, t, J=6.7 Hz), 3.17-3.47 (8H, m), 4.31 (2H, t, J=6.7 Hz), 4.36 (2H, brs), 7.40-7.42 (3H, m), 7.54 (1H, d, J=8.5 Hz), 7.59-7.61 (2H, m), 8.12 (1H, d, J=3.2 Hz), 9.85 (2H, brs), 12.26 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.90-3.70 (8H, m), 4.29 (2H, s), 5.62 (2H, s), 7.05 (2H, d, J=8.5 Hz), 7.43 (2H, t, J=8.8 Hz), 7.53 (2H, d, J=7.6 Hz), 8.10-8.14 (2H, m), 9.52 (1H, s), 11.82 (1H, s).
1H-NMR (CDCl3) δ: 2.46 (4H, brs), 2.54 (3H, s), 2.93 (4H, t, J=4.9 Hz), 2.99 (1H, brs), 3.10 (2H, t, J=7.1 Hz), 3.48 (2H, s), 4.22 (2H, t, J=7.1 Hz), 6.90-6.93 (2H, m), 7.22-7.28 (4H, m), 7.90-7.93 (2H, m).
1H-NMR (DMSO-d6) δ: 3.06 (2H, t, J=6.8 Hz), 3.17-3.56 (8H, m), 4.35 (2H, s), 4.46 (2H, t, J=6.8 Hz), 6.85 (1H, dd, J=8.8, 0.5 Hz), 7.38 (2H, d, J=8.1 Hz), 7.59 (2H, d, J=7.8 Hz), 7.79 (1H, dd, J=8.8, 2.7 Hz), 8.20 (1H, t, J=1.5 Hz), 9.87 (2H, brs), 12.26 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.08 (2H, t, J=6.8 Hz), 3.28-3.66 (8H, m), 4.37 (2H, s), 4.50 (2H, t, J=6.8 Hz), 6.86 (1H, dd, J=5.0, 4.3 Hz), 7.00-7.02 (1H, m), 7.40 (2H, d, J=8.1 Hz), 7.61 (2H, d, J=8.1 Hz), 7.74-7.78 (1H, m), 8.15-8.19 (1H, m), 9.96 (2H, brs), 12.28 (1H, brs).
1H-NMR (DMSO-d6) δ: 0.53-0.57 (2H, m), 0.82-0.88 (2H, m), 1.80-1.87 (1H, m), 3.04 (2H, t, J=6.7 Hz), 3.17-3.50 (8H, m), 4.16 (2H, t, J=6.7 Hz), 4.34 (2H, brs), 6.79-6.83 (2H, m), 6.97-6.99 (2H, m), 7.40 (2H, d, J=7.8 Hz), 7.55 (2H, brs), 9.55 (2H, brs), 12.03 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.25-3.46 (8H, m), 4.31 (2H, s), 5.14 (2H, s), 7.02-7.07 (2H, m), 7.11-7.18 (2H, m), 7.36-7.43 (2H, m), 7.73 (1H, s), 9.56 (2H, s).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 1.69 (1H, brs), 2.32-2.57 (4H, m), 2.77-2.93 (10H, m), 3.45-3.55 (4H, m), 6.66-6.72 (2H, m), 7.08-7.14 (2H, m), 7.14-7.19 (2H, m), 7.21-7.28 (2H, m).
1H-NMR (DMSO-d6) δ: 0.87 (3H, t, J=7.3 Hz), 1.53-1.56 (2H, m), 2.67-3.35 (8H, m), 3.80-3.87 (2H, m), 4.32-4.34 (2H, m), 5.10 (2H, s), 6.93 (2H, d, J=8.5 Hz), 7.11 (2H, d, J=8.5 Hz), 7.42-7.60 (3H, br m), 9.51 (2H, s), 12.27 (1H, s).
1H-NMR (DMSO-d6) δ: 3.13-3.48 (8H, m), 4.28-4.30 (2H, m), 5.13 (2H, s), 7.04-7.07 (2H, m), 7.13-7.16 (2H, m), 7.44-7.46 (1H, m), 7.61-7.64 (2H, m), 9.44-9.47 (2H, m), 12.17-12.20 (1H, m).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=6.1 Hz), 2.40-2.43 (4H, m), 2.89-2.90 (4H, m), 3.47 (2H, s), 4.39-4.45 (1H, m), 5.05 (2H, s), 6.83 (2H, d, J=9.0 Hz), 6.90 (2H, d, J=9.0 Hz), 7.10 (2H, d, J=9.5 Hz), 7.42 (1H, t, J=7.6 Hz).
1H-NMR (DMSO-d6) δ: 1.20 (6H, d, J=6.8 Hz), 2.91 (1H, septet, J=6.8 Hz), 3.00-4.20 (13H, m), 4.37 (2H, s), 7.36 (4H, t, J=7.8 Hz), 7.43 (2H, d, J=7.8 Hz), 7.61 (2H, d, J=8.1 Hz), 9.89 (2H, brs), 12.27 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.60-4.60 (18H, m), 7.20-7.70 (8H, m), 9.88 (2H, brs), 12.27 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.98 (2H, t, J=8.1 Hz), 3.10-3.60 (14H, m), 7.17 (4H, brs), 7.36 (2H, d, J=8.3 Hz), 7.58 (2H, d, J=8.1 Hz), 9.67 (2H, brs), 12.11 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.08 (2H, t, J=6.6 Hz), 3.24-3.43 (8H, m), 4.30-4.33 (4H, m), 7.40-7.43 (3H, m), 7.47-7.51 (1H, m), 7.57-7.59 (2H, m), 8.12 (1H, dd, J=3.2, 0.5 Hz), 9.72 (2H, brs), 12.18 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.21 (3H, s), 3.06 (2H, t, J=6.8 Hz), 3.25 (2H, brs), 3.41-3.62 (4H, m), 4.36-4.47 (6H, m), 6.78 (1H, d, J=8.5 Hz), 7.39 (2H, d, J=8.3 Hz), 7.59-7.61 (3H, m), 7.99 (1H, dd, J=1.6, 0.9 Hz), 9.83 (2H, brs), 12.23 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.61 (3H, s), 3.11 (2H, t, J=6.7 Hz), 3.24-3.74 (8H, m), 4.33 (2H, brs), 4.42 (2H, t, J=6.7 Hz), 7.42 (2H, d, J=8.1 Hz), 7.58-7.60 (2H, m), 7.71 (1H, dd, J=8.8, 2.9 Hz), 7.97-7.99 (1H, m), 8.46 (1H, d, J=2.7 Hz), 9.65 (2H, brs), 11.53 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.41 (3H, s), 2.90-3.65 (8H, m), 4.30 (2H, brs), 5.59 (2H, s), 7.03 (2H, d, J=8.8 Hz), 7.39 (2H, d, J=7.8 Hz), 7.53 (2H, d, J=7.1 Hz), 7.92-7.95 (2H, m), 9.58 (1H, brs), 11.92 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.06 (2H, t, J=6.8 Hz), 3.40-3.53 (8H, m), 4.33 (2H, brs), 4.46 (2H, t, J=6.8 Hz), 6.81 (1H, dd, J=8.8, 0.5 Hz), 7.38 (2H, d, J=7.8 Hz), 7.54-7.56 (2H, m), 7.89 (1H, dd, J=8.8, 2.7 Hz), 8.28 (1H, dd, J=2.7, 0.5 Hz), 9.59 (2H, brs), 12.06 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.00-3.70 (15H, m), 3.77 (3H, s), 4.33 (2H, brs), 7.00-7.10 (2H, m), 7.35 (2H, d, J=8.1 Hz), 7.40-7.51 (2H, m), 7.57 (2H, d, J=7.6 Hz), 9.64 (2H, brs).
1H-NMR (DMSO-d6) δ: 2.39 (3H, s), 3.07 (2H, t, J=6.8 Hz), 3.24-3.27 (2H, m), 3.43-3.46 (6H, m), 4.37 (2H, s), 4.46 (2H, t, J=6.8 Hz), 6.66 (1H, d, J=8.1 Hz), 6.87 (1H, d, J=7.3 Hz), 7.41 (2H, d, J=7.8 Hz), 7.60-7.66 (3H, m), 9.85 (2H, s), 12.25 (1H, s).
1H-NMR (DMSO-d6) δ: 3.05 (2H, t, J=6.7 Hz), 3.32-3.57 (8H, m), 3.78 (3H, s), 4.22 (2H, t, J=6.7 Hz), 4.35 (2H, brs), 6.75 (1H, dd, J=9.0, 0.5 Hz), 7.39-7.41 (3H, m), 7.58-7.60 (2H, m), 7.85 (1H, d, J=2.7 Hz), 9.76 (2H, brs), 12.20 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.03 (2H, t, J=7.1 Hz), 3.22-3.57 (8H, m), 4.07 (2H, t, J=7.1 Hz), 4.32 (2H, brs), 7.19 (1H, d, J=8.3 Hz), 7.24 (1H, dd, J=8.3, 2.0 Hz), 7.31 (2H, d, J=8.1 Hz), 7.51-7.53 (3H, m), 9.75 (2H, brs), 12.14 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.23 (3H, s), 2.85-3.70 (10H, m), 4.42 (1H, s), 5.52 (2H, s), 6.84-6.87 (2H, m), 7.08 (2H, dd, J=8.8, 0.5 Hz), 7.80 (2H, d, J=8.1 Hz), 8.08 (2H, d, J=8.3 Hz), 9.51 (1H, brs), 12.32 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.31 (3H, t, J=6.9 Hz), 3.18-3.79 (8H, m), 3.96 (2H, q, J=6.9 Hz), 4.25-4.34 (6H, m), 6.85-6.93 (4H, m), 7.07 (2H, d, J=8.8 Hz), 7.57-7.59 (2H, m), 9.70 (2H, brs), 12.05 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.23-3.50 (8H, m), 3.70 (3H, s), 4.24-4.26 (2H, m), 4.30-4.32 (4H, m), 6.87-6.92 (4H, m), 7.06 (2H, d, J=8.8 Hz), 7.59 (2H, d, J=8.5 Hz), 9.93 (2H, brs), 12.20 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.23 (3H, s), 3.20-3.43 (8H, m), 4.35 (2H, brs), 4.70 (2H, dd, J=5.6, 1.1 Hz), 6.58 (1H, dt, J=16.1, 5.6 Hz), 6.77 (1H, d, J=16.1 Hz), 6.88 (2H, dt, J=9.1, 2.5 Hz), 7.09 (2H, d, J=8.3 Hz), 7.55-7.58 (4H, m), 9.60 (2H, brs), 12.10 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.99 (2H, t, J=7.4 Hz), 3.22-3.43 (8H, m), 4.18 (2H, t, J=7.4 Hz), 4.30 (2H, brs), 7.16-7.20 (1H, m), 7.31-7.37 (4H, m), 7.53 (2H, d, J=6.8 Hz), 7.64 (1H, dd, J=7.7, 0.9 Hz), 9.70 (2H, brs), 12.10 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.77 (3H, s), 3.11 (2H, t, J=6.6 Hz), 3.29-3.58 (8H, m), 4.30 (2H, t, J=6.6 Hz), 4.38 (2H, brs), 7.03 (1H, dd, J=8.8, 2.4 Hz), 7.44-7.46 (3H, m), 7.62-7.67 (2H, m), 7.89 (1H, d, J=8.8 Hz), 9.81 (2H, brs), 12.18 (1H, s).
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=7.1 Hz), 2.33-2.46 (2H, m), 2.60 (3H, s), 2.78-2.85 (1H, m), 3.06 (2H, t, J=6.7 Hz), 3.20 (1H, brs), 3.47-3.66 (3H, m), 3.99-4.02 (1H, m), 4.16-4.19 (3H, m), 4.44-4.51 (1H, m), 6.83-6.86 (2H, m), 7.12-7.14 (2H, m), 7.41 (2H, d, J=8.1 Hz), 7.56-7.58 (2H, m), 9.66 (1H, brs), 9.77 (1H, brs), 11.76 (1H, brs).
1H-NMR (CDCl3) δ: 2.40 (4H, brs), 2.87 (4H, t, J=4.9 Hz), 3.47 (2H, s), 4.69 (2H, dd, J=5.8, 1.2 Hz), 6.40 (1H, dt, J=15.9, 5.8 Hz), 6.72 (1H, d, J=15.9 Hz), 6.93-6.97 (3H, m), 7.26-7.32 (4H, m), 7.35-7.37 (2H, m).
1H-NMR (CDCl3) δ: 1.24-1.37 (2H, m), 1.63 (1H, brs), 2.01-2.10 (2H, m), 2.66-2.76 (2H, m), 2.96 (2H, t, J=7.3 Hz), 3.11 (2H, dt, J=13.2, 3.6 Hz), 3.28-3.60 (2H, m), 4.06 (2H, t, J=7.3 Hz), 6.51-6.61 (2H, m), 6.78-6.86 (2H, m), 6.90-7.00 (2H, m), 7.02-7.09 (2H, m).
1H-NMR (CDCl3) δ: 1.20 (6H, d, J=6.8 Hz), 1.27-1.39 (2H, m), 1.77 (1H, brs), 2.03-2.12 (2H, m), 2.67-2.85 (5H, m), 3.13 (2H, dt, J=12.9, 3.7 Hz), 3.26-3.68 (5H, m), 6.51-6.61 (4H, m), 6.99-7.07 (4H, m).
1H-NMR (DMSO-d6) δ: 1.78-1.96 (2H, m), 2.02-2.12 (2H, m), 2.22 (3H, s), 2.90 (2H, q, J=11.5 Hz), 3.00 (2H, t, J=6.8 Hz), 3.26-3.38 (2H, m), 3.40-4.10 (3H, m), 4.13 (2H, t, J=6.8 Hz), 6.78-6.84 (2H, m), 7.04-7.10 (2H, m), 7.16-7.44 (4H, m), 8.86-8.99 (1H, m), 9.16-9.29 (1H, m).
1H-NMR (DMSO-d6) δ: 1.69-1.76 (2H, m), 2.64 (2H, t, J=7.7 Hz), 3.40-3.57 (10H, m), 4.35 (2H, s), 7.26-7.31 (2H, m), 7.55-7.59 (2H, m), 9.85 (2H, brs), 12.10 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.41 (8H, brs), 4.36 (2H, s), 4.86 (2H, dd, J=5.7, 1.1 Hz), 6.60 (1H, dt, J=16.0, 5.7 Hz), 6.82 (1H, d, J=16.0 Hz), 7.16-7.20 (2H, m), 7.57 (2H, d, J=8.2 Hz), 7.62 (2H, d, J=8.2 Hz), 7.77-7.81 (2H, m), 9.73 (2H, brs).
1H-NMR (DMSO-d6) δ: 3.40 (8H, brs), 3.70 (3H, s), 4.34 (2H, brs), 4.68 (2H, dd, J=5.6, 1.1 Hz), 6.58 (1H, dt, J=16.1, 5.6 Hz), 6.78 (1H, d, J=16.1 Hz), 6.85-6.89 (2H, m), 6.92-6.96 (2H, m), 7.55-7.61 (4H, m), 9.62 (2H, brs).
1H-NMR (DMSO-d6) δ: 3.38 (8H, brs), 4.32 (2H, s), 4.72 (2H, dd, J=5.6, 1.0 Hz), 6.58 (1H, dt, J=16.1, 5.6 Hz), 6.79 (1H, d, J=16.1 Hz), 7.04-7.99 (2H, m), 7.10-7.16 (2H, m), 7.56-7.59 (4H, m), 9.55 (2H, brs), 12.04 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.17 (6H, d, J=7.1 Hz), 2.78-2.88 (1H, m), 3.38 (8H, brs), 4.32 (2H, s), 4.71 (2H, d, J=5.2 Hz), 6.59 (1H, dt, J=16.0, 5.2 Hz), 6.78 (1H, d, J=16.0 Hz), 6.91 (2H, d, J=8.5 Hz), 7.15 (2H, d, J=8.5 Hz), 7.55-7.61 (4H, m), 9.58 (2H, brs), 12.03 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.41 (8H, brs), 4.36 (2H, s), 4.85 (2H, dd, J=5.7, 1.2 Hz), 6.59 (1H, dt, J=16.0, 5.7 Hz), 6.82 (1H, d, J=16.0 Hz), 7.45 (1H, dd, J=8.8, 0.5 Hz), 7.54-7.64 (5H, m), 8.19 (1H, d, J=3.2 Hz), 9.74 (2H, brs), 12.19 (1H, brs).
1H-NMR (CDCl3) δ: 2.50 (3H, s), 4.76 (2H, dd, J=5.3, 1.6 Hz), 6.55 (1H, dt, J=16.3, 5.3 Hz), 6.80 (1H, d, J=16.3 Hz), 7.08 (1H, d, J=8.5 Hz), 7.17 (1H, dd, J=8.5, 2.9 Hz), 7.56 (2H, d, J=8.3 Hz), 7.85 (2H, dt, J=8.3, 1.7 Hz), 8.26 (1H, d, J=2.9 Hz), 10.00 (1H, s).
1H-NMR (DMSO-d6) δ: 2.59-2.71 (3H, m), 3.46 (8H, brs), 4.37 (2H, s), 4.97 (2H, d, J=5.6 Hz), 6.60 (1H, dt, J=16.0, 5.6 Hz), 6.86 (1H, d, J=16.0 Hz), 7.58 (2H, d, J=8.3 Hz), 7.63 (2H, d, J=8.3 Hz), 7.79 (1H, d, J=9.0 Hz), 8.11 (1H, dd, J=9.0, 2.8 Hz), 8.53 (1H, d, J=2.8 Hz), 9.74 (2H, brs), 12.12 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.43 (8H, brs), 4.14 (2H, dd, J=4.8, 1.7 Hz), 4.33 (2H, s), 6.47 (1H, dt, J=16.0, 4.8 Hz), 6.59 (1H, d, J=16.0 Hz), 7.50 (2H, d, J=8.2 Hz), 7.57 (2H, d, J=8.2 Hz), 9.61 (2H, brs), 11.98 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.00-2.07 (2H, m), 2.78 (2H, t, J=7.8 Hz), 3.41 (8H, brs), 3.98 (2H, t, J=6.3 Hz), 4.31 (2H, s), 6.91-6.94 (3H, m), 7.26-7.34 (4H, m), 7.54 (2H, d, J=8.1 Hz), 9.59 (2H, brs), 11.91 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.64 (2H, t, J=7.2 Hz), 3.05 (2H, t, J=6.6 Hz), 3.24-3.55 (9H, m), 4.19-4.30 (5H, m), 6.83 (2H, d, J=8.5 Hz), 7.10 (2H, d, J=8.5 Hz), 7.40 (2H, d, J=7.8 Hz), 7.56-7.59 (2H, m), 9.82 (2H, s), 12.23 (1H, s).
1H-NMR (DMSO-d6) δ: 2.01-2.08 (2H, m), 2.77 (2H, t, J=7.7 Hz), 3.40-3.45 (8H, m), 4.07 (2H, t, J=6.2 Hz), 4.33 (2H, hrs), 7.32 (2H, d, J=8.0 Hz), 7.42 (1H, dd, J=8.8, 0.6 Hz), 7.49 (1H, dd, J=8.8, 3.2 Hz), 7.56 (2H, d, J=8.0 Hz), 8.12 (1H, dd, J=3.2, 0.6 Hz), 9.73 (2H, brs), 12.10 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.04-2.11 (2H, m), 2.66 (3H, s), 2.79 (2H, t, J=7.6 Hz), 3.39-3.47 (8H, m), 4.19 (2H, t, J=6.2 Hz), 4.35 (2H, s), 7.33 (2H, d, J=8.2 Hz), 7.58 (2H, d, J=8.2 Hz), 7.79 (1H, d, J=8.8 Hz), 8.09 (1H, dd, J=8.8, 2.9 Hz), 8.48 (1H, d, J=2.9 Hz), 9.93 (2H, brs), 12.20 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.07-3.43 (10H, m), 4.23-4.31 (4H, m), 6.96 (2H, d, J=9.0 Hz), 7.31 (2H, d, J=9.0 Hz), 7.44-7.49 (3H, m), 9.75 (2H, s), 12.33 (1H, s).
1H-NMR (DMSO-d6) δ: 3.12 (2H, t, J=6.5 Hz), 3.21-3.49 (7H, m), 3.95-3.97 (1H, m), 4.32-4.34 (4H, m), 7.13 (2H, d, J=8.5 Hz), 7.29-7.34 (2H, m), 7.64 (3H, d, J=8.8 Hz), 9.60 (2H, s), 12.18-12.20 (1H, m).
1H-NMR (DMSO-d6) δ: 1.97-2.04 (2H, m), 2.22 (3H, s), 2.76 (2H, t, J=7.7 Hz), 3.40 (8H, brs), 3.93 (2H, t, J=6.2 Hz), 4.32 (2H, brs), 6.82 (2H, d, J=8.5 Hz), 7.07 (2H, d, J=8.5 Hz), 7.32 (2H, d, J=7.8 Hz), 7.55 (2H, d, J=7.8 Hz), 9.70 (2H, brs), 12.07 (1H, brs).
To a solution of tert-butyl 4-(4-{[4-(propan-2-yloxy)phenoxy]methyl}benzyl)-piperazine-1-carboxylate (5.42 g) in CH2Cl2 (41 mL) was added TFA (10 mL) at room temperature, then the reaction mixture was stirred for 8 hours. The reaction mixture was basified with 5 M aqueous NaOH, and extracted with CH2Cl2. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure to afford 1-(4-{[4-(propan-2-yloxy)phenoxy]methyl}benzyl)piperazine as a colorless solid (5.73 g).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=5.9 Hz), 1.73 (1H, brs), 2.35-2.47 (4H, m), 2.88 (4H, t, J=4.9 Hz), 3.49 (2H, s), 4.42 (1H, septet, J=5.9 Hz), 4.98 (2H, s), 6.78-6.93 (4H, m), 7.29-7.43 (4H, m).
The following compounds were produced in the same manner as in Reference Example 326 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.65 (1H, brs), 2.42 (4H, brs), 2.89 (4H, t, J=4.9 Hz), 3.49 (2H, s), 5.01 (2H, s), 6.86-6.93 (2H, m), 7.20-7.26 (2H, m), 7.31-7.39 (4H, m).
1H-NMR (CDCl3) δ: 1.80 (1H, brs), 2.33 (3H, s), 2.35-2.45 (4H, m), 2.87 (4H, t, J=4.9 Hz), 3.05 (2H, t, J=7.3 Hz), 3.41 (2H, s), 4.13 (2H, t, J=7.3 Hz), 6.79-6.88 (2H, m), 7.08-7.28 (6H, m).
1H-NMR (CDCl3) δ: 1.24 (6H, d, J=6.9 Hz), 1.94 (1H, brs), 2.33-2.43 (4H, m), 2.80-2.92 (5H, m), 3.06 (2H, t, J=7.3 Hz), 3.41 (2H, s), 4.14 (2H, t, J=7.3 Hz), 6.79-6.88 (2H, m), 7.15-7.28 (6H, m).
1H-NMR (CDCl3) δ: 1.91 (1H, brs), 2.35-2.50 (4H, m), 2.89 (4H, t, J=4.6 Hz), 3.50 (2H, s), 3.77 (3H, s), 4.99 (2H, s), 6.78-6.93 (4H, m), 7.30-7.43 (4H, m).
1H-NMR (CDCl3) δ: 1.39 (3H, t, J=6.9 Hz), 2.18 (1H, brs), 2.38-2.50 (4H, m), 2.90 (4H, t, J=4.9 Hz), 3.50 (2H, s), 3.98 (2H, q, J=6.9 Hz), 4.99 (2H, s), 6.78-6.93 (4H, m), 7.30-7.43 (4H, m).
1H-NMR (CDCl3) δ: 1.29 (6H, d, J=5.9 Hz), 1.86 (1H, brs), 2.33-2.52 (4H, m), 2.88 (4H, t, J=4.9 Hz), 3.05 (2H, t, J=7.3 Hz), 3.46 (2H, s), 4.11 (2H, t, J=7.3 Hz), 4.40 (1H, septet, J=5.9 Hz), 6.81 (4H, s), 7.18-7.34 (4H, m).
1H-NMR (CDCl3) δ: 1.38 (3H, t, J=6.9 Hz), 1.69 (1H, brs), 2.34-2.50 (4H, m), 2.88 (4H, t, J=4.9 Hz), 3.05 (2H, t, J=6.9 Hz), 3.47 (2H, s), 3.97 (2H, q, J=6.9 Hz), 4.11 (2H, t, J=6.9 Hz), 6.81 (4H, s), 7.16-7.30 (4H, m).
1H-NMR (CDCl3) δ: 1.61 (1H, brs), 2.34-2.48 (4H, m), 2.88 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=6.9 Hz), 3.47 (2H, s), 4.14 (2H, t, J=6.9 Hz), 6.72-6.83 (1H, m), 6.85-6.95 (2H, m), 7.10-7.30 (5H, m).
1H-NMR (DMSO-d6) δ: 2.92-3.14 (6H, m), 3.22-3.45 (4H, m), 4.01 (2H, brs), 4.31 (2H, t, J=6.6 Hz), 7.11 (2H, d, J=8.2 Hz), 7.38 (4H, s), 7.76 (2H, d, J=8.2 Hz), 9.03 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.93-3.13 (6H, m), 3.15 (3H, s), 3.27 (4H, brs), 4.04 (2H, brs), 4.33 (2H, t, J=6.9 Hz), 7.16 (2H, d, J=8.9 Hz), 7.39 (4H, s), 7.83 (2H, d, J=8.9 Hz), 9.09 (2H, brs).
1H-NMR (DMSO-d6) δ: 2.93-3.11 (6H, m), 3.32 (4H, brs), 3.99 (2H, brs), 4.18 (2H, t, J=6.9 Hz), 6.78 (2H, d, J=8.9 Hz), 7.36 (4H, s), 7.58 (2H, d, J=8.9 Hz), 8.99 (2H, brs), 11.12 (1H, brs).
1H-NMR (CDCl3) δ: 1.29 (6H, d, J=6.9 Hz), 1.68 (1H, brs), 2.45 (4H, brs), 2.90 (4H, t, J=4.6 Hz), 2.95 (1H, septet, J=6.9 Hz), 3.62 (2H, s), 7.03 (1H, d, J=8.7 Hz), 7.12-7.19 (2H, m), 7.24-7.30 (2H, m), 7.62 (1H, dd, J=6.9, 1.8 Hz), 7.67 (1H, s), 7.77 (1H, d, J=8.7 Hz), 8.07 (1H, d, J=8.7 Hz).
1H-NMR (CDCl3) δ: 1.58 (1H, brs), 2.44 (4H, brs), 2.89 (4H, t, J=4.5 Hz), 3.61 (2H, s), 3.84 (3H, s), 6.91-6.99 (2H, m), 7.02 (1H, d, J=9.2 Hz), 7.13-7.20 (2H, m), 7.61 (1H, dd, J=8.2 Hz), 7.64-7.69 (1H, m), 7.74 (1H, d, J=8.7 Hz), 8.06 (1H, d, J=9.2 Hz).
1H-NMR (CDCl3) δ: 1.27 (3H, d, J=6.1 Hz), 2.27 (3H, s), 2.40 (4H, brs), 2.78 (1H, dd, J=13.7, 6.6 Hz), 2.88 (4H, t, J=4.9 Hz), 3.07 (1H, dd, J=13.7, 5.9 Hz), 3.45 (2H, s), 4.47-4.54 (1H, m), 6.78 (2H, dt, J=9.4, 2.6 Hz), 7.05 (2H, dd, J=8.7, 0.6 Hz), 7.18 (2H, d, J=8.1 Hz), 7.23 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.39 (3H, d, J=7.1 Hz), 2.27 (3H, s), 2.41 (4H, brs), 2.88 (4H, t, J=4.9 Hz), 3.17-3.25 (1H, m), 3.47 (2H, s), 3.91 (1H, dd, J=9.2, 7.8 Hz), 4.05 (1H, dd, J=9.2, 5.7 Hz), 6.78 (2H, d, J=8.8 Hz), 7.05 (2H, d, J=8.8 Hz), 7.22 (2H, d, J=8.3 Hz), 7.27 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 2.42 (4H, brs), 2.89 (4H, t, J=4.9 Hz), 3.39 (3H, s), 3.47 (2H, s), 4.09 (2H, dd, J=6.1, 1.5 Hz), 6.26 (1H, dt, J=16.1, 6.1 Hz), 6.60 (1H, d, J=16.1 Hz), 7.27 (2H, d, J=8.3 Hz), 7.34 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 2.28 (3H, s), 2.35 (3H, s), 2.40 (4H, brs), 2.88 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.4 Hz), 3.43 (2H, s), 4.10 (2H, t, J=7.4 Hz), 6.79 (2H, dt, J=9.3, 2.5 Hz), 7.05-7.12 (4H, m), 7.16 (1H, d, J=7.8 Hz).
1H-NMR (CDCl3) δ: 2.35 (3H, s), 2.41 (4H, brs), 2.89 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.3 Hz), 3.44 (2H, s), 4.09 (2H, t, J=7.3 Hz), 6.79-6.85 (2H, m), 6.92-7.00 (2H, m), 7.09-7.16 (3H, m).
1H-NMR (CDCl3) δ: 2.39-2.42 (4H, m), 2.86-2.88 (10H, m), 3.05 (2H, t, J=7.2 Hz), 3.46 (2H, s), 4.11 (2H, t, J=7.2 Hz), 6.72-6.73 (2H, m), 6.82-6.84 (2H, m), 7.21-7.27 (4H, m).
1H-NMR (CDCl3) δ: 1.28 (3H, d, J=6.1 Hz), 2.39 (4H, brs), 2.79 (1H, dd, J=13.7, 6.6 Hz), 2.88 (4H, t, J=4.9 Hz), 3.04 (1H, dd, J=13.7, 6.1 Hz), 3.46 (2H, s), 4.41-4.49 (1H, m), 6.77-6.82 (2H, m), 6.90-6.96 (2H, m), 7.17 (2H, d, J=8.1 Hz), 7.24 (2H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 2.28 (3H, s), 2.35 (3H, s), 2.40 (4H, brs), 2.85 (4H, t, J=4.9 Hz), 3.03 (2H, t, J=7.2 Hz), 3.41 (2H, s), 4.12 (2H, t, J=7.2 Hz), 6.80 (2H, dt, J=9.3, 2.5 Hz), 7.00-7.08 (4H, m), 7.19 (1H, d, J=7.6 Hz).
1H-NMR (CDCl3) δ: 1.28 (6H, s), 1.89-1.93 (2H, m), 2.39-2.42 (4H, m), 2.89-2.90 (4H, m), 3.43 (2H, s), 3.59 (2H, s), 6.98-7.00 (2H, m), 7.10 (1H, d, J=12.0 Hz).
To a solution of 9H-fluoren-9-ylmethyl 4-(4-{(E)-3-[(5-bromopyridin-2-yl)oxy]-prop-1-en-1-yl}benzyl)piperazine-1-carboxylate (0.604 g) in CH2Cl2 (10 mL) was added piperidine (0.196 mL). After stirring at room temperature for 1 hour, to the reaction mixture was added piperidine (0.784 mL) and stirred at room temperature for 4 hours. Then to the reaction mixture was added saturated aqueous NH4Cl and CH2Cl2. The organic layer was washed with saturated aqueous NH4Cl and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was washed with Et2O to afford 1-(4-{(E)-3-[(5-bromopyridin-2-yl)oxy]prop-1-en-1-yl}benzyl)piperazine as a white powder (0.282 g).
1H-NMR (CDCl3) δ: 2.72 (4H, t, J=4.8 Hz), 3.19 (4H, t, J=4.8 Hz), 3.54 (2H, s), 4.96 (2H, d, J=6.1 Hz), 6.42 (1H, dt, J=15.9, 6.1 Hz), 6.68-6.72 (2H, m), 7.23-7.26 (2H, m), 7.36 (2H, d, J=8.1 Hz), 7.65 (1H, dd, J=8.7, 2.5 Hz), 8.20 (1H, d, J=2.5 Hz).
The following compound was produced in the same manner as in Reference Example 349 using appropriate starting materials.
1H-NMR (CDCl3) δ: 2.25 (3H, s), 2.74 (4H, t, J=4.8 Hz), 3.21 (4H, t, J=4.9 Hz), 3.54 (2H, s), 4.96 (2H, dd, J=6.0, 1.2 Hz), 6.45 (1H, dt, J=15.9, 6.0 Hz), 6.69-6.72 (2H, m), 7.23 (2H, d, J=8.2 Hz), 7.36 (2H, d, J=8.2 Hz), 7.40 (1H, ddd, J=8.5, 2.4, 0.5 Hz), 7.96-7.97 (1H, m).
To an EtOH (500 mL) solution of butyl (E)-3-{3-chloro-4-[(5-nitropyridin-2-yl)oxy]phenyl}prop-2-enoate (45.4 g) and tin powder (57.3 g) was slowly added conc. HCl (36.6 mL) at 0° C., then the resultant mixture was stirred at room temperature for 1 hour. The reaction mixture was neutralized with 5 M aqueous NaOH, and the mixture was filtered off on Celite. The filtrate was evaporated and water was added to the residue, and the mixture was extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=2/1) to afford butyl (E)-3-{4-[(5-amino-pyridin-2-yl)oxy]-3-chlorophenyl}prop-2-enoate (39.9 g) as a pale yellow solid.
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.38-1.50 (2H, m), 1.64-1.74 (2H, m), 3.58 (2H, brs), 4.21 (2H, t, J=6.8 Hz), 6.37 (1H, d, J=16.1 Hz), 6.85 (1H, d, J=7.8 Hz), 7.08-7.15 (2H, m), 7.39 (1H, dd, J=8.3, 2.0 Hz), 7.55-7.67 (3H, m).
The following compounds were produced in the same manner as in Reference Example 351 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.1 Hz), 3.50 (2H, s), 3.83 (3H, s), 4.27 (2H, q, J=7.2 Hz), 6.36 (1H, d, J=15.6 Hz), 6.82 (1H, d, J=8.8 Hz), 7.03-7.14 (4H, m), 7.65 (2H, dd, J=9.5, 6.6 Hz).
1H-NMR (CDCl3) δ: 0.96 (3H, t, J=7.3 Hz), 1.37-1.51 (2H, m), 1.64-1.74 (2H, m), 2.24 (3H, s), 3.55 (2H, brs), 4.20 (2H, q, J=6.6 Hz), 6.35 (1H, d, J=15.8 Hz), 6.76 (1H, d, J=8.6 Hz), 6.93 (1H, d, J=8.2 Hz), 7.09 (1H, dd, J=8.6, 3.0 Hz), 7.31-7.35 (1H, m), 7.41 (1H, brs), 7.63 (1H, d, J=15.8 Hz), 7.69 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.39-1.48 (2H, m), 1.65-1.72 (2H, m), 2.19 (3H, s), 3.47 (2H, brs), 4.20 (2H, t, J=6.6 Hz), 6.37 (1H, d, J=15.9 Hz), 6.82 (1H, d, J=8.5 Hz), 7.10-7.13 (1H, m), 7.31-7.32 (1H, m), 7.46 (1H, d, J=1.7 Hz), 7.56-7.60 (2H, m).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.2 Hz), 3.41 (2H, brs), 3.79 (6H, s), 4.27 (2H, q, J=7.2 Hz), 6.38 (1H, d, J=15.9 Hz), 6.82 (2H, s), 6.85 (1H, d, J=8.8 Hz), 7.08 (1H, dd, J=8.5, 2.9 Hz), 7.58 (1H, d, J=2.9 Hz), 7.64 (1H, d, J=15.9 Hz).
1H-NMR (CDCl3) δ: 0.96 (3H, t, J=7.3 Hz), 1.37-1.50 (2H, m), 1.64-1.74 (2H, m), 2.40 (3H, s), 3.58 (2H, brs), 4.20 (2H, t, J=6.6 Hz), 6.29 (1H, d, J=15.8 Hz), 6.80 (1H, d, J=8.9 Hz), 6.86-6.90 (2H, m), 7.10 (1H, dd, J=8.6, 3.0 Hz), 7.53-7.56 (1H, m), 7.73 (1H, dd, J=3.0 Hz), 7.92 (1H, d, J=15.8 Hz).
1H-NMR (CDCl3) δ: 2.16 (3H, s), 3.46 (2H, brs), 6.80 (1H, dd, J=8.6, 0.5 Hz), 7.10 (1H, dd, J=8.8, 3.2 Hz), 7.25-7.33 (1H, m), 7.43 (1H, dd, J=2.3, 0.5 Hz), 7.56 (1H, dd, J=2.9, 0.5 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.39-1.49 (2H, m), 1.66-1.73 (2H, m), 3.54 (2H, s), 4.21 (2H, t, J=6.6 Hz), 6.36 (1H, d, J=16.1 Hz), 6.86 (1H, d, J=8.3 Hz), 7.12 (1H, dd, J=9.0, 2.7 Hz), 7.17 (1H, t, J=8.1 Hz), 7.26-7.35 (2H, m), 7.59-7.64 (2H, m).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.1 Hz), 2.12 (6H, s), 3.44 (2H, brs), 4.26 (2H, t, J=7.1 Hz), 6.36 (1H, d, J=16.1 Hz), 6.70 (1H, d, J=8.8 Hz), 7.08 (1H, dd, J=8.6, 2.9 Hz), 7.26 (2H, s), 7.61-7.65 (2H, m).
To a solution of ethyl 6-[(5-nitropyridin-2-yl)oxy]naphthalene-2-carboxylate (23.3 g) in EtOH (460 mL) was added Pd/C (0.367 g) under a H2 atmosphere. Then the reaction mixture was warmed to 50° C., and stirred for 7.5 hours. The reaction mixture was filtered off on celite, and the filtrate was concentrated under reduced pressure. The residual solid was dried under reduced pressure at 60° C. to afford ethyl 6-[(5-aminopyridin-2-yl)oxy]naphthalene-2-carboxylate as a pale brown powder (19.6 g).
1H-NMR (CDCl3) δ: 1.44 (3H, t, J=7.2 Hz), 3.60 (2H, s), 4.43 (2H, q, J=7.2 Hz), 6.87 (1H, dd, J=8.5, 0.5 Hz), 7.14 (1H, dd, J=8.5, 3.2 Hz), 7.32 (1H, dd, J=8.9, 2.3 Hz), 7.41 (1H, d, J=2.2 Hz), 7.74 (1H, d, J=8.5 Hz), 7.76 (1H, dd, J=2.9, 0.5 Hz), 7.93 (1H, d, J=9.0 Hz), 8.03 (1H, dd, J=8.5, 1.7 Hz), 8.57 (1H, s).
To a solution of 2-(4-bromo-2-chloro-5-methylphenoxy)-5-nitropyridine (10.0 g) in AcOEt (150 mL) was added 5% Pt/C (1.00 g) at 0° C. After stirring at room temperature for 5 hours under a hydrogen atmosphere, the reaction mixture was filtered off using celite, and the filtrate was concentrated under reduced pressure to give 6-(4-bromo-2-chloro-5-methyl-phenoxy)pyridin-3-amine as a pink solid (9.13 g).
1H-NMR (CDCl3) δ: 2.33 (3H, s), 3.51 (2H, brs), 6.80-6.83 (1H, m), 7.01 (1H, s), 7.10 (1H, dd, J=8.5, 2.9 Hz), 7.60 (1H, s), 7.63-7.64 (1H, m).
The following compounds were produced in the same manner as in Reference Example 361 using appropriate starting materials.
1H-NMR (CDCl3) δ: 2.16 (3H, s), 3.53 (2H, brs), 6.76 (1H, d, J=8.5 Hz), 7.05 (1H, s), 7.08-7.13 (1H, m), 7.46 (1H, s), 7.66 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.45 (9H, s), 2.38 (4H, t, J=4.9 Hz), 3.02-3.06 (2H, m), 3.41-3.43 (6H, m), 3.48 (2H, brs), 4.07-4.11 (2H, m), 6.62 (2H, d, J=8.8 Hz), 6.73 (2H, d, J=8.8 Hz), 7.22 (2H, d, J=8.3 Hz), 7.25 (2H, d, J=8.8 Hz).
To a THF (400 mL) solution of butyl (E)-3-{4-[(5-aminopyridin-2-yl)oxy]-3-chlorophenyl}prop-2-enoate (30.0 g) was slowly added H2SO4 (6.92 mL) at 0° C. After stirring for 10 minutes, n-pentyl nitrite (17.3 mL) was slowly added to the reaction mixture. Then the resultant mixture was stirred at 0° C. for 1 hour. The resulting precipitate was collected by filtration and dried under reduced pressure to afford a diazonium salt as a pale yellow powder. To acetic acid (400 mL) was slowly added the above diazonium salt at 100° C., then the resultant mixture was stirred at 100° C. for 3 hours. After cooling, the solvent was evaporated and the residue was neutralized with 5 M aqueous NaOH, and the mixture was extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=2/1) to afford butyl (E)-3-{3-chloro-4-[(5-hydroxypyridin-2-yl)oxy]phenyl}prop-2-enoate (14.8 g) as a brown oil.
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.38-1.50 (2H, m), 1.64-1.74 (2H, m), 4.21 (2H, t, J=6.8 Hz), 6.26 (1H, brs), 6.37 (1H, d, J=16.1 Hz), 6.90 (1H, d, J=8.8 Hz), 7.12 (1H, d, J=8.8 Hz), 7.28 (1H, dd, J=8.8, 2.9 Hz), 7.40 (1H, dd, J=8.3, 2.0 Hz), 7.54-7.62 (2H, m), 7.75 (1H, d, J=2.4 Hz).
The following compounds were produced in the same manner as in Reference Example 364 using appropriate starting materials.
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.41-1.46 (2H, m), 1.66-1.72 (2H, m), 2.19 (3H, s), 4.21 (2H, t, J=6.6 Hz), 5.59 (1H, s), 6.37 (1H, d, J=16.2 Hz), 6.87 (1H, d, J=8.9 Hz), 7.24-7.31 (2H, m), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.8 Hz), 7.67 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 0.96 (3H, t, J=7.3 Hz), 1.39-1.48 (2H, m), 1.65-1.72 (2H, m), 2.37 (3H, s), 4.21 (2H, t, J=6.8 Hz), 6.29 (1H, d, J=16.1 Hz), 6.81-6.87 (3H, m), 7.24-7.27 (1H, m), 7.52-7.54 (1H, m), 7.68 (1H, brs), 7.83 (1H, d, J=3.4 Hz), 7.90 (1H, d, J=16.1 Hz).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 3.79 (3H, s), 4.27 (2H, q, J=7.1 Hz), 6.36 (1H, d, J=15.6 Hz), 6.45-6.75 (1H, m), 6.83 (1H, d, J=8.8 Hz), 7.04-7.13 (3H, m), 7.22 (1H, dd, J=8.8, 2.9 Hz), 7.61-7.73 (2H, m).
1H-NMR(CDCl3) δ: 1.34 (3H, t, J=7.2 Hz), 4.27 (2H, q, J=7.2 Hz), 6.35 (1H, brs), 6.35 (1H, d, J=16.1 Hz), 6.87 (1H, d, J=8.8 Hz), 7.06 (2H, dt, J=9.2, 2.4 Hz), 7.27 (1H, dd, J=8.8, 3.1 Hz), 7.51 (2H, dt, J=9.2, 2.4 Hz), 7.65 (1H, d, J=16.1 Hz), 7.85 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 0.96 (3H, t, J=7.3 Hz), 1.39-1.48 (2H, m), 1.65-1.72 (2H, m), 2.21 (3H, s), 4.21 (2H, t, J=6.9 Hz), 6.35 (1H, d, J=15.6 Hz), 6.77 (1H, d, J=8.7 Hz), 6.92 (1H, d, J=8.2 Hz), 7.24 (1H, dd, J=8.9, 3.0 Hz), 7.32 (1H, dd, J=8.5, 2.1 Hz), 7.40 (1H, d, J=1.8 Hz), 7.44 (1H, s), 7.62 (1H, d, J=16.0 Hz), 7.78 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.39-1.49 (2H, m), 1.66-1.73 (2H, m), 4.21 (2H, t, J=6.7 Hz), 5.20 (1H, s), 6.37 (1H, d, J=16.1 Hz), 6.93 (1H, d, J=8.8 Hz), 7.20 (1H, t, J=8.1 Hz), 7.27-7.35 (3H, m), 7.61 (1H, d, J=15.9 Hz), 7.75 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.15 (3H, s), 6.24 (1H, brs), 6.84 (1H, d, J=8.8 Hz), 7.22-7.29 (2H, m), 7.38-7.43 (1H, m), 7.63 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.1 Hz), 2.09 (6H, s), 4.26 (2H, t, J=7.1 Hz), 6.34 (1H, d, J=15.9 Hz), 6.66 (1H, d, J=8.8 Hz), 7.19-7.26 (3H, m), 7.57-7.61 (2H, m), 7.66 (1H, d, J=2.2 Hz).
1H-NMR (DMSO-d6) δ: 1.37 (3H, t, J=7.1 Hz), 4.38 (2H, q, J=7.2 Hz), 7.03 (1H, dd, J=8.7, 0.6 Hz), 7.33-7.37 (2H, m), 7.51 (1H, d, J=2.4 Hz), 7.77 (1H, dd, J=3.2, 0.5 Hz), 7.92-7.98 (2H, m), 8.16 (1H, d, J=9.3 Hz), 8.61 (1H, d, J=0.7 Hz), 9.82 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.30 (3H, s), 6.96 (1H, d, J=8.8 Hz), 7.23 (1H, s), 7.30 (1H, dd, J=8.8, 2.9 Hz), 7.63 (1H, d, J=2.9 Hz), 7.79 (1H, s), 9.66 (1H, s).
1H-NMR (DMSO-d6) δ: 2.09 (3H, s), 6.95 (1H, d, J=8.8 Hz), 7.22 (1H, s), 7.30 (1H, dd, J=8.8, 3.2 Hz), 7.66 (1H, d, J=3.2 Hz), 7.71 (1H, s), 9.67 (1H, s).
1H-NMR (DMSO-d6) δ: 1.27 (3H, t, J=7.1 Hz), 3.72 (6H, s), 4.20 (2H, q, J=7.1 Hz), 6.72 (1H, d, J=16.1 Hz), 6.79 (1H, d, J=8.8 Hz), 7.14 (2H, s), 7.21 (1H, dd, J=8.8, 2.9 Hz), 7.51 (1H, d, J=2.7 Hz), 7.64 (1H, d, J=16.1 Hz), 9.38 (1H, s).
To a 1,4-dioxane (10 mL) solution of 2-(4-bromo-2-chloro-6-methylphenoxy)-5-nitropyridine (1.00 g) and butyl acrylate (0.480 mL) were added N,N-dicyclohexylmethylamine (0.655 mL), tri-tert-butylphosphine tetrafluoroborate (34 mg) and tris(dibenzylideneacetone)dipalladium (0) (40 mg) at room temperature. The resultant mixture was stirred at 70° C. under a nitrogen atmosphere for 4 hours. To the reaction mixture was added water, and extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous MgSO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=9/1 to 1/1) to afford butyl (E)-3-{3-chloro-5-methyl-4-[(5-nitropyridin-2-yl)oxy]phenyl}prop-2-enoate as a yellow powder (1.05 g).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.39-1.49 (2H, m), 1.66-1.73 (2H, m), 2.20 (3H, s), 4.22 (2H, t, J=6.8 Hz), 6.42 (1H, d, J=16.1 Hz), 7.17 (1H, d, J=9.0 Hz), 7.36-7.37 (1H, m), 7.50 (1H, d, J=2.0 Hz), 7.59 (1H, d, J=16.1 Hz), 8.54 (1H, dd, J=9.0, 2.9 Hz), 8.98-8.99 (1H, m).
The following compounds were produced in the same manner as in Reference Example 377 using appropriate starting materials.
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.6 Hz), 1.39-1.48 (2H, m), 1.66-1.73 (2H, m), 2.37 (3H, s), 4.21 (2H, t, J=6.6 Hz), 5.38 (1H, brs), 6.32 (1H, d, J=15.9 Hz), 6.90 (1H, d, J=8.8 Hz), 6.97 (1H, s), 7.26-7.29 (1H, m), 7.62 (1H, s), 7.77 (1H, d, J=2.9 Hz), 7.84 (1H, d, J=15.9 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.39-1.49 (2H, m), 1.66-1.73 (2H, m), 2.20 (3H, s), 4.22 (2H, t, J=6.8 Hz), 5.23-5.30 (1H, m), 6.38 (1H, d, J=15.9 Hz), 6.87 (1H, d, J=8.8 Hz), 7.01 (1H, s), 7.28 (1H, dd, J=8.8, 2.9 Hz), 7.51 (1H, s), 7.82 (1H, d, J=2.9 Hz), 8.02 (1H, d, J=15.9 Hz).
To a DMF (50 mL) solution of 6-(4-bromo-2-chloro-6-methylphenoxy)pyridin-3-ol (5.00 g) were added imidazole (1.41 g) and TBDMSCl (2.87 g) at room temperature. After stirring at room temperature for 5 hours, to the reaction mixture was added saturated aqueous NaHCO3, and extracted with AcOEt. The organic layer was washed with water, saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=9/1 to 2/1) to give 2-(4-bromo-2-chloro-6-methylphenoxy)-5-{[tert-butyl(dimethyl)silyl]oxy}pyridine as a colorless oil (6.16 g).
1H-NMR (CDCl3) δ: 0.18 (6H, s), 0.97 (9H, s), 2.15 (3H, s), 6.86 (1H, dd, J=8.8, 0.7 Hz), 7.21 (1H, dd, J=8.8, 2.9 Hz), 7.30-7.31 (1H, m), 7.43-7.44 (1H, m), 7.65-7.67 (1H, m).
A THF (15 mL) solution of bis(pinacolato)diboron (3.03 g), copper(I) chloride (0.032 g), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (0.188 g) and sodium tert-butoxide (0.063 g) was stirred at room temperature for 30 minutes under an argon atmosphere. To the mixture were added 2-(trimethylsilyl)ethyl but-2-ynoate (2.00 g) and MeOH (0.878 mL) in order. After stirring for 5 hours at room temperature, the mixture was filtered through a pad of Celite and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=19/1 to 9/1) to afford 2-(trimethylsilyl)ethyl (Z)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-2-enoate as a colorless oil (2.86 g).
1H-NMR (CDCl3) δ: 0.05 (9H, s), 0.94-1.06 (2H, m), 1.28 (12H, s), 2.17 (3H, d, J=2.0 Hz), 4.15-4.26 (2H, m), 6.42 (1H, d, J=1.6 Hz).
A mixture of ethyl (E)-2-methyl-3-{[(trifluoromethyl)sulfonyl]oxy}but-2-enoate (2.00 g), bis(pinacolato)diboron (2.02 g), dichlorobis(triphenylphosphine) palladium (II) (0.15 g), triphenylphosphine (0.11 g) and potassium tert-butoxide (1.44 g) in toluene (40 mL) was stirred at 50° C. for 2 hours under an argon atmosphere. The mixture was filtered through a pad of Celite and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=99/1 to 19/1) to afford ethyl (Z)-2-methyl-3-(4,4, ,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-2-enoate as a colorless oil (0.91 g).
1H-NMR (CDCl3) δ: 1.28 (12H, s), 1.30 (3H, t, J=7.3 Hz), 1.87 (3H, q, J=1.6 Hz), 2.10 (3H, q, J=1.6 Hz), 4.22 (2H, q, J=7.3 Hz).
To a solution of 6-(4-bromo-2-chloro-6-methylphenoxy)pyridin-3-ol (5.00 g) in CH2Cl2-THF (70 mL, 5:2) were added 3,4-dihydro-2H-pyran (4.35 mL) and PPTS (200 mg) at room temperature. After stirring at room temperature for 95 hours, the solvent was removed under reduced pressure. To the residue was added saturated aqueous NaHCO3, and extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=4/1 to 1/1) to give 2-(4-bromo-2-chloro-6-methyl-phenoxy)-5-(tetrahydro-2H-pyran-2-yloxy)pyridine as a yellow oil (6.30 g).
1H-NMR (CDCl3) δ: 1.51-2.01 (6H, m), 2.16 (3H, s), 3.57-3.62 (1H, m), 3.86-3.94 (1H, m), 5.28 (1H, t, J=3.2 Hz), 6.88-6.92 (1H, m), 7.30-7.31 (1H, m), 7.43-7.52 (2H, m), 7.87-7.89 (1H, m).
The following compound was produced in the same manner as in Reference Example 105 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.58-1.99 (6H, m), 2.26 (3H, s), 3.58-3.62 (1H, m), 3.86-3.92 (1H, m), 5.28-5.30 (1H, m), 6.96 (1H, d, J=9.0 Hz), 7.49 (1H, dd, J=9.0, 2.9 Hz), 7.70-7.71 (1H, m), 7.82 (1H, d, J=1.7 Hz), 7.86 (1H, d, J=2.9 Hz), 9.92 (1H, s).
To a THF (100 mL) solution of triethyl phosphonoacetate (44.0 mL) was slowly added NaH (60% dispersion in mineral oil, 8.8 g) at 0° C. After stirring for 1 hour, a THF (200 mL) solution of 3,5-dimethyl-4-[(5-nitropyridin-2-yl)oxy]benzaldehyde (54.5 g) was added to the reaction mixture. After stirring at room temperature for 2 hours, AcOEt and H2O were added to the reaction mixture. The resulting precipitate was collected to give ethyl (E)-3-{3,5-dimethyl-4-[(5-nitropyridin-2-yl)oxy]phenyl}prop-2-enoate as a white powder (40.9 g).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 2.12 (6H, s), 4.27 (2H, t, J=7.1 Hz), 6.40 (1H, d, J=16.1 Hz), 7.09 (1H, d, J=9.0 Hz), 7.31 (2H, s), 7.64 (1H, d, J=15.9 Hz), 8.51 (1H, dd, J=9.0, 2.2 Hz), 9.01 (1H, d, J=2.4 Hz).
The following compounds were produced in the same manner as in Reference Example 385 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.36 (3H, t, J=7.1 Hz), 3.81 (6H, s), 4.29 (2H, q, J=7.1 Hz), 6.42 (1H, d, J=16.2 Hz), 6.84 (2H, s), 7.13 (1H, d, J=8.9 Hz), 7.66 (1H, d, J=16.2 Hz), 8.48 (1H, dd, J=9.1, 2.8 Hz), 8.99 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 1.55-1.74 (3H, m), 1.82-1.89 (2H, m), 1.91-2.02 (1H, m), 2.13 (3H, d, J=1.5 Hz), 2.20 (3H, s), 3.56-4.64 (1H, m), 3.85-3.96 (1H, m), 4.27 (2H, q, J=7.1 Hz), 5.29 (1H, t, J=3.3 Hz), 6.91 (1H, dd, J=8.9, 0.5 Hz), 7.20 (1H, d, J=2.0 Hz), 7.35 (1H, d, J=2.1 Hz), 7.46 (1H, dd, J=8.9, 3.1 Hz), 7.55-7.60 (1H, m), 7.91 (1H, d, J=2.4 Hz).
To a solution of ethyl (E)-3-(3-chloro-5-methyl-4-{[5-(tetrahydro-2H-pyran-2-yloxy)pyridin-2-yl]oxy}phenyl)-2-methylprop-2-enoate (2.58 g) in EtOH (40 mL) was added p-toluenesulfonic acid (1.14 g) at room temperature, then the reaction mixture was stirred for 1 hour. The reaction mixture was concentrated under reduced pressure. The residue was diluted with H2O, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=10/1 to 2/1) to afford ethyl (E)-3-{3-chloro-4-[(5-hydroxypyridin-2-yl)oxy]-5-methylphenyl}-2-methylprop-2-enoate as a colorless amorphous (1.98 g).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 2.13 (3H, d, J=1.5 Hz), 2.20 (3H, s), 4.27 (2H, q, J=7.1 Hz), 4.59 (1H, s), 6.90 (1H, d, J=8.8 Hz), 7.18-7.22 (1H, m), 7.26-7.31 (1H, m), 7.35 (1H, d, J=2.0 Hz), 7.56-7.59 (1H, m), 7.72 (1H, d, J=3.2 Hz).
To a DMF (40 mL) solution of butyl (E)-3-{4-[(5-hydroxypyridin-2-yl)oxy]-2-methylphenyl}prop-2-enoate (3.54 g) was added NaH (60% in oil) (467 mg) at 0 ° C. After stirring for 10 minutes, 1-(bromomethyl)-4-methylbenzene (2.10 g) was added, and the resultant mixture was stirred at room temperature for 3.5 hours. To the reaction mixture was added saturated aqueous NH4Cl, and extracted with AcOEt. The organic layer was washed with water, saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt =9/1 to 3/1) to afford butyl (E)-3-[2-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]prop-2-enoate as a yellow solid (4.72 g).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.41-1.47 (2H, m), 1.65-1.73 (2H, m), 2.36 (3H, s), 2.41 (3H, s), 4.20 (2H, t, J=6.8 Hz), 5.03 (2H, s), 6.30 (1H, d, J=15.6 Hz), 6.87-6.93 (3H, m), 7.20 (2H, d, J=7.8 Hz), 7.30 (2H, d, J =7.8 Hz), 7.34 (1H, dd, J=9.0, 3.2 Hz), 7.55-7.57 (1H, m), 7.90-7.94 (2H, m).
The following compounds were produced in the same manner as in Reference Example 389 using appropriate starting materials.
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.4 Hz), 1.37-1.51 (2H, m), 1.64-1.75 m), 2.20 (3H, s), 2.36 (3H, s), 4.21 (2H, t, J=6.8 Hz), 4.99 (2H, s), 6.38 (1H, d, J=16.2 Hz), 6.93 (1H, d, J=8.9 Hz), 7.19 (2H, d, J=8.2 Hz), 7.26-7.38 (4H, m), 7.47 (1H, d, J=2.0 Hz), 7.58 (1H, d, J=16.2 Hz), 7.79 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.4 Hz), 1.38-1.49 (2H, m), 1.64-1.75 (2H, m), 2.20 (3H, s), 4.21 (2H, t, J=6.6 Hz), 5.10 (2H, s), 6.38 (1H, d, J=16.2 Hz), 6.95 (1H, d, J=8.9 Hz), 7.02-7.21 (2H, m), 7.28-7.35 (2H, m), 7.39 (1H, dd, J=8.9, 3.3 Hz), 7.43-7.50 (2H, m), 7.58 (1H, d, J=15.8 Hz), 7.82 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.41-1.47 (2H, m), 1.64-1.74 (2H, m), 2.20 (3H, s), 4.21 (2H, t, J=6.6 Hz), 5.14 (2H, s), 6.38 (1H, d, J=15.8 Hz), 6.95 (1H, d, J=8.9 Hz), 7.26-7.32 (3H, m), 7.38-7.42 (2H, m), 7.47-7.61 (3H, m), 7.82 (1H, d, J=2.6 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.41-1.47 (2H, m), 1.66-1.71 (2H, m), 2.42 (3H, s), 4.21 (2H, t, J=6.8 Hz), 5.18 (2H, s), 6.31 (1H, d, J=15.6 Hz), 6.86-6.93 (3H, m), 7.26-7.33 (2H, m), 7.36-7.42 (2H, m), 7.52-7.58 (2H, m), 7.91-7.96 (2H, m).
1H-NMR (CDCl3) δ: 1.32 (3H, t, J=7.1 Hz), 3.77 (3H, s), 4.25 (2H, q, J=7.1 Hz), 5.11 (2H, s), 6.38 (1H, d, J=16.1 Hz), 6.91 (1H, d, J=8.8 Hz), 7.07-7.14 (3H, m), 7.21-7.28 (2H, m), 7.33-7.37 (2H, m), 7.48-7.51 (1H, m), 7.65 (1H, d, J=16.1 Hz), 7.86 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.37-1.50 (2H, m), 1.64-1.75 (2H, m), 4.21 (2H, t, J=6.8 Hz), 5.17 (2H, s), 6.38 (1H, d, J=16.1 Hz), 6.98 (1H, d, J=9.0 Hz), 7.17 (1H, d, J=8.3 Hz), 7.25-7.32 (2H, m), 7.37-7.45 (3H, m), 7.48-7.55 (1H, m), 7.56-7.66 (2H, m), 7.88 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.2 Hz), 4.26 (2H, q, J=7.2 Hz), 5.18 (2H, s), 6.36 (1H, d, J=15.9 Hz), 6.93 (1H, d, J=8.8 Hz), 7.10 (2H, d, J=8.8 Hz), 7.28-7.31 (2H, m), 7.37-7.43 (2H, m), 7.52-7.54 (3H, m), 7.67 (1H, d, J=15.9 Hz), 7.96 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.16 (3H, s), 5.14 (2H, s), 6.93 (1H, d, J=9.0 Hz), 7.26-7.35 (3H, m), 7.36-7.42 (2H, m), 7.44 (1H, d, J=2.4 Hz), 7.49-7.55 (1H, m), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 2.13 (3H, d, J=1.5 Hz), 2.21 (3H, s), 4.27 (2H, q, J=7.1 Hz), 5.15 (2H, s), 6.94 (1H, dd, J=9.0, 0.5 Hz), 7.17-7.22 (1H, m), 7.25-7.33 (2H, m), 7.35 (1H, d, J=2.2 Hz), 7.37-7.44 (2H, m), 7.50-7.55 (1H, m), 7.55-7.60 (1H, m), 7.83 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 0.07 (9H, s), 1.01-1.09 (2H, m), 2.21 (3H, s), 2.36 (3H, s), 2.55 (3H, d, J=1.2 Hz), 4.21-4.29 (2H, m), 6.09-6.14 (1H, m), 6.82-7.45 (8H, m), 7.75-7.84 (1H, m).
1H-NMR (CDCl3) δ: 2.16 (3H, s), 2.36 (3H, s), 4.99 (2H, s), 6.91 (1H, d, J=8.5 Hz), 7.19 (2H, d, J=7.8 Hz), 7.26-7.34 (3H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.44 (1H, dd, J=2.4, 0.5 Hz), 7.78 (1H, dd, J=8.5, 2.9 Hz).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 2.13 (3H, d, J=1.5 Hz), 2.20 (3H, s), 2.36 (3H, s), 4.27 (2H, q, J=7.1 Hz), 4.99 (2H, s), 6.91 (1H, dd, J=9.0, 0.5 Hz), 7.16-7.22 (3H, m), 7.27-7.32 (2H, m), 7.33-7.37 (2H, m), 7.55-7.61 (1H, m), 7.80 (1H, d, J=2.4 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.42-1.46 (2H, m), 1.66-1.73 (2H, m), 2.20 (3H, s), 4.21 (2H, t, J=6.6 Hz), 5.09 (2H, s), 6.38 (1H, d, J=15.9 Hz), 6.96 (1H, d, J=9.0 Hz), 7.33 (1H, s), 7.38 (1H, dd, J=8.9, 3.1 Hz), 7.47 (1H, d, J=1.7 Hz), 7.52 (2H, d, J=8.5 Hz), 7.58 (1H, d, J=15.9 Hz), 7.64 (2H, d, J=8.3 Hz), 7.78 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.2 Hz), 2.13 (6H, s), 4.26 (2H, q, J=7.1 Hz), 5.13 (2H, s), 6.37 (1H, d, J=15.9 Hz), 6.83 (1H, d, J=9.0 Hz), 7.26-7.31 (4H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.38-7.40 (1H, m), 7.51-7.53 (1H, m), 7.63 (1H, d, J=15.9 Hz), 7.84 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.0 Hz), 2.12 (6H, s), 2.35 (3H, s), 4.26 (2H, q, J=7.0 Hz), 4.98 (2H, s), 6.36 (1H, d, J=16.1 Hz), 6.81 (1H, d, J=8.8 Hz), 7.19 (2H, d, J=7.6 Hz), 7.27-7.34 (5H, m), 7.63 (1H, d, J=15.9 Hz), 7.82 (1H, d, J=2.0 Hz).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.1 Hz), 2.12 (6H, s), 4.26 (2H, q, J=7.1 Hz), 4.99 (2H, s), 6.36 (1H, d, J=16.1 Hz), 6.83 (1H, d, J=9.0 Hz), 7.05-7.09 (2H, m), 7.27 (2H, brs), 7.32 (1H, dd, J=9.0, 3.2 Hz), 7.36-7.40 (2H, m), 7.63 (1H, d, J=16.1 Hz), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.2 Hz), 2.12 (6H, s), 3.81 (3H, s), 4.26 (2H, q, J=7.2 Hz), 4.95 (2H, s), 6.36 (1H, d, J=15.9 Hz), 6.81 (1H, d, J=8.8 Hz), 6.91 (2H, dt, J=9.3, 2.4 Hz), 7.27 (2H, brs), 7.31-7.34 (3H, m), 7.63 (1H, d, J=15.9 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.1 Hz), 2.12 (6H, s), 4.26 (2H, q, J=7.1 Hz), 5.09 (2H, s), 6.37 (1H, d, J=15.9 Hz), 6.85 (1H, d, J=9.0 Hz), 7.27 (2H, s), 7.34 (1H, dd, J=8.9, 3.1 Hz), 7.52 (2H, d, J=8.3 Hz), 7.63 (1H, d, J=15.9 Hz), 7.68 (2H, d, J=8.3 Hz), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.37-1.50 (2H, m), 1.64-1.74 (2H, m), 4.21 (2H, t, J=6.6 Hz), 5.02 (2H, s), 6.38 (1H, d, J=15.9 Hz), 6.96 (1H, d, J=8.8 Hz), 7.03-7.12 (2H, m), 7.16 (1H, d, J=8.5 Hz), 7.32-7.46 (4H, m), 7.56-7.66 (2H, m), 7.85 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.6 Hz), 1.39-1.48 (2H, m), 1.66-1.73 (2H, m), 2.38 (3H, s), 4.21 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.32 (1H, d, J=15.9 Hz), 6.96 (1H, d, J=8.8 Hz), 7.00 (1H, s), 7.27-7.32 (2H, m), 7.38-7.43 (2H, m), 7.51-7.54 (1H, m), 7.63 (1H, s), 7.84 (1H, d, J=15.9 Hz), 7.89 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.39-1.49 (2H, m), 1.66-1.73 (2H, m), 2.36 (3H, s), 2.38 (3H, s), 4.21 (2H, t, J=6.6 Hz), 5.01 (2H, s), 6.32 (1H, d, J=15.9 Hz), 6.93 (1H, d, J=8.8 Hz), 6.98 (1H, s), 7.19 (2H, d, J=8.1 Hz), 7.29 (2H, d, J=8.1 Hz), 7.36 (1H, dd, J=8.8, 2.9 Hz), 7.63 (1H, s), 7.84 (1H, d, J=15.9 Hz), 7.87 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.6 Hz), 1.40-1.49 (2H, m), 1.66-1.73 (2H, m), 2.20 (3H, s), 4.22 (2H, t, J=6.9 Hz), 5.17 (2H, s), 6.39 (1H, d, J=15.9 Hz), 6.91 (1H, d, J=8.8 Hz), 7.04 (1H, s), 7.26-7.33 (2H, m), 7.38-7.42 (2H, m), 7.51-7.54 (2H, m), 7.92 (1H, d, J=3.2 Hz), 8.02 (1H, d, J=15.9 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.41-1.49 (2H, m), 1.66-1.73 (2H, m), 2.20 (3H, s), 2.36 (3H, s), 4.21 (2H, t, J=6.6 Hz), 5.02 (2H, s), 6.38 (1H, d, J=15.9 Hz), 6.89 (1H, d, J=9.0 Hz), 7.02 (1H, s), 7.19 (2H, d, J=7.8 Hz), 7.30 (2H, d, J=7.8 Hz), 7.35 (1H, dd, J=9.0, 2.9 Hz), 7.51 (1H, s), 7.90 (1H, d, J=2.9 Hz), 8.02 (1H, d, J=15.9 Hz).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.1 Hz), 2.12 (6H, s), 2.56 (3H, s), 4.26 (2H, q, J=7.1 Hz), 5.12 (2H, s), 6.36 (1H, d, J=16.1 Hz), 6.83 (1H, d, J=9.0 Hz), 7.09 (1H, d, J=7.6 Hz), 7.28-7.30 (3H, m), 7.37 (1H, dd, J=8.9, 2.9 Hz), 7.60-7.64 (2H, m), 7.84 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.38 (3H, t, J=7.1 Hz), 3.83 (6H, s), 4.30 (2H, q, J=7.1 Hz), 5.25 (2H, s), 6.41 (1H, d, J=15.9 Hz), 6.85 (2H, s), 7.00 (1H, d, J=8.8 Hz), 7.42 (1H, dd, J=8.8, 2.9 Hz), 7.45-7.49 (1H, m), 7.63-7.69 (3H, m), 7.73 (1H, d, J=7.8 Hz), 7.85 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 3.79 (6H, s), 4.28 (2H, q, J=7.1 Hz), 5.09 (2H, s), 6.39 (1H, d, J=15.9 Hz), 6.83 (2H, s), 6.97 (1H, d, J=9.0 Hz), 7.33 (1H, dd, J=9.0, 2.9 Hz), 7.52 (2H, d, J=8.3 Hz), 7.62-7.69 (3H, m), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.2 Hz), 2.12 (6H, s), 4.26 (2H, q, J=7.1 Hz), 5.06 (2H, s), 6.37 (1H, d, J=15.9 Hz), 6.85 (1H, d, J=8.8 Hz), 7.27 (2H, d, J=4.9 Hz), 7.32-7.36 (3H, m), 7.63 (1H, d, J=16.1 Hz), 7.80 (1H, d, J=2.9 Hz), 8.63 (2H, d, J=5.6 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.37-1.50 (2H, m), 1.64-1.74 (2H, m), 4.21 (2H, t, J=7.3 Hz), 5.12 (2H, s), 6.38 (1H, d, J=15.9 Hz), 6.99 (1H, dd, J=9.0, 0.5 Hz), 7.17 (1H, d, J=8.5 Hz), 7.38 (1H, dd, J=9.0, 3.2 Hz), 7.43 (1H, dd, J=8.5, 2.2 Hz), 7.51-7.56 (2H, m), 7.58-7.65 (2H, m), 7.65-7.72 (2H, m), 7.83 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 3.79 (6H, s), 4.28 (2H, q, J=7.1 Hz), 5.19 (2H, s), 6.38 (1H, d, J=15.9 Hz), 6.82 (2H, s), 6.96 (1H, d, J=9.0 Hz), 7.36 (1H, dd, J=8.8, 2.7 Hz), 7.55 (1H, d, J=8.3 Hz), 7.64 (1H, d, J=16.1 Hz), 7.82 (1H, d, J=2.9 Hz), 8.03 (1H, s), 8.14 (1H, d, J=8.5 Hz), 9.01 (1H, s).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.41-1.48 (2H, m), 1.67-1.71 (2H, m), 2.39 (3H, s), 4.21 (2H, t, J=6.6 Hz), 5.11 (2H, s), 6.32 (1H, d, J=15.9 Hz), 6.96-6.98 (1H, m), 7.00 (1H, s), 7.37 (1H, dd, J=9.0, 3.2 Hz), 7.52-7.54 (2H, m), 7.63 (1H, s), 7.66-7.70 (2H, m), 7.82-7.86 (2H, m).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.40-1.49 (2H, m), 1.66-1.73 (2H, m), 2.19 (3H, s), 4.22 (2H, t, J=6.8 Hz), 5.13 (2H, s), 6.39 (1H, d, J=15.9 Hz), 6.92 (1H, d, J=8.8 Hz), 7.04 (1H, s), 7.37 (1H, dd, J=8.8, 3.2 Hz), 7.52-7.55 (3H, m), 7.68-7.70 (2H, m), 7.88 (1H, d, J=3.2 Hz), 8.02 (1H, d, J=15.9 Hz).
1H-NMR (CDCl3) δ: 1.34 (3H, t, J=7.1 Hz), 2.12 (6H, s), 4.26 (2H, q, J=7.1 Hz), 5.25 (2H, d, J=0.7 Hz), 6.37 (1H, d, J=15.9 Hz), 6.85 (1H, dd, J=8.8, 0.5 Hz), 7.27 (2H, d, J=0.5 Hz), 7.34 (1H, dd, J=8.8, 2.9 Hz), 7.63 (1H, d, J=16.1 Hz), 7.83 (1H, dd, J=2.0, 0.5 Hz), 7.87 (1H, d, J=0.7 Hz), 8.83 (1H, d, J=0.7 Hz).
1H-NMR (CDCl3) δ: 1.33 (3H, d, J=7.1 Hz), 2.12 (6H, s), 4.26 (2H, t, J=7.1 Hz), 5.23 (2H, s), 6.36 (1H, d, J=15.9 Hz), 6.82-6.85 (1H, m), 7.27 (2H, s), 7.37-7.40 (2H, m), 7.63 (1H, d, J=15.9 Hz), 7.85-7.86 (1H, m), 8.83-8.85 (1H, m).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.39-1.49 (2H, m), 1.66-1.73 (2H, m), 2.20 (3H, s), 4.21 (2H, t, J=6.6 Hz), 5.01 (2H, s), 6.38 (1H, d, J=16.1 Hz), 6.51 (1H, t, J=73.7 Hz), 6.95 (1H, d, J=8.8 Hz), 7.14 (2H, d, J=8.5 Hz), 7.33 (1H, brs), 7.37 (1H, dd, J=8.8, 2.9 Hz), 7.41 (2H, d, J=8.5 Hz), 7.47 (1H, brs), 7.58 (1H, d, J=16.1 Hz), 7.78 (1H, d, J=2.9 Hz).
To a solution of 2-(4-bromo-2-chloro-6-methylphenoxy)-5-{[tert-butyl(dimethyl)-silyl]oxy}pyridine (1.00 g) in 1,4-dioxane (23.3 mL) were added 2 M aqueous K2CO3 (2.33 mL) and Pd(PPh3)4 (81 mg) under a N2 atmosphere, then the reaction mixture was stirred over night at 50° C. Then the reaction mixture was added Pd(PPh3)4 (81 mg) and stirred at 80° C. for 6 hours. The reaction mixture was concentrated under reduced pressure, and diluted with AcOEt. The mixture was filtered off on celite, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=10/1 to 4/1) to afford 2-(trimethylsilyl)ethyl (E)-3-{4-[(5-{[tert-butyl(dimethyl)silyl]oxy}pyridin-2-yl)oxy]-3-chloro-5-methylphenyl}but-2-enoate as a colorless oil (0.630 g).
1H-NMR (CDCl3) δ: 0.07 (9H, s), 0.18 (6H, s), 0.97 (9H, s), 1.00-1.10 (2H, m), 2.20 (3H, s), 2.54 (3H, d, J=1.2 Hz), 4.22-4.29 (2H, m), 6.08-6.13 (1H, m), 6.87 (1H, dd, J=8.8, 0.7 Hz), 7.22 (1H, d, J=8.8, 2.9 Hz), 7.24-7.30 (1H, m), 7.38-7.44 (1H, m), 7.69 (1H, dd, J=2.9, 0.5 Hz).
The following compounds were produced in the same manner as in Reference Example 424 using appropriate starting materials.
1H-NMR (CDCl3) δ: 0.07 (9H, s), 1.01-1.09 (2H, m), 2.21 (3H, s), 2.55 (3H, d, J=1.2 Hz), 4.21-4.29 (2H, m), 5.15 (2H, s), 6.09-6.12 (1H, m), 6.95 (1H, dd, J=8.8, 0.5 Hz), 7.25-7.32 (3H, m), 7.36-7.43 (3H, m), 7.49-7.55 (1H, m), 7.83 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 1.79-1.84 (3H, m), 2.18 (3H, s), 2.22-2.25 (3H, m), 2.36 (3H, s), 4.26 (2H, q, J=7.1 Hz), 5.00 (2H, s), 6.88 (1H, dd, J=8.8, 0.5 Hz), 6.94 (1H, dd, J=2.2, 0.7 Hz), 7.08 (1H, dd, J=2.0, 0.5 Hz), 7.19 (2H, d, J=7.6 Hz), 7.29 (2H, d, J=8.1 Hz), 7.35 (1H, dd, J=8.8, 3.2 Hz), 7.82 (1H, dd, J=3.0, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.35 (3H, t, J=7.1 Hz), 1.79-1.84 (3H, m), 2.19 (3H, s), 2.20-2.25 (3H, m), 4.26 (2H, q, J=7.1 Hz), 5.15 (2H, s), 6.91 (1H, dd, J=8.8, 0.5 Hz), 6.94 (1H, dd, J=2.2, 0.5 Hz), 7.08 (1H, dd, J=2.2, 0.5 Hz), 7.25-7.35 (2H, m), 7.35-7.43 (2H, m), 7.50-7.55 (1H, m), 7.85 (1H, dd, J=2.9, 0.5 Hz).
To a solution of 2-(trimethylsilyl)ethyl (E)-3-{4-[(5-{[tert-butyl(dimethyl)silyl]-oxy}pyridin-2-yl)oxy]-3-chloro-5-methylphenyl}but-2-enoate (0.630 g) in EtOH (12 mL) was added PPTS (0.296 g) at room temperature, then the reaction mixture was stirred for 4 days. The reaction mixture was warmed to 60° C., and stirred over night. The reaction mixture was concentrated under reduced pressure. The residue was diluted with pH 7 phosphate buffer, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=8/1 to 2/1) to afford 2-(trimethylsilyl)ethyl (E)-3-{3-chloro-4-[(5-hydroxypyridin-2-yl)oxy]-5-methylphenyl}but-2-enoate as a colorless oil (0.490 g).
1H-NMR (CDCl3) δ: 0.07 (9H, s), 1.01-1.09 (2H, m), 2.20 (3H, s), 2.54 (3H, d, J=1.5 Hz), 4.21-4.29 (2H, m), 4.94 (1H, s), 6.09-6.12 (1H, m), 6.89 (1H, d, J=8.8 Hz), 7.26-7.30 (2H, m), 7.39 (1H, d, J=1.7 Hz), 7.70 (1H, dd, J=3.0, 0.5 Hz).
The following compounds were produced in the same manner as in Reference Example 20 using appropriate starting materials.
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.41-1.47 (2H, m), 1.64-1.74 (2H, m), 2.19 (3H, s), 3.04 (2H, t, J=6.6 Hz), 4.13 (2H, t, J=6.4 Hz), 4.21 (2H, t, J=6.6 Hz), 6.38 (1H, d, J=15.8 Hz), 6.91 (1H, d, J=8.9 Hz), 7.18-7.21 (2H, m), 7.28-7.31 (4H, m), 7.46 (1H, d, J=2.0 Hz), 7.58 (1H, d, J=15.8 Hz), 7.71 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.4 Hz), 1.39-1.46 (2H, m), 1.64-1.74 (2H, m), 2.19 (3H, s), 2.33 (3H, s), 3.04 (2H, t, J=7.1 Hz), 4.13 (2H, t, J=6.9 Hz), 4.21 (2H, t, J=6.8 Hz), 6.38 (1H, d, J=15.8 Hz), 6.90 (1H, d, J=8.9 Hz), 7.12-7.16 (4H, m), 7.28-7.32 (2H, m), 7.46 (1H, d, J=2.0 Hz), 7.58 (1H, d, J=15.8 Hz), 7.72 (1H, d, J=3.3 Hz).
1H-NMR (CDCl3) δ: 0.97 (3H, t, J=7.3 Hz), 1.37-1.52 (2H, m), 1.64-1.74 (2H, m), 2.19 (3H, s), 3.03 (2H, t, J=6.4 Hz), 4.13 (2H, t, J=6.6 Hz), 4.21 (2H, t, J=6.6 Hz), 6.38 (1H, d, J=15.8 Hz), 6.92 (1H, d, J=8.9 Hz), 7.10 (1H, dd, J=8.2, 2.0 Hz), 7.27-7.32 (2H, m), 7.36-7.38 (2H, m), 7.46 (1H, d, J=2.0 Hz), 7.58 (1H, d, J=16.2 Hz), 7.71 (1H, d, J=3.0 Hz).
To an EtOH (50 mL) solution of butyl (E)-3-[2-methyl-4-({5-[(4-methylbenzyl)-oxy]pyridin-2-yl}oxy)phenyl]prop-2-enoate (4.67 g) was added 5 M NaOH (3.25 mL) at room temperature. After stirring for 14 hours, 5 M NaOH (1.08 mL) and water (25 mL) were added, and then the reaction mixture was refluxed for 2 hours. The solvent was removed under reduced pressure. The residue was dissolved in water, and neutralized with 6 M HCl at 0° C. The resulting precipitate was collected by filtration and dried to afford (E)-3-[2-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]prop-2-enoic acid as a colorless solid (4.06 g).
1H-NMR (DMSO-d6) δ: 2.30 (3H, s), 2.36 (3H, s), 5.09 (2H, s), 6.37 (1H, d, J=15.9 Hz), 6.88 (1H, dd, J=8.5, 2.7 Hz), 6.94 (1H, d, J=2.7 Hz), 7.04 (1H, d, J=9.0 Hz), 7.20 (2H, d, J=7.8 Hz), 7.34 (2H, d, J=7.8 Hz), 7.58 (1H, dd, J=9.0, 3.2 Hz), 7.72 (1H, d, J=8.5 Hz), 7.77 (1H, d, J=15.9 Hz), 7.95 (1H, d, J=3.2 Hz), 12.39 (1H, brs).
The following compounds were produced in the same manner as in Reference Example 432 using appropriate starting materials.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 3.02 (2H, t, J=6.6 Hz), 4.20 (2H, t, J=6.8 Hz), 6.57 (1H, d, J=16.2 Hz), 7.06 (1H, d, J=8.9 Hz), 7.34-7.37 (4H, m), 7.50-7.55 (2H, m), 7.64 (1H, d, J=1.6 Hz), 7.73 (1H, d, J=3.0 Hz), 7.75 (1H, d, J=2.0 Hz), 12.43 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.26 (3H, s), 2.97 (2H, t, J=6.9 Hz), 4.17 (2H, t, J=6.9 Hz), 6.56 (1H, d, J=16.2 Hz), 7.06 (1H, d, J=8.9 Hz), 7.10 (2H, d, J=7.9 Hz), 7.19 (2H, d, J=7.9 Hz), 7.49-7.57 (2H, m), 7.64 (1H, d, J=1.6 Hz), 7.73 (1H, d, J=3.0 Hz), 7.75 (1H, d, J=2.0 Hz), 12.45 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 3.04 (2H, t, J=6.6 Hz), 4.22 (2H, t, J=6.6 Hz), 6.57 (1H, d, J=15.8 Hz), 7.07 (1H, d, J=8.9 Hz), 7.33 (1H, dd, J=8.4, 2.1 Hz), 7.51-7.58 (3H, m), 7.63-7.64 (2H, m), 7.74-7.75 (2H, m), 12.45 (1H, brs).
1H-NMR (DMSO-d6)δ: 2.10 (3H, s), 2.30 (3H, s), 5.05 (2H, s), 6.57 (1H, d, J=15.8 Hz), 7.09 (1H, d, J=8.9 Hz), 7.20 (2H, d, J=7.9 Hz), 7.33 (2H, d, J=7.9 Hz), 7.52-7.61 (2H, m), 7.65 (1H, d, J=1.3 Hz), 7.76 (1H, d, J=2.0 Hz), 7.80 (1H, d, J=3.0 Hz), 12.45 (1H, s).
1H-NMR (CDCl3) δ: 2.21 (4H, s), 5.11 (2H, s), 6.37 (1H, d, J=16.2 Hz), 6.97 (1H, d, J=8.9 Hz), 7.04-7.22 (2H, m), 7.29-7.49 (5H, m), 7.64 (1H, d, J=15.8 Hz), 7.82 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.22 (3H, s), 5.15 (2H, s), 6.36 (1H, d, J=15.8 Hz), 6.98 (1H, d, J=8.9 Hz), 7.26-7.35 (3H, m), 7.37-7.44 (2H, m), 7.49-7.54 (2H, m), 7.64 (1H, d, J=15.8 Hz), 7.83 (1H, d, J=2.6 Hz).
1H-NMR (CDCl3) δ: 3.82 (3H, s), 5.16 (2H, s), 6.36 (1H, d, J=15.9 Hz), 6.96 (1H, d, J=8.8 Hz), 7.11-7.20 (3H, m), 7.26-7.32 (3H, m), 7.37-7.43 (2H, m), 7.51-7.55 (1H, m), 7.72 (1H, d, J=15.9 Hz), 7.89 (1H, d, J=2.9 Hz).
1H-NMR (DMSO-d6) δ: 5.19 (2H, s), 6.58 (1H, d, J=15.9 Hz), 7.14 (1H, d, J=8.8 Hz), 7.25 (1H, d, J=8.5 Hz), 7.37-7.44 (2H, m), 7.48-7.74 (5H, m), 7.93 (1H, d, J=3.2 Hz), 7.95 (1H, d, J=2.0 Hz).
1H-NMR (DMSO-d6) δ: 2.37 (3H, s), 5.20 (2H, s), 6.38 (1H, d, J=15.6 Hz), 6.90 (1H, dd, J=8.3, 2.4 Hz), 6.96 (1H, d, J=2.4 Hz), 7.07 (1H, d, J=8.8 Hz), 7.38-7.46 (2H, m), 7.51-7.55 (1H, m), 7.61-7.65 (2H, m), 7.73 (1H, d, J=8.3 Hz), 7.82 (1H, d, J=15.6 Hz), 8.01 (1H, d, J=2.9 Hz), 12.40 (1H, brs).
1H-NMR (CDCl3) δ: 5.19 (2H, s), 6.37 (1H, d, J=15.9 Hz), 6.95 (1H, d, J=8.8 Hz), 7.12 (2H, dt, J=9.0, 2.3 Hz), 7.29-7.32 (2H, m), 7.38-7.43 (2H, m), 7.52-7.55 (1H, m), 7.56 (2H, d, J=8.8 Hz), 7.76 (1H, d, J=15.9 Hz), 7.97 (1H, d, J=3.2 Hz).
1H-NMR (DMSO-d6) δ: 2.05 (3H, d, J=1.5 Hz), 2.12 (3H, s), 2.30 (3H, s), 5.05 (2H, s), 7.09 (1H, dd, J=9.0, 0.5 Hz), 7.19 (2H, d, J=7.8 Hz), 7.33 (2H, d, J=8.1 Hz), 7.38 (1H, d, J=2.0 Hz), 7.48 (1H, d, J=2.0 Hz), 7.52-7.56 (1H, m), 7.58 (1H, dd, J=8.8, 3.2 Hz), 7.81 (1H, dd, J=3.2, 0.5 Hz), 12.61 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.73 (3H, d, J=1.7 Hz), 2.11 (3H, s), 2.18-2.23 (3H, m), 5.17 (2H, s), 7.09 (1H, d, J=9.0 Hz), 7.12-7.15 (1H, m), 7.21 (1H, d, J=2.0 Hz), 7.35-7.45 (2H, m), 7.48-7.55 (1H, m), 7.59-7.66 (2H, m), 7.88 (1H, d, J=3.2 Hz), 12.51 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.71-1.75 (3H, m), 2.10 (3H, s), 2.17-2.22 (3H, m), 2.30 (3H, s), 5.05 (2H, s), 7.06 (1H, dd, J=9.0, 0.5 Hz), 7.09-7.14 (1H, m), 7.17-7.23 (3H, m), 7.33 (2H, d, J=8.1 Hz), 7.58 (1H, dd, J=9.0, 3.2 Hz), 7.81 (1H, dd, J=2.9, 0.5 Hz), 12.55 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.05 (3H, d, J=1.5 Hz), 2.13 (3H, s), 5.17 (2H, s), 7.12 (1H, dd, J=9.0, 0.5 Hz), 7.36-7.46 (3H, m), 7.46-7.57 (3H, m), 7.58-7.67 (2H, m), 7.86 (1H, dd, J=3.2, 0.5 Hz), 12.62 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 5.23 (2H, s), 6.58 (1H, d, J=16.1 Hz), 7.13 (1H, d, J=8.8 Hz), 7.55 (1H, d, J=15.9 Hz), 7.62-7.69 (4H, m), 7.77-7.79 (3H, m), 7.84 (1H, d, J=3.2 Hz), 12.49 (1H, s).
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 5.16 (2H, s), 6.47 (1H, d, J=15.9 Hz), 7.02 (1H, d, J=9.0
Hz), 7.39-7.41 (2H, m), 7.45 (2H, brs), 7.49-7.53 (2H, m), 7.60-7.63 (2H, m), 7.85 (1H, d, J=2.9 Hz).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.30 (3H, s), 5.04 (2H, s), 6.47 (1H, d, J=15.9 Hz), 6.98 (1H, d, J=8.5 Hz), 7.19 (2H, d, J=7.1 Hz), 7.32 (2H, d, J=7.1 Hz), 7.43 (2H, brs), 7.50 (1H, d, J=16.1 Hz), 7.55 (1H, d, J=8.8 Hz), 7.80 (1H, brs).
1H-NMR (CDCl3) δ: 2.13 (6H, s), 4.99 (2H, s), 6.35 (1H, d, J=16.1 Hz), 6.86 (1H, d, J=9.0 Hz), 7.04-7.10 (2H, m), 7.29 (2H, brs), 7.33-7.40 (3H, m), 7.68 (1H, d, J=16.1 Hz), 7.82 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.14 (6H, s), 3.82 (3H, s), 4.96 (2H, s), 6.35 (1H, d, J=15.9 Hz), 6.85 (1H, d, J=9.0 Hz), 6.91 (2H, dt, J=9.2, 2.4 Hz), 7.29 (2H, brs), 7.31-7.36 (3H, m), 7.68 (1H, d, J=15.9 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.13 (6H, s), 5.10 (2H, s), 6.35 (1H, d, J=16.1 Hz), 6.89 (1H, d, J=8.8 Hz), 7.26-7.29 (3H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.53 (2H, d, J=8.3 Hz), 7.67-7.69 (3H, m), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (DMSO-d6) δ: 5.12 (2H, s), 6.57 (1H, d, J=16.1 Hz), 7.12 (1H, d, J=8.8 Hz), 7.18-7.28 (3H, m), 7.47-7.66 (4H, m), 7.69 (1H, dd, J=8.5, 2.2 Hz), 7.90 (1H, d, J=2.9 Hz), 7.95 (1H, d, J=2.0 Hz), 12.49 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.30 (3H, s), 2.35 (3H, s), 5.08 (2H, s), 6.51 (1H, d, J=15.9 Hz), 7.08 (1H, d, J=8.8 Hz), 7.12 (1H, s), 7.20 (2H, d, J=7.8 Hz), 7.33 (2H, d, J=7.8 Hz), 7.59 (1H, dd, J=9.0, 2.2 Hz), 7.71 (1H, d, J=15.9 Hz), 7.87 (1H, d, J=2.7 Hz), 7.90 (1H, s), 12.48 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.35 (3H, s), 5.19 (2H, s), 6.51 (1H, d, J=15.9 Hz), 7.11 (1H, d, J=9.0 Hz), 7.14 (1H, s), 7.37-7.43 (2H, m), 7.50-7.54 (1H, m), 7.59-7.66 (2H, m), 7.71 (1H, d, J=15.9 Hz), 7.91-7.93 (2H, m), 12.49 (1H, s).
1H-NMR (CDCl3) δ: 2.13 (3H, s), 5.20 (2H, s), 6.58 (1H, d, J=15.9 Hz), 7.11 (1H, d, J=8.8 Hz), 7.16 (1H, s), 7.37-7.43 (2H, m), 7.50-7.54 (1H, m), 7.60-7.66 (2H, m), 7.82 (1H, d, J=15.9 Hz), 7.92 (1H, s), 7.96-7.97 (1H, m), 12.55 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 6.45 (1H, d, J=15.9 Hz), 6.87 (1H, d, J=8.8 Hz), 7.27 (1H, dd, J=8.8, 2.9 Hz), 7.44 (2H, s), 7.52 (1H, d, J=15.9 Hz), 7.55 (1H, d, J=2.9 Hz), 9.49 (1H, s), 12.32 (1H, s).
1H-NMR (DMSO-d6) δ: 2.36 (3H, s), 6.36 (1H, d, J=15.9 Hz), 6.85 (1H, dd, J=8.5, 2.0 Hz), 6.90 (1H, d, J=2.0 Hz), 6.94 (1H, d, J=8.8 Hz), 7.30 (1H, dd, J=8.7, 3.1 Hz), 7.71 (1H, d, J=8.5 Hz), 7.75-7.78 (2H, m), 9.76 (1H, s), 12.37 (1H, s).
1H-NMR (DMSO-d6) δ: 3.72 (6H, s), 5.21 (2H, s), 6.61 (1H, d, J=15.9 Hz), 6.93 (1H, d, J=8.8 Hz), 7.11 (2H, s), 7.52 (1H, dd, J=8.8, 2.9 Hz), 7.58 (1H, d, J=15.9 Hz), 7.64 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz), 7.87 (2H, d, J=8.1 Hz), 12.36 (1H, s).
1H-NMR (DMSO-d6) δ: 3.73 (6H, s), 5.24 (2H, s), 6.61 (1H, d, J=16.1 Hz), 6.95 (1H, d, J=8.8 Hz), 7.11 (2H, s), 7.54-7.61 (3H, m), 7.72-7.78 (2H, m), 7.81 (1H, d, J=2.9 Hz), 7.91 (1H, d, J=7.6 Hz), 12.35 (1H, s).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 5.18 (2H, s), 6.46 (1H, d, J=16.1 Hz), 7.02 (1H, d, J=9.0 Hz), 7.43-7.45 (4H, m), 7.52 (1H, d, J=16.1 Hz), 7.60 (1H, dd, J=9.0, 2.9 Hz), 7.83 (1H, d, J=2.9 Hz), 8.58 (2H, d, J=5.9 Hz), 12.33 (1H, s).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.59 (3H, s), 5.25 (2H, s), 6.46 (1H, d, J=15.9 Hz), 7.04 (1H, d, J=9.0 Hz), 7.44-7.47 (3H, m), 7.52-7.55 (2H, m), 7.63 (1H, dd, J=9.0, 2.9 Hz), 7.85 (1H, d, J=2.9 Hz), 8.01 (1H, brs).
1H-NMR (DMSO-d6) δ: 5.25 (2H, s), 6.57 (1H, d, J=15.9 Hz), 7.13 (1H, d, J=9.0 Hz), 7.23 (1H, d, J=8.5 Hz), 7.50-7.73 (4H, m), 7.84-7.95 (5H, m), 12.45 (1H, brs).
1H-NMR (DMSO-d6) δ: 3.72 (6H, s), 5.26 (2H, s), 6.61 (1H, d, J=15.9 Hz), 6.93 (1H, d, J=9.0 Hz), 7.11 (2H, s), 7.54 (1H, dd, J=9.0, 2.9 Hz), 7.59 (1H, d, J=15.9 Hz), 7.61-7.63 (1H, m), 7.81 (1H, d, J=2.9 Hz), 8.10 (1H, d, J=8.5 Hz), 8.26 (1H, s), 9.41 (1H, s), 12.36 (1H, s).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 2.30 (3H, s), 5.09 (2H, s), 6.58 (1H, d, J=15.9 Hz), 7.08 (1H, d, J=8.8 Hz), 7.14 (1H, s), 7.20 (2H, d, J=8.1 Hz), 7.33 (2H, d, J=8.1 Hz), 7.59 (1H, dd, J=8.8, 2.9 Hz), 7.82 (1H, d, J=15.9 Hz), 7.91-7.92 (2H, m), 12.57 (1H, s).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 5.26 (2H, s), 6.59 (1H, d, J=15.9 Hz), 7.11 (1H, d, J=8.8 Hz), 7.15 (1H, s), 7.62-7.66 (3H, m), 7.82 (1H, d, J=15.9 Hz), 7.88 (2H, d, J=8.5 Hz), 7.92 (1H, s), 7.94 (1H, d, J=2.9 Hz), 12.58 (1H, s).
1H-NMR (DMSO-d6) δ: 2.35 (3H, s), 5.25 (2H, s), 6.51 (1H, d, J=15.9 Hz), 7.10-7.13 (2H, m), 7.61-7.66 (3H, m), 7.71 (1H, d, J=15.9 Hz), 7.86-7.90 (4H, m), 12.49 (1H, s).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 5.39 (2H, d, J=0.5 Hz), 6.46 (1H, d, J=16.1 Hz), 7.01 (1H, dd, J=9.0, 0.5 Hz), 7.46 (2H, s), 7.52 (1H, d, J=15.9 Hz), 7.60 (1H, dd, J=9.0, 3.2 Hz), 7.83 (1H, dd, J=3.2, 0.5 Hz), 8.00 (1H, d, J=0.7 Hz), 9.13 (1H, d, J=0.7 Hz), 12.35 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 5.22 (2H, s), 6.46 (1H, d, J=15.9 Hz), 7.01 (1H, d, J=9.0 Hz), 7.45 (2H, s), 7.52 (1H, d, J=15.9 Hz), 7.61 (1H, dd, J=9.0, 3.2 Hz), 7.83 (1H, d, J=2.0 Hz), 7.84 (1H, d, J=3.2 Hz), 9.12 (1H, d, J=2.0 Hz), 12.33 (1H, s).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 5.10 (2H, s), 6.57 (1H, d, J=15.9 Hz), 7.10 (1H, d, J=8.8 Hz), 7.20 (2H, d, J=8.3 Hz), 7.24 (1H, t, J=74.1 Hz), 7.50-7.57 (3H, m), 7.60 (1H, dd, J=8.8, 2.9 Hz), 7.65 (1H, brs), 7.75 (1H, brs), 7.81 (1H, d, J=2.9 Hz), 12.45 (1H, s).
To a DMF (40 mL) solution of butyl (E)-3-{3-fluoro-4-[(5-hydroxypyridin-2-yl)oxy]phenyl}prop-2-enoate (3.82 g) and 2-chlorobenzyl chloride (1.6 mL) was added sodium hydride (60% w/w in oil, 0.60 g) at 0° C., and stirred at room temperature for 3 hours. The reaction mixture was quenched by addition of saturated NH4Cl (90 mL), and extracted with AcOEt. The organic layer was washed with water, saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=19/1 to 9/1) to afford (E)-3-[4-({5-[(2-Chlorobenzyl)oxy]pyridin-2-yl}oxy)-3-fluorophenyl]prop-2-enoic acid butyl ester (3.53 g).
To an EtOH (40 mL) solution of the ester was added 5 M NaOH (6.9 mL), and stirred for 2.5 hours at 50° C., then EtOH was evaporated. The residue was dissolved in water, and acidified with 6 M HCl. The resulting precipitate was collected by filtration and dried to afford (E)-3-[4-({5-[(2-Chlorobenzyl)oxy]pyridin-2-yl}oxy)-3-fluorophenyl]prop-2-enoic acid as a white powder (2.78 g).
1H-NMR (DMSO-d6) δ: 5.19 (2H, s), 6.57 (1H, d, J=16.1 Hz), 7.15 (1H, d, J=8.8 Hz), 7.30 (1H, t, J=8.3 Hz), 7.37-7.44 (2H, m), 7.51-7.57 (3H, m), 7.60-7.63 (1H, m), 7.65 (1H, dd, J=8.9, 3.1 Hz), 7.76 (1H, dd, J=12.0, 2.0 Hz), 7.92 (1H, d, J=2.9 Hz).
The following compounds were produced in the same manner as in Reference Example 471 using appropriate starting materials.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 5.20 (2H, s), 6.58 (1H, dd, J=15.9, 0.7 Hz), 7.13 (1H, d, J=9.0 Hz), 7.28 (1H, t, J=7.9 Hz), 7.55 (2H, t, J=7.9 Hz), 7.60-7.67 (3H, m), 7.77 (1H, d, J=1.5 Hz), 7.85 (1H, d, J=2.9 Hz), 12.50 (1H, s).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 5.21 (2H, s), 6.58 (1H, d, J=15.9 Hz), 7.13 (1H, d, J=9.0 Hz), 7.23-7.28 (1H, m), 7.39 (1H, t, J=6.8 Hz), 7.43-7.49 (1H, m), 7.55 (1H, d, J=16.1 Hz), 7.64-7.67 (2H, m), 7.77 (1H, d, J=1.7 Hz), 7.85 (1H, d, J=3.2 Hz), 12.48 (1H, s).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 2.31 (3H, s), 5.08 (2H, s), 6.46 (1H, d, J=15.9 Hz), 6.96 (1H, d, J=8.3 Hz), 7.02 (1H, d, J=9.0 Hz), 7.20 (2H, d, J=8.1 Hz), 7.33 (2H, d, J=8.1 Hz), 7.50-7.59 (3H, m), 7.64 (1H, d, J=2.0 Hz), 7.88 (1H, d, J=3.2 Hz), 12.36 (1H, s).
1H-NMR (DMSO-d6) δ: 2.13 (3H, s), 5.23 (2H, s), 6.47 (1H, d, J=15.9 Hz), 6.99 (1H, d, J=8.3 Hz), 7.05 (1H, d, J=9.0 Hz), 7.43 (1H, t, J=7.9 Hz), 7.51-7.57 (2H, m), 7.60-7.68 (4H, m), 7.94 (1H, d, J=3.2 Hz), 12.24 (1H, s).
1H-NMR (DMSO-d6) δ: 2.13 (3H, s), 5.19 (2H, s), 6.47 (1H, d, J=16.1 Hz), 6.99 (1H, d, J=8.3 Hz), 7.05 (1H, d, J=8.8 Hz), 7.37-7.44 (2H, m), 7.52-7.58 (3H, m), 7.61-7.65 (3H, m), 7.93 (1H, d, J=2.9 Hz), 12.38 (1H, s).
1H-NMR (DMSO-d6) δ: 5.22 (2H, s), 7.16 (1H, dd, J=8.8, 0.5 Hz), 7.37-7.45 (3H, m), 7.51-7.56 (1H, m), 7.60 (1H, d, J=2.2 Hz), 7.62-7.66 (1H, m), 7.68 (1H, dd, J=8.8, 3.2 Hz), 7.93 (1H, d, J=8.8 Hz), 7.97 (1H, dd, J=8.5, 1.5 Hz), 8.03 (1H, dd, J=3.2, 0.5 Hz), 8.15 (1H, d, J=9.0 Hz), 8.61 (1H, d, J=0.7 Hz), 13.03 (1H, brs).
1H-NMR (CDCl3) δ: 2.21 (3H, s), 5.10 (2H, s), 6.09-6.33 (1H, m), 6.37 (1H, d, J=16.1 Hz), 6.96-7.01 (1H, m), 7.34 (1H, s), 7.38-7.41 (1H, m), 7.48-7.54 (3H, m), 7.64 (1H, d, J=16.1 Hz), 7.68-7.85 (3H, m).
1H-NMR (DMSO-d6) δ: 3.36 (1H, brs), 5.26 (2H, s), 7.15 (1H, dd, J=8.8, 0.5 Hz), 7.24-7.30 (1H, m), 7.36 (1H, dd, J=8.8, 2.4 Hz), 7.39-7.51 (2H, m), 7.58 (1H, d, J=2.4 Hz), 7.68 (1H, dd, J=8.8, 3.2 Hz), 7.89 (1H, d, J=9.0 Hz), 7.98 (1H, dd, 8.5, 1.7 Hz), 8.02 (1H, dd, J=3.2, 0.5 Hz), 8.12 (1H, d, J=9.3 Hz), 8.58 (1H, d, J=0.7 Hz).
1H-NMR (DMSO-d6) δ: 5.23 (2H, s), 6.57 (1H, d, J=15.9 Hz), 7.14 (1H, d, J=9.0 Hz), 7.23-7.32 (2H, m), 7.37-7.41 (1H, m), 7.42-7.49 (1H, m), 7.54 (1H, dd, J=8.2, 1.8 Hz), 7.58 (1H, d, J=16.1 Hz), 7.66 (1H, dd, J=9.0, 3.2 Hz), 7.77 (1H, dd, J=12.0, 2.0 Hz), 7.92 (1H, d, J=2.7 Hz), 12.47 (1H, brs).
1H-NMR (DMSO-d6) Es: 5.14 (2H, s), 6.57 (1H, d, J=16.1 Hz), 7.11-7.16 (2H, m), 7.27-7.34 (2H, m), 7.54 (1H, dd, J=8.3, 1.7 Hz), 7.59 (1H, d, J=15.9 Hz), 7.62-7.67 (2H, m), 7.77 (1H, dd, J=12.0, 2.0 Hz), 7.91 (1H, d, J=2.9 Hz), 12.46 (1H, brs).
1H-NMR (DMSO-d6) δ: 5.12 (2H, s), 6.57 (1H, d, J=15.9 Hz), 7.13 (1H, dd, J=9.0, 0.5 Hz), 7.27-7.34 (2H, m), 7.46 (1H, dt, J=14.8, 5.4 Hz), 7.52-7.64 (4H, m), 7.77 (1H, dd, J=12.0, 2.0 Hz), 7.89 (1H, dd, J=3.2, 0.5 Hz), 12.45 (1H, brs).
1H-NMR (DMSO-d6) δ: 5.25 (2H, s), 6.56 (1H, d, J=16.1 Hz), 7.14 (1H, d, J=8.8 Hz), 7.29 (1H, t, J=8.3 Hz), 7.50-7.66 (5H, m), 7.77 (1H, dd, J=12.0, 2.0 Hz), 7.87-7.90 (3H, m), 12.46 (1H, s).
To a THF (50 mL) solution of butyl (E)-3-{4-[(5-aminopyridin-2-yl)oxy]-3-chloro-5-methylphenyl}prop-2-enoate (5.00 g) were added sulfuric acid (1.1 mL) and n-pentyl nitrite (2.44 g) at 0° C. After stirring for 1 hour, the resulting precipitate was collected by filtration and dried under reduced pressure to afford a diazonium salt as a pale brown powder (6.45 g).
To acetic acid (100 mL) was added an acetic acid (50 mL) solution of the diazonium salt (6.45 g) at 100-110° C. After stirring for 1 hour, acetic acid was evaporated. K2CO3 (9.58 g) was added to an EtOH (50 mL) solution of the residue at room temperature. After stirring over night, EtOH was evaporated. To the residue were added water and AcOEt, and the mixture was acidified with 1 M HCl. The organic layer was washed with saturated NaHCO3, saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=7/3 to 1/1) to afford (E)-3-{3-chloro-4-[(5-hydroxypyridin-2-yl)oxy]-5-methylphenyl}prop-2-enoic acid butyl ester (4.73 g).
To a MeOH (10 mL) solution of the ester (4.73 g) was added 5 M NaOH (2 mL), and stirred for 1 hour at 50° C., then MeOH was evaporated. The residue was dissolved in water, and acidified with 6 M HCl. The resulting precipitate was collected by filtration and dried to afford (E)-3-{3-chloro-4-[(5-hydroxypyridin-2-yl)oxy]-5-methylphenyl}prop-2-enoic acid as a pale yellow powder (3.77 g).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 6.56 (1H, d, J=16.2 Hz), 6.96 (1H, d, J=8.9 Hz), 7.30 (1H, dd, J=8.9, 3.0 Hz), 7.52 (1H, d, J=10.2 Hz), 7.53 (1H, d, J=15.8 Hz), 7.63 (1H, d, J=1.6 Hz), 7.74 (1H, d, J=2.0 Hz), 9.58 (1H, s), 12.45 (1H, brs).
The following compounds were produced in the same manner as in Reference Example 15 using appropriate starting materials.
1H-NMR (DMSO-d6) δ: 2.13 (3H, s), 2.45-2.54 (3H, m), 5.17 (2H, s), 6.14-6.18 (1H, m), 7.12 (1H, d, J=8.8 Hz), 7.36-7.45 (2H, m), 7.48-7.54 (2H, m), 7.54-7.58 (2H, m), 7.60-7.70 (1H, m), 7.85 (1H, d, J=2.9 Hz), 12.32 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.30 (3H, s), 2.48 (3H, d, J=1.5 Hz), 5.05 (2H, s), 6.14-6.18 (1H, m), 7.09 (1H, dd, J=9.0, 0.5 Hz), 7.19 (2H, d, J=7.8 Hz), 7.33 (2H, d, J=8.1 Hz), 7.47-7.52 (1H, m), 7.54-7.57 (1H, m), 7.58 (1H, dd, J=9.0, 3.2 Hz), 7.79 (1H, dd, J=3.2, 0.5 Hz), 12.31 (1H, brs).
To a DMF (26 mL) solution of (E)-3-{4-[(5-hydroxypyridin-2-yl)oxy]-3,5-dimethylphenyl}prop-2-enoic acid (1.300 g) and 1-{4-[2-(4-chlorophenoxy)ethyl]benzyl}-piperazine hydrochloride (2.116 g) were added HOBT (0.070 g), WSC (1.310 g), and Et3N (1.905 mL) at room temperature, then the resultant mixture was stirred at room temperature over night. The mixture was poured into water, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/1 to 1/0 and then AcOEt/MeOH=4/1) to afford (E)-1-(4-{4-[2-(4-chlorophenoxy)ethyl]benzyl}piperazin-1-yl)-3-{4-[(5-hydroxypyridin-2-yl)oxy]-3,5-dimethylphenyl}prop-2-en-1-one as a pale yellow amorphous powder (2.57 g).
1H-NMR (CDCl3) δ: 2.09 (6H, s), 2.47-2.48 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.73-3.76 (2H, m), 4.13 (2H, t, J=7.0 Hz), 6.70 (1H, d, J=8.8 Hz), 6.75 (1H, d, J=15.4 Hz), 6.81 (2H, d, J=9.0 Hz), 7.21-7.26 (10H, m), 7.57 (1H, d, J=15.4 Hz), 7.72 (1H, d, J=2.7 Hz).
The following compounds were produced in the same manner as in Reference Example 487 using appropriate starting materials.
1H-NMR (CDCl3) δ: 2.17 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.50 (2H, s), 3.63-3.73 (4H, m), 6.39 (1H, s), 6.77 (1H, d, J=15.5 Hz), 6.86 (1H, d, J=8.9 Hz), 7.14-7.20 (4H, m), 7.24-7.28 (2H, m), 7.41 (1H, d, J=2.0 Hz), 7.54 (1H, d, J=15.2 Hz), 7.67 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.16 (3H, s), 2.48 (4H, t, J=4.6 Hz), 3.07 (2H, t, J=6.9 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.13 (2H, t, J=6.9 Hz), 6.78-6.81 (4H, m), 6.93-6.96 (2H, m), 7.22-7.28 (6H, m), 7.38 (1H, d, J=2.0 Hz), 7.53 (1H, d, J=15.5 Hz), 7.66 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.9 Hz), 2.18 (3H, s), 2.48 (4H, t, J=4.8 Hz), 2.85 (1H, septet, J=6.9 Hz), 3.08 (2H, t, J=6.9 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.15 (2H, t, J=6.9 Hz), 6.10 (1H, s), 6.75-6.88 (4H, m), 7.13 (2H, d, J=8.9 Hz), 7.26-7.28 (6H, m), 7.41 (1H, d, J=2.0 Hz), 7.55 (1H, d, J=15.2 Hz), 7.68 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.28 (3H, s), 2.48 (4H, t, J=4.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.75 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.97 (1H, s), 6.75-6.81 (3H, m), 6.87 (1H, d, J=8.9 Hz), 7.07 (2H, d, J=8.6 Hz), 7.24-7.29 (6H, m), 7.42 (1H, s), 7.55 (1H, d, J=15.2 Hz), 7.68 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.17 (3H, s), 2.48 (4H, t, J=4.8 Hz), 3.07 (2H, t, J=6.9 Hz), 3.52 (2H, s), 3.64-3.76 (4H, m), 3.70 (3H, s), 4.12 (2H, t, J=6.9 Hz), 6.76-6.84 (5H, m), 7.24-7.27 (8H, m), 7.40 (1H, d, J=2.0 Hz), 7.54 (1H, d, J=15.2 Hz), 7.67 (1H, d, J=3.0 Hz).
(E)-3-{3-Chloro-4-[(5-hydroxypyridin-2-yl)oxy]-5-methylphenyl}-1-(4-{4-[2-(4-chlorophenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one
1H-NMR (DMSO-d6) δ: 2.09 (3H, s), 2.35 (2H, s), 2.41 (2H, s), 3.01 (2H, t, J=6.8 Hz), 3.49 (2H, s), 3.56 (2H, s), 3.72 (2H, s), 4.18 (2H, t, J=6.8 Hz), 6.94-6.98 (3H, m), 7.24-7.32 (8H, m), 7.43 (1H, d, J=15.4 Hz), 7.55 (1H, dd, J=2.9, 0.5 Hz), 7.61 (1H, d, J=2.0 Hz), 7.81 (1H, d, J=2.2 Hz), 9.57 (1H, s).
1H-NMR (CDCl3) δ: 1.48 (9H, s), 2.20 (3H, s), 3.49-3.70 (8H, m), 5.14 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.94-6.96 (1H, m), 7.25-7.32 (3H, m), 7.38-7.41 (2H, m), 7.47 (1H, d, J=2.2 Hz), 7.51-7.53 (1H, m), 7.60 (1H, d, J=15.4 Hz), 7.81-7.82 (1H, m).
1H-NMR (CDCl3) δ: 1.49 (9H, s), 2.20 (3H, s), 2.36 (3H, s), 3.49-3.72 (8H, m), 4.99 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.91-6.93 (1H, m), 7.19 (2H, d, J=7.8 Hz), 7.28-7.30 (3H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.47 (1H, d, J=2.0 Hz), 7.60 (1H, d, J=15.4 Hz), 7.79-7.80 (1H, m).
1H-NMR (CDCl3) δ: 2.31 (3H, s), 2.48-2.50 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.75-3.77 (2H, m), 4.12-4.14 (2H, m), 6.69 (1H, d, J=15.4 Hz), 6.79-6.87 (5H, m), 6.94-6.96 (2H, m), 7.25-7.26 (5H, m), 7.48 (1H, d, J=8.5 Hz), 7.85-7.89 (3H, m).
1H-NMR (CDCl3) δ: 1.25-1.27 (3H, m), 1.48 (9H, s), 2.19 (3H, s), 2.35 (3H, s), 2.90-4.88 (7H, m), 4.98 (2H, s), 6.77 (1H, d, J=15.4 Hz), 6.92 (1H, d, J=8.8 Hz), 7.18 (2H, d, J=7.8 Hz), 7.27-7.29 (3H, m), 7.35 (1H, dd, J=8.8, 2.9 Hz), 7.46 (1H, d, J=2.0 Hz), 7.59 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.25-1.27 (3H, m), 1.48 (9H, s), 2.19 (3H, s), 2.35 (3H, s), 2.89-4.87 (7H, m), 4.98 (2H, s), 6.77 (1H, d, J=15.4 Hz), 6.91-6.93 (1H, m), 7.18 (2H, d, J=7.8 Hz), 7.28-7.30 (3H, m), 7.36 (1H, dd, J=8.8, 2.9 Hz), 7.46 (1H, d, J=2.2 Hz), 7.59 (1H, d, J=15.4 Hz), 7.78-7.79 (1H, m).
1H-NMR (CDCl3) δ: 1.16 (3H, d, J=6.6 Hz), 1.48 (9H, s), 2.20 (3H, s), 2.35 (3H, s), 2.78 (3H, m), 3.79-3.97 (2H, m), 4.35-4.62 (2H, m), 4.98 (2H, s), 6.72-6.83 (1H, m), 6.92 (1H, d, J=8.8 Hz), 7.18 (2H, d, J=7.8 Hz), 7.28-7.30 (3H, m), 7.36 (1H, dd, J=8.8, 2.9 Hz), 7.46 (1H, brs), 7.62 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.49 (9H, s), 2.20 (3H, s), 2.36 (3H, s), 3.77-3.90 (6H, m), 4.06-4.10 (2H, m), 4.99 (2H, s), 6.72-6.80 (1H, m), 6.92 (1H, d, J=8.8 Hz), 7.19 (2H, d, J=7.8 Hz), 7.28-7.30 (3H, m), 7.36 (1H, dd, J=8.8, 2.9 Hz), 7.46-7.47 (1H, m), 7.61-7.66 (1H, m), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.49 (9H, s), 2.13 (6H, s), 3.49 (4H, brs), 3.65-3.69 (4H, m), 4.99 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.82 (1H, dd, J=9.0, 0.5 Hz), 7.04-7.10 (2H, m), 7.26 (2H, brs), 7.32 (1H, dd, J=9.0, 3.2 Hz), 7.35-7.40 (2H, m), 7.64 (1H, d, J=15.4 Hz), 7.81 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.49 (9H, s), 2.12 (6H, s), 3.49 (4H, brs), 3.65-3.70 (4H, m), 6.74-6.79 (2H, m), 7.23-7.25 (3H, m), 7.62 (1H, d, J=15.4 Hz), 7.73 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.49 (9H, s), 2.12 (6H, s), 3.78-3.90 (6H, m), 4.06-4.11 (2H, m), 5.09 (2H, s), 6.75 (1H, t, J=14.9 Hz), 6.85 (1H, d, J=9.0 Hz), 7.25-7.27 (2H, m), 7.34 (1H, dd, J=9.0, 3.1 Hz), 7.52 (2H, d, J=8.3 Hz), 7.65-7.69 (3H, m), 7.79-7.80 (1H, m).
To a solution of (E)-3-[4-(chloromethyl)-3-methylphenyl]prop-2-en-1-yl 4-methylphenyl ether (0.180 g) and (E)-3-{4-[(5-hydroxypyridin-2-yl)oxy]-3,5-dimethylphenyl}-1-(piperazin-1-yl)prop-2-en-1-one (0.222 g) in DMF (2 mL) was added KHCO3 (0.063 g) at room temperature under an Ar atmosphere. The mixture was heated at 100° C. for 3 hours, and then cooled to room temperature, and evaporated under reduced pressure. To the residue was added saturated aqueous NaHCO3, and the mixture was extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4. The residue was purified by silica gel column chromatography (AcOEt) to afford (2E)-3-{4-[(5-hydroxypyridin-2-yl)oxy]-3,5-dimethylphenyl}-1-(4-{2-methyl-4-[(1E)-3-(4-methylphenoxy)prop-1-en-1-yl]benzyl}piperazin-1-yl)prop-2-en-1-one (0.286 g) as a colorless powder.
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.29 (3H, s), 2.37 (3H, s), 2.48 (4H, t, J=4.2 Hz), 3.47 (2H, s), 3.62 (2H, brs), 3.72 (2H, brs), 4.67 (2H, dd, J=5.8, 1.4 Hz), 5.46 (1H, brs), 6.40 (1H, dt, J=16.0, 5.8 Hz), 6.68 (1H, dt, J=16.0, 1.4 Hz), 6.75 (1H, d, J=8.8 Hz), 6.78 (1H, d, J=15.4 Hz), 6.86 (2H, dt, J=9.3, 2.6 Hz), 7.09 (2H, d, J=8.3 Hz), 7.20-7.25 (6H, m), 7.60 (1H, d, J=15.4 Hz), 7.73 (1H, d, J=3.2 Hz).
The following compound was produced in the same manner as in Reference Example 231 using appropriate starting materials.
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.92 (4H, t, J=5.1 Hz), 3.65-3.71 (4H, m), 6.72 (1H, d, J=8.8 Hz), 6.77 (1H, d, J=15.4 Hz), 7.21-7.24 (3H, m), 7.59 (1H, d, J=15.4 Hz), 7.71 (1H, dd, J=3.2, 0.5 Hz).
The following compound was produced in the same manner as in Reference Example 326 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.67 (1H, s), 2.20 (3H, s), 2.91 (4H, t, J=5.1 Hz), 3.62-3.70 (4H, m), 5.14 (2H, s), 6.81 (1H, d, J=15.4 Hz), 6.93-6.95 (1H, m), 7.25-7.31 (3H, m), 7.36-7.42 (2H, m), 7.46 (1H, d, J=2.2 Hz), 7.50-7.54 (1H, m), 7.58 (1H, d, J=15.4 Hz), 7.81-7.82 (1H, m).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.90-2.92 (4H, m), 3.63-3.73 (4H, m), 4.99 (2H, s), 6.81 (1H, d, J=15.4 Hz), 6.91 (1H, dd, J=8.8, 0.5 Hz), 7.19 (2H, d, J=7.8 Hz), 7.28-7.30 (3H, m), 7.36 (1H, dd, J=8.9, 2.9 Hz), 7.46 (1H, d, J=2.0 Hz), 7.58 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.35 (3H, d, J=6.6 Hz), 1.59 (1H, brs), 2.19 (3H, s), 2.35 (3H, s), 2.70-4.98 (9H, m), 6.79 (1H, d, J=15.4 Hz), 6.90-6.92 (1H, m), 7.18 (2H, d, J=7.6 Hz), 7.28-7.30 (3H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.46 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79-7.80 (1H, m).
1H-NMR (CDCl3) δ: 1.35 (3H, d, J=6.4 Hz), 1.64 (1H, brs), 2.19 (3H, s), 2.35 (3H, s), 2.70-4.98 (9H, m), 6.79 (1H, d, J=15.4 Hz), 6.90-6.93 (1H, m), 7.18 (2H, d, J=7.8 Hz), 7.28-7.30 (3H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.46 (1H, d, J=2.2 Hz), 7.58 (1H, d, J=15.4 Hz), 7.79-7.80 (1H, m).
1H-NMR (CDCl3) δ: 1.13 (3H, d, J=5.4 Hz), 1.64 (1H, brs), 2.19 (3H, s), 2.35-2.43 (3.5H, m), 2.77-2.87 (3H, m), 3.06-3.09 (1H, m), 3.17-3.24 (0.5H, m), 3.88-3.98 (1H, m), 4.57-4.61 (1H, m), 4.98 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.91 (1H, d, J=8.8 Hz), 7.19 (2H, d, J=7.8 Hz), 7.28-7.30 (3H, m), 7.35 (1H, dd, J=8.8, 2.9 Hz), 7.46 (1H, brs), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 3.16-3.19 (2H, m), 3.76-3.97 (6H, m), 4.98 (2H, s), 6.74-6.82 (1H, m), 6.92 (1H, d, J=9.0 Hz), 7.19 (2H, d, J=8.1 Hz), 7.28-7.30 (3H, m), 7.36 (1H, dd, J=9.0, 2.9 Hz), 7.45-7.47 (1H, m), 7.60-7.66 (1H, m), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.91 (4H, t, J=5.1 Hz), 3.65-3.71 (4H, m), 4.99 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.81 (1H, dd, J=9.0, 0.6 Hz), 7.04-7.10 (2H, m), 7.24-7.27 (2H, m), 7.32 (1H, dd, J=9.0, 3.1 Hz), 7.35-7.40 (2H, m), 7.62 (1H, d, J=15.4 Hz), 7.81 (1H, dd, J=3.1, 0.6 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 3.18 (2H, t, J=5.4 Hz), 3.77-3.97 (6H, m), 5.09 (2H, s), 5.84 (1H, brs), 6.78 (1H, t, J=15.4 Hz), 6.84 (1H, d, J=9.0 Hz), 7.25-7.26 (2H, m), 7.33 (1H, dd, J=9.0, 3.1 Hz), 7.52 (2H, d, J=8.5 Hz), 7.66-7.70 (3H, m), 7.80 (1H, d, J=2.7 Hz).
To a solution of (E)-3-[4-({5-[(4-methoxybenzyl)oxy]pyridin-2-yl}oxy)-3,5-dimethylphenyl]prop-2-enoic acid (0.122 g) and 1-{4-[(E)-3-(4-methylphenoxy)prop-1-en-1-yl]benzyl}piperazine dihydrochloride (0.119 g) in DMF (2 mL) were added Et3N (0.08 mL), WSC (0.070 g), and HOBT (0.055 g) at room temperature under an Ar atmosphere. The mixture was stirred at room temperature for 14 hours, and evaporated under reduced pressure. To the residue was added saturated aqueous NaHCO3, and the mixture was extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (AcOEt). The resulting powder was crystallized from EtOH (10 mL) to give (2E)-3-[4-({5-[(4-methoxybenzyl)oxy]pyridin-2-yl}oxy)-3,5-dimethylphenyl]-1-(4-{4-[(1E)-3-(4-methylphenoxy)prop-1-en-1-yl]benzyl}piperazin-1-yl)prop-2-en-1-one (0.195 g) as a colorless powder.
mp: 130-132° C.
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.29 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.52 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 3.81 (3H, s), 4.68 (2H, dd, J=5.9, 1.5 Hz), 4.95 (2H, s), 6.41 (1H, dt, J=16.1, 5.9 Hz), 6.72 (1H, d, J=16.1 Hz), 6.78 (1H, d, J=15.4 Hz), 6.79 (1H, dd, J=8.8, 0.7 Hz), 6.86 (2H, dt, J=9.3, 2.6 Hz), 6.91 (2H, dt, J=9.3, 2.6 Hz), 7.09 (2H, dd, J=8.8, 0.7 Hz), 7.25-7.34 (7H, m), 7.38 (2H, d, J=8.3 Hz), 7.61 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.7 Hz).
The following compounds were produced in the same manner as in Example 1 using appropriate starting materials.
mp: 136-138° C.
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.29 (3H, s), 2.48 (4H, t, J=4.8 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.68 (2H, dd, J=5.9, 1.5 Hz), 4.98 (2H, s), 6.41 (1H, dt, J=16.0, 5.9 Hz), 6.72 (1H, d, J=16.0 Hz), 6.78 (1H, d, J=15.4 Hz), 6.81 (1H, d, J=9.0 Hz), 6.86 (2H, dt, J=9.1, 2.5 Hz), 7.04-7.10 (4H, m), 7.25-7.26 (2H, m), 7.29 (2H, d, J=8.3 Hz), 7.32 (1H, dd, J=9.0, 3.2 Hz), 7.36-7.39 (4H, m), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.2 Hz).
mp: 152° C.
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.29 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=5.1 Hz), 3.53 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.68 (2H, dd, J=5.7, 1.3 Hz), 4.98 (2H, s), 6.41 (1H, dt, J=16.0, 5.7 Hz), 6.72 (1H, d, J=16.0 Hz), 6.79 (1H, d, J=15.4 Hz), 6.86 (2H, dt, J=9.2, 2.6 Hz), 6.91 (1H, d, J=8.8 Hz), 7.09 (2H, d, J=8.8 Hz), 7.19 (2H, d, J=8.1 Hz), 7.28-7.29 (5H, m), 7.33-7.39 (3H, m), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.21 (6H, s), 2.48 (4H, t, J=4.8 Hz), 3.53 (2H, s), 3.65-3.74 (4H, m), 3.81 (3H, s), 4.70 (2H, dd, J=5.7, 1.3 Hz), 4.94 (2H, s), 6.42 (1H, dt, J=16.1, 5.7 Hz), 6.71-6.80 (3H, m), 6.89-6.92 (2H, m), 6.94-6.98 (3H, m), 7.25 (2H, s), 7.28-7.34 (7H, m), 7.38 (2H, d, J=8.3 Hz), 7.61 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.48 (4H, t, J=4.8 Hz), 3.53 (2H, s), 3.65-3.74 (4H, m), 4.71 (2H, dd, J=5.7, 1.3 Hz), 5.09 (2H, s), 6.43 (1H, dt, J=16.1, 5.7 Hz), 6.71-6.85 (3H, m), 6.94-6.98 (3H, m), 7.25-7.34 (7H, m), 7.38 (2H, d, J=8.1 Hz), 7.51-7.53 (2H, m), 7.61 (1H, d, J=15.4 Hz), 7.67-7.70 (2H, m), 7.79-7.80 (1H, m).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.48 (4H, t, J=4.8 Hz), 3.53 (2H, s), 3.65-3.74 (4H, m), 4.71 (2H, d, J=5.7 Hz), 4.98 (2H, s), 6.42 (1H, dt, J=16.1, 5.7 Hz), 6.71-6.82 (3H, m), 6.94-6.98 (3H, m), 7.04-7.10 (2H, m), 7.25-7.33 (7H, m), 7.36-7.39 (4H, m), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.47 (4H, t, J=4.9 Hz), 3.51 (2H, s), 3.63-3.76 (7H, m), 4.64 (2H, dd, J=5.8, 1.5 Hz), 5.08 (2H, s), 6.39 (1H, dt, J=16.0, 5.8 Hz), 6.70 (1H, d, J=16.0 Hz), 6.76-6.85 (3H, m), 6.87-6.90 (2H, m), 6.94 (1H, dd, J=8.8, 0.5 Hz), 7.26-7.28 (3H, m), 7.34-7.37 (3H, m), 7.44 (1H, d, J=2.2 Hz), 7.50-7.57 (3H, m), 7.65-7.68 (2H, m), 7.747-7.754 (1H, m).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.54 (2H, s), 3.65-3.74 (4H, m), 4.76 (2H, dd, J=5.8, 1.5 Hz), 5.09 (2H, s), 6.38 (1H, dt, J=15.9, 5.8 Hz), 6.74 (1H, d, J=15.9 Hz), 6.80 (1H, d, J=15.4 Hz), 6.95-7.02 (3H, m), 7.29-7.31 (3H, m), 7.35-7.39 (3H, m), 7.45 (1H, d, J=2.0 Hz), 7.51-7.62 (5H, m), 7.67-7.69 (2H, m), 7.76 (1H, d, J=2.9 Hz).
mp: 112.7-113.3° C.
1H-NMR (CDCl3) δ: 1.23 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.48 (4H, t, J=4.8 Hz), 2.81-2.92 (1H, m), 3.53 (2H, s), 3.64-3.75 (4H, m), 4.68 (2H, dd, J=5.8, 1.5 Hz), 5.09 (2H, s), 6.42 (1H, dt, J=16.0, 5.8 Hz), 6.72 (1H, d, J=16.0 Hz), 6.80 (1H, d, J=15.4 Hz), 6.88-6.91 (2H, m), 6.95 (1H, d, J=8.8 Hz), 7.13-7.17 (2H, m), 7.28-7.30 (3H, m), 7.35-7.39 (3H, m), 7.45 (1H, d, J=2.0 Hz), 7.52 (2H, d, J=8.5 Hz), 7.57 (1H, d, J=15.4 Hz), 7.67-7.70 (2H, m), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.54 (2H, s), 3.65-3.75 (4H, m), 4.74 (2H, dd, J=5.9, 1.2 Hz), 5.09 (2H, s), 6.36 (1H, dt, J=15.9, 5.9 Hz), 6.73 (1H, d, J=15.9 Hz), 6.80 (1H, d, J=15.5 Hz), 6.96 (1H, d, J=8.8 Hz), 7.238-7.243 (2H, m), 7.29-7.31 (3H, m), 7.36-7.39 (3H, m), 7.45 (1H, d, J=2.0 Hz), 7.51-7.53 (2H, m), 7.57 (1H, d, J=15.5 Hz), 7.67-7.69 (2H, m), 7.76 (1H, d, J=2.9 Hz), 8.12 (1H, t, J=1.8 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47-2.49 (7H, m), 3.53 (2H, s), 3.65-3.74 (4H, m), 4.72 (2H, dd, J=5.9, 1.2 Hz), 5.09 (2H, s), 6.39 (1H, dt, J=15.9, 5.9 Hz), 6.73 (1H, d, J=15.9 Hz), 6.80 (1H, d, J=15.4 Hz), 6.95 (1H, d, J=9.0 Hz), 7.07 (1H, d, J=8.5 Hz), 7.17 (1H, dd, J=8.5, 2.9 Hz), 7.29 (3H, d, J=7.6 Hz), 7.35-7.39 (3H, m), 7.45 (1H, d, J=2.0 Hz), 7.51-7.59 (3H, m), 7.68 (2H, d, J=8.1 Hz), 7.76 (1H, d, J=3.2 Hz), 8.25 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.53 (2H, s), 3.64-3.75 (4H, m), 4.97 (2H, dd, J=6.1, 1.2 Hz), 5.10 (2H, s), 6.44 (1H, dt, J=15.9, 6.1 Hz), 6.71-6.73 (2H, m), 6.80 (1H, d, J=15.4 Hz), 6.96 (1H, d, J=8.8 Hz), 7.26-7.30 (3H, m), 7.36-7.39 (3H, m), 7.46 (1H, d, J=2.0 Hz), 7.52 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.65-7.70 (3H, m), 7.77 (1H, d, J=2.9 Hz), 8.21 (1H, d, J=2.4 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.25 (3H, s), 2.48 (4H, t, J=4.6 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.97 (2H, dd, J=6.1, 1.2 Hz), 5.09 (2H, s), 6.46 (1H, dt, J=15.9, 6.1 Hz), 6.69-6.74 (2H, m), 6.80 (1H, d, J=15.4 Hz), 6.95 (1H, d, J=9.0 Hz), 7.26-7.29 (3H, m), 7.35-7.42 (4H, m), 7.45 (1H, d, J=2.2 Hz), 7.51-7.59 (3H, m), 7.68 (2H, dt, J=8.2, 1.8 Hz), 7.77 (1H, d, J=2.9 Hz), 7.96-7.97 (1H, m).
mp: 168.4-169.1° C.
1H-NMR (DMSO-d6) δ: 2.09 (3H, s), 2.30 (3H, s), 2.36-2.42 (4H, m), 3.52 (2H, s), 3.57 (2H, brs), 3.73 (2H, brs), 5.05 (2H, s), 5.08 (2H, s), 7.02-7.09 (3H, m), 7.18-7.46 (12H, m), 7.56-7.62 (2H, m), 7.79-7.83 (2H, m).
mp: 167.1-167.6° C.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.39 (4H, brs), 3.52 (2H, s), 3.56 (2H, brs), 3.72 (2H, brs), 5.08 (2H, s), 5.16 (2H, s), 7.03 (2H, d, J=8.9 Hz), 7.11 (1H, d, J=8.9 Hz), 7.26-7.53 (11H, m), 7.60-7.66 (3H, m), 7.84-7.85 (2H, m).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.49 (4H, t, J=4.9 Hz), 2.86 (1H, septet, J=6.8 Hz), 3.54 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 5:03 (2H, s), 5.14 (2H, s), 6.80 (1H, d, J=15.6 Hz), 6.91-6.95 (3H, m), 7.15 (2H, d, J=8.8 Hz), 7.26-7.41 (9H, m), 7.45-7.47 (1H, m), 7.50-7.54 (1H, m), 7.57 (1H, d, J=15.6 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.35 (3H, s), 2.49 (4H, t, J=4.9 Hz), 2.86 (1H, septet, J=6.8 Hz), 3.54 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.98 (2H, s), 5.03 (2H, s), 6.80 (1H, d, J=15.6 Hz), 6.90-6.93 (3H, m), 7.13-7.20 (4H, m), 7.28-7.30 (3H, m), 7.33-7.37 (3H, m), 7.40 (2H, d, J=7.8 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.6 Hz), 7.79 (1H, d, J=3.4 Hz).
mp: 152.3-153.9° C.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.35-2.43 (4H, m), 3.52 (2H, s), 3.56 (2H, brs), 3.73 (2H, brs), 5.06 (2H, s), 5.16 (2H, s), 6.99-7.04 (2H, m), 7.10-7.15 (3H, m), 7.27-7.45 (8H, m), 7.49-7.55 (1H, m), 7.59-7.65 (3H, m), 7.83-7.85 (2H, m).
mp: 153.2-153.9° C.
1H-NMR (DMSO-d6) δ: 2.09 (3H, s), 2.30 (3H, s), 2.35-2.43 (4H, m), 3.52 (2H, s), 3.56 (2H, brs), 3.72 (2H, brs), 5.05 (2H, s), 5.06 (2H, s), 7.00-7.14 (5H, m), 7.19 (2H, d, J=8.1 Hz), 7.27-7.35 (5H, m), 7.40-7.45 (3H, m), 7.58 (1H, dd, J=8.6, 3.2 Hz), 7.62 (1H, d, J=1.7 Hz), 7.79 (1H, d, J=3.2 Hz), 7.82 (1H, d, J=1.7 Hz).
1H-NMR (CDCl3) δ: 1.31 (6H, d, J=6.1 Hz), 2.41 (3H, s), 2.49 (4H, brs), 3.54 (2H, s), 3.64 (2H, brs), 3.75 (2H, brs), 4.42 (1H, septet, J=6.1 Hz), 5.00 (2H, s), 5.17 (2H, s), 6.71 (1H, d, J=15.4 Hz), 6.81-6.86 (2H, m), 6.88-6.93 (5H, m), 7.26-7.43 (8H, m), 7.51-7.54 (2H, m), 7.90 (1H, d, J=15.4 Hz), 7.95 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.31 (6H, d, J=6.1 Hz), 2.51-2.53 (4H, m), 3.57 (2H, s), 3.65-3.67 (2H, m), 3.75-3.77 (2H, m), 3.81 (3H, s), 4.40-4.45 (1H, m), 5.00 (2H, s), 5.15 (2H, s), 6.76-6.93 (6H, m), 7.05-7.19 (3H, m), 7.26-7.40 (8H, m), 7.50-7.54 (1H, m), 7.64 (1H, d, J=15.4 Hz), 7.87 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.31 (6H, d, J=6.1 Hz), 2.19 (3H, s), 2.49 (4H, t, J=5.0 Hz), 3.55 (2H, s), 3.65 (2H, s), 3.75 (2H, s), 4.42 (1H, septet, J=6.1 Hz), 5.00 (2H, s), 5.11 (2H, s), 6.79-6.85 (3H, m), 6.88-6.92 (2H, m), 6.95 (1H, d, J=8.8 Hz), 7.12 (1H, td, J=7.8, 1.0 Hz), 7.29 (1H, d, J=2.0 Hz), 7.33-7.41 (7H, m), 7.46 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz).
mp: 149.0-151.2° C.
1H-NMR (DMSO-d6) δ: 2.09 (3H, s), 2.30 (3H, s), 2.35-3.42 (4H, m), 3.52 (2H, s), 3.56 (2H, brs), 3.72 (2H, brs), 5.00 (2H, s), 5.05 (2H, s), 5.95 (2H, s), 6.44 (1H, dd, J=8.3, 2.7 Hz), 6.70 (1H, d, J=2.7 Hz), 6.81 (1H, d, J=8.3 Hz), 7.07 (1H, d, J=9.0 Hz), 7.19 (2H, d, J=8.1 Hz), 7.27-7.34 (5H, m), 7.38-7.45 (3H, m), 7.58 (1H, dd, J=9.0, 3.2 Hz), 7.62 (1H, d, J=1.7 Hz), 7.79 (1H, d, J=3.2 Hz), 7.82 (1H, d, J=1.7 Hz).
1H-NMR (CDCl3) δ: 1.23 (6H, d, J=7.1 Hz), 2.49 (4H, t, J=4.8 Hz), 2.83-2.90 (1H, m), 3.54 (2H, s), 3.65-3.75 (4H, m), 5.03 (2H, s), 5.18 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.91-6.94 (3H, m), 7.09 (2H, d, J=8.5 Hz), 7.15 (2H, d, J=8.5 Hz), 7.28-7.42 (8H, m), 7.51-7.54 (3H, m), 7.65 (1H, d, J=15.4 Hz), 7.95 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.31 (6H, d, J=6.1 Hz), 2.49 (4H, t, J=4.8 Hz), 3.55 (2H, s), 3.64 (2H, s), 3.75 (2H, s), 4.42 (1H, septet, J=6.1 Hz), 5.00 (2H, s), 5.16 (2H, s), 6.78-6.93 (5H, m), 6.97 (1H, d, J=8.8 Hz), 7.19 (1H, t, J=8.1 Hz), 7.26-7.41 (10H, m), 7.52 (1H, t, J=4.6 Hz), 7.61 (1H, d, J=15.1 Hz), 7.86 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.36 (3H, s), 2.40 (3H, s), 2.48 (4H, brs), 2.86 (1H, septet, J=6.8 Hz), 3.54 (2H, s), 3.63-3.75 (4H, m), 5.02 (4H, s), 6.71 (1H, d, J=15.1 Hz), 6.86-6.93 (5H, m), 7.13-7.17 (2H, m), 7.19 (2H, d, J=7.8 Hz), 7.29-7.35 (5H, m), 7.40 (2H, d, J=8.3 Hz), 7.51-7.53 (1H, m), 7.88-7.93 (2H, m).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.54 (2H, s), 3.64-3.74 (4H, m), 4.53 (2H, s), 4.54 (2H, s), 5.14 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=8.8 Hz), 7.02-7.06 (2H, m), 7.26-7.41 (11H, m), 7.46 (1H, brs), 7.51-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.54 (2H, s), 3.64-3.74 (4H, m), 4.53 (2H, s), 4.54 (2H, s), 4.98 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.91 (1H, d, J=8.8 Hz), 7.01-7.07 (2H, m), 7.19 (2H, d, J=7.8 Hz), 7.28-7.37 (10H, m), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.24 (6H, d, J=7.1 Hz), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.90 (1H, septet, J=7.1 Hz), 3.53 (2H, s), 3.64-3.74 (4H, m), 4.53 (2H, s), 4.54 (2H, s), 5.14 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=8.8 Hz), 7.21 (2H, d, J=8.1 Hz), 7.27-7.41 (11H, m), 7.45 (1H, d, J=2.0 Hz), 7.50-7.53 (1H, m), 7.56 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.24 (6H, d, J=6.8 Hz), 2.18 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.90 (1H, septet, J=6.8 Hz), 3.53 (2H, s), 3.63-3.74 (4H, m), 4.53 (2H, s), 4.54 (2H, s), 4.98 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.91 (1H, d, J=8.8 Hz), 7.17-7.36 (14H, m), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.54-2.58 (4H, m), 3.64-3.68 (4H, m), 3.74-3.77 (2H, m), 5.01 (2H, s), 5.09 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.88-7.01 (5H, m), 7.12-7.18 (2H, m), 7.28 (1H, s), 7.35-7.40 (2H, m), 7.45 (1H, s), 7.51-7.58 (3H, m), 7.68 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.35 (3H, s), 2.54-2.58 (4H, m), 3.65-3.68 (4H, m), 3.74-3.77 (2H, m), 4.98 (2H, s), 5.00 (2H, s), 6.78 (1H, d, J=15.1 Hz), 6.88-6.92 (3H, m), 6.96-7.00 (2H, m), 7.12-7.20 (4H, m), 7.26-7.30 (3H, m), 7.34-7.40 (2H, m), 7.44 (1H, d, J=1.2 Hz), 7.55 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 0.93 (3H, t, J=7.3 Hz), 1.56-1.66 (2H, m), 2.19 (3H, s), 2.48-2.49 (4H, m), 2.52-2.54 (2H, m), 3.53 (2H, s), 3.64-3.66 (2H, m), 3.74-3.77 (2H, m), 5.09 (4H, s), 6.80 (1H, d, J=15.4 Hz), 6.91 (2H, d, J=8.5 Hz), 6.95 (1H, d, J=8.8 Hz), 7.08-7.13 (4H, m), 7.29 (1H, s), 7.37 (1H, dd, J=9.0, 2.9 Hz), 7.44-7.48 (2H, m), 7.52 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.3 Hz), 7.77 (1H, d, J=2.9 Hz).
mp: 133.0-133.4° C.
1H-NMR (CDCl3) δ: 2.20 (3H, s), 2.48-2.49 (4H, m), 3.53 (2H, s), 3.64-3.67 (2H, m), 3.74-3.77 (2H, m), 5.07 (2H, s), 5.14 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.90-7.01 (5H, m), 7.12 (2H, d, J=9.3 Hz), 7.26-7.31 (3H, m), 7.38-7.46 (4H, m), 7.50-7.53 (1H, m), 7.58 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 0.93 (3H, t, J=7.3 Hz), 1.56-1.64 (2H, m), 2.19 (3H, s), 2.35 (3H, s), 2.48-2.49 (4H, m), 2.53 (2H, t, J=7.7 Hz), 3.53 (2H, s), 3.64-3.66 (2H, m), 3.74-3.76 (2H, m), 4.98 (2H, s), 5.09 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.91 (3H, d, J=8.1 Hz), 7.10 (2H, d, J=5.9 Hz), 7.12 (2H, d, J=6.1 Hz), 7.18 (2H, d, J=7.8 Hz), 7.27-7.30 (3H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.43-7.48 (2H, m), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48-2.50 (4H, m), 3.54 (2H, s), 3.64-3.67 (2H, m), 3.74-3.77 (2H, m), 5.08 (2H, s), 5.09 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.90-7.01 (5H, m), 7.12 (2H, d, J=9.3 Hz), 7.29 (1H, s), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.42-7.47 (2H, m), 7.52 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.1 Hz), 7.76 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.31 (6H, d, J=5.9 Hz), 2.20 (3H, s), 2.48-2.49 (4H, m), 3.53 (2H, s), 3.64-3.67 (2H, m), 3.74-3.77 (2H, m), 4.39-4.46 (1H, m), 5.06 (2H, s), 5.14 (2H, s), 6.78-6.85 (3H, m), 6.91 (2H, d, J=9.0 Hz), 6.94 (1H, d, J=9.0 Hz), 7.11 (2H, d, J=9.0 Hz), 7.27-7.31 (3H, m), 7.38-7.41 (2H, m), 7.43-7.48 (2H, m), 7.50-7.53 (1H, m), 7.58 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.31 (6H, d, J=6.1 Hz), 2.19 (3H, s), 2.48-2.49 (4H, m), 3.53 (2H, s), 3.64-3.66 (2H, m), 3.74-3.76 (2H, m), 4.39-4.45 (1H, m), 5.06 (2H, s), 5.09 (2H, s), 6.78-6.86 (3H, m), 6.91 (2H, d, J=9.3 Hz), 6.95 (1H, d, J=9.0 Hz), 7.10 (1H, s), 7.12 (1H, s), 7.29 (1H, s), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.43-7.47 (2H, m), 7.52 (2H, d, J=8.3 Hz), 7.57 (1H, d, J=15.1 Hz), 7.68 (2H, d, J=8.3 Hz), 7.76 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.37 (3H, s), 2.50 (4H, t, J=4.9 Hz), 2.86 (1H, septet, J=6.8 Hz), 3.55 (2H, s), 3.65-3.75 (4H, m), 5.03 (2H, s), 5.16 (2H, s), 6.73 (1H, d, J=15.4 Hz), 6.91-6.96 (3H, m), 6.99 (1H, s), 7.15 (2H, d, J=8.5 Hz), 7.26-7.35 (4H, m), 7.38-7.41 (4H, m), 7.51-7.53 (1H, m), 7.59 (1H, s), 7.83 (1H, d, J=15.4 Hz), 7.88 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.48-2.49 (4H, m), 3.55 (2H, s), 3.64-3.67 (2H, m), 3.73-3.76 (2H, m), 5.03 (2H, s), 5.09 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.84 (1H, d, J=8.8 Hz), 6.90 (2H, d, J=9.0 Hz), 7.23-7.25 (4H, m), 7.31-7.40 (5H, m), 7.52 (2H, d, J=8.1 Hz), 7.61 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.1 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.31 (6H, d, J=6.1 Hz), 2.11 (6H, s), 2.47-2.50 (4H, m), 3.54 (2H, s), 3.64-3.66 (2H, m), 3.73-3.76 (2H, m), 4.41-4.43 (1H, m), 5.00 (2H, s), 5.09 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.82-6.84 (3H, m), 6.90 (2H, d, J=9.0 Hz), 7.25-7.26 (2H, m), 7.31-7.35 (3H, m), 7.40 (2H, d, J=8.1 Hz), 7.52 (2H, d, J=8.3 Hz), 7.61 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.3 Hz), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.48-2.50 (4H, m), 2.86 (1H, septet, J=6.8 Hz), 3.55 (2H, s), 3.64-3.75 (4H, m), 5.03 (2H, s), 5.17 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.89-6.93 (3H, m), 7.03 (1H, s), 7.13-7.17 (2H, m), 7.27-7.42 (8H, m), 7.46 (1H, s), 7.51-7.54 (1H, m), 7.91-7.95 (2H, m).
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 2.12 (3H, s), 2.30 (3H, s), 2.37-2.43 (4H, m), 2.82 (1H, septet, J=6.8 Hz), 3.52 (2H, s), 3.57-3.72 (4H, m), 5.04 (2H, s), 5.08 (2H, s), 6.90-6.93 (2H, m), 7.07 (1H, d, J=9.0 Hz), 7.11 (1H, s), 7.12-7.16 (2H, m), 7.20 (2H, d, J=7.8 Hz), 7.27 (1H, d, J=15.4 Hz), 7.32-7.34 (4H, m), 7.40 (2H, d, J=7.8 Hz), 7.59 (1H, dd, J=9.0, 3.2 Hz), 7.75 (1H, d, J=15.4 Hz), 7.91 (1H, d, J=3.2 Hz), 7.97 (1H, s).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.36 (3H, s), 2.37 (3H, s), 2.49 (4H, t, J=4.9 Hz), 2.86 (1H, septet, J=6.8 Hz), 3.55 (2H, s), 3.65-3.75 (4H, m), 5.01 (2H, s), 5.03 (2H, s), 6.72 (1H, d, J=15.4 Hz), 6.90-6.94 (3H, m), 6.97 (1H, s), 7.13-7.17 (2H, m), 7.19 (2H, d, J=7.8 Hz), 7.29 (2H, d, J=7.8 Hz), 7.33-7.37 (3H, m), 7.40 (2H, d, J=8.3 Hz), 7.59 (1H, s), 7.81-7.87 (2H, m).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 3.49 (4H, brs), 2.86 (1H, septet, J=6.8 Hz), 3.55 (2H, s), 3.64-3.75 (4H, m), 5.03 (2H, s), 5.12 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.90-6.93 (3H, m), 7.03 (1H, s), 7.13-7.17 (2H, m), 7.33-7.41 (5H, m), 7.46 (1H, s), 7.53 (2H, d, J=8.3 Hz), 7.68-7.70 (2H, m), 7.87 (1H, d, J=3.2 Hz), 7.93 (1H, d, J=15.4 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.37 (3H, s), 2.49 (4H, t, J=4.9 Hz), 2.86 (1H, septet, J=6.8 Hz), 3.55 (2H, s), 3.64-3.75 (4H, m), 5.03 (2H, s), 5.11 (2H, s), 6.73 (1H, d, J=15.4 Hz), 6.90-6.93 (2H, m), 6.95-6.99 (2H, m), 7.13-7.17 (2H, m), 7.33-7.41 (5H, m), 7.51-7.53 (2H, m), 7.59 (1H, s), 7.67-7.70 (2H, m), 7.81-7.85 (2H, m).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.12 (6H, s), 2.49 (4H, t, J=4.9 Hz), 2.86 (1H, septet, J=6.8 Hz), 3.54 (2H, s), 3.65-3.75 (4H, m), 5.03 (2H, s), 5.23 (2H, s), 6.77-6.83 (2H, m), 6.90-6.94 (2H, m), 7.13-7.18 (2H, m), 7.25 (2H, s), 7.33-7.42 (6H, m), 7.61 (1H, d, J=15.4 Hz), 7.86 (1H, d, J=2.9 Hz), 8.83 (1H, d, J=2.2 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.11 (3H, d, J=1.5 Hz), 2.18 (3H, s), 2.36 (3H, s), 2.46 (4H, brs), 2.86 (1H, septet, J=6.8 Hz), 3.55 (2H, s), 3.61 (4H, brs), 4.99 (2H, s), 5.03 (2H, s), 6.41 (2H, s), 6.88-6.95 (3H, m), 7.09 (1H, d, J=1.7 Hz), 7.11-7.21 (4H, m), 7.24-7.42 (7H, m), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.22 (3H, d, J=1.0 Hz), 2.36 (3H, s), 2.45 (4H, dt, J=17.6, 4.9 Hz), 2.87 (1H, septet, J=6.8 Hz), 3.50-3.58 (4H, m), 3.72 (2H, t, J=4.9 Hz), 4.99 (2H, s), 5.03 (2H, s), 6.24 (1H, d, J=1.2 Hz), 6.89-6.95 (3H, m), 7.11-7.21 (4H, m), 7.24-7.31 (3H, m), 7.31-7.43 (6H, m), 7.80 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=6.4 Hz), 2.20 (3H, s), 2.49 (4H, t, J=4.9 Hz), 3.55 (2H, s), 3.59-3.79 (4H, m), 4.42 (1H, septet, J=6.4 Hz), 5.00 (2H, s), 5.14 (2H, s), 6.77-6.86 (3H, m), 6.88-6.97 (3H, m), 7.24-7.42 (9H, m), 7.46 (1H, d, J=2.0 Hz), 7.49-7.54 (1H, m), 7.57 (1H, d, J=15.1 Hz), 7.81 (1H, d, J=3.4 Hz).
1H-NMR (CDCl3) δ: 2.20 (3H, s), 2.49 (4H, t, J=4.9 Hz), 3.55 (2H, s), 3.60-3.80 (7H, m), 5.01 (2H, s), 5.14 (2H, s), 6.77-6.87 (3H, m), 6.89-6.97 (3H, m), 7.24-7.42 (9H, m), 7.46 (1H, d, J=2.0 Hz), 7.49-7.54 (1H, m), 7.57 (1H, d, J=15.1 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.39 (3H, t, J=6.8 Hz), 2.20 (3H, s), 2.49 (4H, t, J=4.9 Hz), 3.55 (2H, s), 3.60-3.82 (4H, m), 3.98 (2H, q, J=6.8 Hz), 5.00 (2H, s), 5.14 (2H, s), 6.78-6.86 (3H, m), 6.88-6.98 (3H, m), 7.24-7.42 (9H, m), 7.46 (1H, d, J=2.0 Hz), 7.48-7.54 (1H, m), 7.57 (1H, d, J=15.1 Hz), 7.81 (1H, d, J=3.4 Hz).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=6.1 Hz), 2.49 (4H, t, J=4.9 Hz), 3.55 (2H, s), 3.60-3.80 (4H, m), 4.42 (1H, septet, J=6.1 Hz), 5.00 (2H, s), 5.16 (2H, s), 6.77-6.86 (3H, m), 6.88-6.92 (2H, m), 6.97 (1H, dd, J=9.0, 0.5 Hz), 7.15 (1H, d, J=8.5 Hz), 7.27-7.38 (4H, m), 7.37-7.43 (5H, m), 7.48-7.55 (1H, m), 7.56-7.64 (2H, m), 7.88 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.20 (3H, s), 2.50 (4H, t, J=4.9 Hz), 3.56 (2H, s), 3.60-3.80 (4H, m), 5.08 (2H, s), 5.14 (2H, s), 6.32 (2H, t, J=2.2 Hz), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=8.8 Hz), 6.99-7.06 (4H, m), 7.25-7.33 (5H, m), 7.36-7.44 (6H, m), 7.46 (1H, d, J=2.0 Hz), 7.49-7.54 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.11 (3H, d, J=1.7 Hz), 2.19 (3H, s), 2.46 (4H, brs), 2.87 (1H, septet, J=7.1 Hz), 3.55 (2H, s), 3.62 (4H, brs), 5.03 (2H, s), 5.14 (2H, s), 6.41 (1H, d, J=1.5 Hz), 6.86-6.96 (3H, m), 7.10 (1H, d, J=2.0 Hz), 7.11-7.18 (2H, m), 7.24-7.42 (9H, m), 7.49-7.56 (1H, m), 7.83 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 1.80 (3H, d, J=1.5 Hz), 1.96 (3H, d, J=1.5 Hz), 2.17 (3H, s), 2.36 (3H, s), 2.40-2.56 (4H, m), 2.87 (1H, septet, J=6.8 Hz), 3.52 (2H, t, J=4.9 Hz), 3.55 (2H, s), 3.73 (2H, brs), 4.99 (2H, s), 5.03 (2H, s), 6.86-6.94 (3H, m), 6.98 (1H, d, J=1.5 Hz), 7.09-7.21 (5H, m), 7.24-7.42 (7H, m), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 1.80 (3H, d, J=1.5 Hz), 1.96 (3H, d, J=1.5 Hz), 2.18 (3H, s), 2.40-2.56 (4H, m), 2.87 (1H, septet, J=6.8 Hz), 3.52 (2H, t, J=4.9 Hz), 3.55 (2H, s), 3.73 (2H, brs), 5.03 (2H, s), 5.15 (2H, s), 6.88-6.94 (3H, m), 6.95-7.00 (1H, m), 7.11 (1H, d, J=2.2 Hz), 7.13-7.18 (2H, m), 7.24-7.43 (8H, m), 7.50-7.55 (1H, m), 7.84 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.20 (3H, s), 2.23 (3H, d, J=0.7 Hz), 2.40-2.51 (4H, m), 2.87 (1H, septet, J=7.1 Hz), 3.50-3.57 (4H, m), 3.72 (2H, brs), 5.03 (2H, s), 5.14 (2H, s), 6.24 (1H, d, J=1.2 Hz), 6.90-6.97 (3H, m), 7.12-7.18 (2H, m), 7.24-7.42 (10H, m), 7.49-7.55 (1H, m), 7.83 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=7.0 Hz), 3.53 (2H, s), 3.63-3.66 (2H, m), 3.73-3.76 (2H, m), 4.13 (2H, t, J=7.0 Hz), 5.10 (2H, s), 6.74 (1H, dd, J=8.9, 2.8 Hz), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, dd, J=8.8, 0.5 Hz), 6.98 (1H, d, J=2.9 Hz), 7.06-7.11 (1H, m), 7.17 (1H, td, J=7.5, 1.1 Hz), 7.22-7.33 (7H, m), 7.39 (1H, dd, J=9.0, 3.2 Hz), 7.45-7.49 (2H, m), 7.57 (1H, d, J=−15.4 Hz), 7.81 (1H, t, J=1.6 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=7.0 Hz), 3.53 (2H, s), 3.63-3.66 (2H, m), 3.73-3.76 (2H, m), 4.13 (3H, t, J=7.0 Hz), 4.98 (2H, s), 6.74 (1H, dd, J=8.9, 2.8 Hz), 6.80 (1H, d, J=15.4 Hz), 6.92 (1H, d, J=8.8 Hz), 6.98 (1H, d, J=2.9 Hz), 7.19 (2H, d, J=7.8 Hz), 7.23 (2H, d, J=8.1 Hz), 7.26-7.31 (6H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
mp: 124.5-124.8° C.
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.18 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.9 Hz), 3.04-3.08 (4H, m), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.13-4.15 (4H, m), 6.78-6.83 (3H, m), 6.90 (1H, d, J=8.9 Hz), 7.13 (2H, d, J=8.9 Hz), 7.19 (2H, d, J=8.6 Hz), 7.25-7.29 (8H, m), 7.45 (1H, d, J=1.6 Hz), 7.56 (1H, d, J=15.5 Hz), 7.71 (1H, d, J=3.3 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.33 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.03 (2H, t, J=6.9 Hz), 3.08 (2H, t, J=6.9 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.12 (2H, t, J=6.9 Hz), 4.13 (2H, t, J=6.9 Hz), 6.78-6.83 (3H, m), 6.88-6.99 (3H, m), 7.12-7.16 (4H, m), 7.22-7.30 (6H, m), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.5 Hz), 7.72 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.11 (2H, t, J=6.8 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.17 (2H, t, J=6.6 Hz), 4.98 (2H, s), 6.77-6.88 (3H, m), 6.91 (1H, d, J=8.9 Hz), 7.10-7.20 (4H, m), 7.26-7.31 (7H, m), 7.36 (1H, dd, J=8.9, 3.0 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.2 Hz), 7.79 (113, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 0.91 (3H, t, J=7.4 Hz), 1.26-1.40 (2H, m), 1.50-1.61 (2H, m), 2.19 (3H, s), 2.36 (3H, s), 2.46-2.57 (6H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.15 (2H, t, J=6.9 Hz), 4.98 (2H, s), 6.77-6.83 (3H, m), 6.91 (1H, d, J=8.9 Hz), 7.05-7.10 (2H, m), 7.19 (2H, d, J=7.9 Hz), 7.23-7.31 (7H, m), 7.36 (1H, dd, J=8.9, 3.0 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.5 Hz), 7.79 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.23 (6H, d, J=6.9 Hz), 2.19 (3H, s), 2.46-2.50 (4H, m), 2.81-2.91 (1H, m), 3.09 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.62-3.66 (2H, m), 3.72-3.76 (2H, m), 4.17 (2H, t, J=7.1 Hz), 5.13 (2H, s), 6.68-6.75 (1H, m), 6.76-6.85 (3H, m), 6.94 (1H, d, J=8.9 Hz), 7.16-7.28 (8H, m), 7.36-7.61 (5H, m), 7.81 (1H, d, J=2.6 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.05 (2H, t, J=6.9 Hz), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.09 (2H, t, J=6.9 Hz), 5.14 (2H, s), 5.90 (2H, s), 6.31 (1H, dd, J=8.7, 2.3 Hz), 6.48 (1H, d, J=2.3 Hz), 6.69 (1H, d, J=8.7 Hz), 6.80 (1H, d, J=15.6 Hz), 6.94 (1H, d, J=9.2 Hz), 7.22-7.32 (7H, m), 7.38-7.41 (2H, m), 7.45 (1H, d, J=1.8 Hz), 7.52 (1H, m), 7.57 (1H, d, J=15.6 Hz), 7.81 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.05 (2H, t, J=6.9 Hz), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.09 (2H, t, J=6.9 Hz), 4.98 (2H, s), 5.90 (2H, s), 6.31 (1H, dd, J=8.7, 2.3 Hz), 6.48 (1H, d, J=2.3 Hz), 6.68 (1H, d, J=8.7 Hz), 6.79 (1H, d, J=15.6 Hz), 6.91 (1H, d, J=9.2 Hz), 7.19 (2H, d, J=9.2 Hz), 7.22-7.30 (7H, m), 7.35 (1H, dd, J=9.2, 3.2 Hz), 7.45 (1H, d, J=2.3 Hz), 7.56 (1H, d, J=15.6 Hz), 7.79 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.19 (3H, s), 2.22 (3H, s), 2.49-2.52 (4H, m), 3.07 (2H, t, J=6.9 Hz), 3.55 (2H, s), 3.64-3.67 (2H, m), 3.74-3.77 (2H, m), 4.13 (2H, t, J=6.9 Hz), 5.13 (2H, s), 6.64 (1H, dd, J=8.2, 2.3 Hz), 6.71 (1H, d, J=1.8 Hz), 6.80 (1H, d, J=15.1 Hz), 6.94 (1H, d, J=8.7 Hz), 7.01 (1H, d, J=8.2 Hz), 7.23-7.31 (7H, m), 7.37-7.58 (5H, m), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.50-2.53 (4H, m), 3.09 (2H, t, J=7.1 Hz), 3.55 (2H, s), 3.65-3.67 (2H, m), 3.73-3.79 (5H, m), 4.16 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.45-6.52 (3H, m), 6.79 (1H, d, J=15.1 Hz), 6.95 (1H, d, J=8.7 Hz), 7.17 (1H, t, J=8.2 Hz), 7.24-7.30 (7H, m), 7.37-7.46 (3H, m), 7.51-7.58 (2H, m), 7.82 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47-2.50 (4H, m), 3.15 (2H, t, J=6.9 Hz), 3.53 (2H, s), 3.63-3.66 (2H, m), 3.73-3.76 (2H, m), 4.22 (2H, t, J=6.9 Hz), 5.14 (2H, s), 6.80 (1H, d, J=15.1 Hz), 6.85-6.91 (2H, m), 6.95 (1H, d, J=9.2 Hz), 7.18 (1H, t, J=7.1 Hz), 7.26-7.32 (7H, m), 7.33-7.42 (3H, m), 7.45 (1H, s), 7.51-7.59 (2H, m), 7.81 (1H, d, J=2.7 Hz).
mp: 125.8-126.2° C.
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.06-3.10 (2H, m), 3.52 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 4.11-4.15 (2H, m), 4.98 (2H, brs), 6.67 (2H, d, J=8.8 Hz), 6.80 (1H, d, J=15.6 Hz), 6.92 (1H, d, J=8.8 Hz), 7.19 (2H, d, J=8.3 Hz), 7.24 (2H, d, J=7.8 Hz), 7.26-7.28 (3H, m), 7.29 (2H, d, J=7.8 Hz), 7.34-7.37 (1H, m), 7.45 (1H, d, J=2.0 Hz), 7.54 (2H, d, J=8.8 Hz), 7.55-7.59 (1H, m), 7.78 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.06-3.10 (2H, m), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.11-4.15 (2H, m), 5.14 (2H, brs), 6.67 (2H, d, J=8.8 Hz), 6.80 (1H, d, J=15.1 Hz), 6.95 (1H, d, J=8.8 Hz), 7.22-7.32 (7H, m), 7.38-7.41 (2H, m), 7.46 (1H, d, J=2.0 Hz), 7.51-7.59 (4H, m), 7.81 (1H, d, J=3.4 Hz).
1H-NMR (CDCl3) S: 2.20 (3H, s), 2.47-2.50 (4H, m), 3.08 (2H, t, J=6.8 Hz), 3.53 (2H, s), 3.64-3.66 (2H, m), 3.73-3.76 (2H, m), 4.14 (2H, t, J=6.8 Hz), 5.14 (2H, s), 6.76-6.85 (3H, m), 6.95 (1H, d, J=8.8 Hz), 7.21-7.29 (9H, m), 7.38-7.59 (5H, m), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=6.8 Hz), 3.52 (2H, s), 3.63-3.65 (2H, m), 3.73-3.76 (2H, m), 4.15 (2H, t, J=6.8 Hz), 5.13 (2H, s), 6.76-6.83 (2H, m), 6.88-6.95 (3H, m), 7.17 (1H, t, J=8.3 Hz), 7.22-7.30 (7H, m), 7.37-7.41 (2H, m), 7.45 (1H, s), 7.50-7.53 (1H, m), 7.57 (1H, d, J=15.6 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47-2.51 (4H, m), 3.17 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.64-3.66 (2H, m), 3.73-3.76 (2H, m), 4.30 (2H, t, J=7.1 Hz), 5.13 (2H, s), 6.81 (1H, d, J=15.1 Hz), 6.94 (1H, d, J=8.8 Hz), 7.06 (1H, d, J=2.9 Hz), 7.26-7.41 (11H, m), 7.45-7.61 (3H, m), 7.81 (1H, d, J=2.9 Hz), 7.98-8.03 (2H, m), 8.74-8.78 (1H, m).
1H-NMR (CDCl3) δ: 2.12 (3H, s), 2.19 (3H, s), 2.25 (3H, s), 2.47-2.48 (4H, m), 3.10 (2H, t, J=7.2 Hz), 3.52 (2H, s), 3.63-3.65 (2H, m), 3.73-3.76 (2H, m), 4.15 (2H, t, J=7.2 Hz), 5.14 (2H, s), 6.68 (1H, d, J=8.3 Hz), 6.76 (1H, d, J=7.6 Hz), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=8.8 Hz), 7.02 (1H, t, J=7.9 Hz), 7.25-7.31 (7H, m), 7.38-7.41 (2H, m), 7.45-7.59 (3H, m), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.31 (3H, s), 2.47-2.48 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.65 (2H, m), 3.73-3.75 (2H, m), 4.15 (2H, t, J=7.1 Hz), 5.13 (2H, s), 6.68-6.83 (4H, m), 6.94 (1H, d, J=9.0 Hz), 7.15 (1H, t, J=7.7 Hz), 7.22-7.30 (7H, m), 7.36-7.41 (2H, m), 7.44-7.60 (3H, m), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.27 (6H, s), 2.48-2.49 (4H, m), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.65 (2H, m), 3.73-3.76 (2H, m), 4.14 (2H, t, J=7.1 Hz), 5.13 (2H, s), 6.53 (2H, s), 6.59 (1H, s), 6.80 (1H, d, J=15.6 Hz), 6.94 (1H, d, J=8.8 Hz), 7.26-7.31 (7H, m), 7.38-7.59 (5H, m), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.75 (2H, s), 4.15 (2H, t, J=7.2 Hz), 5.16 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.83 (2H, d, J=8.8 Hz), 6.97 (1H, d, J=9.0 Hz), 7.13 (2H, d, J=8.8 Hz), 7.19 (1H, t, J=8.1 Hz), 7.24-7.35 (8H, m), 7.38-7.41 (2H, m), 7.50-7.53 (1H, m), 7.61 (1H, d, J=15.4 Hz), 7.86 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.55-2.56 (4H, m), 2.82-2.87 (1H, m), 3.07 (2H, t, J=7.0 Hz), 3.59 (2H, s), 3.67-3.69 (2H, m), 3.76-3.79 (2H, m), 3.80 (3H, s), 4.14 (3H, t, J=6.3 Hz), 5.15 (2H, s), 6.77 (1H, d, J=15.4 Hz), 6.83 (2H, d, J=8.5 Hz), 6.91 (1H, d, J=8.8 Hz), 7.06-7.15 (5H, m), 7.22-7.32 (6H, m), 7.34-7.42 (2H, m), 7.49-7.54 (1H, m), 7.63 (1H, d, J=15.4 Hz), 7.87 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.31 (3H, s), 2.52-2.54 (4H, m), 3.08 (2H, t, J=7.0 Hz), 3.56 (2H, s), 3.66-3.68 (2H, m), 3.75-3.78 (2H, m), 3.80 (3H, s), 4.15 (2H, t, J=7.0 Hz), 5.15 (2H, s), 6.68-6.80 (4H, m), 6.92 (1H, d, J=8.8 Hz), 7.06-7.18 (4H, m), 7.25-7.32 (6H, m), 7.33-7.42 (2H, m), 7.50-7.53 (1H, m), 7.63 (1H, d, J=15.4 Hz), 7.87 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.46-2.49 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.73-3.76 (2H, m), 3.80 (3H, s), 4.12 (2H, t, J=7.0 Hz), 5.14 (2H, s), 6.77-6.84 (3H, m), 6.89-6.97 (3H, m), 7.07-7.15 (3H, m), 7.23-7.30 (6H, m), 7.33-7.41 (2H, m), 7.49-7.54 (1H, m), 7.64 (1H, d, J=15.4 Hz), 7.86 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.28 (3H, s), 2.48-2.49 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.74-3.76 (2H, m), 3.81 (3H, s), 4.14 (2H, t, J=7.1 Hz), 5.15 (2H, s), 6.76-6.82 (3H, m), 6.92 (1H, d, J=8.8 Hz), 7.06-7.10 (4H, m), 7.13-7.16 (1H, m), 7.24-7.31 (6H, m), 7.34-7.41 (2H, m), 7.50-7.54 (1H, m), 7.64 (1H, d, J=15.4 Hz), 7.87 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.40 (3H, s), 2.48 (4H, t, J=4.6 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63 (2H, brs), 3.75 (2H, brs), 4.13 (2H, t, J=7.1 Hz), 5.17 (2H, s), 6.71 (1H, d, J=15.1 Hz), 6.80-6.85 (2H, m), 6.89-6.99 (5H, m), 7.23-7.33 (6H, m), 7.36-7.42 (2H, m), 7.51-7.53 (2H, m), 7.90 (1H, d, J=15.1 Hz), 7.94 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.27 (3H, s), 2.40 (3H, s), 2.48 (4H, brs), 3.07 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63 (2H, brs), 3.75 (2H, brs), 4.14 (2H, t, J=7.1 Hz), 5.17 (2H, s), 6.71 (1H, d, J=15.1 Hz), 6.79 (2H, d, J=8.8 Hz), 6.89-6.91 (3H, m), 7.06 (2H, d, J=8.8 Hz), 7.22-7.42 (8H, m), 7.51-7.53 (2H, m), 7.90 (1H, d, J=15.1 Hz), 7.94 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.40 (3H, s), 2.48 (4H, brs), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63 (2H, brs), 3.75 (2H, brs), 4.15 (2H, t, J=7.1 Hz), 5.17 (2H, s), 6.71 (1H, d, J=15.1 Hz), 6.83 (2H, d, J=8.5 Hz), 6.89-6.91 (3H, m), 7.13 (2H, d, J=8.5 Hz), 7.22-7.42 (8H, m), 7.51-7.53 (2H, m), 7.90 (1H, d, J=15.1 Hz), 7.94 (1H, d, J=2.9 Hz).
mp: 127.3-128.5° C.
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.65 (2H, s), 3.74 (2H, s), 4.13 (2H, t, J=7.2 Hz), 5.11 (2H, s), 6.78-6.85 (3H, m), 6.93-6.99 (3H, m), 7.12 (1H, td, J=7.9, 1.1 Hz), 7.23-7.29 (5H, m), 7.36-7.41 (3H, m), 7.46 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.74 (2H, s), 4.15 (2H, t, J=7.0 Hz), 5.10 (2H, s), 6.78-6.85 (3H, m), 6.95 (1H, d, J=9.0 Hz), 7.09-7.15 (3H, m), 7.24-7.29 (5H, m), 7.37-7.40 (3H, m), 7.46 (1H, d, J=1.7 Hz), 7.57 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.28 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.75 (2H, s), 4.15 (2H, t, J=7.1 Hz), 5.11 (2H, s), 6.78-6.82 (3H, m), 6.95 (1H, d, J=8.8 Hz), 7.07 (2H, d, J=8.8 Hz), 7.09-7.19 (2H, m), 7.22-7.29 (6H, m), 7.38 (1H, dd, J=8.9, 3.1 Hz), 7.46 (1H, d, J=1.7 Hz), 7.57 (1H, d, J=15.1 Hz), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.75 (2H, s), 4.16 (2H, d, J=7.1 Hz), 5.11 (2H, s), 6.78-6.85 (3H, m), 6.95 (1H, d, J=9.0 Hz), 7.10-7.17 (4H, m), 7.22-7.29 (6H, m), 7.38 (1H, dd, J=8.9, 3.1 Hz), 7.46 (1H, d, J=1.7 Hz), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.48 (4H, t, J=4.9 Hz), 2.80-2.90 (1H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.15 (2H, t, J=7.1 Hz), 5.18 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.83 (2H, d, J=8.5 Hz), 6.92 (1H, d, J=9.0 Hz), 7.08 (2H, d, J=8.8 Hz), 7.13 (2H, d, J=8.8 Hz), 7.23-7.31 (6H, m), 7.37-7.42 (2H, m), 7.51-7.54 (3H, m), 7.65 (1H, d, J=15.4 Hz), 7.95 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.47-2.48 (4H, m), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.73-3.76 (2H, m), 3.80 (3H, s), 4.13 (2H, t, J=7.0 Hz), 5.14 (2H, s), 6.76-6.83 (3H, m), 6.92 (1H, d, J=8.8 Hz), 7.07-7.16 (3H, m), 7.20-7.31 (8H, m), 7.34-7.41 (2H, m), 7.50-7.53 (1H, m), 7.64 (1H, d, J=15.4 Hz), 7.86 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=6.8 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.73-3.76 (2H, m), 4.13 (2H, t, J=6.8 Hz), 5.14 (2H, s), 6.72-6.83 (2H, m), 6.93-6.99 (2H, m), 7.22-7.32 (8H, m), 7.37-7.47 (3H, m), 7.50-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.73-3.76 (2H, m), 4.14 (2H, t, J=7.0 Hz), 4.98 (2H, s), 6.77-6.85 (3H, m), 6.92 (1H, d, J=9.0 Hz), 7.17-7.30 (11H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, s), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, brs), 3.14 (2H, t, J=6.8 Hz), 3.53 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 4.27 (2H, d, J=6.8 Hz), 5.14 (2H, brs), 6.80 (1H, d, J=15.4 Hz), 6.95 (2H, d, J=9.0 Hz), 7.24-7.32 (9H, m), 7.38-7.41 (2H, m), 7.46 (1H, d, J=1.7 Hz), 7.51-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz), 8.19 (2H, d, J=9.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, brs), 3.14 (2H, t, J=6.8 Hz), 3.53 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 4.27 (2H, d, J=6.8 Hz), 4.98 (2H, brs), 6.80 (1H, d, J=15.4 Hz), 6.92 (1H, d, J=8.8 Hz), 6.94 (2H, d, J=9.3 Hz), 7.19 (2H, d, J=7.8 Hz), 7.25 (2H, d, J=7.8 Hz), 7.28-7.30 (5H, m), 7.36 (1H, dd, J=8.8, 2.9 Hz), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz), 8.19 (2H, d, J=9.3 Hz).
1H-NMR (CDCl3) δ: 2.21 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.85 (7H, m), 4.13 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.76-6.86 (6H, m), 6.97 (1H, d, J=8.3 Hz), 7.19 (2H, d, J=7.8 Hz), 7.23-7.35 (8H, m), 7.40 (1H, s), 7.63 (1H, d, J=15.4 Hz), 7.88 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.21 (3H, s), 2.28 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.74 (2H, s), 4.15 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.76-6.82 (3H, m), 6.84 (1H, dd, J=8.9, 0.6 Hz), 6.97 (1H, d, J=8.3 Hz), 7.07 (2H, dd, J=8.7, 0.6
Hz), 7.19 (2H, d, J=7.8 Hz), 7.23-7.35 (8H, m), 7.40 (1H, d, J=2.0 Hz), 7.63 (1H, d, J=15.4 Hz), 7.88 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.21 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=5.0 Hz), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.74 (2H, s), 4.15 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.82-6.85 (3H, m), 6.97 (1H, d, J=8.3 Hz), 7.11-7.15 (2H, m), 7.19 (2H, d, J=7.6 Hz), 7.23-7.35 (8H, m), 7.40 (1H, s), 7.63 (1H, d, J=15.4 Hz), 7.88 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.21 (3H, s), 2.48 (4H, t, J=5.0 Hz), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.75 (2H, s), 4.15 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.82-6.85 (2H, m), 6.88 (1H, d, J=8.8 Hz), 6.99 (1H, d, J=8.3 Hz), 7.11-7.15 (2H, m), 7.23-7.27 (5H, m), 7.34-7.37 (2H, m), 7.41 (1H, d, J=2.0 Hz), 7.45 (2H, d, J=7.8 Hz), 7.63 (1H, d, J=15.4 Hz), 7.89 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.21 (3H, s), 2.28 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.74 (2H, s), 4.14 (2H, t, J=7.0 Hz), 5.16 (2H, s), 6.77-6.81 (3H, m), 6.88 (1H, d, J=8.8 Hz), 6.99 (1H, d, J=8.3 Hz), 7.07 (2H, d, J=8.5 Hz), 7.23-7.28 (5H, m), 7.34-7.37 (2H, m), 7.41 (1H, s), 7.45 (2H, d, J=7.8 Hz), 7.63 (1H, d, J=15.4 Hz), 7.89 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.22 (3H, s), 2.28 (3H, s), 2.48 (4H, t, J=5.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.14 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.76-6.81 (3H, m), 6.87 (1H, d, J=8.8 Hz), 6.98 (1H, d, J=8.3 Hz), 7.07 (2H, d, J=8.8 Hz), 7.23-7.32 (6H, m), 7.34-7.42 (4H, m), 7.50-7.55 (1H, m), 7.63 (1H, d, J=15.6 Hz), 7.91 (1H, d, J=3.4 Hz).
1H-NMR (CDCl3) δ: 2.22 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.77-6.89 (4H, m), 6.92-6.99 (3H, m), 7.23-7.30 (6H, m), 7.32-7.42 (4H, m), 7.51-7.54 (1H, m), 7.63 (1H, d, J=15.1 Hz), 7.90 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.22 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.75 (2H, s), 4.15 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.79 (1H, d, J=15.1 Hz), 6.82-6.88 (3H, m), 6.98 (1H, d, J=8.3 Hz), 7.11-7.15 (2H, m), 7.24-7.32 (5H, m), 7.34-7.41 (5H, m), 7.50-7.55 (1H, m), 7.63 (1H, d, J=15.1 Hz), 7.91 (1H, d, J=3.4 Hz).
1H-NMR (CDCl3) δ: 2.22 (3H, s), 2.32 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.09 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.75 (2H, s), 4.16 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.70-6.81 (4H, m), 6.87 (1H, d, J=8.8 Hz), 6.98 (1H, d, J=8.3 Hz), 7.15 (1H, t, J=7.8 Hz), 7.24-7.41 (10H, m), 7.51-7.54 (1H, m), 7.63 (1H, d, J=15.1 Hz), 7.91 (1H, d, J=3.4 Hz).
1H-NMR (CDCl3) δ: 2.28 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.75 (2H, s), 4.15 (2H, t, J=7.2 Hz), 5.16 (2H, s), 6.77-6.84 (3H, m), 6.97 (1H, d, J=9.0 Hz), 7.07 (2H, d, J=8.5 Hz), 7.15-7.45 (11H, m), 7.47-7.56 (1H, m), 7.60 (1H, d, J=2.9 Hz), 7.86 (1H, d, J=15.4 Hz).
1H-NMR (CDCl3) δ: 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.75 (2H, s), 4.13 (2H, t, J=7.2 Hz), 5.16 (2H, s), 6.77-6.84 (3H, m), 6.93-6.98 (3H, m), 7.19 (1H, t, J=8.1 Hz), 7.23-7.35 (8H, m), 7.38-7.41 (2H, m), 7.50-7.53 (1H, m), 7.61 (1H, d, J=15.4 Hz), 7.86 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.32 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.09 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.75 (2H, s), 4.16 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.69-6.77 (3H, m), 6.79 (1H, d, J=15.4 Hz), 6.97 (1H, d, J=9.0 Hz), 7.13-7.21 (2H, m), 7.24-7.35 (8H, m), 7.38-7.41 (2H, m), 7.50-7.53 (1H, m), 7.61 (1H, d, J=15.4 Hz), 7.86 (1H, d, J=2.9 Hz).
mp: 124.3-125.0° C.
1H-NMR (CDCl3) δ: 3.26 (3H, s), 2.40 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.52-3.63 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.02 (2H, s), 6.70 (1H, d, J=15.1 Hz), 6.80-6.99 (7H, m), 7.19 (2H, d, J=7.8 Hz), 7.23-7.35 (7H, m), 7.50-7.53 (1H, m), 7.88-7.93 (2H, m).
1H-NMR (CDCl3) δ: 2.27 (3H, s), 2.36 (3H, s), 2.40 (3H, s), 2.47 (4H, t, J=4.6 Hz), 3.07 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 4.14 (2H, t, J=7.1 Hz), 5.02 (2H, s), 6.70 (1H, d, J=15.1 Hz), 6.78-6.81 (2H, m), 6.86-6.91 (3H, m), 7.05-7.07 (2H, m), 7.19 (2H, d, J=7.8 Hz), 7.23-7.28 (4H, m), 7.30 (2H, d, J=8.1 Hz), 7.33 (1H, dd, J=8.8, 3.2 Hz), 7.05-7.53 (1H, m), 7.90 (1H, d, J=15.1 Hz), 7.92 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=7.1 Hz), 2.36 (3H, s), 2.40 (3H, s), 2.47 (4H, brs), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.02 (2H, s), 6.70 (1H, d, J=15.1 Hz), 6.81-6.85 (2H, m), 6.86-6.91 (3H, m), 7.11-7.14 (2H, m), 7.19 (2H, d, J=7.8 Hz), 7.23-7.35 (7H, m), 7.50-7.53 (1H, m), 7.88-7.93 (2H, m).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.55 (3H, s), 3.12 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.24 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.80 (1H, d, J=15.1 Hz), 6.91-6.95 (3H, m), 7.24-7.31 (7H, m), 7.38-7.41 (2H, m), 7.45-7.46 (1H, m), 7.50-7.53 (1H, m), 7.57 (1H, d, J=15.1 Hz), 7.81 (1H, d, J=2.9 Hz), 7.91 (2H, d, J=8.3 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.55 (3H, s), 3.12 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.64-3.74 (4H, m), 4.13 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.90-6.94 (3H, m), 7.19 (2H, d, J=7.8 Hz), 7.24-7.30 (7H, m), 7.35 (1H, dd, J=8.8, 3.2 Hz), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=3.2 Hz), 7.90-7.94 (2H, m).
1H-NMR (CDCl3) δ: 1.29 (3H, d, J=6.1 Hz), 2.19 (3H, s), 2.28 (3H, s), 2.36 (3H, s), 2.47 (4H, t, J=5.0 Hz), 2.80 (1H, dd, J=13.7, 6.6 Hz), 3.07 (1H, dd, J=13.7, 5.9 Hz), 3.51 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.48-4.55 (1H, m), 4.98 (2H, s), 6.76-6.81 (3H, m), 6.91 (1H, d, J=9.0
Hz), 7.06 (2H, dd, J=8.7, 0.6 Hz), 7.18-7.30 (9H, m), 7.35 (1H, dd, J=9.0, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=3.1 Hz).
1H-NMR (CDCl3) δ: 1.40 (3H, d, J=7.1 Hz), 2.19 (3H, s), 2.27 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.18-3.27 (1H, m), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 3.93 (1H, dd, J=9.3, 7.8 Hz), 4.06 (1H, dd, J=9.3, 5.9 Hz), 4.98 (2H, s), 6.76-6.82 (3H, m), 6.91 (1H, d, J=9.0 Hz), 7.06 (2H, d, J=8.3 Hz), 7.19 (2H, d, J=7.8 Hz), 7.23-7.30 (7H, m), 7.35 (1H, dd, J=9.0, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=3.1 Hz).
1H-NMR (CDCl3) δ: 1.40 (3H, d, J=7.1 Hz), 2.19 (3H, s), 2.27 (3H, s), 2.49 (4H, t, J=5.1 Hz), 3.20-3.25 (1H, m), 3.52 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 3.93 (1H, dd, J=9.3, 7.7 Hz), 4.06 (1H, dd, J=9.3, 5.9 Hz), 5.14 (2H, s), 6.78 (2H, d, J=8.5 Hz), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=9.0 Hz), 7.06 (2H, d, J=8.1 Hz), 7.22-7.32 (7H, m), 7.38-7.41 (2H, m), 7.45 (1H, d, J=2.0 Hz), 7.51-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.28 (3H, d, J=6.1 Hz), 2.19 (3H, s), 2.27 (3H, s), 2.47 (4H, t, J=5.0 Hz), 2.80 (1H, dd, J=13.7, 6.3 Hz), 3.07 (1H, dd, J=13.7, 5.9 Hz), 3.51 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.48-4.55 (1H, m), 5.14 (2H, s), 6.77-6.81 (3H, m), 6.94 (1H, dd, J=8.8, 0.5 Hz), 7.06 (2H, dd, J=8.7, 0.6 Hz), 7.20 (2H, d, J=8.1 Hz), 7.24 (2H, d, J=8.1 Hz), 7.27-7.31 (3H, m), 7.38-7.41 (2H, m), 7.45 (1H, d, J=2.2 Hz), 7.51-7.53 (1H, m), 7.56 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.20-1.26 (6H, m), 1.91-1.93 (2H, m), 2.19-2.21 (3H, m), 2.63-2.67 (2H, m), 2.72-2.76 (2H, m), 2.80-2.89 (1H, m), 3.05-3.10 (2H, m), 3.62 (2H, s), 3.67-3.77 (4H, m), 4.12-4.17 (2H, m), 5.14 (2H, s), 6.74-6.86 (3H, m), 6.94 (1H, d, J=8.8 Hz), 7.11-7.15 (2H, m), 7.22-7.32 (7H, m), 7.37-7.41 (2H, m), 7.44-7.48 (1H, m), 7.50-7.55 (1H, m), 7.58-7.64 (1H, m), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.20-1.23 (6H, m), 1.88-1.96 (2H, m), 2.19-2.20 (3H, m), 2.35 (3H, s), 2.63-2.67 (2H, m), 2.72-2.76 (2H, m), 2.80-2.89 (1H, m), 3.05-3:10 (2H, m), 3.62 (2H, s), 3.66-3.77 (4H, m), 4.09-4.17 (2H, m), 4.98 (2H, s), 6.74-6.86 (3H, m), 6.91 (1H, d, J=8.8 Hz), 7.11-7.14 (2H, m), 7.16-7.30 (9H, m), 7.35 (1H, dd, J=8.8, 3.2 Hz), 7.45 (1H, dd, J=8.5, 2.2 Hz), 7.58-7.63 (1H, m), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.19 (3H, s), 2.47-2.49 (4H, m), 2.81-2.88 (1H, m), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.63-3.65 (2H, m), 3.73-3.75 (2H, m), 4.15 (2H, t, J=7.0 Hz), 5.09 (2H, s), 6.78-6.84 (3H, m), 6.95 (1H, d, J=8.8 Hz), 7.13 (2H, d, J=8.5 Hz), 7.25-7.27 (4H, m), 7.27-7.30 (1H, m), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, s), 7.52 (2H, d, J=8.1 Hz), 7.56 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.3 Hz), 7.76 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.27 (3H, s), 2.47-2.48 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.63-3.65 (2H, m), 3.73-3.75 (2H, m), 4.14 (2H, t, J=7.0 Hz), 5.08 (2H, s), 6.78-6.82 (3H, m), 6.95 (1H, d, J=8.8 Hz), 7.06 (2H, d, J=8.5 Hz), 7.25-7.29 (5H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, s), 7.51 (2H, d, J=8.1 Hz), 7.56 (1H, d, J=15.4 Hz), 7.67 (2H, d, J=8.1 Hz), 7.76 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.41-2.54 (4H, m), 2.84 (1H, septet, J=6.8 Hz), 3.07 (2H, t, J=7.1 Hz), 3.49-3.83 (4H, m), 3.52 (2H, s), 4.14 (2H, t, J=7.1 Hz), 5.19 (2H, s), 6.81-6.84 (2H, m), 6.96 (1H, d, J=9.0 Hz), 7.10-7.14 (2H, m), 7.22-7.33 (7H, m), 7.39-7.42 (2H, m), 7.47 (1H, dd, J=8.3, 1.5 Hz), 7.49 (1H, d, J=2.2 Hz), 7.52-7.55 (1H, m), 7.76 (1H, d, J=8.5 Hz), 7.85-7.88 (2H, m), 7.96 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.41-2.53 (4H, m), 2.84 (1H, septet, J=6.8 Hz), 3.07 (2H, t, J=7.1 Hz), 3.48 (2H, brs), 3.52 (2H, s), 3.83 (2H, brs), 4.14 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.81-6.84 (2H, m), 6.95-7.00 (1H, m), 7.09-7.18 (4H, m), 7.23-7.27 (5H, m), 7.32 (1H, dd, J=8.9, 2.3 Hz), 7.40 (1H, dd, J=8.9, 3.1 Hz), 7.47 (1H, dd, J=8.4, 1.6 Hz), 7.49 (1H, d, J=2.2 Hz), 7.77 (1H, d, J=8.5 Hz), 7.86-7.89 (2H, m), 7.95 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.40 (3H, d, J=6.8 Hz), 2.12 (6H, s), 2.27 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.18-3.29 (1H, m), 3.52 (2H, s), 3.66 (2H, brs), 3.74 (2H, brs), 3.81 (3H, s), 3.92 (1H, dd, J=9.3, 7.7 Hz), 4.06 (1H, dd, J=9.3, 5.9 Hz), 4.95 (2H, s), 6.76-6.80 (4H, m), 6.91 (2H, dt, J=9.1, 2.7 Hz), 7.06 (2H, d, J=8.5 Hz), 7.23-7.34 (9H, m), 7.61 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.40 (3H, d, J=7.1 Hz), 2.12 (6H, s), 2.27 (3H, s), 2.48 (4H, t, J=4.6 Hz), 3.18-3.27 (1H, m), 3.52 (2H, s), 3.66 (2H, brs), 3.75 (2H, brs), 3.91-3.95 (1H, m), 4.06 (1H, dd, J=9.2, 6.2 Hz), 4.99 (2H, s), 6.77-6.82 (4H, m), 7.05-7.09 (4H, m), 7.24-7.33 (7H, m), 7.36-7.39 (2H, m), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.6 Hz), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 4.13 (2H, t, J=7.0 Hz), 4.98 (2H, s), 6.76-6.84 (4H, m), 6.95 (2H, t, J=8.5 Hz), 7.19 (2H, d, J=7:8 Hz), 7.24-7.33 (9H, m), 7.60 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.48 (4H, s), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.65 (2H, brs), 3.76 (5H, brs), 4.12 (2H, q, J=6.8 Hz), 5.13 (2H, s), 6.76-6.83 (6H, m), 7.26-7.29 (8H, m), 7.36 (1H, dd, J=9.0, 2.7 Hz), 7.39-7.41 (1H, m), 7.51-7.52 (1H, m), 7.60 (1H, d, J=15.1 Hz), 7.84 (1H, d, J=2.4 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.6 Hz), 3.05-08 (2H, m), 3.52 (3H, s), 3.65 (2H, brs), 3.76 (4H, brs), 4.11-4.15 (2H, m), 4.98 (2H, s), 6.76-6.86 (5H, m), 7.18 (2H, d, J=7.8 Hz), 7.24-7.33 (10H, m), 7.60 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.48 (4H, t, J=4.6 Hz), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 4.13 (2H, t, J=7.0 Hz), 5.13 (2H, s), 6.78 (1H, d, J=15.6 Hz), 6.80-6.84 (3H, m), 6.93-6.97 (2H, m), 7.23-7.31 (8H, m), 7.34-7.37 (1H, m), 7.38-7.40 (1H, m), 7.51-7.53 (1H, m), 7.61 (1H, d, J=15.4 Hz), 7.84 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.28 (3H, d, J=6.1 Hz), 2.12 (6H, s), 2.27 (3H, s), 2.47 (4H, t, J=4.9 Hz), 2.80 (1H, dd, J=13.8, 6.5 Hz), 3.07 (1H, dd, J=13.8, 6.1 Hz), 3.50 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 3.81 (3H, s), 4.48-4.55 (1H, m), 4.95 (2H, s), 6.76-6.80 (4H, m), 6.91 (2H, dt, J=9.2, 2.3 Hz), 7.06 (2H, d, J=8.8 Hz), 7.19-7.34 (9H, m), 7.60 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.29 (3H, d, J=6.1 Hz), 2.12 (6H, s), 2.28 (3H, s), 2.47 (4H, t, J=4.9 Hz), 2.80 (1H, dd, J=13.7, 6.6 Hz), 3.07 (1H, dd, J=13.7, 6.1 Hz), 3.51 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 4.48-4.56 (1H, m), 4.98 (2H, s), 6.76-6.82 (4H, m), 7.04-7.10 (4H, m), 7.19-7.28 (6H, m), 7.32 (1H, dd, J=9.0, 3.2 Hz), 7.36-7.39 (2H, m), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.27 (3H, s), 2.37 (3H, s), 2.49 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.75 (4H, m), 4.14 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.72 (1H, d, J=15.1 Hz), 6.78-6.81 (2H, m), 6.95-6.96 (1H, m), 6.99 (1H, s), 7.05-7.08 (1H, m), 7.23-7.32 (7H, m), 7.37-7.41 (2H, m), 7.51-7.53 (1H, m), 7.58 (1H, s), 7.83 (1H, d, J=15.1 Hz), 7.88-7.89 (1H, m).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=7.1 Hz), 2.37 (3H, s), 2.49 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=7.1 Hz). 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.72 (1H, d, J=15.4 Hz), 6.82-6.84 (2H, m), 6.95 (1H, d, J=8.8 Hz), 6.99 (1H, s), 7.11-7.14 (2H, m), 7.23-7.32 (6H, m), 7.37-7.41 (2H, m), 7.51-7.53 (1H, m), 7.58 (1H, s), 7.83 (1H, d, J=15.4 Hz), 7.88 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.27 (3H, s), 2.49 (4H, brs), 3.07 (2H, t, J=6.8 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.72 (1H, d, J=15.4 Hz), 6.81-6.84 (2H, m), 6.93-6.99 (4H, m), 7.23-7.31 (6H, m), 7.38-7.40 (2H, m), 7.50-7.53 (1H, m), 7.58 (1H, s), 7.83 (1H, d, J=15.4 Hz), 7.88 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.35 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.72 (1H, d, J=15.1 Hz), 6.81-6.85 (2H, m), 6.91-6.93 (1H, m), 6.97 (1H, s), 7.11-7.14 (2H, m), 7.19 (2H, d, J=7.8 Hz), 7.23-7.30 (6H, m), 7.34-7.37 (1H, m), 7.58 (1H, s), 7.83 (1H, d, J=15.1 Hz), 7.86 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.27 (3H, s), 2.35 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.14 (2H, t, J=7.1 Hz), 5.10 (2H, s), 6.72 (1H, d, J=15.1 Hz), 6.78-6.81 (2H, m), 6.91-6.94 (1H, m), 6.97 (1H, s), 7.05-7.08 (2H, m), 7.19 (2H, d, J=7.8 Hz), 7.23-7.30 (6H, m), 7.35 (1H, dd, J=8.8, 2.9 Hz), 7.58 (1H, s), 7.82 (1H, d, J=15.1 Hz), 7.86 (1H, d, J=2.7 Hz).
1H-NMR (DMSO-d6) δ: 2.30 (3H, s), 2.32 (3H, s), 2.35-2.40 (4H, m), 3.00 (2H, t, J=6.8 Hz), 3.48 (2H, s), 3.56-3.72 (4H, m), 4.16 (2H, t, J=6.8 Hz), 5.07 (2H, s), 6.91-6.96 (2H, m), 7.05-7.12 (4H, m), 7.18-7.29 (7H, m), 7.33 (2H, d, J=8.1 Hz), 7.56-7.64 (2H, m), 7.86-7.87 (1H, m), 8.01 (1H, s).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=6.1 Hz), 2.19 (3H, s), 2.49 (4H, d, J=4.6 Hz), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.10-4.15 (2H, m), 4.38-4.44 (1H, m), 5.14 (2H, s), 6.70-6.82 (5H, m), 6.94 (1H, d, J=9.0 Hz), 7.23-7.31 (7H, m), 7.38-7.41 (2H, m), 7.45 (1H, s), 7.51-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=6.1 Hz), 2.12 (6H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.6 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 4.12 (2H, t, J=7.1 Hz), 4.38-4.44 (1H, m), 4.98 (2H, s), 6.76-6.82 (6H, m), 7.19 (2H, d, J=7.8 Hz), 7.24-7.33 (9H, m), 7.61 (1H, d, J=15.1 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=6.1 Hz), 2.19 (3H, s), 2.36 (3H, s), 2.49 (4H, d, J=4.4 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.12 (2H, t, J=7.0 Hz), 4.38-4.44 (1H, m), 4.98 (2H, s), 6.78-6.82 (5H, m), 6.92 (1H, d, J=8.8 Hz), 7.19 (2H, d, J=7.8 Hz), 7.23-7.31 (7H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, s), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=5.9 Hz), 2.12 (6H, s), 2.48 (4H, t, J=4.6 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 4.12 (2H, t, J=7.1 Hz), 4.38-4.44 (1H, m), 5.13 (2H, s), 6.77-6.83 (6H, m), 7.25-7.31 (8H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.39-7.41 (1H, m), 7.51-7.53 (1H, m), 7.61 (1H, d, J=15.4 Hz), 7.84 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.47-2.48 (4H, m), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.73-3.75 (2H, m), 4.14 (3H, t, J=7.0 Hz), 5.09 (2H, s), 6.79-6.82 (4H, m), 7.20-7.28 (8H, m), 7.33 (1H, dd, J=8.9, 3.1 Hz), 7.52 (2H, d, J=8.1 Hz), 7.60 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.1 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.13 (2H, t, J=4.9 Hz), 5.17 (2H, s), 6.76-6.84 (3H, m), 6.89-6.97 (3H, m), 7.03 (1H, s), 7.23-7.32 (6H, m), 7.37-7.42 (2H, m), 7.45 (1H, s), 7.51-7.53 (1H, m), 7.90-7.94 (2H, m).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 2.21 (3H, s), 2.30 (3H, s), 2.35-2.42 (4H, m), 2.99 (2H, t, J=6.8 Hz), 3.49 (2H, s), 3.57-3.71 (4H, m), 4.13 (2H, t, J=6.8 Hz), 5.08 (2H, s), 6.79-6.83 (2H, m), 7.05-7.08 (3H, m), 7.11 (1H, s), 7.20 (2H, d, J=7.8 Hz), 7.24-7.29 (5H, m), 7.33 (2H, d, J=7.8 Hz), 7.59 (1H, dd, J=9.0, 3.2 Hz), 7.75 (1H, d, J=15.4 Hz), 7.90 (1H, d, J=3.2 Hz), 7.97 (1H, s).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 2.30 (3H, s), 2.35-2.41 (4H, m), 3.00 (2H, t, J=6.8 Hz), 3.49 (2H, s), 3.57-3.71 (4H, m), 4.16 (2H, t, J=6.8 Hz), 5.08 (2H, s), 6.91-6.96 (2H, m), 7.06-7.12 (4H, m), 7.20 (2H, d, J=7.8 Hz), 7.24-7.29 (5H, m), 7.33 (2H, d, J=7.8 Hz), 7.59 (1H, dd, J=9.0, 3.2 Hz), 7.75 (1H, d, J=15.4 Hz), 7.90-7.91 (1H, m), 7.97 (1H, s).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.27 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.14 (2H, t, J=7.1 Hz), 5.17 (2H, s), 6.76-6.81 (3H, m), 6.89-6.91 (1H, m), 7.03-7.07 (3H, m), 7.23-7.33 (6H, m), 7.37-7.42 (2H, m), 7.45 (1H, s), 7.51-7.53 (1H, m), 7.90-7.94 (2H, m).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.02 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.83 (2H, d, J=8.3 Hz), 6.87 (1H, d, J=8.8 Hz), 7.01 (1H, s), 7.12 (2H, d, J=8.5 Hz), 7.19 (2H, d, J=8.1 Hz), 7.23-7.31 (6H, m), 7.34 (1H, dd, J=9.0, 3.2 Hz), 7.44 (1H, s), 7.89-7.94 (2H, m).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.17 (2H, s), 6.76-6.85 (3H, m), 6.89-6.91 (1H, m), 7.03 (1H, s), 7.11-7.15 (2H, m), 7.23-7.32 (6H, m), 7.37-7.42 (2H, m), 7.45 (1H, s), 7.51-7.54 (1H, m), 7.90-7.94 (2H, m).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.27 (6H, s), 2.47-2.48 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.51 (2H, s), 3.64-3.66 (2H, m), 3.73-3.75 (2H, m), 4.14 (2H, t, J=7.0 Hz), 5.08 (2H, s), 6.53 (2H, s), 6.58 (1H, s), 6.79 (1H, d, J=15.4 Hz), 6.83 (1H, d, J=8.9 Hz), 7.25-7.27 (6H, m), 7.33 (1H, dd, J=8.9, 3.1 Hz), 7.51 (2H, d, J=8.3 Hz), 7.61 (1H, d, J=15.4 Hz), 7.67 (2H, d, J=8.3 Hz), 7.79 (1H, d, J=3.1 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.47-2.49 (4H, m), 3.17 (2H, t, J=7.0 Hz), 3.53 (2H, s), 3.64-3.67 (2H, m), 3.73-3.75 (2H, m), 4.30 (2H, t, J=7.0 Hz), 5.08 (2H, s), 6.79 (1H, d, J=15.1 Hz), 6.83 (1H, d, J=9.0 Hz), 7.06 (1H, d, J=2.4 Hz), 7.25 (2H, s), 7.29-7.34 (6H, m), 7.37 (1H, dd, J=9.3, 2.9 Hz), 7.51 (2H, d, J=8.1 Hz), 7.61 (1H, d, J=15.1 Hz), 7.67 (2H, d, J=8.1 Hz), 7.79 (1H, d, J=2.9 Hz), 7.98-8.00 (2H, m), 8.75 (1H, dd, J=4.2, 1.2 Hz).
1H-NMR (CDCl3) Et: 1.23 (6H, d, J=6.8 Hz), 2.49 (4H, s), 2.83-2.90 (1H, m), 3.09 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.66 (2H, brs), 3.76 (2H, brs), 3.80 (4H, s), 4.17 (2H, t, J=7.0 Hz), 5.22 (2H, s), 6.72 (1H, d, J=8.1 Hz), 6.76-6.83 (5H, m), 6.97 (1H, d, J=8.8 Hz), 7.19 (1H, t, J=7.9 Hz), 7.26-7.27 (6H, m), 7.38 (1H, dd, J=9.0, 2.9 Hz), 7.42-7.46 (1H, m), 7.60-7.64 (3H, m), 7.70 (1H, d, J=7.8 Hz), 7.82 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.49 (4H, brs), 3.08 (2H, t, J=7.0 Hz), 3.53 (2H, s), 3.66 (2H, brs), 3.76 (2H, brs), 3.80 (6H, s), 4.13 (2H, t, J=7.0 Hz), 5.22 (2H, s), 6.76-6.84 (5H, m), 6.93-6.98 (3H, m), 7.26 (4H, brs), 7.38 (1H, dd, J=9.0, 2.9 Hz), 7.43-7.46 (1H, m), 7.60-7.64 (3H, m), 7.70 (1H, d, J=7.8 Hz), 7.82 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.49 (4H, brs), 3.08 (2H, t, J=7.0 Hz), 3.53 (2H, s), 3.66 (2H, brs), 3.76 (2H, brs), 3.79 (6H, s), 4.13 (2H, t, J=7.1 Hz), 5.08 (2H, s), 6.77 (1H, d, J=15.4 Hz), 6.79 (2H, s), 6.82 (2H, dd, J=9.0, 4.4 Hz), 6.93-6.97 (3H, m), 7.23-7.29 (4H, m), 7.32 (1H, dd, J=9.0, 2.9 Hz), 7.52 (2H, d, J=8.3 Hz), 7.61 (1H, d, J=15.1 Hz), 7.67 (2H, d, J=8.3 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.23 (6H, d, J=6.8 Hz), 2.49 (4H, s), 2.82-2.88 (1H, m), 3.09 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.66 (2H, brs), 3.76 (2H, brs), 3.79 (4H, s), 4.17 (2H, t, J=7.1 Hz), 5.08 (2H, s), 6.72 (1H, d, J=8.1 Hz), 6.76-6.83 (5H, m), 6.96 (1H, d, J=9.0 Hz), 7.19 (1H, t, J=7.8 Hz), 7.26-7.27 (4H, m), 7.32 (1H, dd, J=9.0, 2.9 Hz), 7.52 (2H, d, J=8.1 Hz), 7.61 (1H, d, J=15.4 Hz), 7.67 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.28 (3H, s), 2.37 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.09 (2H, t, J=7.4 Hz), 3.49 (2H, s), 3.65-3.74 (4H, m), 4.11 (2H, t, J=7.4 Hz), 4.98 (2H, s), 6.76-6.82 (4H, m), 7.05-7.12 (6H, m), 7.18 (1H, d, J=7.6 Hz), 7.25-7.26 (2H, m), 7.32 (1H, dd, J=8.9, 3.1 Hz), 7.36-7.39 (2H, m), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.1 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.28 (3H, s), 2.36 (3H, s), 2.37 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.09 (2H, t, J=7.3 Hz), 3.49 (2H, s), 3.65-3.74 (4H, m), 4.12 (2H, t, J=7.3 Hz), 4.98 (2H, s), 6.78-6.81 (3H, m), 6.91 (1H, dd, J=8.9, 0.6 Hz), 7.06-7.12 (4H, m), 7.17-7.20 (3H, m), 7.28-7.30 (3H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, dd, J=3.1, 0.6 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.18 (3H, s), 2.22 (3H, s), 2.47-2.49 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.73-3.76 (2H, m), 4.14 (2H, t, J=7.0 Hz), 5.05 (2H, s), 6.64 (1H, dd, J=8.1, 2.4 Hz), 6.71 (1H, d, J=2.0 Hz), 6.79 (1H, d, J=15.4 Hz), 6.83 (1H, d, J=9.0 Hz), 7.01 (1H, d, J=8.3 Hz), 7.26-7.27 (6H, m), 7.32-7.35 (3H, m), 7.61 (1H, d, J=15.1 Hz), 7.80 (1H, d, J=2.9 Hz), 8.62 (2H, d, J=5.6 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.27 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.14 (2H, t, J=7.1 Hz), 5.12 (2H, s), 6.77-6.81 (3H, m), 6.90-6.92 (1H, m), 7.03 (1H, s), 7.05-7.08 (2H, m), 7.23-7.28 (4H, m), 7.36 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, s), 7.53 (2H, d, J=8.5 Hz), 7.68-7.70 (2H, m), 7.87 (1H, d, J=3.2 Hz), 7.92 (1H, d, J=15.4 Hz).
1H-NMR (CDCl3) δ: 2.37 (3H, s), 2.49 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.65-3.75 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.11 (2H, s), 6.73 (1H, d, J=15.4 Hz), 6.80-6.85 (2H, m), 6.92-6.99 (4H, m), 7.23-7.28 (4H, m), 7.36 (1H, dd, J=9.0, 3.2 Hz), 7.52 (2H, d, J=8.5 Hz), 7.58 (1H, s), 7.67-7.70 (2H, m), 7.81-7.85 (2H, m).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.12 (2H, s), 6.77-6.85 (3H, m), 6.90-6.99 (3H, m), 7.03 (1H, s), 7.23-7.28 (4H, m), 7.36 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, s), 7.52-7.54 (2H, m), 7.68-7.71 (2H, m), 7.87 (1H, d, J=3.2 Hz), 7.92 (1H, d, J=15.4 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=7.1 Hz), 2.37 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.75 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.11 (2H, s), 6.73 (1H, d, J=15.4 Hz), 6.81-6.85 (2H, m), 6.96 (1H, dd, J=8.8, 0.5 Hz), 6.99 (1H, s), 7.11-7.14 (2H, m), 7.23-7.28 (4H, m), 7.36 (1H, dd, J=8.8, 3.2 Hz), 7.51-7.53 (2H, m), 7.58 (1H, s), 7.67-7.70 (2H, m), 7.81-7.85 (2H, m).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.18 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.75 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.12 (2H, s), 6.77-6.85 (3H, m), 6.90-6.92 (1H, m), 7.03 (1H, s), 7.11-7.14 (2H, m), 7.23-7.28 (4H, m), 7.36 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, s), 7.52-7.54 (2H, m), 7.68-7.71 (2H, m), 7.86-7.87 (1H, m), 7.92 (1H, d, J=15.4 Hz).
1H-NMR (CDCl3) δ: 2.27 (3H, s), 2.37 (3H, s), 2.49 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.75 (4H, m), 4.14 (2H, t, J=7.1 Hz), 5.11 (2H, s), 6.73 (1H, d, J=15.1 Hz), 6.78-6.81 (2H, m), 6.96 (1H, d, J=8.8 Hz), 6.99 (1H, s), 7.05-7.08 (2H, m), 7.23-7.28 (4H, m), 7.36 (1H, dd, J=8.8, 3.2 Hz), 7.52 (2H, d, J=8.1 Hz), 7.58 (1H, s), 7.67-7.69 (2H, m), 7.81-7.85 (2H, m).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.47-2.48 (4H, m), 2.55 (3H, s), 3.14 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.73-3.75 (2H, m), 4.21 (2H, t, J=7.0 Hz), 5.12 (2H, s), 6.78-6.81 (2H, m), 6.85-6.89 (2H, m), 7.08 (1H, d, J=7.8 Hz), 7.16-7.18 (1H, m), 7.24-7.30 (7H, m), 7.33-7.37 (2H, m), 7.58-7.63 (2H, m), 7.84 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.67 (2H, m), 3.73-3.75 (2H, m), 4.15 (2H, t, J=7.0 Hz), 5.05 (2H, s), 6.79-6.83 (3H, m), 6.89-6.91 (2H, m), 7.16-7.18 (1H, m), 7.25-7.27 (6H, m), 7.32-7.35 (3H, m), 7.61 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz), 8.62 (2H, d, J=5.9 Hz).
1H-NMR (CDCl3) δ: 1.30 (6H, d, J=6.1 Hz), 2.49 (4H, s), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.65 (2H, brs), 3.75 (2H, brs), 3.79 (6H, s), 4.12 (2H, t, J=7.0 Hz), 4.41 (1H, septet, J=6.1 Hz), 5.18 (2H, s), 6.75-6.79 (3H, m), 6.81 (4H, s), 6.95 (1H, d, J=8.8 Hz), 7.26 (4H, brs), 7.35 (1H, dd, J=8.8, 2.9 Hz), 7.54 (1H, d, J=8.5 Hz), 7.61 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz), 8.02 (1H, s), 8.14 (1H, d, J=8.5 Hz), 9.01 (1H, s).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.37 (3H, s), 2.48 (4H, t, J=4.8 Hz), 3.09 (2H, t, J=7.3 Hz), 3.49 (2H, s), 3.66-3.73 (4H, m), 4.10 (2H, t, J=7.3 Hz), 4.99 (2H, s), 6.76-6.85 (4H, m), 6.93-7.00 (2H, m), 7.05-7.13 (4H, m), 7.18 (1H, d, J=7.6 Hz), 7.25-7.26 (2H, m), 7.32 (1H, dd, J=8.9, 3.1 Hz), 7.36-7.39 (2H, m), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.1 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.37 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.09 (2H, t, J=7.3 Hz), 3.49 (2H, s), 3.64-3.74 (4H, m), 4.10 (2H, t, J=7.3 Hz), 4.99 (2H, s), 6.78-6.84 (3H, m), 6.90-7.00 (3H, m), 7.10-7.13 (2H, m), 7.17-7.20 (3H, m), 7.28-7.30 (3H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=3.1 Hz).
1H-NMR (CDCl3) δ: 2.49 (4H, t, J=4.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.66 (2H, brs), 3.75 (2H, brs), 3.79 (6H, s), 4.13 (2H, t, J=7.1 Hz), 5.18 (2H, s), 6.75-6.79 (3H, m), 6.81-6.84 (2H, m), 6.93-6.98 (3H, m), 7.24 (2H, d, J=8.1 Hz), 7.27 (2H, d, J=8.1 Hz), 7.35 (1H, dd, J=9.0, 2.9 Hz), 7.54 (1H, d, J=8.5 Hz), 7.61 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz), 8.02 (1H, s), 8.14 (1H, d, J=8.5 Hz), 9.01 (1H, s).
1H-NMR (CDCl3) δ: 1.29 (9H, s), 2.48 (4H, t, J=5.0 Hz), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.63-3.74 (4H, m), 4.16 (2H, t, J=7.1 Hz), 4.99 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.82-6.86 (2H, m), 6.96 (1H, dd, J=9.0, 0.5 Hz), 7.10-7.37 (13H, m), 7.60 (1H, d, J=15.4 Hz), 7.81 (1H, dd, J=3.1, 0.6 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.43 (3H, s), 2.47-2.48 (4H, m), 3.08 (2H, t, J=7.2 Hz), 3.51 (2H, s), 3.64-3.66 (2H, m), 3.73-3.75 (2H, m), 4.49 (2H, t, J=7.2 Hz), 5.09 (2H, s), 6.51 (1H, d, J=8.3 Hz), 6.69-6.70 (1H, m), 6.79 (1H, d, J=15.4 Hz), 6.83 (1H, d, J=8.9 Hz), 7.25-7.26 (6H, m), 7.33 (1H, dd, J=8.9, 2.9 Hz), 7.43-7.45 (1H, m), 7.52 (2H, d, J=8.1 Hz), 7.60 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.1 Hz), 7.80 (1H, d, J=2.9 Hz).
mp: 152.9-154.3° C.
1H-NMR (CDCl3) δ: 2.20 (3H, s), 2.28 (3H, s), 2.50 (4H, t, J=5.0 Hz), 3.60 (2H, s), 3.67-3.76 (4H, m), 5.14 (2H, s), 5.22 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.83-6.87 (2H, m), 6.95 (1H, dd, J=9.0, 0.5 Hz), 7.08 (2H, dd, J=8.7, 0.6 Hz), 7.25-7.32 (3H, m), 7.38-7.41 (2H, m), 7.46-7.53 (4H, m), 7.58 (1H, d, J=15.4 Hz), 7.81 (1H, dd, J=2.9, 0.5 Hz), 7.97-8.00 (2H, m).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.37 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.09 (2H, t, J=7.3 Hz), 3.49 (2H, s), 3.66 (2H, brs), 3.74 (2H, brs), 3.81 (3H, s), 4.10 (2H, t, J=7.3 Hz), 4.95 (2H, s), 6.76-6.85 (4H, m), 6.89-7.00 (4H, m), 7.10-7.13 (2H, m), 7.18 (1H, d, J=7.8 Hz), 7.25-7.26 (2H, m), 7.30-7.34 (3H, m), 7.61 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz).
mp: 137.1-137.9° C.
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.48 (4H, t, J=5.0 Hz), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.74 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.11 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.82-6.85 (2H, m), 6.97 (1H, dd, J=8.9, 0.6 Hz), 7.11-7.15 (2H, m), 7.19 (1H, t, J=8.1 Hz), 7.23-7.38 (7H, m), 7.51-7.54 (2H, m), 7.60 (1H, d, J=15.4 Hz), 7.67-7.70 (2H, m), 7.81 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.27 (3H, s), 2.46-2.49 (4H, m), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.14 (2H, t, J=7.1 Hz), 5.22 (2H, s), 6.76-6.83 (4H, m), 7.05-7.08 (2H, m), 7.23-7.28 (6H, m), 7.36-7.41 (2H, m), 7.60 (1H, d, J=15.4 Hz), 7.86 (1H, d, J=3.2 Hz), 8.83 (1H, d, J=2.2 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.47 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.22 (2H, s), 6.76-6.84 (4H, m), 6.92-6.97 (2H, m), 7.23-7.28 (6H, m), 7.36-7.40 (2H, m), 7.60 (1H, d, J=15.4 Hz), 7.86 (1H, d, J=2.9 Hz), 8.83-8.84 (1H, m).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.12 (6H, s), 2.47 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.65-3.74 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.22 (2H, s), 6.77-6.85 (4H, m), 7.11-7.15 (2H, m), 7.23-7.28 (6H, m), 7.36-7.41 (2H, m), 7.61 (1H, d, J=15.4 Hz), 7.86 (1H, dd, J=3.2, 2.7 Hz), 8.83 (1H, d, J=2.0 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.28 (3H, s), 2.37 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.09 (2H, t, J=7.4 Hz), 3.49 (2H, s), 3.66 (2H, brs), 3.75 (2H, brs), 3.81 (3H, s), 4.11 (2H, t, J=7.4 Hz), 4.95 (2H, s), 6.76-6.82 (4H, m), 6.91 (2H, dt, J=9.1, 2.4 Hz), 7.06-7.13 (4H, m), 7.18 (1H, d, J=7.6 Hz), 7.25-7.26 (2H, m), 7.30-7.34 (3H, m), 7.61 (1H, d, J=15.1 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.37 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.09 (2H, t, J=7.3 Hz), 3.65 (2H, brs), 3.75 (2H, brs), 4.10 (2H, t, J=7.3 Hz), 5.09 (2H, s), 6.76-6.85 (4H, m), 6.93-6.98 (2H, m), 7.10-7.13 (2H, m), 7.18 (1H, d, J=7.6 Hz), 7.25-7.26 (4H, m), 7.33 (1H, dd, J=8.9, 3.1 Hz), 7.52 (2H, d, J=8.5 Hz), 7.61 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.5 Hz), 7.79 (1H, d, J=3.1 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.28 (3H, s), 2.47-2.49 (4H, m), 3.06-3.09 (2H, m), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.11-4.16 (2H, m), 5.00 (2H, s), 6.51 (1H, t, J=73.8 Hz), 6.80 (1H, d, J=15.3 Hz), 6.80 (2H, d, J=8.3 Hz), 6.93 (1H, d, J=8.8 Hz), 7.07 (2H, d, J=8.3 Hz), 7.14 (2H, d, J=8.3 Hz), 7.26 (4H, brs), 7.28 (1H, brs), 7.36 (1H, dd, J=8.8, 2.9 Hz), 7.40 (2H, d, J=8.3 Hz), 7.45 (1H, brs), 7.56 (1H, d, J=15.3 Hz), 7.78 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.29 (3H, d, J=6.1 Hz), 2.12 (6H, s), 2.46 (4H, t, J=4.9 Hz), 2.81 (1H, dd, J=13.7, 6.3 Hz), 3.05 (1H, dd, J=13.7, 6.1 Hz), 3.51 (2H, s), 3.64-3.74 (4H, m), 3.81 (3H, s), 4.43-4.51 (1H, m), 4.95 (2H, s), 6.76-6.82 (4H, m), 6.90-6.96 (4H, m), 7.19 (2H, d, J=8.1 Hz), 7.24-7.26 (4H, m), 7.30-7.34 (3H, m), 7.61 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.29 (3H, d, J=6.1 Hz), 2.12 (6H, s), 2.47 (4H, t, J=5.0 Hz), 2.81 (1H, dd, J=13.7, 6.3 Hz), 3.05 (1H, dd, J=13.7, 6.1 Hz), 3.51 (2H, s), 3.65 (2H, brs), 3.74 (2H, brs), 4.43-4.51 (1H, m), 4.98 (2H, s), 6.76-6.82 (4H, m), 6.91-6.95 (2H, m), 7.05-7.09 (2H, m), 7.19 (2H, d, J=8.1 Hz), 7.24-7.26 (4H, m), 7.32 (1H, dd, J=8.9, 3.1 Hz), 7.36-7.40 (2H, m), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.1 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.28 (3H, s), 2.36 (3H, s), 2.47 (4H, t, J=5.0 Hz), 3.04 (2H, t, J=7.2 Hz), 3.47 (2H, s), 3.63 (2H, brs), 3.71 (2H, brs), 4.14 (2H, t, J=7.2 Hz), 4.99 (2H, s), 6.79 (1H, d, J=15.6 Hz), 6.79-6.82 (2H, m), 7.05-7.09 (5H, m), 7.19 (1H, d, J=7.3 Hz), 7.25-7.26 (4H, m), 7.32 (1H, dd, J=8.9, 3.1 Hz), 7.36-7.39 (2H, m), 7.61 (1H, d, J=15.6 Hz), 7.81 (1H, d, J=3.1 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.28 (3H, s), 2.37 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.04 (2H, t, J=7.3 Hz), 3.47 (2H, s), 3.63 (2H, brs), 3.71 (2H, brs), 3.81 (3H, s), 4.14 (2H, t, J=7.3 Hz), 4.95 (2H, s), 6.77-6.82 (3H, m), 6.91 (2H, dt, J=9.3, 2.4 Hz), 7.06-7.09 (3H, m), 7.19 (1H, d, J=7.6 Hz), 7.25-7.26 (4H, m), 7.30-7.34 (3H, m), 7.61 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.74-1.76 (1H, m), 2.19 (3H, s), 2.47-2.49 (4H, m), 2.80 (2H, t, J=6.5 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.65 (2H, m), 3.73-3.75 (2H, m), 3.81 (2H, t, J=6.5 Hz), 4.15 (2H, t, J=7.1 Hz), 5.09 (2H, s), 6.80-6.84 (3H, m), 6.95 (1H, d, J=8.8 Hz), 7.13 (2H, d, J=8.3 Hz), 7.25-7.27 (5H, m), 7.36-7.38 (1H, m), 7.45-7.58 (4H, m), 7.68 (2H, d, J=8.1 Hz), 7.76 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.09 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.58 (2H, t, J=7.1 Hz), 5.09 (2H, s), 6.79 (1H, d, J=5.1 Hz), 6.82 (1H, d, J=1.5 Hz), 6.96 (1H, dd, J=9.0, 0.5 Hz), 7.24-7.29 (5H, m), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.51-7.59 (3H, m), 7.68 (2H, dt, J=8.2, 1.7 Hz), 7.74-7.77 (2H, m), 8.42-8.43 (1H, m).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.47-2.48 (4H, m), 3.11 (2H, t, J=7.0 Hz), 3.51 (2H, s), 3.65-3.67 (2H, m), 3.73-3.76 (2H, m), 4.15 (2H, t, J=7.0 Hz), 5.09 (2H, s), 6.79-6.82 (4H, m), 7.04-7.07 (2H, m), 7.21-7.25 (5H, m), 7.33 (1H, dd, J=8.9, 3.1 Hz), 7.52 (2H, d, J=8.1 Hz), 7.61 (1H, d, J=15.1 Hz), 7.68 (2H, d, J=8.1 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.51-2.53 (4H, m), 3.10 (2H, t, J=6.7 Hz), 3.61 (2H, s), 3.65-3.67 (2H, m), 3.73-3.76 (2H, m), 4.21 (2H, t, J=6.7 Hz), 5.09 (2H, s), 6.78-6.83 (2H, m), 6.96-7.03 (4H, m), 7.27-7.32 (4H, m), 7.52-7.53 (4H, m), 7.60 (1H, d, J=15.1 Hz), 7.67 (2H, d, J=8.1 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.10 (3H, d, J=1.5 Hz), 2.18 (3H, s), 2.28 (3H, s), 2.36 (3H, s), 2.45 (4H, brs), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.54-3.75 (4H, brs), 4.14 (2H, t, J=7.1 Hz), 4.99 (2H, s), 6.41 (1H, d, J=1.5 Hz), 6.77-6.93 (2H, m), 6.90 (1H, dd, J=9.0, 0.5 Hz), 7.02-7.11 (3H, m), 7.18 (2H, d, J=7.6 Hz), 7.22-7.31 (7H, m), 7.35 (1H, dd, J=9.0, 2.9 Hz), 7.80 (1H, dd, J=2.9, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.22 (3H, d, J=1.2 Hz), 2.36 (3H, s), 2.44 (4H, dt, J=17.3, 4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.53 (2H, t, J=4.9 Hz), 3.72 (2H, t, J=4.9 Hz), 4.15 (2H, t, J=7.1 Hz), 4.99 (2H, s), 6.23 (1H, d, J=1.0 Hz), 6.80-6.88 (2H, m), 6.91 (1H, dd, J=8.8, 0.5 Hz), 7.09-7.15 (2H, m), 7.18 (2H, d, J=7.8 Hz), 7.22-7.31 (7H, m), 7.32-7.39 (2H, m), 7.80 (1H, d, J=2.4 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.22 (3H, d, J=1.2 Hz), 2.28 (3H, s), 2.36 (3H, s), 2.44 (4H, dt, J=17.1, 4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.53 (2H, t, J=4.9 Hz), 3.72 (2H, t, J=4.9 Hz), 4.14 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.23 (1H, d, J=1.2 Hz), 6.76-6.82 (2H, m), 6.91 (1H, dd, J=8.8, 0.5 Hz), 7.04-7.09 (2H, m), 7.18 (2H, d, J=7.8 Hz), 7.21-7.31 (7H, m), 7.33-7.39 (2H, m), 7.80 (1H, dd, J=2.9, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.22 (3H, d, J=1.2 Hz), 2.36 (3H, s), 2.44 (4H, dt, J=16.7, 4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.53 (2H, t, J=4.9 Hz), 3.72 (2H, t, J=4.9 Hz), 4.13 (2H, t, J=7.1 Hz), 4.99 (2H, s), 6.23 (1H, d, J=1.0 Hz), 6.79-6.87 (2H, m), 6.89-7.01 (3H, m), 7.16-7.31 (9H, m), 7.32-7.39 (2H, m), 7.80 (1H, dd, J=2.9, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.32 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.599-3.80 (4H, m), 4.16 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.67-6.84 (4H, m), 6.97 (1H, dd, J=8.8, 0.5 Hz), 7.12-7.18 (2H, m), 7.24-7.32 (6H, m), 7.36-7.42 (3H, m), 7.48-7.55 (1H, m), 7.58-7.63 (2H, m), 7.87 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.59-3.80 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.78-6.86 (3H, m), 6.91-7.00 (3H, m), 7.15 (1H, d, J=8.3 Hz), 7.22-7.34 (6H, m), 7.36-7.43 (3H, m), 7.48-7.55 (1H, m), 7.56-7.63 (2H, m), 7.87 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=7.1 Hz), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.77-6.88 (3H, m), 6.97 (1H, d, J=8.5 Hz), 7.10-7.18 (3H, m), 7.23-7.33 (6H, m), 7.37-7.44 (3H, m), 7.49-7.56 (1H, m), 7.66-7.64 (2H, m), 7.87 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.28 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.16 (2H, s), 6.77-6.84 (3H, m), 6.97 (1H, d, J=9.0 Hz), 7.04-7.10 (2H, m), 7.15 (1H, d, J=8.5 Hz), 7.23-7.33 (6H, m), 7.37-7.43 (3H, m), 7.48-7.55 (1H, m), 7.56-7.64 (2H, m), 7.88 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.40 (3H, t, J=7.1 Hz), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.00 (2H, q, J=7.1 Hz), 4.14 (2H, q, J=7.7 Hz), 5.14 (2H, s), 6.43-6.52 (3H, m), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=8.8 Hz), 7.10-7.60 (13H, m), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.09-2.13 (3H, m), 2.18 (3H, s), 2.36 (3H, s), 2.45 (4H, brs), 3.07 (2H, t, J=6.8 Hz), 3.52 (2H, s), 3.62 (4H, brs), 4.13 (2H, q, J=7.1 Hz), 4.99 (2H, s), 6.41 (1H, brs), 6.79-6.86 (2H, m), 6.88-6.99 (3H, m), 7.09 (1H, s), 7.19 (2H, d, J=7.8 Hz), 7.24-7.32 (7H, m), 7.32-7.38 (1H, m), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.10 (3H, d, J=1.7 Hz), 2.18 (3H, s), 2.45 (4H, brs), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.61 (4H, brs), 4.15 (2H, t, J=7.3 Hz), 5.14 (2H, s), 6.39-6.43 (1H, m), 6.80-6.86 (2H, m), 6.93 (1H, dd, J=9.0, 0.5 Hz), 7.06-7.15 (3H, m), 7.24-7.32 (7H, m), 7.37-7.42 (2H, m), 7.49-7.55 (1H, m), 7.83 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.11 (3H, d, J=1.7 Hz), 2.18 (3H, s), 2.45 (4H, brs), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.62 (4H, brs), 4.13 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.39-6.43 (1H, m), 6.79-6.86 (2H, m), 6.91-7.00 (3H, m), 7.08-7.11 (1H, m), 7.24-7.32 (7H, m), 7.36-7.42 (2H, m), 7.49-7.55 (1H, m), 7.83 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.10 (3H, d, J=1.5 Hz), 2.18 (3H, s), 2.28 (3H, s), 2.45 (4H, brs), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.62 (4H, brs), 4.14 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.39-6.43 (1H, m), 6.77-6.83 (2H, m), 6.93 (1H, d, J=9.0 Hz), 7.03-7.12 (3H, m), 7.24-7.32 (7H, m), 7.36-7.42 (2H, m), 7.49-7.56 (1H, m), 7.83 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.10 (3H, d, J=1.5 Hz), 2.18 (3H, s), 2.28 (3H, s), 2.45 (4H, brs), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.62 (4H, brs), 4.14 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.39-6.43 (1H, m), 6.77-6.83 (2H, m), 6.93 (1H, d, J=9.0 Hz), 7.03-7.12 (3H, m), 7.24-7.32 (7H, m), 7.36-7.42 (2H, m), 7.49-7.56 (1H, m), 7.83 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.80 (3H, d, J=1.5 Hz), 1.95 (3H, d, J=1.5 Hz), 2.17 (3H, s), 2.28 (3H, s), 2.36 (3H, s), 2.40-2.55 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.49-3.54 (4H, m), 3.73 (2H, brs), 4.14 (2H, t, J=7.1 Hz), 4.99 (2H, s), 6.76-6.82 (2H, m), 6.88 (1H, dd, J=8.8, 0.5 Hz), 6.96-6.99 (1H, m), 7.00-7.08 (2H, m), 7.10 (1H, d, J=1.7 Hz), 7.15-7.32 (8H, m), 7.35 (1H, dd, J=8.8, 2.9 Hz), 7.81 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.80 (3H, d, J=1.5 Hz), 1.95 (3H, d, J=1.5 Hz), 2.17 (3H, s), 2.36 (3H, s), 2.40-2.56 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.49-3.55 (4H, m), 3.73 (2H, brs), 4.13 (2H, t, J=7.1 Hz), 4.99 (2H, s), 6.79-6.86 (2H, m), 6.88 (1H, dd, J=8.8, 0.5 Hz), 6.91-7.00 (3H, m), 7.10 (1H, d, J=1.5 Hz), 7.19 (2H, d, J=7.8 Hz), 7.24-7.32 (6H, m), 7.35 (1H, dd, J=8.8, 3.2 Hz), 7.81 (1H, dd, J=2.9, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.80 (3H, d, J=1.5 Hz), 1.96 (3H, d, J=1.5 Hz), 2.18 (3H, s), 2.40-2.55 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.49-3.55 (4H, m), 3.73 (2H, brs), 4.13 (2H, t, J=7.1 Hz), 5.15 (2H, s), 6.79-6.86 (2H, m), 6.89-7.00 (4H, m), 7.11 (1H, d, J=2.0 Hz), 7.24-7.32 (6H, m), 7.36-7.43 (2H, m), 7.49-7.55 (1H, m), 7.84 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 1.80 (3H, d, J=1.5 Hz), 1.96 (3H, d, J=1.5 Hz), 2.17 (3H, s), 2.38-2.56 (4H, m), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.49-3.55 (4H, m), 3.74 (2H, brs), 4.15 (2H, t, J=7.1 Hz), 5.15 (2H, s), 6.80-6.87 (2H, m), 6.91 (1H, d, J=8.8 Hz), 6.98 (1H, d, J=1.5 Hz), 7.09-7.16 (3H, m), 7.24-7.32 (6H, m), 7.35-7.43 (2H, m), 7.49-7.55 (1H, m), 7.84 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.80 (3H, d, J=1.5 Hz), 1.95 (3H, d, J=1.5 Hz), 2.18 (3H, s), 2.28 (3H, s), 2.38-2.55 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.49-3.55 (4H, m), 3.73 (2H, brs), 4.14 (2H, t, J=7.1 Hz), 5.25 (2H, s), 6.78-6.82 (2H, m), 6.91 (1H, d, J=8.8 Hz), 6.96-6.99 (1H, m), 7.03-7.09 (2H, m), 7.10 (1H, d, J=2.0 Hz), 7.24-7.32 (6H, m), 7.35-7.43 (2H, m), 7.49-7.55 (1H, m), 7.84 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.22 (3H, d, J=1.0 Hz), 2.28 (3H, s), 2.44 (4H, dt, J=17.3, 4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.49-3.56 (4H, m), 3.66-3.76 (2H, m), 4.14 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.24 (1H, d, J=1.0 Hz), 6.76-6.82 (2H, m), 6.94 (1H, d, J=9.0 Hz), 7.06 (2H, d, J=8.3 Hz), 7.23-7.32 (7H, m), 7.34-7.42 (3H, m), 7.49-7.55 (1H, m), 7.82 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.22 (3H, d, J=0.7 Hz), 2.44 (4H, dt, J=16.8, 5.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.49-3.56 (4H, m), 3.66-3.77 (2H, m), 4.14 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.24 (1H, s), 6.79-6.85 (2H, m), 6.94 (1H, d, J=9.0 Hz), 7.20-7.32 (9H, m), 7.34-7.42 (3H, m), 7.50-7.55 (1H, m), 7.82 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.22 (3H, d, J=1.0 Hz), 2.44 (41, dt, J=16.6, 4.5 Hz), 3.08 (2H, t, J=7.1 Hz), 3.49-3.57 (4H, m), 3.68-3.76 (2H, m), 4.13 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.24 (1H, d, J=1.2 Hz), 6.80-6.87 (2H, m), 6.91-7.00 (3H, m), 7.20-7.32 (7H, m), 7.34-7.42 (3H, m), 7.49-7.54 (1H, m), 7.82 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.22 (3H, d, J=1.0 Hz), 2.44 (4H, dt, J=16.4, 4.6 Hz), 3.07 (2H, t, J=7.1 Hz), 3.49-3.57 (4H, m), 3.68-3.74 (2H, m), 3.76 (3H, s), 4.12 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.24 (1H, s), 6.79-6.87 (4H, m), 6.94 (1H, d, J=8.8 Hz), 7.34-7.43 (7H, m), 7.34-7.42 (3H, m), 7.49-7.55 (1H, m), 7.82 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.22 (3H, d, J=1.0 Hz), 2.40-2.50 (4H, m), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.49-3.56 (4H, m), 3.68-3.75 (2H, m), 4.15 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.23 (1H, d, J=1.2 Hz), 6.80-6.86 (2H, m), 6.94 (1H, d, J=9.0 Hz), 7.10-7.16 (2H, m), 7.20-7.32 (7H, m), 7.34-7.42 (3H, m), 7.49-7.54 (1H, m), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.77-6.86 (3H, m), 6.90-7.00 (3H, m), 7.02-7.10 (2H, m), 7.15 (1H, d, J=8.5 Hz), 7.22-7.32 (4H, m), 7.32-7.42 (4H, m), 7.56-7.63 (2H, m), 7.84 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.77-6.87 (3H, m), 6.95 (1H, d, J=8.8 Hz), 7.03-7.17 (5H, m), 7.22-7.29 (4H, m), 7.34-7.42 (4H, m), 7.56-7.63 (2H, m), 7.84 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.28 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.76-6.84 (3H, m), 6.95 (1H, dd, J=9.0, 0.5 Hz), 7.03-7.11 (4H, m), 7.15 (1H, d, J=8.3 Hz), 7.22-7.30 (4H, m), 7.33-7.42 (4H, m), 7.56-7.62 (2H, m), 7.84 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.39 (3H, t, J=7.1 Hz), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.00 (2H, q, J=7.1 Hz), 4.15 (2H, t, J=7.1 Hz), 5.11 (2H, s), 6.44-6.51 (3H, m), 6.80 (1H, d, J=15.4 Hz), 6.97 (1H, dd, J=8.8, 0.5 Hz), 7.11-7.18 (2H, m), 7.22-7.30 (4H, m), 7.34-7.42 (2H, m), 7.49-7.55 (2H, m), 7.56-7.62 (2H, m), 7.67-7.71 (2H, m), 7.82 (1H, dd, J=2.9, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.48 (4H, t, J=4.9 Hz), 3.09 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 3.78 (3H, s), 4.16 (2H, t, J=7.1 Hz), 5.11 (2H, s), 6.45-6.53 (3H, m), 6.80 (1H, d, J=15.4 Hz), 6.97 (1H, dd, J=9.0, 0.5 Hz), 7.13-7.20 (2H, m), 7.22-7.30 (4H, m), 7.34-7.42 (2H, m), 7.50-7.55 (2H, m), 7.56-7.62 (2H, m), 7.64-7.72 (2H, m), 7.82 (1H, dd, J=2.9, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.40 (3H, t, J=7.1 Hz), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.00 (2H, q, J=7.1 Hz), 4.15 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.44-6.51 (3H, m), 6.80 (1H, d, J=15.4 Hz), 6.95 (1H, d, J=8.8 Hz), 7.02-7.11 (2H, m), 7.11-7.18 (2H, m), 7.22-7.30 (4H, m), 7.33-7.42 (4H, m), 7.56-7.63 (2H, m), 7.84 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.40 (3H, t, J=7.1 Hz), 2.11 (6H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.00 (2H, q, J=7.1 Hz), 4.15 (2H, t, J=7.1 Hz), 5.25 (2H, d, J=0.7 Hz), 6.44-6.51 (3H, m), 6.78 (1H, d, J=15.4 Hz), 6.83 (1H, d, J=9.0 Hz), 7.15 (1H, t, J=8.1 Hz), 7.23-7.29 (6H, m), 7.33 (1H, dd, J=9.0, 3.2 Hz), 7.60 (1H, d, J=15.4 Hz), 7.83 (1H, d, J=2.9 Hz), 7.87 (1H, d, J=0.7 Hz), 8.83 (1H, d, J=0.5 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.8 Hz), 2.11 (6H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 2.60-3.80 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.25 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.81-6.86 (3H, m), 7.10-7.16 (2H, m), 7.23-7.30 (6H, m), 7.33 (1H, dd, J=9.0, 3.2 Hz), 7.60 (1H, d, J=15.4 Hz), 7.83 (1H, d, J=3.2 Hz), 7.87 (1H, s), 8.83 (1H, s).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.28 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.25 (2H, d, J=0.7 Hz), 6.75-6.85 (4H, m), 7.04-7.10 (2H, m), 7.24-7.30 (6H, m), 7.33 (1H, dd, J=9.0, 3.2 Hz), 7.60 (1H, d, J=15.4 Hz), 7.83 (1H, d, J=2.7 Hz), 7.87 (1H, d, J=0.7 Hz), 8.83 (1H, d, J=0.5 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.25 (2H, d, J=0.7 Hz), 6.78 (1H, d, J=15.4 Hz), 6.81-6.86 (3H, m), 6.92-6.99 (2H, m), 7.22-7.30 (6H, m), 7.33 (1H, dd, J=9.0, 3.2 Hz), 7.60 (1H, d, J=15.4 Hz), 7.80-7.85 (1H, m), 7.87 (1H, d, J=0.7 Hz), 8.83 (1H, d, J=0.7 Hz).
1H-NMR (CDCl3) δ: 1.29 (6H, d, J=5.9 Hz), 2.11 (6H, s), 2.48 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.12 (2H, t, J=7.1 Hz), 4.41 (1H, septet, J=5.9 Hz), 5.25 (2H, d, J=0.7 Hz), 6.78 (1H, d, J=15.4 Hz), 6.81-6.85 (5H, m), 7.24-7.30 (6H, m), 7.33 (1H, dd, J=9.0, 3.2 Hz), 7.60 (1H, d, J=15.4 Hz), 7.83 (1H, d, J=3.2 Hz), 7.87 (1H, d, J=0.7 Hz), 8.83 (1H, d, J=0.5 Hz).
mp: 132.9-133.6° C.
1H-NMR (CDCl3) δ: 2.07-2.11 (2H, m), 2.18 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.80 (2H, t, J=7.3 Hz), 3.51 (2H, s), 3.64-3.74 (4H, m), 3.92 (2H, t, J=6.4 Hz), 4.98 (2H, s), 6.77-6.85 (3H, m), 6.90-6.99 (3H, m), 7.16-7.20 (4H, m), 7.23-7.30 (5H, m), 7.34-7.37 (1H, m), 7.45 (1H, d, J=2.2 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79-7.80 (1H, m).
mp: 108.6-109.2° C.
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.07-2.11 (2H, m), 2.18 (3H, s), 2.35 (3H, s), 2.47 (4H, t, J=4.9 Hz), 2.80 (2H, t, J=7.6 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.51 (2H, s), 3.64-3.74 (4H, m), 3.95 (2H, t, J=6.4 Hz), 4.98 (2H, s), 6.77-6.85 (3H, m), 6.91 (1H, d, J=9.0 Hz), 7.11-7.15 (2H, m), 7.17-7.20 (4H, m), 7.23-7.30 (5H, m), 7.35 (1H, dd, J=9.0, 2.9 Hz), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
mp: 110.6-112.3° C.
1H-NMR (CDCl3) δ: 2.07-2.11 (2H, m), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.80 (2H, t, J=7.3 Hz), 3.51 (2H, s), 3.64-3.74 (4H, m), 3.92 (2H, t, J=6.4 Hz), 5.14 (2H, s), 6.78-6.85 (3H, m), 6.93-6.99 (3H, m), 7.17 (2H, d, J=8.3 Hz), 7.23-7.32 (5H, m), 7.37-7.41 (2H, m), 7.45 (1H, d, J=2.0 Hz), 7.50-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81-7.82 (1H, m).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.07-2.11 (2H, m), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.80 (2H, t, J=7.6 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.51 (2H, s), 3.64-3.74 (4H, m), 3.95 (2H, t, J=6.4 Hz), 5.14 (2H, s), 6.78-6.85 (3H, m), 6.94 (1H, d, J=9.0 Hz), 7.13 (2H, d, J=8.8 Hz), 7.18 (2H, d, J=7.8 Hz), 7.23-7.31 (5H, m), 7.37-7.40 (2H, m), 7.45 (1H, d, J=2.0 Hz), 7.50-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (2H, tt, J=6.9, 6.9 Hz), 2.19 (3H, s), 2.48 (4H, t, J=4.8 Hz), 2.81 (2H, t, J=6.9 Hz), 3.51 (2H, s), 3.64-3.74 (4H, m), 3.97 (2H, t, J=6.9 Hz), 5.09 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.89-6.96 (4H, m), 7.18 (2H, d, J=7.8 Hz), 7.23-7.30 (5H, m), 7.37 (1H, ddd, J=8.9, 3.1, 1.0 Hz), 7.45 (1H, s), 7.51-7.58 (3H, m), 7.68 (2H, d, J=7.8 Hz), 7.76 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.06-2.13 (2H, m), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.80 (2H, t, J=7.6 Hz), 3.52 (2H, s), 3.65-3.75 (4H, m), 3.93 (2H, t, J=6.2 Hz), 5.10 (2H, s), 6.78-6.85 (3H, m), 6.93-7.00 (3H, m), 7.18 (2H, d, J=8.2 Hz), 7.25 (2H, d, J=8.2 Hz), 7.29 (1H, d, J=2.0 Hz), 7.37 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, d, J=2.2 Hz), 7.52 (2H, dd, J=7.9, 0.6 Hz), 7.57 (1H, d, J=15.4 Hz), 7.69 (2H, dt, J=8.2, 1.7 Hz), 7.77 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.09-2.16 (2H, m), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.81 (2H, t, J=7.6 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 3.99 (2H, t, J=6.2 Hz), 5.09 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.95 (1H, d, J=8.8 Hz), 7.15-7.18 (3H, m), 7.21-7.26 (3H, m), 7.29 (1H, d, J=1.5 Hz), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.52 (2H, d, J=8.3 Hz), 7.57 (1H, d, J=15.4 Hz), 7.67-7.69 (2H, m), 7.76 (1H, d, J=3.2 Hz), 8.03 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.07-2.14 (2H, m), 2.19 (3H, s), 2.47-2.49 (7H, m), 2.81 (2H, t, J=7.6 Hz), 3.51 (2H, s), 3.64-3.74 (4H, m), 3.98 (2H, t, J=6.2 Hz), 5.09 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.95 (1H, dd, J=8.9, 0.6 Hz), 7.05 (1H, d, J=8.3 Hz), 7.09 (1H, dd, J=8.5, 2.9 Hz), 7.17 (2H, d, J=8.1 Hz), 7.24 (2H, d, J=8.3 Hz), 7.29 (1H, t, J=1.1 Hz), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.51-7.59 (3H, m), 7.68 (2H, dt, J=8.2, 1.8 Hz), 7.76 (1H, dd, J=3.2, 0.5 Hz), 8.18 (1H, dd, J=2.9, 0.7 Hz).
1H-NMR (CDCl3) δ: 2.05-2.12 (2H, m), 2.19 (3H, s), 2.28 (3H, s), 2.48 (4H, t, J=5.0 Hz), 2.80 (2H, t, J=7.6 Hz), 3.51 (2H, s), 3.64-3.74 (4H, m), 3.94 (2H, t, J=6.2 Hz), 5.09 (2H, s), 6.78-6.82 (3H, m), 6.95 (1H, d, J=9.0 Hz), 7.07 (2H, d, J=8.4 Hz), 7.18 (2H, d, J=8.1 Hz), 7.24 (2H, d, J=8.1 Hz), 7.29 (1H, d, J=1.7 Hz), 7.37 (1H, dd, J=8.9, 3.2 Hz), 7.45 (1H, d, J=2.0 Hz), 7.51-7.58 (3H, m), 7.68 (2H, dt, J=8.4, 1.7 Hz), 7.77 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.22 (3H, s), 1.23 (3H, s), 2.06-2.13 (2H, m), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.78-2.91 (3H, m), 3.51 (2H, s), 3.64-3.74 (4H, m), 3.95 (2H, t, J=6.3 Hz), 5.09 (2H, s), 6.78-6.85 (3H, m), 6.95 (1H, dd, J=9.0, 0.5 Hz), 7.13 (2H, dt, J=9.4, 2.4 Hz), 7.18 (2H, d, J=8.1 Hz), 7.24 (2H, d, J=8.1 Hz), 7.29 (1H, d, J=2.0 Hz), 7.37 (1H, dd, J=9.0, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.51-7.59 (3H, m), 7.68 (2H, dt, J=8.3, 1.7 Hz), 7.77 (1H, dd, J=3.1, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.36-1.49 (2H, m), 2.10-2.21 (5H, m), 2.28 (3H, s), 2.36 (3H, s), 2.93-3.07 (3H, m), 3.22-3.60 (3H, m), 4.00-4.11 (3H, m), 4.50-4.64 (1H, m), 4.98 (2H, s), 6.56-6.62 (2H, m), 6.76-6.82 (2H, m), 6.83 (1H, d, J=15.4 Hz), 6.92 (1H, dd, J=9.0, 0.5 Hz), 7.20-7.12 (4H, m), 7.18 (2H, d, J=7.8 Hz), 7.24-7.31 (3H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.46 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.1 Hz), 7.79 (1H, dd, J=2.9, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.34-1.48 (2H, m), 2.10-2.20 (5H, m), 2.35 (3H, s), 2.92-3.07 (3H, m), 3.20-3.39 (1H, m), 3.42-3.60 (2H, m), 4.00-4.11 (3H, m), 4.48-4.64 (1H, m), 4.98 (2H, s), 6.56-6.62 (2H, m), 6.78-6.88 (3H, m), 6.90-6.99 (3H, m), 7.06-7.12 (2H, m), 7.18 (2H, d, J=7.8 Hz), 7.26-7.31 (3H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.46 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, dd, J=2.4, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.20 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.35 (3H, s), 2.49 (4H, t, J=4.9 Hz), 2.80 (1H, septet, J=6.8 Hz), 2.90 (2H, t, J=7.1 Hz), 3.38 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.82 (5H, m), 4.98 (2H, s), 6.54-6.60 (2H, m), 6.79 (1H, d, J=15.4 Hz), 6.91 (1H, dd, J=8.8, 0.5 Hz), 7.01-7.08 (2H, m), 7.16-7.22 (4H, m), 7.25-7.30 (5H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.20 (6H, d, J=7.1 Hz), 2.19 (3H, s), 2.49 (4H, t, J=4.9 Hz), 2.80 (1H, septet, J=7.1 Hz), 2.91 (2H, t, J=7.1 Hz), 3.38 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.52-3.80 (5H, m), 5.14 (2H, s), 6.54-6.60 (2H, m), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, dd, J=8.8, 0.5 Hz), 7.01-7.08 (2H, m), 7.16-7.22 (2H, m), 7.22-7.32 (5H, m), 7.36-7.42 (2H, m), 7.45 (1H, d, J=2.0 Hz), 7.48-7.54 (1H, m), 7.56 (1H, d, J=15.4 Hz), 7.81 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.19 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.76-2.90 (6H, m), 3.49-3.56 (4H, m), 3.60-3.80 (4H, m), 4.98 (2H, s), 6.66-6.72 (2H, m), 6.79 (1H, d, J=15.4 Hz), 6.91 (1H, dd, J=9.0, 0.5 Hz), 7.08-7.14 (2H, m), 7.15-7.21 (4H, m), 7.24-7.32 (5H, m), 7.35 (1H, dd, J=8.8, 3.2 Hz), 7.45 (1H, d, J=2.2 Hz), 7.56 (1H, d, J=15.4 Hz), 7.78 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47 (4H, t, J=4.9 Hz), 2.78-2.90 (5H, m), 3.48-3.55 (4H, m), 3.60-3.80 (4H, m), 5.14 (2H, s), 6.60-6.67 (2H, m), 6.80 (1H, d, J=15.4 Hz), 6.90-6.98 (3H, m), 7.15 (2H, d, J=8.1 Hz), 7.22-7.31 (5H, m), 7.36-7.42 (2H, m), 7.45 (1H, d, J=2.0 Hz), 7.49-7.55 (1H, m), 7.56 (1H, d, J=15.1 Hz), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.49 (4H, t, J=4.9 Hz), 2.90 (2H, t, J=7.1 Hz), 3.36 (2H, t, J=7.1 Hz), 3.50-3.80 (7H, m), 5.14 (2H, s), 6.51-6.56 (2H, m), 6.79 (1H, d, J=15.4 Hz), 6.85-6.91 (2H, m), 6.94 (1H, d, J=9.0 Hz), 7.18 (2H, d, J=8.1 Hz), 7.24-7.31 (5H, m), 7.35-7.41 (2H, m), 7.45 (1H, d, J=1.7 Hz), 7.49-7.54 (1H, m), 7.56 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.47 (4H, t, J=4.9 Hz), 2.78-2.90 (5H, m), 3.47-3.55 (4H, m), 3.60-3.80 (4H, m), 4.98 (2H, s), 6.60-6.66 (2H, m), 6.79 (1H, d, J=15.4 Hz), 6.88-6.98 (3H, m), 7.12-7.21 (4H, m), 7.20-7.32 (5H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.35 (3H, s), 2.49 (4H, t, J=4.9 Hz), 2.90 (2H, t, J=6.8 Hz), 3.36 (2H, t, J=6.8 Hz), 3.50-3.80 (7H, m), 4.98 (2H, s), 6.50-6.58 (2H, m), 6.79 (1H, d, J=15.4 Hz), 6.84-6.94 (3H, m), 7.18 (4H, d, J=7.8 Hz), 7.24-7.31 (5H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, d, J=1.7 Hz), 7.56 (1H, d, J=15.1 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.49 (4H, t, J=4.9 Hz), 2.90 (2H, t, J=6.8 Hz), 3.36 (2H, t, J=7.1 Hz), 3.49-3.80 (7H, m), 5.01 (2H, s), 6.50-6.58 (2H, m), 6.80 (1H, d, J=15.4 Hz), 6.84-6.92 (2H, m), 6.95 (1H, dd, J=8.8, 0.5 Hz), 7.04-7.11 (2H, m), 7.15 (1H, d, J=8.3 Hz), 7.18 (2H, d, J=8.1 Hz), 7.24-7.30 (2H, m), 7.33-7.42 (4H, m), 7.56-7.63 (2H, m), 7.84 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.49 (4H, t, J=4.9 Hz), 2.90 (2H, t, J=6.8 Hz), 3.36 (2H, t, J=7.1 Hz), 3.49-3.80 (7H, m), 5.11 (2H, s), 6.50-6.57 (2H, m), 6.80 (1H, d, J=15.4 Hz), 6.85-6.92 (2H, m), 6.97 (1H, dd, J=8.8, 0.5 Hz), 7.12-7.21 (3H, m), 7.24-7.30 (2H, m), 7.33-7.43 (2H, m), 7.49-7.55 (2H, m), 7.57-7.62 (2H, m), 7.66-7.71 (2H, m), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.49 (4H, t, J=4.9 Hz), 2.90 (2H, t, J=6.8 Hz), 3.36 (2H, t, J=7.1 Hz), 3.43 (1H, brs), 3.52 (2H, s), 3.60-3.80 (7H, m), 5.11 (2H, s), 6.55-6.61 (2H, m), 6.75-6.84 (3H, m), 6.97 (1H, d, J=8.8 Hz), 7.15 (1H, d, J=8.3 Hz), 7.18 (2H, d, J=8.1 Hz), 7.24-7.30 (2H, m), 7.35-7.42 (2H, m), 7.52 (2H, d, J=15.6 Hz), 7.55-7.63 (2H, m), 7.66-7.71 (2H, m), 7.82 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.49 (4H, t, J=4.9 Hz), 2.90 (2H, t, J=6.8 Hz), 3.36 (2H, t, J=7.1 Hz), 3.40-3.60 (3H, m), 3.60-3.80 (7H, m), 5.01 (2H, s), 6.56-6.62 (2H, m), 6.75-6.84 (3H, m), 6.95 (1H, d, J=9.0 Hz), 7.04-7.11 (2H, m), 7.15 (1H, d, J=8.5 Hz), 7.18 (2H, d, J=8.1 Hz), 7.24-7.30 (2H, m), 7.33-7.42 (4H, m), 7.56-7.63 (2H, m), 7.84 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.49 (4H, t, J=4.9 Hz), 2.90 (2H, t, J=6.8 Hz), 3.36 (2H, t, J=7.1 Hz), 3.40-3.50 (3H, m), 3.60-3.80 (7H, m), 4.98 (2H, s), 6.56-6.61 (2H, m), 6.76-6.82 (3H, m), 6.91 (1H, d, J=8.8 Hz), 7.18 (4H, d, J=8.1 Hz), 7.24-7.31 (5H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, d, J=2.2 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.20 (6H, d, J=6.8 Hz), 1.32-1.48 (2H, m), 2.10-2.22 (5H, m), 2.35 (3H, s), 2.75-2.85 (3H, m), 2.90-3.10 (1H, m), 3.22-3.38 (3H, m), 3.41-3.60 (3H, m), 4.00-4.11 (1H, m), 4.49-4.67 (1H, m), 4.98 (2H, s), 6.53-6.62 (4H, m), 6.84 (1H, d, J=15.4 Hz), 6.92 (1H, d, J=8.8 Hz), 7.01-7.08 (4H, m), 7.18 (2H, d, J=7.8 Hz), 7.26-7.31 (3H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.46 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.52 (4H, t, J=5.0 Hz), 3.60-3.80 (6H, m), 3.85 (3H, s), 5.14 (2H, s), 6.80 (1H, d, J=15.6 Hz), 6.91-6.98 (3H, m), 7.05 (1H, d, J=8.7 Hz), 7.13-7.21 (2H, m), 7.22-7.32 (2H, m), 7.36-7.42 (2H, m), 7.46 (1H, d, J=1.8 Hz), 7.48-7.69 (4H, m), 7.76 (1H, d, J=8.2 Hz), 7.81 (1H, d, J=3.2 Hz), 8.02 (1H, s), 8.07 (1H, d, J=8.7 Hz).
1H-NMR (CDCl3) δ: 1.29 (6H, d, J=6.9 Hz), 2.53 (4H, t, J=5.0 Hz), 2.96 (1H, septet, J=6.9 Hz), 3.60-3.82 (6H, m), 5.14 (2H, s), 6.80 (1H, d, J=15.6 Hz), 6.94 (1H, d, J=8.7 Hz), 7.05 (1H, d, J=8.7 Hz), 7.12-7.19 (2H, m), 7.24-7.32 (5H, m), 7.36-7.42 (2H, m), 7.46 (1H, d, J=1.8 Hz), 7.49-7.54 (1H, m), 7.57 (1H, d, J=15.6 Hz), 7.63 (1H, dd, J=8.7, 1.8 Hz), 7.67 (1H, s), 7.76-7.84 (2H, m), 8.08 (1H, d, J=8.7 Hz).
1H-NMR (CDCl3) δ: 2.52 (4H, t, J=4.9 Hz), 3.60-3.80 (6H, m), 3.84 (3H, s), 5.11 (2H, s), 6.80 (1H, d, J=15.6 Hz), 6.92-6.99 (3H, m), 7.04 (1H, d, J=8.8 Hz), 7.12-7.20 (3H, m), 7.34-7.42 (2H, m), 7.49-7.55 (2H, m), 7.57-7.64 (3H, m), 7.65-7.71 (3H, m), 7.76 (1H, d, J=8.8 Hz), 7.82 (1H, d, J=2.9 Hz), 8.07 (1H, d, J=8.8 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.46 (4H, t, J=4.9 Hz), 3.47 (2H, s), 3.63-3.73 (4H, m), 5.14 (2H, s), 5.22 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.88-6.92 (2H, m), 6.95 (1H, d, J=8.8 Hz), 7.15-7.21 (2H, m), 7.23-7.32 (5H, m), 7.38-7.41 (2H, m), 7.45 (1H, d, J=2.2 Hz), 7.51-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz), 8.04-8.09 (2H, m).
mp: 117.5-118.4° C.
1H-NMR (CDCl3) δ: 2.21 (3H, s), 2.43-2.46 (7H, m), 3.47 (2H, s), 3.63-3.73 (4H, m), 5.16 (2H, s), 5.25 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.87-6.92 (3H, m), 6.98 (1H, d, J=8.3 Hz), 7.21-7.27 (3H, m), 7.30 (2H, d, J=8.1 Hz), 7.34-7.37 (2H, m), 7.41 (1H, d, J=2.0 Hz), 7.45 (2H, d, J=8.1 Hz), 7.63 (1H, d, J=15.4 Hz), 7.89-7.93 (3H, m).
mp: 140.3-141.4° C.
mp: 142.2-142.9° C.
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.47 (4H, t, J=4.9 Hz), 3.03 (2H, t, J=6.4 Hz), 3.50 (2H, s), 3.65-3.74 (4H, m), 4.13 (2H, t, J=6.4 Hz), 6.79 (1H, d, J=15.5 Hz), 6.91 (1H, d, J=8.9 Hz), 7.10 (1H, dd, J=8.2, 2.0 Hz), 7.28-7.32 (6H, m), 7.37-7.38 (2H, m), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.2 Hz), 7.71 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.40-1.43 (1H, m), 2.20 (3H, s), 2.47-2.50 (4H, m), 2.88 (2H, t, J=6.6 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.73-3.76 (2H, m), 3.85-3.90 (2H, m), 5.14 (2H, s), 6.80 (1H, d, J=15.6 Hz), 6.95 (1H, d, J=8.8 Hz), 7.19-7.32 (7H, m), 7.38-7.59 (5H, m), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47-2.51 (4H, m), 3.52 (2H, s), 3.64-3.67 (2H, m), 3.74-3.77 (2H, m), 5.13 (2H, s), 6.81 (1H, d, J=15.4 Hz), 6.92-6.99 (5H, m), 7.25-7.31 (7H, m), 7.38-7.40 (2H, m), 7.46 (1H, d, J=1.5 Hz), 7.50-7.53 (1H, m), 7.58 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.35 (3H, s), 2.48-2.49 (4H, m), 3.52 (2H, s), 3.64-3.67 (2H, m), 3.74-3.76 (2H, m), 4.98 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.91-6.97 (5H, m), 7.17-7.20 (2H, m), 7.26-7.30 (7H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.46 (1H, d, J=1.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.52-2.53 (4H, m), 3.59 (2H, s), 3.66-3.68 (2H, m), 3.76-3.78 (2H, m), 5.14 (2H, s), 6.81 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=9.0 Hz), 7.25-7.47 (11H, m), 7.50-7.62 (6H, m), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.35 (3H, s), 2.52-2.53 (4H, m), 3.59 (2H, s), 3.65-3.68 (2H, m), 3.76-3.78 (2H, m), 4.98 (2H, s), 6.81 (1H, d, J=15.4 Hz), 6.91 (1H, d, J=8.8 Hz), 7.18 (2H, d, J=7.8 Hz), 7.26-7.46 (10H, m), 7.55-7.62 (5H, m), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.25 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.35 (3H, s), 2.48-2.49 (4H, m), 2.87-2.94 (1H, m), 3.51 (2H, s), 3.64-3.66 (2H, m), 3.74-3.76 (2H, m), 4.98 (2H, s), 6.81 (1H, d, J=15.4 Hz), 6.90-6.98 (5H, m), 7.17-7.21 (4H, m), 7.25-7.30 (5H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.46 (1H, d, J=1.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.25 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.53-2.57 (4H, m), 2.88-2.93 (1H, m), 3.57 (2H, s), 3.66-3.69 (2H, m), 3.76-3.78 (2H, m), 5.09 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.92-6.97 (5H, m), 7.19 (2H, d, J=8.3 Hz), 7.24-7.30 (3H, m), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=1.5 Hz), 7.52 (2H, d, J=8.1 Hz), 7.56 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.48 (4H, t, J=5.0 Hz), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.75 (4H, m), 4.15 (2H, t, J=7.0 Hz), 5.06 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.82-6.88 (3H, m), 6.88-6.93 (1H, m), 6.96 (1H, dd, J=8.8, 0.5 Hz), 7.11-7.15 (2H, m), 7.19 (1H, t, J=8.1 Hz), 7.23-7.30 (5H, m), 7.33 (1H, dd, J=11.4, 2.1 Hz), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.41-7.47 (1H, m), 7.60 (1H, d, J=15.4 Hz), 7.84 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.48 (4H, t, J=5.0 Hz), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.15 (2H, t, J=7.0 Hz), 5.13 (2H, s), 6.79 (1H, d, J=15.6 Hz), 6.82-6.85 (2H, m), 6.97 (1H, d, J=9.0 Hz), 7.08-7.30 (11H, m), 7.33 (1H, dd, J=11.2, 2.0 Hz), 7.38 (1H, dd, J=8.9, 3.1 Hz), 7.60 (1H, d, J=15.4 Hz), 7.85 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.46-2.47 (4H, m), 3.50 (2H, s), 3.63-3.66 (2H, m), 3.73-3.75 (2H, m), 5.09 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.96 (1H, d, J=9.0 Hz), 7.26-7.32 (5H, m), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=1.2 Hz), 7.52 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.3 Hz), 7.76 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.34 (3H, s), 2.47-2.48 (4H, m), 3.50 (2H, s), 3.64-3.68 (2H, m), 3.71-3.73 (2H, m), 5.09 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.95 (1H, d, J=8.8 Hz), 7.14 (2H, d, J=7.8 Hz), 7.21 (2H, d, J=7.8 Hz), 7.29 (1H, s), 7.37 (1H, dd, J=9.0, 2.9 Hz), 7.47-7.55 (4H, m), 7.67 (2H, d, J=8.1 Hz), 7.76 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.39 (3H, s), 3.52 (2H, s), 3.64 (2H, brs), 3.73 (2H, brs), 4.10 (2H, dd, J=6.1, 1.5 Hz), 4.98 (2H, s), 6.28 (1H, dt, J=16.1, 6.1 Hz), 6.61 (1H, d, J=16.1 Hz), 6.79 (1H, d, J=15.4 Hz), 6.91 (1H, dd, J=8.9, 0.6 Hz), 7.19 (2H, d, J=7.8 Hz), 7.27-7.30 (5H, m), 7.34-7.37 (3H, m), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, dd, J=3.2, 0.6 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.35 (3H, s), 2.47-2.48 (4H, m), 3.50 (2H, s), 3.63-3.66 (2H, m), 3.72-3.75 (2H, m), 5.09 (2H, s), 6.78 (11H, d, J=15.4 Hz), 6.83 (1H, d, J=8.8 Hz), 7.14 (2H, d, J=7.8 Hz), 7.21 (2H, d, J=8.1 Hz), 7.25-7.26 (2H, m), 7.33 (1H, dd, J=8.9, 3.1 Hz), 7.52 (2H, d, J=8.1 Hz), 7.60 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.1 Hz), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.48-2.49 (4H, m), 3.52 (2H, s), 3.65-3.68 (2H, m), 3.74-3.76 (2H, m), 5.09 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.84 (1H, d, J=8.8 Hz), 6.94-6.96 (4H, m), 7.25-7.35 (7H, m), 7.52 (2H, d, J=8.1 Hz), 7.61 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.1 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.48 (4H, t, J=4.8 Hz), 3.39 (3H, s), 3.52 (2H, s), 3.65 (2H, brs), 3.73 (2H, brs), 4.10 (2H, dd, J=6.0, 1.3 Hz), 4.98 (2H, s), 6.28 (1H, dt, J=15.9, 6.0 Hz), 6.61 (1H, d, J=15.9 Hz), 6.78 (1H, d, J=15.4 Hz), 6.81 (1H, d, J=8.8 Hz), 7.04-7.09 (2H, m), 7.24-7.39 (9H, m), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.52-2.53 (4H, m), 3.58 (2H, s), 3.66-3.69 (2H, m), 3.75-3.78 (2H, m), 5.08 (2H, s), 6.79-6.83 (2H, m), 7.25 (2H, s), 7.31-7.36 (2H, m), 7.39-7.46 (4H, m), 7.52 (2H, d, J=8.3 Hz), 7.58-7.61 (5H, m), 7.68 (2H, d, J=8.1 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.40-1.41 (1H, m), 2.11 (6H, s), 2.47-2.49 (4H, m), 2.87 (2H, t, J=6.5 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.73-3.75 (2H, m), 3.87-3.88 (2H, m), 5.09 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.84 (1H, d, J=8.9 Hz), 7.20 (2H, d, J=8.1 Hz), 7.26-7.28 (4H, m), 7.33 (1H, dd, J=8.9, 2.9 Hz), 7.52 (2H, d, J=8.1 Hz), 7.61 (1H, d, J=15.4 Hz), 7.68 (2H, d, J=8.1 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.42-1.45 (1H, m), 2.12 (6H, s), 2.47-2.49 (4H, m), 2.88 (2H, t, J=6.5 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.73-3.75 (2H, m), 3.87-3.88 (2H, m), 5.06 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.84 (1H, d, J=8.8 Hz), 7.20 (2H, d, J=8.1 Hz), 7.26-7.28 (4H, m), 7.33-7.34 (3H, m), 7.61 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz), 8.62 (2H, d, J=5.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.48 (4H, t, J=5.0 Hz), 3.39 (3H, s), 3.52 (2H, s), 3.66 (2H, brs), 3.74 (2H, brs), 3.81 (3H, s), 4.10 (2H, dd, J=6.2, 1.5 Hz), 4.95 (2H, s), 6.28 (1H, dt, J=15.9, 6.2 Hz), 6.61 (1H, d, J=15.9 Hz), 6.76-6.80 (2H, m), 6.91 (2H, dt, J=9.1, 2.4 Hz), 7.24-7.37 (9H, m), 7.61 (1H, d, J=15.1 Hz), 7.82 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.15-2.18 (1H, m), 2.46-2.48 (4H, m), 2.85 (2H, t, J=6.7 Hz), 3.50 (2H, s), 3.63-3.65 (2H, m), 3.72-3.75 (2H, m), 3.79 (3H, s), 3.84 (2H, t, J=6.7 Hz), 5.14 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.90-6.91 (1H, m), 7.08-7.14 (3H, m), 7.19 (2H, d, J=8.1 Hz), 7.26-7.29 (4H, m), 7.34-7.40 (2H, m), 7.50-7.52 (1H, m), 7.63 (1H, d, J=15.4 Hz), 7.86-7.86 (1H, m).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.51 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 5.01 (2H, s), 6.51 (1H, t, J=73.8 Hz), 6.80 (1H, d, J=15.4 Hz), 6.93 (1H, d, J=8.8 Hz), 7.13-7.15 (4H, m), 7.21 (2H, d, J=7.8 Hz), 7.29 (1H, brs), 7.36 (1H, dd, J=8.8, 2.9 Hz), 7.41 (2H, d, 8.5 Hz), 7.45 (1H, brs), 7.56 (1H, d, J=15.4 Hz), 7.78 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.34 (6H, d, J=6.1 Hz), 2.19 (3H, s), 2.47 (4H, brs), 3.47 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.54 (1H, septet, J=6.1 Hz), 5.00 (2H, s), 6.51 (1H, t, J=73.8 Hz), 6.80 (1H, d, J=15.4 Hz), 6.85 (2H, d, J=8.3 Hz), 6.93 (1H, d, J=8.8 Hz), 7.14 (2H, d, J=8.3 Hz), 7.21 (2H, d, J=8.3 Hz), 7.29 (1H, brs), 7.36 (1H, dd, J=8.8, 2.7 Hz), 7.40 (2H, d, J=8.3 Hz), 7.45 (1H, brs), 7.56 (1H, d, J=15.4 Hz), 7.78 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 1.33 (1H, brs), 1.87-1.94 (2H, m), 2.19 (3H, s), 2.48 (4H, t, J=5.0 Hz), 2.71 (2H, t, J=7.8 Hz), 3.51 (2H, s), 3.64-3.74 (6H, m), 5.09 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.95 (1H, dd, J=9.0, 0.5 Hz), 7.17 (2H, d, J=8.1 Hz), 7.23-7.29 (3H, m), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.51-7.58 (3H, m), 7.67-7.70 (2H, m), 7.76-7.77 (1H, m).
1H-NMR (CDCl3) δ: 1.52 (1H, brs), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.53 (2H, s), 3.64-3.74 (4H, m), 4.33 (2H, d, J=5.7 Hz), 5.09 (2H, s), 6.37 (1H, dt, J=16.0, 5.7 Hz), 6.62 (1H, d, J=16.0 Hz), 6.80 (1H, d, J=15.6 Hz), 6.96 (1H, d, J=8.8 Hz), 7.26-7.29 (3H, m), 7.35-7.39 (3H, m), 7.45 (1H, d, J=2.0 Hz), 7.51-7.59 (3H, m), 7.68 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.30 (6H, s), 2.19 (3H, s), 2.47-2.49 (5H, m), 3.49 (2H, s), 3.60 (2H, s), 3.65-3.67 (2H, m), 3.74-3.77 (2H, m), 5.09 (2H, s), 6.81 (1H, d, J=15.4 Hz), 6.94-7.05 (3H, m), 7.12 (1H, d, J=11.0 Hz), 7.28-7.29 (1H, m), 7.36-7.38 (1H, m), 7.44-7.47 (1H, m), 7.53-7.57 (3H, m), 7.68 (2H, d, J=8.1 Hz), 7.76 (1H, d, J=2.9 Hz).
To a solution of (E)-3-{3-chloro-5-methyl-4-[(5-{[4-(trifluoromethyl)benzyl]-oxy}pyridin-2-yl)oxy]phenyl}prop-2-enoic acid (139 mg) and 4-{2-[4-(piperazin-1-ylmethyl)-phenyl]ethoxy}benzonitrile trifluoroacetate (131 mg) in DMF (6 mL) was added DEPC (0.073 mL) and Et3N (0.165 mL) at 0° C. After stirring at 0° C. for 1 hour, to the reaction mixture was added H2O, and extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous MgSO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (AcOEt) to give 4-{2-[4-({4-[(E)-3-{3-chloro-5-methyl-4-[(5-{[4-(trifluoromethyl)benzyl]oxy}pyridin-2-yl)oxy]phenyl}prop-2-enoyl]piperazin-1-yl}methyl)phenyl]ethoxy}benzonitrile as a pale yellow amorphous (195 mg).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, brs), 3.11 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.65-3.74 (4H, m), 4.21 (2H, t, J=7.1 Hz), 5.09 (2H, s), 6.81 (1H, d, J=15.4 Hz), 6.92-6.95 (3H, m), 7.25-7.29 (5H, m), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.51-7.59 (5H, m), 7.64 (2H, d, J=8.1 Hz), 7.78 (1H, d, J=3.2 Hz).
The following compounds were produced in the same manner as in Example 289 using appropriate starting materials.
1H-NMR (CDCl3) δ: 2.02-2.08 (2H, m), 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=5.0 Hz), 2.81-2.88 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.14 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.69 (1H, dd, J=8.1, 2.4 Hz), 6.79-6.81 (2H, m), 6.92 (1H, d, J=9.0 Hz), 7.10 (1H, d, J=8.1 Hz), 7.19 (2H, d, J=7.8 Hz), 7.23-7.28 (7H, m, J=8.6 Hz), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.26 (3H, s), 2.47 (4H, brs), 3.07 (2H, t, J=7.1 Hz), 3.50 (2H, s), 3.63-3.74 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.06 (2H, s), 6.79-6.82 (3H, m), 6.94 (1H, d, J=8.8 Hz), 7.05 (2H, d, J=8.5 Hz), 7.24-7.27 (5H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, s), 7.50 (2H, d, J=8.3 Hz), 7.57 (1H, d, J=15.4 Hz), 7.62 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.47 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.0 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 4.12 (2H, t, J=7.0 Hz), 5.07 (2H, s), 6.79-6.83 (3H, m), 6.94 (1H, d, J=9.0 Hz), 7.20-7.26 (7H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=1.7 Hz), 7.51 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.47 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 4.12 (2H, t, J=7.1 Hz), 5.07 (2H, s), 6.64-6.67 (2H, m), 6.81 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=8.8 Hz), 7.22-7.28 (5H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.50-7.52 (4H, m), 7.57 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.3 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=7.1 Hz), 2.18 (3H, s), 2.47 (4H, t, J=4.9 Hz), 2.81-2.88 (1H, m), 3.07 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 4.14 (2H, t, J=7.1 Hz), 5.06 (2H, s), 6.80-6.83 (3H, m), 6.94 (1H, d, J=9.0 Hz), 7.12 (2H, d, J=8.8 Hz), 7.25-7.27 (5H, m), 7.36 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, d, J=1.7 Hz), 7.50 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.74-1.76 (4H, m), 2.18 (3H, s), 2.47 (4H, t, J=4.9 Hz), 2.67-2.71 (4H, m), 3.06 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.06 (2H, s), 6.61 (1H, s), 6.66 (1H, dd, J=8.3, 2.4 Hz), 6.81 (1H, d, J=15.4 Hz), 6.93-6.95 (2H, m), 7.25-7.27 (5H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, s), 7.50 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.3 Hz), 7.77 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.46 (4H, brs), 3.15 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.61-3.74 (4H, m), 4.27 (2H, t, J=7.1 Hz), 5.04 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.93 (1H, d, J=8.8 Hz), 7.12-7.15 (2H, m), 7.28-7.35 (7H, m), 7.38-7.42 (1H, m), 7.45-7.49 (3H, m), 7.57 (1H, d, J=15.4 Hz), 7.62 (2H, d, J=8.1 Hz), 7.67-7.74 (3H, m), 7.77 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.28 (3H, s), 2.45 (4H, brs), 3.47 (2H, s), 3.62-3.73 (4H, m), 4.27-4.30 (4H, brs), 5.06 (2H, s), 6.81-6.84 (3H, m), 6.91-6.94 (3H, m), 7.08 (2H, d, J=8.5 Hz), 7.23 (2H, d, J=9.0 Hz), 7.29 (1H, s), 7.36 (1H, dd, J=9.0, 3.2 Hz), 7.47-7.50 (3H, m), 7.57 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.10 (2H, t, J=6.8 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.19 (2H, t, J=6.8 Hz), 5.08 (2H, s), 6.81 (1H, d, J=15.4 Hz), 6.95 (1H, d, J=9.0 Hz), 7.07 (1H, dd, J=8.5, 3.2 Hz), 7.23-7.30 (5H, m), 7.33 (1H, d, J=8.5 Hz), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.52 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.64 (2H, d, J=8.1 Hz), 7.78 (1H, d, J=2.9 Hz), 8.03 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.37 (3H, t, J=7.1 Hz), 2.18 (3H, s), 2.47 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 3.96 (2H, q, J=7.1 Hz), 4.11 (2H, t, J=7.1 Hz), 5.07 (2H, s), 6.79-6.83 (5H, m), 6.94 (1H, d, J=8.8 Hz), 7.23-7.28 (5H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, s), 7.51 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.3 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47 (4H, brs), 3.01 (3H, s), 3.12 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.25 (2H, t, J=7.1 Hz), 5.09 (2H, s), 6.83 (1H, d, J=15.4 Hz), 6.95 (1H, d, J=8.8 Hz), 6.99-7.01 (2H, m), 7.24-7.30 (5H, m), 7.38 (1H, dd, J=8.9, 3.1 Hz), 7.46 (1H, d, J=2.0 Hz), 7.52 (2H, d, J=7.8 Hz), 7.57 (1H, d, J=15.4 Hz), 7.64 (2H, d, J=8.1 Hz), 7.78 (1H, d, J=2.7 Hz), 7.83-7.85 (2H, m).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.22 (3H, d, J=1.7 Hz), 2.47 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.10 (2H, t, J=7.0 Hz), 5.07 (2H, s), 6.62-6.66 (1H, m), 6.68-6.71 (1H, m), 6.81 (1H, d, J=15.4 Hz), 6.87 (1H, t, J=9.0 Hz), 6.94 (1H, d, J=9.0 Hz), 7.23-7.28 (5H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=1.7 Hz), 7.51 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.46 (4H, t, J=4.9 Hz), 3.48 (2H, s), 3.63-3.73 (4H, m), 4.27-4.31 (4H, m), 5.08 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.87-6.95 (5H, m), 7.21-7.25 (4H, m), 7.29 (1H, s), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.51 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.1 Hz), 7.78 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.32 (3H, s), 2.45 (4H, t, J=4.9 Hz), 3.05 (2H, t, J=7.1 Hz), 3.46 (2H, s), 3.62-3.73 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.07 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.85 (2H, d, J=8.8 Hz), 6.94 (1H, d, J=9.0 Hz), 7.12 (2H, d, J=7.8 Hz), 7.16-7.24 (4H, m), 7.28 (1H, s), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.51 (2H, d, J=8.1 Hz), 7.56 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.45 (4H, t, J=4.9 Hz), 3.03 (2H, t, J=7.1 Hz), 3.46 (2H, s), 3.62-3.73 (4H, m), 3.78 (3H, s), 4.12 (2H, t, J=7.1 Hz), 5.07 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.82-6.87 (4H, m), 6.94 (1H, d, J=8.8 Hz), 7.18-7.25 (4H, m), 7.28 (1H, s), 7.36 (1H, dd, J=8.8, 3.2 Hz), 7.45 (1H, d, J=2.0 Hz), 7.51 (2H, d, J=8.1 Hz), 7.56 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.3 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47 (4H, t, J=5.0 Hz), 3.06 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.64-3.74 (4H, m), 4.49 (2H, t, J=7.1 Hz), 5.08 (2H, s), 6.67 (1H, dd, J=8.8, 0.5 Hz), 6.81 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=9.0 Hz), 7.22-7.29 (5H, m), 7.36 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, d, J=2.0 Hz), 7.48-7.53 (3H, m), 7.57 (1H, d, J=15.4 Hz), 7.64 (2H, d, J=8.1 Hz), 7.78 (1H, d, J=2.7 Hz), 8.07 (1H, dd, J=2.7, 0.5 Hz).
1H-NMR (CDCl3) δ: 0.57-0.61 (2H, m), 0.85-0.90 (2H, m), 1.80-1.86 (1H, m), 2.19 (3H, s), 2.47 (4H, t, J=5.0 Hz), 3.06 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.07 (2H, s), 6.78-6.82 (3H, m), 6.94 (1H, dd, J=8.8, 0.5 Hz), 6.97-7.00 (2H, m), 7.23-7.28 (5H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.51 (2H, d, J=8.1 Hz), 7.57 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.1 Hz), 7.78 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.47 (4H, t, J=5.0 Hz), 3.08 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 4.52 (2H, t, J=7.1 Hz), 5.08 (2H, s), 6.70-6.73 (1H, m), 6.79-6.85 (2H, m), 6.94 (1H, dd, J=9.0, 0.5 Hz), 7.26-7.29 (5H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.50-7.59 (4H, m), 7.63 (2H, d, J=8.3 Hz), 7.78 (1H, d, J=2.7 Hz), 8.12-8.14 (1H, m).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.47 (4H, t, J=5.0 Hz), 3.07 (2H, t, J=7.0 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 4.12 (2H, t, J=7.0 Hz), 5.07 (2H, s), 6.73-6.80 (3H, m), 6.94 (1H, d, J=8.8 Hz), 7.22-7.28 (5H, m), 7.32-7.37 (3H, m), 7.45 (1H, d, J=2.0 Hz), 7.51 (2H, d, J=8.1 Hz), 7.56 (1H, d, J=15.4 Hz), 7.63 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.22 (3H, s), 2.34 (3H, s), 2.47 (4H, t, J=5.0 Hz), 3.07 (2H, t, J=7.1 Hz), 3.50 (2H, s), 3.63-3.74 (4H, m), 4.47 (2H, t, J=7.1 Hz), 4.97 (2H, s), 6.63 (1H, d, J=8.3 Hz), 6.80 (1H, d, J=15.4 Hz), 6.90 (1H, d, J=8.8 Hz), 7.18 (2H, d, J=8.1 Hz), 7.25-7.29 (7H, m), 7.33-7.38 (2H, m), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz), 7.94 (1H, d, J=2.4 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.35 (3H, s), 2.48 (4H, brs), 3.10 (2H, t, J=6.7 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.20 (2H, t, J=6.7 Hz), 4.98 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.91 (1H, d, J=8.8 Hz), 7.14-7.29 (11H, m), 7.35 (1H, dd, J=8.2, 2.3 Hz), 7.45 (1H, s), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.2 Hz), 8.03 (1H, d, J=2.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.35 (3H, s), 2.47-2.49 (7H, m), 3.09 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.19 (2H, t, J=7.0 Hz), 4.98 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.91 (1H, d, J=4.6 Hz), 7.04 (1H, d, J=8.3 Hz), 7.09 (1H, dd, J=8.4, 2.8 Hz), 7.18 (2H, d, J=7.6 Hz), 7.23-7.29 (7H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.7 Hz), 8.18 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.34 (3H, s), 2.47 (4H, t, J=4.9 Hz), 3.06 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.63-3.74 (4H, m), 4.48 (2H, t, J=7.1 Hz), 4.97 (2H, s), 6.63 (1H, dd, J=8.8, 0.5 Hz), 6.80 (1H, d, J=15.4 Hz), 6.91 (1H, dd, J=8.8, 0.5 Hz), 7.18 (2H, d, J=7.8 Hz), 7.22-7.29 (7H, m), 7.34 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.61 (1H, dd, J=8.8, 2.7 Hz), 7.79 (1H, d, J=2.7 Hz), 8.16 (1H, dd, J=2.6, 0.6 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.35 (3H, s), 2.47 (4H, t, J=5.0 Hz), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 3.87 (3H, s), 4.16 (2H, t, J=7.0 Hz), 4.97 (2H, s), 6.66 (1H, d, J=8.8 Hz), 6.80 (1H, d, J=15.4 Hz), 6.91 (1H, d, J=9.0 Hz), 7.17-7.20 (3H, m), 7.23-7.29 (7H, m), 7.35 (1H, dd, J=8.9, 3.2 Hz), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (2H, t, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.34 (3H, s), 2.38-2.40 (4H, m), 3.04 (2H, t, J=7.1 Hz), 3.47 (2H, s), 3.63-3.73 (4H, m), 4.01 (2H, t, J=7.1 Hz), 4.97 (2H, s), 6.57 (1H, d, J=8.3 Hz), 6.82 (1H, d, J=15.4 Hz), 6.91 (1H, d, J=8.8 Hz), 7.01 (1H, dd, J=8.3, 2.0 Hz), 7.12 (2H, d, J=8.1 Hz), 7.16-7.22 (5H, m), 7.27-7.29 (3H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.44 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.78 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.38 (3H, t, J=7.0 Hz), 2.18 (3H, s), 2.35 (3H, s), 2.46 (4H, t, J=5.0 Hz), 3.48 (2H, s), 3.66-3.73 (4H, m), 3.97 (2H, q, J=7.0 Hz), 4.26-4.29 (4H, m), 4.97 (2H, s), 6.78-6.92 (8H, m), 7.18 (2H, d, J=8.1 Hz), 7.22-7.29 (5H, m), 7.35 (1H, dd, J=8.8, 3.2 Hz), 7.45 (1H, d, J=2.2 Hz), 7.56 (1H, d, J=15.1 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, brs), 3.50 (2H, brs), 3.68-3.74 (7H, m), 4.27-4.32 (4H, m), 4.99 (2H, s), 6.77-6.84 (3H, m), 6.92-6.97 (5H, m), 7.19 (2H, d, J=8.1 Hz), 7.24-7.30 (5H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.46 (1H, d, J=1.7 Hz), 7.57 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.34 (3H, s), 2.43 (4H, brs), 3.02 (2H, t, J=7.3 Hz), 3.49 (2H, s), 3.64-3.72 (4H, m), 4.14 (2H, t, J=7.3 Hz), 4.97 (2H, s), 6.81 (1H, d, J=15.4 Hz), 6.89-6.93 (2H, m), 7.12-7.18 (5H, m), 7.21-7.29 (6H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.40 (1H, dd, J=7.8, 1.2 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.78 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.80 (3H, s), 3.13 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.25 (2H, t, J=7.0 Hz), 4.98 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.91 (1H, d, J=9.3 Hz), 6.98 (1H, dd, J=8.8, 2.4 Hz), 7.18 (2H, d, J=7.8 Hz), 7.28-7.29 (7H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.43-7.46 (2H, m), 7.57 (1H, d, J=15.4 Hz), 7.64 (1H, d, J=8.8 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.21 (6H, d, J=6.9 Hz), 1.86-2.03 (1H, m), 2.17-2.19 (7H, m), 2.34 (3H, s), 2.81-2.88 (1H, m), 3.02-3.08 (2.5H, m), 3.15-3.17 (0.5H, m), 3.40-3.64 (4H, m), 3.82-3.91 (1.5H, m), 3.99-4.02 (0.5H, m), 4.14 (2H, t, J=7.1 Hz), 4.96 (2H, s), 6.64 (1H, dd, J=15.4, 8.8 Hz), 6.81-6.84 (2H, m), 6.91 (1H, dd, J=8.8, 2.4 Hz), 7.12 (2H, dd, J=8.5, 2.2 Hz), 7.17 (2H, d, J=7.8 Hz), 7.22-7.30 (7H, m), 7.33-7.36 (1H, m), 7.47 (1H, d, J=1.7 Hz), 7.61 (1H, dd, J=15.4, 4.9 Hz), 7.78-7.80 (1H, m).
1H-NMR (CDCl3) δ: 0.58-0.61 (2H, m), 0.86-0.89 (2H, m), 1.81-1.86 (1H, m), 2.18 (3H, s), 2.35 (3H, s), 2.47 (4H, t, J=5.0 Hz), 3.07 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.64-3.74 (4H, m), 4.13 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.78-6.82 (3H, m), 6.91 (1H, d, J=9.0 Hz), 6.98-7.00 (2H, m), 7.18 (2H, d, J=7.8 Hz), 7.23-7.29 (7H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
To a CH2Cl2 (5 mL) solution of (E)-3-[3-chloro-5-methyl-4-({5-[(4-methyl-benzyl)oxy]pyridin-2-yl}oxy)phenyl]prop-2-enoic acid (200 mg) was added N,N-dimethyl-4-{2-[4-(piperazin-1-ylmethyl)phenyl]ethoxy}aniline (191 mg), DCC (151 mg), and DMAP (5.96 mg) at room temperature, then the resultant mixture was stirred over night. The mixture was evaporated. The residue was added AcOEt, then filtered off, and the filtrate was evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/1 to 1/0 and then AcOEt/MeOH=4/1) to afford (E)-3-[3-chloro-5-methyl-4-({5-[(4-methylbenzyl)oxy]-pyridin-2-yl}oxy)phenyl]-1-[4-(4-{2-[4-(dimethylamino)phenoxy]ethyl}benzyl)piperazin-1-yl]prop-2-en-1-one as a pale brown amorphous powder (184 mg).
1H-NMR (DMSO-d6) δ: 2.09 (3H, s), 2.30 (3H, s), 2.34-2.36 (2H, m), 2.40-2.42 (2H, m), 2.78 (6H, s), 2.97 (2H, t, J=7.0 Hz), 3.32 (2H, s), 3.49 (2H, s), 3.55-3.57 (2H, m), 3.70-3.73 (2H, m), 4.08 (2H, t, J=7.0 Hz), 5.05 (2H, s), 6.67-6.69 (2H, m), 6.79-6.81 (2H, m), 7.07 (1H, d, J=9.3 Hz), 7.19 (2H, d, J=7.8 Hz), 7.24-7.34 (7H, m), 7.43 (1H, d, J=15.4 Hz), 7.57-7.59 (1H, m), 7.62-7.62 (1H, m), 7.79-7.82 (2H, m).
To a DMF (5 mL) solution of (E)-3-{3-chloro-4-[(5-hydroxypyridin-2-yl)oxy]-5-methylphenyl}-1-(4-{4-[2-(4-methylphenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one (479 mg) and 4-methylbenzyl bromide (155 mg) was added sodium hydride (60% w/w in oil, 42 mg) at 0° C., and stirred for 1 hour. The reaction mixture was quenched by addition of saturated aqueous NH4Cl (10 mL), and extracted with AcOEt. The organic layer was washed with water, saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (AcOEt/MeOH=1/0 to 9/1) to afford (E)-3-[3-chloro-5-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]-1-(4-{4-[2-(4-methylphenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one (480 mg).
1H-NMR (CDCl3) δ: 2.18 (3H, s), 2.28 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (4H, m), 4.15 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.76-6.84 (3H, m), 6.91 (1H, d, J=8.8 Hz), 7.06 (2H, d, J=8.8 Hz), 7.18 (2H, d, J=8.3 Hz), 7.23-7.29 (7H, m), 7.35 (1H, ddd, J=9.0, 3.2, 0.7 Hz), 7.45 (1H, d, J=1.7 Hz), 7.56 (1H, d, J=15.1 Hz), 7.79 (1H, d, J=3.2 Hz).
The following compounds were produced in the same manner as in Example 322 using appropriate starting materials.
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=4.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.60-3.80 (4H, m), 4.13 (2H, t, J=7.1 Hz), 4.99 (2H, s), 6.75-6.87 (3H, m), 6.88-6.99 (3H, m), 7.17-7.31 (9H, m), 7.35 (1H, dd, J=8.9, 3.3 Hz), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.5 Hz), 7.79 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.60-3.80 (4H, m), 4.13 (2H, t, J=7.1 Hz), 5.00 (2H, s), 6.77-6.87 (3H, m), 6.90-7.01 (3H, m), 7.21-7.38 (10H, m), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.2 Hz), 7.77 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=4.8 Hz), 2.85 (1H, septet, J=6.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.73 (4H, m), 4.15 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.79-6.84 (3H, m), 6.91 (1H, d, J=8.9 Hz), 7.11-7.30 (11H, m), 7.35 (1H, dd, J=8.9, 3.3 Hz), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.2 Hz), 7.79 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.9 Hz), 3.08 (2H, t, J=6.9 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.15 (2H, t, J=7.1 Hz), 5.00 (2H, s), 6.77-6.86 (3H, m), 6.93 (1H, d, J=8.9 Hz), 7.13 (2H, d, J=8.6 Hz), 7.28-7.34 (10H, m), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.5 Hz), 7.77 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.13 (2H, t, J=6.9 Hz), 5.09 (2H, s), 6.79-6.83 (3H, m), 6.92-6.99 (3H, m), 7.24-7.27 (5H, m), 7.37 (1H, dd, J=8.9, 3.0 Hz), 7.45 (1H, d, J=2.0 Hz), 7.53-7.57 (3H, m), 7.65 (2H, d, J=7.9 Hz), 7.78 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=6.9 Hz), 3.53 (2H, s), 3.59-3.83 (4H, m), 4.13 (2H, t, J=7.1 Hz), 4.99 (2H, s), 6.65-6.87 (3H, m), 6.90-6.99 (3H, m), 7.02-7.11 (2H, m), 7.20-7.30 (5H, m), 7.31-7.41 (3H, m), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.5 Hz), 7.78 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.25 (6H, d, J=6.9 Hz), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.91 (1H, septet, J=6.9 Hz), 3.08 (2H, t, J=6.9 Hz), 3.52 (2H, s), 3.65-3.74 (4H, m), 4.13 (2H, t, J=6.9 Hz), 4.99 (2H, s), 6.76-6.85 (3H, m), 6.93-6.96 (3H, m), 7.28-7.34 (10H, m), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.5 Hz), 7.80 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.28 (3H, s), 2.48 (4H, t, J=4.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64-3.74 (4H, m), 4.15 (2H, t, J=7.1 Hz), 4.99 (2H, s), 6.78-6.81 (3H, m), 6.93 (1H, d, J=8.9 Hz), 7.04-7.10 (4H, m), 7.27-7.28 (5H, m), 7.35-7.39 (3H, m), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.5 Hz), 7.78 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.58-3.82 (4H, m), 4.15 (2H, t, J=6.9 Hz), 4.99 (2H, s), 6.72-6.87 (3H, m), 6.93 (1H, d, J=8.9 Hz), 7.01-7.18 (4H, m), 7.22-7.29 (5H, m), 7.32-7.41 (3H, m), 7.45 (1H, d, J=1.6 Hz), 7.57 (1H, d, J=15.5 Hz), 7.78 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.20 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.65-3.74 (4H, m), 4.13 (2H, t, J=6.9 Hz), 5.05 (2H, s), 6.81-6.83 (3H, m), 6.93-6.97 (3H, m), 7.23-7.31 (5H, m), 7.35-7.38 (2H, m), 7.46 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.5 Hz), 7.75 (1H, d, J=7.9 Hz), 7.80 (1H, d, J=3.0 Hz), 8.60 (1H, dd, J=4.8, 1.5 Hz), 8.66 (1H, d, J=2.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.65-3.74 (4H, m), 4.13 (2H, t, J=6.9 Hz), 5.17 (2H, s), 6.79 (1H, d, J=9.2 Hz), 6.80-6.85 (2H, m), 6.92-6.99 (3H, m), 7.25-7.27 (6H, m), 7.41 (1H, dd, J=8.9, 3.0 Hz), 7.45 (1H, d, J=2.0 Hz), 7.50 (1H, d, J=7.9 Hz), 7.57 (1H, d, J=15.5 Hz), 7.73 (1H, td, J=7.7, 1.8 Hz), 7.82 (1H, d, J=3.0 Hz), 8.59 (1H, d, J=4.6 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.55-3.83 (7H, m), 4.13 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.77-6.87 (5H, m), 6.92 (1H, d, J=8.9 Hz), 7.19 (2H, d, J=7.9 Hz), 7.23-7.31 (7H, m), 7.36 (1H, dd, J=8.9, 3.3 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.5 Hz), 7.79 (1H, d, J=3.3 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.65-3.74 (4H, m), 4.13 (2H, t, J=6.9 Hz), 5.03 (2H, s), 6.78-6.85 (3H, m), 6.94-6.98 (3H, m), 7.24-7.28 (5H, m), 7.35-7.39 (2H, m), 7.46 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.5 Hz), 7.73 (1H, dd, J=8.2, 2.6 Hz), 7.78 (1H, d, J=3.0 Hz), 8.43 (1H, d, J=2.3 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.05 (2H, s), 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.79-2.91 (1H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.74 (2H, s), 4.12 (3H, t, J=10.7 Hz), 5.05 (2H, s), 6.73-6.89 (3H, m), 6.90-6.99 (1H, m), 7.08-7.18 (2H, m), 7.27-7.42 (0H, m), 7.43-7.48 (1H, m), 7.52-7.62 (1H, m), 7.75 (1H, dt, J=7.8, 1.9 Hz), 7.80 (2H, d, J=3.0 Hz), 8.60 (2H, dd, J=4.9, 1.6 Hz), 8.66 (2H, d, J=1.3 Hz).
1H-NMR (CDCl3) δ: 1.20-1.25 (6H, m), 2.19 (3H, s), 2.47-2.51 (4H, m), 2.82-2.88 (1H, m), 3.08 (2H, t, J=6.9 Hz), 3.53 (2H, s), 3.65-3.71 (4H, m), 4.07-4.18 (2H, m), 5.03 (2H, s), 6.81-6.86 (3H, m), 6.95 (1H, d, J=9.2 Hz), 7.13 (2H, d, J=8.2 Hz), 7.24-7.28 (3H, m), 7.34-7.39 (3H, m), 7.47 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.5 Hz), 7.73-7.78 (2H, m), 8.42 (1H, d, J=2.0 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.19 (3H, s), 2.47-2.49 (4H, m), 2.80-2.90 (1H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.74 (2H, s), 4.15 (2H, t, J=7.1 Hz), 5.17 (2H, s), 6.77-6.95 (4H, m), 7.11-7.15 (2H, m), 7.22-7.27 (6H, m), 7.40-7.44 (2H, m), 7.51-7.57 (2H, m), 7.72-7.75 (1H, m), 7.82 (1H, d, J=3.0 Hz), 8.58-8.60 (1H, m).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.74 (2H, s), 4.13 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.75-6.87 (3H, m), 6.90-7.01 (3H, m), 7.22-7.26 (3H, m), 7.28-7.32 (3H, m), 7.35-7.43 (2H, m), 7.45 (1H, d, J=2.0 Hz), 7.48-7.61 (3H, m), 7.79-7.84 (1H, m).
1H-NMR (CDCl3) δ: 2.20 (3H, s), 2.36 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=6.9 Hz), 3.53 (2H, s), 3.63-3.66 (2H, m), 3.72-3.76 (2H, m), 4.13 (2H, t, J=6.9 Hz), 5.01 (2H, s), 6.77-6.89 (3H, m), 6.89-7.00 (3H, m), 7.14-7.25 (4H, m), 7.25-7.27 (3H, m), 7.27-7.31 (1H, m), 7.34-7.41 (2H, m), 7.46 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.5 Hz), 7.82 (1H, d, J=2.6 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.63-3.67 (2H, m), 3.72-3.76 (2H, m), 4.13 (2H, t, J=7.1 Hz), 5.10 (2H, s), 6.77-6.99 (6H, m), 7.02-7.23 (3H, m), 7.23-7.27 (2H, m), 7.29-7.49 (6H, m), 7.57 (1H, d, J=15.2 Hz), 7.82 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.28 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.72-3.76 (2H, m), 4.15 (2H, t, J=7.1 Hz), 5.10 (2H, s), 6.80 (3H, dd, J=11.9, 3.3 Hz), 6.94 (1H, d, J=8.9 Hz), 7.03-7.20 (4H, m), 7.21-7.41 (7H, m), 7.43-7.51 (2H, m), 7.57 (1H, d, J=15.5 Hz), 7.82 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.28 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.72-3.76 (2H, m), 4.15 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.79-6.81 (3H, m), 6.94 (1H, d, J=8.9 Hz), 7.07 (2H, d, J=8.2 Hz), 7.23-7.32 (7H, m), 7.39-7.44 (3H, m), 7.53-7.57 (2H, m), 7.81 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.20 (3H, s), 2.28 (3H, s), 2.36 (3H, s), 2.47-2.49 (4H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.72-3.76 (2H, m), 4.14 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.76-6.85 (3H, m), 6.93 (1H, d, J=8.9 Hz), 7.07 (2H, d, J=8.2 Hz), 7.20-7.29 (8H, m), 7.33-7.41 (2H, m), 7.46 (1H, d, J=2.3 Hz), 7.57 (1H, d, J=15.5 Hz), 7.82 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.19 (3H, s), 2.47-2.49 (4H, m), 2.56 (3H, s), 2.80-2.90 (1H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.62-3.66 (2H, m), 3.72-3.76 (2H, m), 4.15 (2H, t, J=7.1 Hz), 5.13 (2H, s), 6.77-6.86 (3H, m), 6.93 (1H, d, J=8.9 Hz), 7.08-7.15 (3H, m), 7.22-7.27 (4H, m), 7.27-7.34 (2H, m), 7.40 (1H, dd, J=8.9, 3.0 Hz), 7.45 (1H, d, J=2.0 Hz), 7.54-7.64 (2H, m), 7.81 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.19 (3H, s), 2.47-2.49 (4H, m), 2.80-2.90 (1H, m), 3.08 (2H, t, J=7.1 Hz), 152 (2H, s), 3.63-3.66 (2H, m), 3.72-3.76 (2H, m), 4.15 (2H, t, J=7.1 Hz), 5.10 (2H, s), 6.74-6.87 (3H, m), 6.93 (1H, d, J=8.9 Hz), 7.05-7.19 (4H, m), 7.22-7.27 (3H, m), 7.29-7.41 (4H, m), 7.42-7.51 (2H, m), 7.57 (1H, d, J=15.2 Hz), 7.81 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.20 (3H, s), 2.36 (3H, s), 2.45-2.53 (4H, m), 2.80-2.90 (1H, m), 3.08 (2H, t, J=6.9 Hz), 3.52 (2H, s), 3.63-3.67 (2H, m), 3.72-3.76 (2H, m), 4.15 (2H, t, J=6.9 Hz), 5.01 (2H, s), 6.75-6.86 (3H, m), 6.93 (1H, d, J=8.9 Hz), 7.13 (2H, d, J=8.2 Hz), 7.19-7.30 (8H, m), 7.33-7.42 (2H, m), 7.46 (1H, s), 7.57 (1H, d, J=15.5 Hz), 7.82 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.46-2.50 (4H, m), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.73-3.78 (5H, m), 4.13 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.76-6.85 (5H, m), 6.94 (1H, d, J=8.9 Hz), 7.23-7.32 (7H, m), 7.37-7.60 (5H, m), 7.81 (1H, d, J=2.6 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.48-2.49 (4H, m), 2.82-2.89 (1H, m), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.73-3.76 (2H, m), 3.84 (3H, s), 4.15 (2H, t, J=7.0 Hz), 5.08 (2H, s), 6.78-6.85 (3H, m), 6.89-6.92 (2H, m), 6.97 (1H, t, J=7.4 Hz), 7.13 (2H, d, J=8.5 Hz), 7.21-7.33 (6H, m), 7.37-7.42 (2H, m), 7.45 (1H, s), 7.57 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.48-2.49 (4H, m), 2.81-2.89 (1H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.73-3.75 (2H, m), 4.15-4.18 (2H, m), 5.09 (2H, s), 6.77-6.85 (3H, m), 6.95 (1H, d, J=8.8 Hz), 7.02 (1H, td, J=8.3, 2.4 Hz), 7.11-7.18 (3H, m), 7.23-7.30 (5H, m), 7.38 (1H, dd, J=8.9, 3.1 Hz), 7.45-7.51 (2H, m), 7.57 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.47-2.49 (4H, m), 2.81-2.88 (1H, m), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.73-3.76 (2H, m), 4.15 (2H, t, J=7.0 Hz), 5.22 (2H, s), 6.77-6.86 (3H, m), 6.96 (1H, d, J=8.8 Hz), 7.13 (2H, d, J=8.5 Hz), 7.20-7.29 (5H, m), 7.41-7.47 (3H, m), 7.57 (1H, d, J=15.4 Hz), 7.64 (2H, d, J=4.2 Hz), 7.71 (1H, d, J=7.6 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.48-2.49 (4H, m), 2.81-2.89 (1H, m), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.63-3.66 (2H, m), 3.73-3.76 (2H, m), 4.14-4.18 (2H, m), 5.03 (2H, s), 6.78-6.85 (3H, m), 6.94 (1H, d, J=8.8 Hz), 6.98-7.05 (1H, m), 7.10-7.18 (4H, m), 7.23-7.30 (5H, m), 7.31-7.39 (2H, m), 7.45 (1H, s), 7.57 (1H, d, J=15.4 Hz), 7.78 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.36 (3H, s), 2.47-2.49 (4H, m), 2.80-2.89 (1H, m), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.63-3.65 (2H, m), 3.73-3.76 (2H, m), 4.15 (2H, t, J=7.0 Hz), 4.99 (2H, s), 6.77-6.85 (3H, m), 6.92 (1H, d, J=9.0 Hz), 7.11-7.16 (3H, m), 7.18-7.29 (8H, m), 7.37 (1H, dd, J=9.0, 2.9 Hz), 7.45 (1H, s), 7.57 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.47-2.49 (4H, m), 2.81-2.89 (1H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.63-3.65 (2H, m), 3.73-3.75 (2H, m), 4.15 (2H, t, J=7.1 Hz), 5.00 (2H, s), 6.78-6.86 (3H, m), 6.94 (1H, d, J=9.0 Hz), 7.13 (2H, d, J=8.5 Hz), 7.24-7.32 (8H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.41 (1H, s), 7.45-7.46 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.9 Hz), 2.20 (3H, s), 2.41-2.54 (4H, m), 2.79-2.91 (1H, m), 3.08 (2H, t, J=6.9 Hz), 3.52 (2H, s), 3.63-3.67 (2H, m), 3.72-3.76 (2H, m), 4.16 (2H, t, J=6.9 Hz), 5.14 (2H, s), 6.77-6.85 (3H, m), 6.94 (1H, d, J=8.9 Hz), 7.13 (2H, d, J=8.6 Hz), 7.25-7.31 (7H, m), 7.36-7.62 (5H, m), 7.82 (1H, d, J=2.6 Hz).
mp: 136-137° C.
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.48 (4H, t, J=4.9 Hz), 3.53 (2H, s), 3.66 (2H, brs), 3.74 (2H, brs), 3.81 (3H, s), 4.67 (2H, dd, J=5.9, 1.3 Hz), 4.95 (2H, s), 6.39 (1H, dt, J=15.9, 5.9 Hz), 6.72 (1H, d, J=15.9 Hz), 6.78 (1H, d, J=15.4 Hz), 6.79 (1H, d, J=8.8 Hz), 6.88-6.93 (4H, m), 6.95-7.00 (2H, m), 7.25-7.26 (2H, m), 7.28-7.34 (5H, m), 7.38 (2H, d, J=8.1 Hz), 7.61 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.29 (3H, s), 2.37 (3H, s), 2.47 (4H, t, J=4.9 Hz), 3.47 (2H, s), 3.62-3.75 (4H, m), 3.81 (3H, s), 4.67 (2H, dd, J=5.7, 1.3 Hz), 4.95 (2H, s), 6.40 (1H, dt, J=16.1, 5.7 Hz), 6.68 (1H, d, J=16.1 Hz), 6.77-6.80 (2H, m), 6.86 (2H, dt, J=9.2, 2.4 Hz), 6.91 (2H, dt, J=9.2, 2.4 Hz), 7.09 (2H, d, J=8.8 Hz), 7.21-7.22 (3H, m), 7.25-7.26 (2H, m), 7.30-7.34 (3H, m), 7.61 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.24 (6H, d, J=6.9 Hz), 2.18 (3H, s), 2.34 (3H, s), 2.46 (4H, t, J=4.9 Hz), 2.91 (1H, septet, J=6.9 Hz), 3.49 (2H, s), 3.60-3.82 (4H, m), 4.97 (2H, s), 6.80 (1H, d, J=15.5 Hz), 6.91 (1H, d, J=8.9 Hz), 7.09-7.39 (10H, m), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.5 Hz), 7.79 (1H, d, J=3.0 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.35 (3H, s), 2.35 (3H, s), 2.47 (4H, t, J=4.9 Hz), 3.50 (2H, s), 3.64-3.73 (4H, m), 4.98 (2H, s), 6.79 (1H, d, J=15.5 Hz), 6.91 (1H, dd, J=4.5, 2.2 Hz), 7.13-7.23 (6H, m), 7.27-7.29 (3H, m), 7.35 (1H, dd, J=8.9, 3.3 Hz), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.5 Hz), 7.79 (1H, d, J=2.6 Hz).
To a solution of (E)-3-{3-chloro-4-[(5-hydroxypyridin-2-yl)oxy]-5-methyl-phenyl}-1-(4-{4-[2-(4-chlorophenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one (400 mg) was added 3-fluoro-4-methylbenzyl bromide (144 mg) and K2CO3 (134 mg) at room temperature, then the reaction mixture was stirred for 4 hours. The reaction mixture was diluted with H2O and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (AcOEt) to afford (E)-3-[3-chloro-4-({5-[(3-fluoro-4-methylbenzyl)oxy]pyridin-2-yl}oxy)-5-methylphenyl]-1-(4-{4-[2-(4-chlorophenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one as a colorless amorphous (430 mg).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.27 (3H, d, J=1.7 Hz), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.74 (2H, s), 4.14 (2H, t, J=7.0 Hz), 4.98 (2H, s), 6.78-6.84 (3H, m), 6.93 (1H, dd, J=8.8, 0.5 Hz), 7.16-7.29 (10H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.77 (1H, d, J=3.2 Hz).
The following compounds were produced in the same manner as in Example 360 using appropriate starting materials.
1H-NMR (CDCl3) δ: 2.23 (3H, s), 2.29 (3H, d, J=1.7 Hz), 2.31 (3H, s), 2.51 (4H, t, J=4.9 Hz), 3.11 (2H, t, J=7.1 Hz), 3.55 (2H, s), 3.67 (2H, s), 3.77 (2H, s), 4.18 (2H, t, J=7.1 Hz), 5.04 (2H, s), 6.81-6.85 (3H, m), 6.97 (1H, dd, J=9.0, 0.5 Hz), 7.03-7.12 (3H, m), 7.17-7.23 (2H, m), 7.26-7.32 (5H, m), 7.40 (1H, dd, J=8.9, 3.1 Hz), 7.49 (1H, d, J=2.2 Hz), 7.60 (1H, d, J=15.4 Hz), 7.83 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.20 (3H, s), 2.27 (3H, d, J=2.0 Hz), 2.48 (4H, t, J=4.9 Hz), 2.81 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.74 (2H, s), 4.15 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.78-6.85 (3H, m), 6.94 (1H, d, J=8.8 Hz), 7.00-7.07 (1H, m), 7.11-7.20 (4H, m), 7.24-7.29 (5H, m), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.46 (1H, d, J=1.7 Hz), 7.57 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.20 (3H, s), 2.27 (3H, d, J=2.0 Hz), 2.49 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.65 (2H, s), 3.75 (2H, s), 4.13 (2H, t, J=7.1 Hz), 5.01 (2H, s), 6.78-6.85 (3H, m), 6.91-6.99 (3H, m), 7.00-7.07 (1H, m), 7.15-7.18 (2H, m), 7.24-7.30 (5H, m), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.46 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.20 (3H, s), 2.27 (3H, d, J=2.0 Hz), 2.48 (4H, t, J=5.0 Hz), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.65 (2H, s), 3.74 (2H, s), 4.14 (2H, t, J=7.0 Hz), 5.01 (2H, s), 6.78-6.84 (3H, m), 6.95 (1H, dd, J=8.9, 0.6 Hz), 7.00-7.05 (1H, m), 7.15-7.29 (9H, m), 7.37 (1H, dd, J=8.9, 3.1 Hz), 7.46 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.80 (1H, dd, J=3.1, 0.6 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.08 (2H, t, J=7.1 Hz), 3.53 (2H, s), 3.65 (2H, s), 3.74 (2H, s), 4.14 (2H, d, J=7.1 Hz), 4.98 (2H, s), 6.78-6.85 (4H, m), 6.91-6.98 (5H, m), 7.23-7.29 (5H, m), 7.36 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.27 (3H, d, J=1.7 Hz), 2.48 (4H, t, J=4.8 Hz), 3.08 (2H, t, J=7.0 Hz), 3.53 (2H, s), 3.64 (2H, s), 3.74 (2H, s), 4.13 (2H, t, J=7.0 Hz), 4.98 (2H, s), 6.78-6.85 (3H, m), 6.92-7.00 (3H, m), 7.05-7.07 (2H, m), 7.18 (1H, t, J=7.7 Hz), 7.23-7.29 (5H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.77 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.27 (3H, d, J=1.7 Hz), 2.48 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.60-3.80 (7H, m), 4.13 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.78-6.86 (5H, m), 6.93 (1H, dd, J=8.8, 0.5 Hz), 7.05-7.07 (2H, m), 7.16-7.20 (1H, m), 7.24-7.29 (5H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.77 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.74 (2H, s), 4.14 (2H, t, J=7.0 Hz), 4.98 (2H, s), 6.78-6.85 (4H, m), 6.91-6.95 (2H, m), 6.98 (1H, s), 7.20-7.29 (7H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.58-3.80 (7H, m), 4.13 (2H, t, J=6.6 Hz), 4.98 (2H, s), 6.78-6.85 (6H, m), 6.90-7.00 (1H, m), 6.98 (1H, s), 7.23-7.29 (6H, m), 7.36 (1H, dd, J=8.8, 3.2 Hz), 7.45 (1H, d, J=1.7 Hz), 7.57 (1H, d, J=15.4 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.18 (3H, d, J=4.9 Hz), 2.27-2.28 (6H, m), 2.48 (4H, t, J=4.9 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.75 (2H, s), 4.15 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.78-6.82 (3H, m), 6.93 (1H, d, J=8.8 Hz), 7.05-7.08 (4H, m), 7.18 (1H, t, J=7.7 Hz), 7.24-7.29 (5H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.19 (3H, s), 2.27 (3H, d, J=1.7 Hz), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.74 (2H, s), 4.15 (2H, t, J=7.0 Hz), 4.98 (2H, s), 6.78-6.85 (3H, m), 6.93 (1H, dd, J=9.0, 0.5 Hz), 7.05-7.07 (2H, m), 7.11-7.15 (2H, m), 7.18 (1H, t, J=7.9 Hz), 7.24-7.29 (5H, m), 7.35 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.77 (1H, d, J=2.7 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.28 (3H, s), 2.35 (3H, d, J=0.5 Hz), 2.48 (4H, t, J=5.0 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.74 (2H, s), 4.15 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.78-6.85 (4H, m), 6.91-6.98 (3H, m), 7.07 (2H, dd, J=8.7, 0.6 Hz), 7.23-7.29 (5H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.77-7.78 (1H, m).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.19 (3H, s), 2.35 (3H, s), 2.48 (4H, t, J=4.9 Hz), 2.85 (1H, septet, J=7.1 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.74 (2H, s), 4.15 (2H, t, J=7.1 Hz), 4.98 (2H, s), 6.78-6.85 (4H, m), 6.91-6.98 (1H, m), 6.98 (1H, s), 7.13 (2H, d, J=8.3 Hz), 7.24-7.29 (6H, m), 7.36 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, d, J=2.0 Hz), 7.57 (1H, d, J=15.4 Hz), 7.77 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.20 (3H, s), 2.47-2.49 (4H, m), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, brs), 3.76 (5H, brs), 4.13 (2H, t, J=7.1 Hz), 5.46 (2H, s), 6.80 (1H, d, J=15.6 Hz), 6.82 (2H, d, J=9.6 Hz), 6.84 (2H, d, J=9.6 Hz), 6.96 (1H, d, J=9.0 Hz), 7.26 (4H, s), 7.28 (1H, s), 7.41 (1H, dd, J=9.0, 2.9 Hz), 7.45 (1H, s), 7.51 (1H, t, J=7.8 Hz), 7.57 (1H, d, J=15.4 Hz), 7.68-7.72 (1H, m), 7.82 (1H, d, J=2.9 Hz), 7.86 (1H, d, J=7.6 Hz), 8.16 (1H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=6.8 Hz), 2.19 (3H, s), 2.48 (4H, s), 2.85 (1H, qq, J=6.8, 6.8 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, s), 3.74 (2H, s), 4.15 (2H, t, J=7.1 Hz), 5.46 (2H, s), 6.78-6.84 (3H, m), 6.96 (1H, d, J=9.0 Hz), 7.13 (2H, d, J=8.5 Hz), 7.26 (4H, s), 7.29 (1H, s), 7.41 (1H, dd, J=9.0, 2.9 Hz), 7.45 (1H, s), 7.51 (1H, t, J=7.7 Hz), 7.57 (1H, d, J=15.4 Hz), 7.69-7.72 (1H, m), 7.82 (1H, d, J=2.9 Hz), 7.86 (1H, d, J=7.8 Hz), 8.16 (1H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.28 (3H, s), 2.48 (4H, t, J=4.6 Hz), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.15 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.80 (2H, d, J=8.5 Hz), 6.80 (1H, d, J=15.1 Hz), 6.96 (1H, d, J=9.0 Hz), 7.07 (2H, d, J=8.3 Hz), 7.26 (4H, s), 7.29 (1H, s), 7.38 (1H, dd, J=9.0, 2.9 Hz), 7.45 (1H, s), 7.57 (1H, d, J=15.1 Hz), 7.59 (2H, d, J=8.5 Hz), 7.78 (1H, d, J=2.9 Hz), 8.25 (2H, d, J=8.5 Hz).
1H-NMR (CDCl3) δ: 1.22 (6H, d, J=7.1 Hz), 2.19 (3H, s), 2.47-2.49 (4H, m), 2.82-2.88 (1H, m), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, brs), 3.64 (2H, brs), 3.74 (2H, brs), 4.15 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.78-6.84 (3H, m), 6.96 (1H, d, J=8.8 Hz), 7.13 (2H, d, J=8.5 Hz), 7.26 (4H, s), 7.29 (1H, s), 7.38 (1H, dd, J=8.8, 2.9 Hz), 7.45 (1H, s), 7.54-7.60 (3H, m), 7.78 (1H, d, J=2.9 Hz), 8.25 (2H, d, J=8.8 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.28 (3H, s), 2.48 (4H, s), 3.08 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.15 (2H, t, J=7.1 Hz), 5.46 (2H, s), 6.80 (2H, d, J=8.5 Hz), 6.80 (1H, d, J=14.9 Hz), 6.96 (1H, d, J=8.8 Hz), 7.07 (2H, d, J=8.3 Hz), 7.26 (4H, s), 7.28 (1H, s), 7.41 (1H, dd, J=8.8, 2.9 Hz), 7.45 (1H, s), 7.49-7.53 (1H, m), 7.56 (1H, d, J=15.4 Hz), 7.70 (1H, t, J=7.3 Hz), 7.82 (1H, d, J=2.9 Hz), 7.86 (1H, d, J=7.8 Hz), 8.16 (1H, d, J=8.1 Hz).
1H-NMR (CDCl3) δ: 2.40 (3H, s), 2.46-2.49 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.62-3.65 (2H, m), 3.73-3.76 (2H, m), 4.13 (2H, t, J=7.0 Hz), 5.06 (2H, s), 6.71 (1H, d, J=15.1 Hz), 6.81-6.84 (2H, m), 6.88-6.97 (5H, m), 7.02 (1H, td, J=8.4, 2.0 Hz), 7.13-7.17 (2H, m), 7.23-7.28 (2H, m), 7.34-7.36 (2H, m), 7.52-7.53 (1H, m), 7.89-7.91 (2H, m).
1H-NMR (CDCl3) δ: 2.40 (3H, s), 2.46-2.49 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.62-3.65 (2H, m), 3.73-3.76 (2H, m), 3.85 (3H, s), 4.13 (2H, t, J=7.0 Hz), 5.12 (2H, s), 6.70 (1H, d, J=15.1 Hz), 6.81-6.99 (9H, m), 7.23-7.33 (5H, m), 7.36 (1H, dd, J=8.8, 2.9 Hz), 7.42 (1H, d, J=7.1 Hz), 7.51-7.52 (1H, m), 7.90 (1H, d, J=15.1 Hz), 7.95 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 2.36 (3H, s), 2.40 (3H, s), 2.46-2.48 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.51 (2H, s), 3.62-3.64 (2H, m), 3.73-3.76 (2H, m), 4.12 (2H, t, J=7.0 Hz), 5.02 (2H, s), 6.71 (1H, d, J=15.1 Hz), 6.80-6.84 (2H, m), 6.86-6.97 (5H, m), 7.14 (1H, d, J=7.3 Hz), 7.19-7.28 (7H, m), 7.34 (1H, dd, J=8.9, 3.1 Hz), 7.51-7.52 (1H, m), 7.90-7.92 (2H, m).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.47-2.48 (4H, m), 3.08 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.73-3.75 (2H, m), 4.14 (2H, t, J=7.0 Hz), 5.07 (2H, s), 6.79-6.81 (4H, m), 7.01 (1H, td, J=8.3, 2.4 Hz), 7.15 (1H, dd, J=8.3, 2.4 Hz), 7.22-7.26 (8H, m), 7.34 (1H, dd, J=8.9, 3.1 Hz), 7.49 (1H, dd, J=8.5, 6.1 Hz), 7.61 (1H, d, J=15.4 Hz), 7.83 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.47-2.48 (4H, m), 3.07 (2H, t, J=7.0 Hz), 3.52 (2H, s), 3.64-3.66 (2H, m), 3.73-3.75 (2H, m), 4.13 (2H, t, J=7.0 Hz), 4.99 (2H, s), 6.78-6.81 (4H, m), 7.20-7.34 (12H, m), 7.40 (1H, s), 7.61 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz).
To a DMF (5 mL) solution of (E)-3-(3,5-dimethyl-4-{[5-(pyridin-4-ylmethoxy)-pyridin-2-yl]oxy}phenyl)-1-{4-[4-(2-hydroxyethyl)benzyl]piperazin-1-yl}prop-2-en-1-one (400 mg) was added NaH (35.9 mg, 60% in mineral oil) at 0° C., then the resultant mixture was stirred for 1 hour. To the mixture was added 4-chlorobenzyl chloride (0.093 mL) at 0° C., then the resultant mixture was stirred at room temperature for 3 hours. The mixture was poured into saturated aqueous NH4Cl, and extracted with AcOEt. The organic layer was washed with H2O and saturated aqueous NaCl, dried over anhydrous Na2SO4, and evaporated. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/1 to 1/0 and then AcOEt/MeOH=4/1) to afford (E)-1-[4-(4-{2-[(4-chlorobenzyl)oxy]ethyl}benzyl)piperazin-1-yl]-3-(3,5-dimethyl-4-{[5-(pyridin-4-ylmethoxy)pyridin-2-yl]oxy}phenyl)prop-2-en-1-one as a pale yellow amorphous powder (91 mg).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.48-2.50 (4H, m), 2.92 (2H, t, J=7.0 Hz), 3.53 (2H, s), 3.67-3.69 (4H, m), 3.73-3.76 (2H, m), 4.49 (2H, s), 5.06 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.84 (1H, d, J=8.8 Hz), 7.18-7.35 (13H, m), 7.61 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz), 8.62 (2H, d, J=5.6 Hz).
The following compounds were produced in the same manner as in Example 384 using appropriate starting materials.
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.34 (3H, s), 2.47-2.48 (4H, m), 2.92 (2H, t, J=7.2 Hz), 3.51 (2H, s), 3.63-3.70 (4H, m), 3.73-3.75 (2H, m), 4.49 (2H, s), 5.14 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=9.0 Hz), 7.12-7.15 (2H, m), 7.18-7.31 (9H, m), 7.38-7.41 (2H, m), 7.45 (1H, s), 7.49-7.54 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.34 (3H, s), 2.47-2.48 (4H, m), 2.92 (2H, t, J=7.2 Hz), 3.51 (2H, s), 3.63-3.70 (4H, m), 3.73-3.75 (2H, m), 4.49 (2H, s), 5.14 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=9.0 Hz), 7.12-7.15 (2H, m), 7.18-7.31 (9H, m), 7.38-7.41 (2H, m), 7.45 (1H, s), 7.49-7.54 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.47-2.49 (4H, m), 2.92 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.61-3.71 (2H, m), 3.73-3.75 (2H, m), 4.49 (2H, s), 5.14 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=9.0 Hz), 7.18-7.31 (11H, m), 7.38-7.41 (2H, m), 7.45 (1H, d, J=1.2 Hz), 7.50-7.54 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.48-2.50 (4H, m), 2.92 (2H, t, J=7.0 Hz), 3.53 (2H, s), 3.67-3.69 (4H, m), 3.73-3.76 (2H, m), 4.48 (2H, s), 5.05 (2H, s), 6.78 (1H, d, J=15.4 Hz), 6.83 (1H, d, J=9.0 Hz), 6.99-7.02 (2H, m), 7.18-7.20 (2H, m), 7.25-7.27 (6H, m), 7.33-7.34 (3H, m), 7.61 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz), 8.62 (2H, d, J=5.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (6H, s), 2.33 (3H, s), 2.47-2.48 (4H, m), 2.91 (2H, t, J=7.1 Hz), 3.51 (2H, s), 3.66-3.68 (4H, m), 3.73-3.75 (2H, m), 4.49 (2H, s), 5.04 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.83 (1H, d, J=9.0 Hz), 7.13 (2H, d, J=7.8 Hz), 7.18-7.26 (8H, m), 7.32-7.35 (3H, m), 7.61 (1H, d, J=15.4 Hz), 7.80 (1H, d, J=2.9 Hz), 8.62 (2H, d, J=5.6 Hz).
1H-NMR (CDCl3) δ: 0.18-0.22 (2H, m), 0.51-0.56 (2H, m), 1.04-1.10 (1H, m), 2.19 (3H, s), 2.46-2.49 (4H, m), 2.91 (2H, t, J=7.3 Hz), 3.30 (2H, d, J=6.8 Hz), 3.51 (2H, s), 3.65-3.67 (4H, m), 3.73-3.75 (2H, m), 5.14 (2H, s), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=8.8 Hz), 7.18-7.32 (7H, m), 7.37-7.42 (2H, m), 7.46 (1H, s), 7.51-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
To a DMF (7 mL) solution of (E)-3-[3-chloro-4-({5-[(2-chlorobenzyl)oxy]-pyridin-2-yl}oxy)-5-methylphenyl]-1-(piperazin-1-yl)prop-2-en-1-one (0.70 g) and 4-vinylbenzyl chloride (240 μL) was added K2CO3 (291 mg) at room temperature. After stirring at room temperature for 36 hours, to the reaction mixture was added water, and extracted with AcOEt. The organic layer was washed with water, saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/1 to 0/1 and then AcOEt/MeOH=19/1) to give (E)-3-[3-chloro-4-({5-[(2-chlorobenzyl)oxy]pyridin-2-yl}oxy)-5-methylphenyl]-1-[4-(4-ethenylbenzyl)-piperazin-1-yl]prop-2-en-1-one as a colorless powder (0.73 g).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.53 (2H, s), 3.64-3.74 (4H, m), 5.14 (2H, s), 5.24 (1H, d, J=11.0 Hz), 5.74 (1H, d, J=17.6 Hz), 6.71 (1H, dd, J=17.6, 11.0 Hz), 6.80 (1H, d, J=15.4 Hz), 6.94 (1H, d, J=9.3 Hz), 7.26-7.31 (5H, m), 7.37-7.41 (4H, m), 7.45 (1H, brs), 7.51-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
To a CH2Cl2 (5 mL) solution of (E)-3-[3-chloro-5-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]-1-[(3S)-3-methylpiperazin-1-yl]prop-2-en-1-one (0.50 g) and 4-[2-(4-fluorophenoxy)ethyl]benzaldehyde (298 mg) was added NaBH(OAc)3 (323 mg) at room temperature. The resultant mixture was stirred at room temperature for 3 days. To the reaction mixture was added saturated aqueous NaHCO3, and extracted with CH2Cl2. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/1 to 0/1) to give (E)-3-[3-chloro-5-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]-1-[(3S)-4-{4-[2-(4-fluorophenoxy)ethyl]benzyl}-3-methylpiperazin-1-yl]prop-2-en-1-one as a yellow powder (451 mg).
1H-NMR (CDCl3) δ: 1.19 (3H, d, J=6.1 Hz), 2.13-2.19 (4H, m), 2.35 (3H, s), 2.51-2.54 (1H, m), 2.73-2.76 (1H, m), 2.94-3.41 (5H, m), 3.75-3.79 (1H, m), 3.94-4.26 (4H, m), 4.98 (2H, s), 6.75-6.86 (3H, m), 6.90-7.00 (3H, m), 7.18 (2H, d, J=8.1 Hz), 7.22-7.30 (7H, m), 7.35 (1H, dd, J=8.9, 2.9 Hz), 7.43-7.47 (1H, m), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
The following compounds were produced in the same manner as in Example 392 using appropriate starting materials.
1H-NMR (CDCl3) δ: 1.37 (3H, brs), 2.03-2.09 (1H, m), 2.18-2.20 (4H, m), 2.27 (3H, s), 2.35 (3H, s), 2.69-4.98 (13H, m), 6.76-6.82 (3H, m), 6.98-6.92 (1H, m), 7.04-7.08 (2H, m), 7.18 (2H, d, J=7.8 Hz), 7.23-7.30 (7H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.44 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.4 Hz), 7.78-7.79 (1H, m).
1H-NMR (CDCl3) δ: 1.37 (3H, brs), 2.04-2.10 (1H, m), 2.18-2.21 (4H, m), 2.35 (3H, s), 2.69-4.98 (13H, m), 6.76-6.85 (3H, m), 6.90-6.99 (3H, m), 7.18 (2H, d, J=7.8 Hz), 7.22-7.31 (7H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.37 (3H, brs), 2.03-2.10 (1H, m), 2.18-2.20 (4H, m), 2.35 (3H, s), 2.69-4.98 (13H, m), 6.76-6.85 (3H, m), 6.90-6.99 (3H, m), 7.18 (2H, d, J=7.8 Hz), 7.22-7.29 (7H, m), 7.35 (1H, dd, J=8.8, 2.9 Hz), 7.45 (1H, d, J=2.2 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.37 (3H, brs), 2.03-2.09 (1H, m), 2.18-2.20 (4H, m), 2.28 (3H, s), 2.35 (3H, s), 2.69-4.98 (13H, m), 6.76-6.82 (3H, m), 6.91 (1H, d, J=8.8 Hz), 7.06 (2H, d, J=8.3 Hz), 7.18 (2H, d J=7.8 Hz), 7.23-7.31 (7H, m), 7.35 (1H, dd, J=8.8, 2.9 Hz), 7.45 (1H, d, J=2.0 Hz), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 1.18 (3H, d, J=5.9 Hz), 2.11-2.19 (4H, m), 2.27 (3H, s), 2.35 (3H, s), 2.51-2.53 (1H, m), 2.73-2.76 (1H, m), 2.94-3.41 (5H, m), 3.74-3.78 (1H, m), 3.93-4.27 (4H, m), 4.98 (2H, s), 6.75-6.82 (3H, m), 6.91 (1H, d, J=9.0 Hz), 7.04-7.08 (2H, m), 7.18 (2H, d, J=7.8 Hz), 7.22-7.30 (7H, m), 7.35 (1H, dd, J=9.0, 3.2 Hz), 7.43-7.46 (1H, m), 7.56 (1H, d, J=15.4 Hz), 7.79 (1H, d, J=3.2 Hz).
mp: 142-144° C.
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.36 (3H, s), 2.48 (4H, t, J=5.0 Hz), 3.53 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 4.66 (2H, dd, J=5.9, 1.5 Hz), 4.98 (2H, s), 6.39 (1H, dt, J=16.0, 5.9 Hz), 6.72 (1H, d, J=16.0 Hz), 6.79 (1H, d, J=15.4 Hz), 6.87-6.93 (3H, m), 6.95-7.01 (2H, m), 7.19 (2H, d, J=7.6 Hz), 7.28-7.30 (5H, m), 7.34-7.39 (3H, m), 7.45 (1H, d, J=2.2 Hz), 7.57 (1H, d, J=15.4 Hz), 7.79 (1H, dd, J=2.9, 0.5 Hz).
mp: 101-104° C.
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.48 (4H, t, J=4.9 Hz), 3.53 (2H, s), 3.66 (2H, brs), 3.74 (2H, brs), 4.67 (2H, dd, J=5.8, 1.3 Hz), 4.99 (2H, s), 6.39 (1H, dt, J=16.0, 5.8 Hz), 6.72 (1H, d, J=16.0 Hz), 6.76-6.82 (2H, m), 6.87-6.92 (2H, m), 6.95-7.00 (2H, m), 7.04-7.10 (2H, m), 7.25-7.33 (5H, m), 7.36-7.39 (4H, m), 7.61 (1H, d, J=15.6 Hz), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (DMSO-d6 at 70° C.) δ: 1.16 (6H, d, J=6.8 Hz), 2.10 (3H, s), 2.30 (3H, s), 2.78-2.85 (1H, m), 2.90-3.00 (4H, m), 3.63-3.70 (4H, m), 3.83-3.85 (4H, m), 4.13-4.16 (2H, m), 5.05 (2H, s), 6.81-6.84 (2H, m), 7.02 (1H, d, J=9.0 Hz), 7.10-7.12 (2H, m), 7.17-7.32 (9H, m), 7.44 (1H, d, J=15.1 Hz), 7.54-7.57 (2H, m), 7.75 (1H, brs), 7.78 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.11 (3H, s), 2.12 (3H, s), 2.96-3.08 (4H, m), 3.70-3.86 (8H, m), 4.09-4.14 (2H, m), 5.08 (2H, s), 6.71-6.85 (4H, m), 6.94 (2H, t, J=8.4 Hz), 7.21-7.35 (7H, m), 7.52 (2H, d, J=8.1 Hz), 7.63-7.69 (3H, m), 7.79 (1H, d, J=2.2 Hz).
1H-NMR (CDCl3) δ: 2.11 (3H, s), 2.12 (3H, s), 2.96-3.08 (4H, m), 3.70-3.86 (11H, m), 4.09-4.15 (2H, m), 5.08 (2H, s), 6.75 (1H, t, J=15.8 Hz), 6.82-6.85 (5H, m), 7.21-7.24 (4H, m), 7.28-7.35 (3H, m), 7.52 (2H, d, J=8.3 Hz), 7.64-7.69 (3H, m), 7.80 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.14 (3H, d, J=1.5 Hz), 2.29 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.53 (2H, s), 3.65 (2H, brs), 3.73 (2H, brs), 4.72 (2H, d, J=6.3 Hz), 4.99 (2H, s), 6.05-6.08 (1H, m), 6.78 (1H, d, J=15.4 Hz), 6.81 (1H, d, J=9.0 Hz), 6.85 (2H, dt, J=9.3, 2.5 Hz), 7.05-7.10 (4H, m), 7.25-7.33 (5H, m), 7.36-7.41 (4H, m), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.2 Hz).
1H-NMR (CDCl3) δ: 1.98 (3H, d, J=1.2 Hz), 2.12 (6H, s), 2.29 (3H, s), 2.49 (4H, t, J=4.9 Hz), 3.53 (2H, s), 3.66 (2H, brs), 3.75 (2H, brs), 4.54 (2H, s), 4.98 (2H, s), 6.61 (1H, brs), 6.79 (1H, d, J=15.4 Hz), 6.81 (1H, dd, J=9.0, 0.5 Hz), 6.87 (2H, dt, J=9.1, 2.4 Hz), 7.04-7.10 (4H, m), 7.25-7.33 (7H, m), 7.36-7.40 (2H, m), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, dd, J=3.2, 0.5 Hz).
1H-NMR (CDCl3) δ: 1.38 (3H, t, J=7.1 Hz), 2.19 (3H, s), 2.48 (4H, brs), 3.07 (2H, t, J=7.1 Hz), 3.52 (2H, s), 3.64 (2H, brs), 3.74 (2H, brs), 3.97 (2H, q, J=7.1 Hz), 4.12 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.78-6.82 (5H, m), 6.94 (1H, d, J=9.0 Hz), 7.23-7.31 (7H, m), 7.38-7.41 (2H, m), 7.45 (1H, brs), 7.51-7.53 (1H, m), 7.57 (1H, d, J=15.4 Hz), 7.82 (1H, d, J=2.9 Hz).
1H-NMR (CDCl3) δ: 2.19 (3H, s), 2.46 (4H, t, J=4.6 Hz), 3.04 (2H, t, J=7.1 Hz), 3.47 (2H, s), 3.63 (2H, brs), 3.73 (2H, brs), 3.80 (3H, s), 4.13 (2H, t, J=7.1 Hz), 5.14 (2H, s), 6.79 (1H, d, J=15.4 Hz), 6.86 (4H, d, J=8.4 Hz), 6.94 (1H, d, J=8.8 Hz), 7.20 (2H, d, J=8.4 Hz), 7.21 (2H, d, J=8.4 Hz), 7.26-7.31 (3H, m), 7.38-7.41 (2H, m), 7.45 (1H, brs), 7.51-7.53 (1H, m), 7.56 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=2.9 Hz).
To a solution of (E)-3-[4-({5-[(4-fluorobenzyl)oxy]pyridin-2-yl}oxy)-3,5-dimethylphenyl]-1-(piperazin-1-yl)prop-2-en-1-one (0.328 g) and (E)-3-[4-(chloromethyl)-2-methylphenyl]prop-2-en-1-yl 4-methylphenyl ether (0.204 g) in DMF (2 mL) was added DIPEA (0.13 mL) at room temperature under an Ar atmosphere. The mixture was stirred at room temperature for 20.5 hours, and then heated at 50° C. for 1 hour, and then cooled to room temperature, and evaporated under reduced pressure. To the residue was added saturated aqueous NaHCO3, and the mixture was extracted with AcOEt. The organic layer was washed with saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (AcOEt) to afford (2E)-3-[4-({5-[(4-fluorobenzyl)oxy]pyridin-2-yl}oxy)-3,5-dimethylphenyl]-1-(4-{3-methyl-4-[(1E)-3-(4-methylphenoxy)prop-1-en-1-yl]benzyl}piperazin-1-yl)prop-2-en-1-one (0.370 g) as a colorless oil.
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.29 (3H, s), 2.34 (3H, s), 2.48 (4H, t, J=4.9 Hz), 3.49 (2H, s), 3.66-3.75 (4H, m), 4.69 (2H, dd, J=5.8, 1.3 Hz), 4.98 (2H, s), 6.29 (1H, dt, J=15.9, 5.8 Hz), 6.78 (1H, d, J=15.4 Hz), 6.81 (1H, d, J=9.0 Hz), 6.87 (2H, dt, J=9.3, 2.6 Hz), 6.92 (1H, d, J=15.9 Hz), 7.05-7.13 (6H, m), 7.25 (2H, brs), 7.32 (1H, dd, J=9.0, 3.1 Hz), 7.36-7.39 (2H, m), 7.44 (1H, d, J=7.8 Hz), 7.61 (1H, d, J=15.4 Hz), 7.81 (1H, d, J=3.1 Hz).
To a solution of (E)-3-[3-chloro-5-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]-1-(4-{4-[2-(4-chlorophenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one (3.410 g) in EtOH (50 mL) was added 6 M HCl (0.86 mL) at 50° C. The mixture was stirred at room temperature for 16 hours. The resulting precipitate was collected, and crystallized from EtOH (300 mL) and water (100 mL) to give (E)-3-[3-chloro-5-methyl-4-({5-[(4-methylbenzyl)oxy]pyridin-2-yl}oxy)phenyl]-1-(4-{4-[2-(4-chlorophenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one hydrochloride (3.060 g) as a colorless powder.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 3.06-3.58 (6H, m), 3.07 (2H, t, J=6.7 Hz), 4.22 (2H, t, J=6.7 Hz), 4.33 (2H, brs), 4.53-4.57 (2H, m), 5.06 (2H, s), 6.96 (2H, dt, J=9.9, 2.9 Hz), 7.09 (1H, d, J=9.0 Hz), 7.20 (2H, d, J=7.8 Hz), 7.27-7.34 (5H, m), 7.42-7.52 (5H, m), 7.59 (1H, dd, J=9.0, 3.1 Hz), 7.63 (1H, d, J=2.0 Hz), 7.79 (1H, d, J=3.1 Hz), 7.84 (1H, d, J=2.0 Hz), 10.82 (1H, s).
The following compounds were produced in the same manner as in Example 408 using appropriate starting materials.
mp: 186.6-189.0° C.
mp: 215.1-215.5° C.
mp: 134.7-136.4° C.
mp: 200.7-201.4° C.
mp: 183.8-184.2° C.
mp: 189.4-190.5° C.
mp: 175.1-176.7° C.
mp: 192.8-193.8° C.
mp: 175.1-176.7° C.
mp: 180.2-182.7° C. (dec.)
mp: 196.6-198.0° C.
mp: 185.2-186.4° C.
mp: 207.4-207.9° C.
mp: 199.8-201.6° C.
mp: 186.7-187.8° C.
mp: 224.7-225.8° C.
mp: 207.9-208.3° C.
mp: 225.4-225.9° C.
mp: 224.7-224.8° C.
mp: 219.8-220.2° C.
mp: 224.4-228.8° C.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.80-3.80 (8H, m), 4.19 (2H, t, J=6.6 Hz), 4.32 (2H, brs), 4.45-4.63 (2H, m), 5.11 (2H, s), 6.90-6.98 (2H, m), 7.05-7.15 (3H, m), 7.29 (1H, d, J=15.5 Hz), 7.39-7.57 (9H, m), 7.58-7.65 (2H, m), 7.80 (1H, d, J=3.3 Hz), 7.84 (1H, d, J=1.6 Hz), 11.08 (1H, brs).
mp: 227.1-227.2° C.
mp: 201.9-202.6° C.
mp: 232.1-232.7° C.
mp: 180.1-181.1° C.
mp: 225.9-226.5° C.
mp: 214.3-216.2° C.
mp: 231.5-231.8° C.
mp: 228.9-229.5° C.
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.9 Hz), 2.11 (3H, s), 2.82 (1H, septet, J=6.9 Hz), 2.90-3.50 (7H, m), 3.55 (1H, brs), 4.18 (2H, t, J=6.6 Hz), 4.33 (2H, brs), 4.45-4.62 (2H, m), 5.09 (2H, s), 6.80-6.88 (2H, m), 7.06-7.16 (3H, m), 7.18-7.32 (3H, m), 7.40-7.55 (7H, m), 7.56-7.65 (2H, m), 7.80 (1H, d, J=3.0 Hz), 7.84 (1H, d, J=1.6 Hz), 10.83 (1H, brs).
mp: 230.5-230.6° C.
mp: 225.1-226.6° C.
mp: 240.5-241.0° C.
mp: 227.7-229.3° C.
mp: 214.8-215.3° C.
mp: 180.9-182.0° C.
mp: 166.4-167.7° C.
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=6.9 Hz), 2.11 (3H, s), 2.76-2.87 (1H, m), 3.00-3.11 (4H, m), 3.35-3.38 (7H, m), 4.18 (2H, t, J=6.8 Hz), 4.32 (2H, brs), 4.52-4.57 (2H, br m), 5.16 (2H, s), 6.84 (2H, d, J=8.6 Hz), 7.07-7.18 (3H, m), 7.21-7.70 (11H, m), 7.71-7.89 (3H, m), 10.73 (1H, s).
mp: 224.0-224.5° C.
mp: 210.3-210.6° C.
mp: 211.9-214.0° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.22 (3H, s), 2.32 (3H, s), 2.89-3.40 (8H, m), 4.17 (2H, t, J=6.8 Hz), 4.30-4.34 (2H, m), 4.51-4.56 (2H, m), 5.10 (2H, s), 6.77-6.85 (2H, m), 7.01-7.14 (4H, m), 7.19-7.33 (4H, m), 7.39-7.56 (6H, m), 7.62-7.66 (2H, m), 7.81-7.87 (2H, m), 11.25 (1H, s).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.22 (3H, s), 3.03-3.59 (8H, m), 4.17 (2H, t, J=6.8 Hz), 4.31-4.34 (2H, m), 4.51-4.56 (2H, m), 5.15 (2H, s), 6.80-6.84 (2H, m), 7.07-7.12 (3H, m), 7.21-7.33 (3H, m), 7.44-7.63 (9H, m), 7.83-7.85 (2H, m), 11.06-11.10 (1H, m).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 2.22 (3H, s), 2.94-3.60 (8H, m), 4.17 (2H, t, J=6.6 Hz), 4.31-4.35 (2H, m), 4.52-4.57 (2H, m), 5.17 (2H, s), 6.79-6.84 (2H, m), 7.10 (3H, dd, J=14.0, 8.7 Hz), 7.30 (1H, d, J=15.2 Hz), 7.37-7.54 (8H, m), 7.59-7.69 (3H, m), 7.82-7.87 (2H, m), 10.93-10.97 (1H, m).
mp: 218.0-218.2° C.
mp: 188.0-189.5° C.
mp: 168.4-169.8° C.
mp: 200.7-201.9° C.
mp: 176.0-177.8° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.05 (2H, t, J=6.4 Hz), 3.14-3.62 (6H, m), 3.68 (3H, s), 4.15 (2H, t, J=6.4 Hz), 4.31-4.34 (2H, m), 4.52-4.57 (2H, m), 5.17 (2H, s), 6.85 (4H, s), 7.12 (1H, d, J=8.9 Hz), 7.27-7.54 (9H, m), 7.60-7.68 (3H, m), 7.83-7.86 (2H, m), 10.84 (1H, s).
mp: 182.0-182.5° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.01-3.63 (8H, m), 4.13 (2H, t, J=6.6 Hz), 4.32 (2H, brs), 4.51-4.57 (2H, m), 5.17 (2H, s), 5.94 (2H, s), 6.36 (1H, dd, J=8.6, 2.6 Hz), 6.63 (1H, d, J=2.6 Hz), 6.79 (1H, d, J=8.6 Hz), 7.12 (1H, d, J=8.9 Hz), 7.28-7.67 (12H, m), 7.84-7.85 (2H, m), 11.36 (1H, brs).
mp: 229.5-231.3° C. (dec.)
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 3.01-3.58 (8H, m), 4.13 (2H, t, J=6.6 Hz), 4.32 (2H, brs), 4.51-4.57 (2H, m), 5.05 (2H, s), 5.94 (2H, s), 6.36 (1H, dd, J=8.6, 2.6 Hz), 6.62 (1H, d, J=2.6 Hz), 6.79 (1H, d, J=8.6 Hz), 7.09 (1H, d, J=8.9 Hz), 7.18-7.63 (12H, m), 7.78-7.84 (2H, m), 11.01 (1H, brs).
mp: 210.3-210.9° C.
1H-NMR (DMSO-d6) δ: 2.12 (6H, s), 2.16 (3H, s), 3.04-3.05 (3H, m), 3.13-3.67 (5H, m), 4.15 (2H, t, J=6.6 Hz), 4.33 (2H, s), 4.54 (2H, d, J=11.9 Hz), 5.17 (2H, s), 6.64 (1H, d, J=8.2 Hz), 6.73 (1H, s), 7.01 (1H, d, J=8.2 Hz), 7.13 (1H, d, J=8.7 Hz), 7.31 (1H, d, J=15.6 Hz), 7.38-7.53 (8H, m), 7.61-7.67 (3H, m), 7.83-7.87 (2H, m), 11.26 (1H, s).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 2.99-3.19 (4H, m), 3.46-3.57 (4H, m), 3.72 (3H, s), 4.20 (2H, t, J=6.6 Hz), 4.32-4.35 (2H, m), 4.53-4.56 (2H, m), 5.17 (2H, s), 6.45-6.54 (3H, m), 7.12-7.19 (2H, m), 7.31 (1H, d, J=15.1 Hz), 7.38-7.54 (8H, m), 7.60-7.68 (3H, m), 7.83-7.87 (2H, m), 10.94 (1H, s).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.97-3.19 (4H, m), 3.35-3.61 (4H, m), 4.26-4.37 (4H, m), 4.53-4.56 (2H, m), 5.17 (2H, s), 6.94 (1H, t, J=7.6 Hz), 7.11-7.17 (2H, m), 7.26-7.33 (2H, m), 7.38-7.53 (9H, m), 7.61-7.67 (3H, m), 7.84-7.86 (2H, m), 11.00 (1H, s).
mp: 214.2-214.7° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.05-4.53 (14H, m), 5.17 (2H, s), 6.79 (2H, d, J=8.8 Hz), 7.13 (1H, d, J=8.8 Hz), 7.31 (1H, d, J=15.6 Hz), 7.40-7.43 (4H, m), 7.48-7.53 (4H, m), 7.58 (2H, d, J=8.3 Hz), 7.61-7.67 (3H, m), 7.84-7.85 (2H, m), 10.92 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.00-3.16 (4H, m), 3.33-3.60 (4H, m), 4.21 (2H, t, J=6.6 Hz), 4.32 (2H, s), 4.53 (2H, s), 5.17 (2H, s), 6.96 (2H, d, J=8.8 Hz), 7.13 (1H, d, J=8.8 Hz), 7.28-7.34 (3H, m), 7.37-7.55 (8H, m), 7.60-7.68 (3H, m), 7.83-7.86 (2H, m), 10.99 (1H, s).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.96-3.22 (4H, m), 3.32-3.76 (4H, m), 4.32-4.35 (2H, m), 4.42 (2H, t, J=6.6 Hz), 4.53-4.56 (2H, m), 5.17 (2H, s), 7.13 (1H, d, J=8.8 Hz), 7.31 (1H, d, J=15.1 Hz), 7.38-7.43 (2H, m), 7.48-7.53 (4H, m), 7.57-7.71 (7H, m), 7.83-7.89 (3H, m), 8.19 (1H, d, J=9.3 Hz), 8.77 (1H, d, J=8.3 Hz), 9.01 (1H, d, J=4.4 Hz), 11.39 (1H, s).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.07-3.08 (2H, m), 3.17-3.68 (6H, m), 4.25 (2H, t, J=6.6 Hz), 4.32-4.34 (2H, m), 4.53-4.55 (2H, m), 5.17 (2H, s), 6.91 (1H, d, J=6.3 Hz), 6.96-7.03 (2H, m), 7.13 (1H, d, J=8.8 Hz), 7.28-7.32 (2H, m), 7.38-7.54 (8H, m), 7.61-7.67 (3H, m), 7.82-7.86 (2H, m), 10.47 (1H, s).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 2.26 (3H, s), 2.99-3.11 (4H, m), 3.18-3.65 (4H, m), 4.19 (2H, t, J=6.6 Hz), 4.31-4.34 (2H, m), 4.53-4.56 (2H, m), 5.17 (2H, s), 6.70-6.77 (3H, m), 7.11-7.16 (2H, m), 7.31 (1H, d, J=15.4 Hz), 7.38-7.44 (4H, m), 7.47-7.58 (4H, m), 7.60-7.67 (3H, m), 7.84-7.87 (2H, m), 11.32 (1H, s).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 2.21 (6H, s), 3.00-3.07 (4H, m), 3.25-3.63 (4H, m), 4.16 (2H, t, J=6.6 Hz), 4.30-4.33 (2H, m), 4.53-4.56 (2H, m), 5.17 (2H, s), 6.53-6.56 (3H, m), 7.12 (1H, d, J=8.8 Hz), 7.31 (1H, d, J=15.4 Hz), 7.38-7.44 (4H, m), 7.47-7.57 (4H, m), 7.60-7.67 (3H, m), 7.84-7.86 (2H, m), 11.38 (1H, s).
1H-NMR (DMSO-d6) δ: 2.00 (3H, s), 2.12 (3H, s), 2.18 (3H, s), 2.97-3.67 (8H, m), 4.16 (2H, t, J=6.3 Hz), 4.31-4.34 (2H, m), 4.53-4.56 (2H, m), 5.17 (2H, s), 6.73 (1H, d, J=7.3 Hz), 6.78 (1H, d, J=8.1 Hz), 7.00 (1H, t, J=7.8 Hz), 7.13 (1H, d, J=9.0 Hz), 7.31 (1H, d, J=15.4 Hz), 7.38-7.48 (5H, m), 7.51-7.58 (3H, m), 7.60-7.68 (3H, m), 7.84-7.87 (2H, m), 11.30 (1H, s).
mp: 201.2-202.5° C.
mp: 197.0-199.5° C.
mp: 185.6-186.3° C.
mp: 193.5-195.8° C.
1H-NMR (DMSO-d6) δ: 2.36 (3H, s), 3.04-3.57 (8H, m), 4.19 (2H, t, J=6.6 Hz), 4.32 (2H, brs), 4.48-4.57 (2H, m), 5.20 (2H, s), 6.91-6.97 (4H, m), 7.05-7.12 (4H, m), 7.38-7.44 (4H, m), 7.51-7.55 (3H, m), 7.61-7.65 (2H, m), 7.74 (1H, d, J=15.1 Hz), 7.81 (1H, d, J=9.0 Hz), 7.99 (1H, d, J=3.2 Hz), 10.98 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.21 (3H, s), 2.35 (3H, s), 3.03-3.54 (8H, m), 4.16 (2H, t, J=6.6 Hz), 4.32 (2H, brs), 4.48-4.56 (2H, m), 5.20 (2H, s), 6.81 (2H, m), 6.93-6.96 (2H, m), 7.05-7.12 (4H, m), 7.38-7.44 (4H, m), 7.49-7.54 (3H, m), 7.61-7.65 (2H, m), 7.74 (1H, d, J=15.1 Hz), 7.81 (1H, d, J=9.0 Hz), 7.99 (1H, d, J=3.2 Hz), 10.79 (1H, brs).
mp: 209.6-212.0° C.
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=6.9 Hz), 2.35 (3H, s), 2.81 (1H, septet, J=6.9 Hz), 3.03-3.56 (8H, m), 4.17 (2H, t, J=6.6 Hz), 4.32-4.53 (4H, m), 5.20 (2H, s), 6.81-6.87 (2H, m), 6.93-6.96 (2H, m), 7.04-7.14 (4H, m), 7.37-7.44 (4H, m), 7.50-7.55 (3H, m), 7.61-7.66 (2H, m), 7.74 (1H, d, J=15.5 Hz), 7.79-7.83 (1H, m), 7.99 (1H, d, J=3.0 Hz), 10.91 (1H, brs).
mp: 194.9-197.8° C.
1H-NMR (DMSO-d6) δ: 2.26 (3H, s), 3.06 (2H, t, J=6.5 Hz), 3.14-3.67 (6H, m), 3.75 (3H, s), 4.19 (2H, t, J=6.5 Hz), 4.31-4.34 (2H, m), 4.52-4.55 (2H, m), 5.17 (2H, s), 6.70-6.76 (3H, m), 6.99 (1H, d, J=8.8 Hz), 7.09-7.17 (2H, m), 7.25 (1H, d, J=15.4 Hz), 7.31 (1H, d, J=8.1 Hz), 7.39-7.44 (4H, m), 7.49-7.62 (7H, m), 7.86 (1H, d, J=2.9 Hz), 11.07 (1H, s).
mp: 196.7-198.7° C.
mp: 203.4-205.7° C.
mp: 209.8-211.0° C.
mp: 181.4-182.0° C.
mp: 228.9-229.4° C.
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=7.1 Hz), 2.78-2.85 (1H, m), 2.99-3.60 (6H, m), 3.06 (2H, t, J=6.6 Hz), 4.17 (2H, t, J=6.6 Hz), 4.32 (2H, brs), 4.53 (2H, brs), 5.21 (2H, s), 6.84 (2H, d, J=8.8 Hz), 7.07-7.14 (5H, m), 7.21 (1H, d, J=15.4 Hz), 7.40-7.43 (4H, m), 7.52-7.56 (4H, m), 7.62-7.67 (2H, m), 7.75 (2H, d, J=8.5 Hz), 8.00 (1H, d, J=3.2 Hz), 11.28 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.22 (3H, s), 2.95-3.60 (8H, m), 4.17 (2H, t, J=6.6 Hz), 4.33 (2H, s), 4.53 (2H, s), 5.21 (2H, s), 6.82 (2H, d, J=−8.5 Hz), 7.07 (2H, d, J=8.5 Hz), 7.13 (1H, d, J=8.8 Hz), 7.23-7.32 (2H, m), 7.38-7.51 (7H, m), 7.64-7.68 (2H, m), 7.84-7.86 (2H, m), 10.71 (1H, s).
mp: 180.1-181.7° C.
mp: 200.9-202.3° C.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 3.11-4.53 (14H, m), 5.05 (2H, s), 7.09 (1H, d, J=9.0 Hz), 7.16 (2H, d, J=8.6 Hz), 7.20 (2H, d, J=7.8 Hz), 7.30 (1H, d, J=15.4 Hz), 7.33 (2H, d, J=7.8 Hz), 7.44 (2H, d, J=7.8 Hz), 7.49 (1H, d, J=15.4 Hz), 7.54 (2H, d, J=7.3 Hz), 7.58-7.61 (1H, m), 7.63 (1H, brs), 7.79 (1H, d, J=2.9 Hz), 7.84 (1H, brs), 8.20 (2H, d, J=8.3 Hz), 11.09 (1H, brs).
mp: 194.8-195.2° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.11-4.53 (14H, m), 5.17 (2H, s), 7.12 (1H, d, J=9.0 Hz), 7.16 (2H, d, J=9.0 Hz), 7.30 (1H, d, J=15.4 Hz), 7.39-7.47 (5H, m), 7.51-7.55 (3H, m), 7.61-7.67 (3H, m), 7.84-7.85 (2H, m), 8.20 (2H, d, J=9.0 Hz), 10.98 (1H, brs).
mp: 200.2-202.1° C.
mp: 199.2-200.2° C.
mp: 218.8-219.2° C.
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=7.1 Hz), 2.13 (3H, s), 2.30 (3H, s), 2.81 (1H, septet, J=6.8 Hz), 2.90-3.70 (8H, m), 4.18 (2H, t, J=6.6 Hz), 4.32 (2H, s), 4.52 (2H, s), 5.08 (2H, s), 6.82-6.86 (2H, m), 6.98 (1H, d, J=8.3 Hz), 7.01 (1H, d, J=9.0 Hz), 7.11-7.15 (2H, m), 7.17-7.21 (3H, m), 7.33 (2H, d, J=8.1 Hz), 7.43 (2H, d, J=8.1 Hz), 7.49-7.59 (5H, m), 7.68 (1H, d, J=1.7 Hz), 7.87 (1H, d, J=3.2 Hz), 10.67 (1H, brs).
mp: 227.6-228.7° C.
mp: 216.2-216.9° C.
mp: 171.1-172.6° C.
mp: 194.6-197.5° C.
mp: 186.5-186.8° C.
mp: 179.1-179.9° C.
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=6.8 Hz), 2.11 (3H, s), 2.79-2.84 (1H, m), 2.99-3.64 (8H, m), 4.18 (2H, t, J=6.6 Hz), 4.31-4.34 (2H, m), 4.52-4.55 (2H, m), 5.13 (2H, s), 6.84 (2H, d, J=8.5 Hz), 7.10-7.15 (3H, m), 7.30 (1H, d, J=15.4 Hz), 7.40-7.48 (6H, m), 7.50-7.56 (3H, m), 7.61-7.65 (2H, m), 7.81 (1H, d, J=2.7 Hz), 7.85 (1H, s), 11.13 (1H, s).
mp: 180.7-181.2° C.
1H-NMR (DMSO-d6) δ: 2.14 (3H, s), 2.22 (3H, s),2.90-3.60 (8H, m), 4.17 (2H, t, J=6.7 Hz), 4.33 (2H, s), 4.54 (2H, s), 5.23 (2H, s), 6.80-6.83 (2H, m), 6.99-7.08 (4H, m), 7.20 (1H, d, J=15.1 Hz), 7.41-7.56 (7H, m), 7.60 (1H, dd, J=7.6, 1.5 Hz), 7.64 (1H, dd, J=9.0, 3.2 Hz), 7.67 (2H, dd, J=8.1, 1.5 Hz), 7.93 (1H, d, J=3.2 Hz), 10.56 (1H, brs).
mp: 171.3-172.3° C.
1H-NMR (DMSO-d6) δ: 2.14 (3H, s), 2.22 (3H, s), 2.90-3.70 (8H, m), 4.17 (2H, t, J=6.6 Hz), 4.32 (2H, s), 4.53 (2H, s), 5.19 (2H, s), 6.80-6.83 (2H, m), 7.00 (1H, d, J=8.3 Hz), 7.06 (3H, t, J=8.8 Hz), 7.21 (1H, d, J=15.1 Hz), 7.38-7.43 (4H, m), 7.49-7.56 (5H, m), 7.60-7.65 (2H, m), 7.69 (1H, d, J=2.0 Hz), 7.92 (1H, d, J=3.4 Hz), 10.91 (1H, brs).
mp: 192.9-194.6° C.
mp: 178.2-178.9° C.
mp: 174.5-174.9° C.
mp: 203.1-203.8° C.
mp: 205.4-206.0° C.
mp: 196.6-197.3° C.
mp: 184.2-186.2° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.22 (3H, s), 2.80-3.80 (8H, m), 4.17 (2H, t, J=6.8 Hz), 4.32 (2H, brs), 4.51-4.56 (2H, m), 5.09 (2H, s), 6.82 (2H, d, J=8.6 Hz), 7.09 (3H, t, J=8.9 Hz), 7.19-7.26 (2H, m), 7.30 (1H, d, J=15.5 Hz), 7.41-7.55 (8H, m), 7.60-7.63 (2H, m), 7.81 (1H, d, J=3.0 Hz), 7.85 (1H, d, J=1.6 Hz), 11.15 (1H, brs).
mp: 176.8-177.7° C.
mp: 212.6-212.9° C. (dec.)
1H-NMR (DMSO-d6) δ: 2.21 (3H, s), 2.31 (3H, s), 2.35 (3H, s), 3.03-3.45 (8H, m), 4.16 (2H, t, J=6.6 Hz), 4.32 (2H, brs), 4.52 (2H, brs), 5.09 (2H, s), 6.80-6.83 (2H, m), 6.91-6.93 (2H, m), 7.01-7.12 (4H, m), 7.20 (2H, d, J=7.8 Hz), 7.34 (2H, d, J=7.8 Hz), 7.41-7.43 (2H, m), 7.49-7.51 (2H, m), 7.57-7.60 (1H, m), 7.74 (1H, d, J=15.1 Hz), 7.79 (1H, d, J=9.5 Hz), 7.93-7.94 (1H, m), 10.76 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.05-3.15 (5H, m), 3.39-3.57 (3H, m), 4.20 (2H, t, J=6.6 Hz), 4.32-4.35 (2H, m), 4.52-4.56 (2H, m), 5.24 (2H, s), 6.77-6.81 (2H, m), 7.12 (1H, d, J=8.8 Hz), 7.30 (1H, d, J=15.4 Hz), 7.41-7.53 (5H, m), 7.56-7.59 (2H, m), 7.62-7.69 (4H, m), 7.78 (2H, d, J=8.3 Hz), 7.83 (1H, d, J=3.2 Hz), 7.85 (1H, d, J=1.5 Hz), 10.97 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.22 (3H, s), 3.04-3.15 (5H, m), 3.35-3.56 (3H, m), 4.17 (2H, t, J=6.6 Hz), 4.33 (2H, brs), 4.52-4.56 (2H, m), 5.24 (2H, s), 6.82 (2H, d, J=8.8 Hz), 7.07 (2H, d, J=8.8 Hz), 7.12 (1H, d, J=9.0 Hz), 7.30 (1H, d, J=15.4 Hz), 7.42-7.53 (5H, m), 7.62-7.69 (4H, m), 7.78 (2H, d, J=8.3 Hz), 7.83 (1H, d, J=3.2 Hz), 7.85 (1H, d, J=1.7 Hz), 10.89 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.01-3.19 (3H, m), 3.34-3.62 (5H, m), 4.22 (2H, t, J=6.6 Hz), 4.31-4.33 (2H, m), 4.52-4.56 (2H, m), 5.24 (2H, s), 6.95-6.98 (2H, m), 7.12 (1H, d, J=9.0 Hz), 7.29-7.33 (3H, m), 7.41-7.56 (5H, m), 7.62-7.69 (4H, m), 7.78 (2H, d, J=8.1 Hz), 7.83 (1H, d, J=2.9 Hz), 7.85 (1H, s), 11.30 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=6.8 Hz), 2.10 (3H, s), 2.78-2.85 (1H, m), 3.04-3.08 (5H, m), 3.35-3.55 (3H, m), 4.18 (2H, t, J=6.7 Hz), 4.34 (2H, brs), 4.52-4.56 (2H, m), 5.24 (2H, s), 6.84 (2H, d, J=8.5 Hz), 7.11-7.14 (3H, m), 7.30 (1H, d, J=15.1 Hz), 7.42-7.52 (5H, m), 7.62-7.67 (4H, m), 7.78 (2H, d, J=8.1 Hz), 7.82 (1H, d, J=2.9 Hz), 7.85 (1H, s), 10.80 (1H, s).
1H-NMR (DMSO-d6) δ: 1.68-1.70 (4H, m), 2.10 (3H, s), 2.61-2.66 (4H, m), 3.03-3.15 (5H, m), 3.35-3.54 (3H, m), 4.15 (2H, t, J=6.6 Hz), 4.33 (2H, brs), 4.51-4.54 (2H, m), 5.24 (2H, s), 6.60-6.66 (2H, m), 6.93 (1H, d, J=8.3 Hz), 7.12 (1H, d, J=8.8 Hz), 7.30 (1H, d, J=15.4 Hz), 7.41-7.51 (5H, m), 7.62-7.68 (4H, m), 7.77 (2H, d, J=8.3 Hz), 7.82 (1H, d, J=2.9 Hz), 7.85 (1H, s), 10.73 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 3.11-3.18 (5H, m), 3.42-3.53 (3H, m), 4.33-4.36 (4H, m), 4.53-4.56 (2H, m), 5.24 (2H, s), 7.11-7.16 (2H, m), 7.29-7.35 (3H, m), 7.45-7.53 (6H, m), 7.62-7.69 (4H, m), 7.77-7.85 (7H, m), 10.64 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.07-3.11 (5H, m), 3.36-3.54 (3H, m), 4.30-4.33 (4H, m), 4.52-4.54 (2H, m), 5.24 (2H, s), 7.12 (1H, d, J=8.8 Hz), 7.30 (1H, d, J=15.6 Hz), 7.39-7.55 (7H, m), 7.62-7.69 (4H, m), 7.77 (2H, d, J=8.3 Hz), 7.82 (1H, d, J=3.2 Hz), 7.85 (1H, s), 8.11 (1H, d, J=2.9 Hz), 10.70 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.28 (3H, t, J=7.1 Hz), 2.11 (3H, s), 3.01-3.15 (5H, m), 3.35-3.56 (3H, m), 3.93 (2H, q, J=7.1 Hz), 4.14 (2H, t, J=6.6 Hz), 4.33 (2H, brs), 4.52-4.56 (2H, m), 5.24 (2H, s), 6.81-6.86 (4H, m), 7.12 (1H, d, J=9.0 Hz), 7.30 (1H, d, J=15.4 Hz), 7.41-7.53 (5H, m), 7.63-7.69 (4H, m), 7.77 (2H, d, J=8.1 Hz), 7.83 (1H, d, J=3.2 Hz), 7.85 (1H, d, J=1.7 Hz), 10.93 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 2.50 (3H, s), 3.00-3.61 (8H, m), 4.30-4.34 (4H, m), 4.52-4.55 (2H, m), 5.05 (2H, s), 7.04 (2H, d, J=9.0 Hz), 7.09 (1H, d, J=9.0 Hz), 7.19 (2H, d, J=8.1 Hz), 7.28-7.34 (3H, m), 7.43-7.63 (7H, m), 7.79 (1H, d, J=2.9 Hz), 7.84-7.85 (1H, m), 7.91 (2H, d, J=8.8 Hz), 11.25 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.00-3.18 (5H, m), 3.42-3.60 (3H, m), 4.31-4.34 (4H, m), 4.52-4.56 (2H, m), 5.24 (2H, s), 7.11-7.14 (3H, m), 7.31 (1H, d, J=15.4 Hz), 7.43-7.55 (5H, m), 7.62-7.69 (4H, m), 7.75-7.79 (4H, m), 7.83 (1H, d, J=3.2 Hz), 7.85 (1H, s), 11.19 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.19 (3H, d, J=1.7 Hz), 3.02-3.08 (5H, m), 3.39-3.56 (3H, m), 4.17 (2H, t, J=6.6 Hz), 4.34 (2H, brs), 4.52-4.55 (2H, m), 5.24 (2H, s), 6.72-6.76 (1H, m), 6.83-6.86 (1H, m), 7.02 (1H, t, J=9.2 Hz), 7.12 (1H, d, J=8.8 Hz), 7.30 (1H, d, J=15.4 Hz), 7.42-7.52 (5H, m), 7.64-7.68 (4H, m), 7.77 (2H, d, J=8.1 Hz), 7.82 (1H, d, J=2.9 Hz), 7.84 (1H, s), 10.83 (1H, brs).
mp: 193.6-194.8° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.22 (3H, s), 3.04-4.55 (14H, m), 5.29 (2H, s), 6.82 (2H, d, J=8.5 Hz), 7.07 (2H, d, J=8.3 Hz), 7.12 (1H, d, J=9.0 Hz), 7.29 (1H, d, J=15.4 Hz), 7.42 (2H, d, J=7.3 Hz), 7.47-7.51 (3H, m), 7.63-7.66 (2H, m), 7.73 (2H, d, J=8.5 Hz), 7.83-7.84 (2H, m), 8.27 (2H, d, J=8.5 Hz), 11.08 (1H, s).
mp: 221.7-222.9° C.
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=7.1 Hz), 2.10 (3H, s), 2.81 (1H, septet, J=6.8 Hz), 3.05-4.53 (14H, m), 5.29 (2H, s), 6.84 (2H, d, J=8.5 Hz), 7.12 (2H, d, J=9.3 Hz), 7.13 (1H, d, J=8.5 Hz), 7.29 (1H, d, J=15.4 Hz), 7.44-7.49 (5H, m), 7.63-7.66 (2H, m), 7.73 (2H, d, J=8.5 Hz), 7.83-7.84 (2H, m), 8.27 (2H, d, J=8.5 Hz), 10.61 (1H, brs).
mp: 175.7-176.6° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.22 (3H, s), 3.04-4.53 (14H, m), 5.47 (2H, s), 6.81 (2H, d, J=8.5 Hz), 7.07 (2H, d, J=8.3 Hz), 7.11 (1H, d, J=8.8 Hz), 7.29 (1H, d, J=15.4 Hz), 7.42-7.51 (5H, m), 7.62-7.66 (3H, m), 7.80-7.84 (4H, m), 8.13 (1H, d, J=8.1 Hz), 10.57 (1H, brs).
mp: 182.3-184.5° C.
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=6.8 Hz), 2.11 (3H, s), 2.81 (1H, qq, J=6.8, 6.8 Hz), 3.05-4.53 (14H, m), 5.47 (2H, s), 6.84 (2H, d, J=8.5 Hz), 7.11 (1H, d, J=8.5 Hz), 7.13 (2H, d, J=8.3 Hz), 7.29 (1H, d, J=15.4 Hz), 7.42-7.51 (5H, m), 7.63-7.66 (3H, m), 7.80-7.84 (4H, m), 8.13 (1H, d, J=8.1 Hz), 10.45 (1H, brs).
mp: 156.6-159.1° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.03-4.55 (17H, m), 5.47 (2H, s), 6.84 (2H, d, J=9.3 Hz), 6.87 (2H, d, J=9.5 Hz), 7.11 (1H, d, J=9.0 Hz), 7.30 (1H, d, J=15.4 Hz), 7.42 (2H, d, J=7.8 Hz), 7.49 (1H, d, J=15.6 Hz), 7.53 (2H, d, J=7.6 Hz), 7.62-7.66 (3H, m), 7.78-7.84 (4H, m), 8.13 (1H, d, J=8.3 Hz), 11.09 (1H, s).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.03-3.15 (5H, m), 3.34-3.57 (3H, m), 4.32 (2H, brs), 4.46-4.55 (4H, m), 5.24 (2H, s), 6.85 (1H, d, J=9.0 Hz), 7.12 (1H, d, J=8.8 Hz), 7.30 (1H, d, J=15.4 Hz), 7.41 (2H, d, J=7.6 Hz), 7.47-7.53 (3H, m), 7.62-7.69 (4H, m), 7.76-7.85 (5H, m), 8.21 (1H, d, J=2.7 Hz), 10.97 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.32 (3H, d, J=7.1 Hz), 2.11 (3H, s), 2.21 (3H, s), 3.06-3.59 (7H, m), 4.02 (1H, dd, J=9.5, 6.8 Hz), 4.07 (1H, dd, J=9.5, 6.8 Hz), 4.32 (2H, brs), 4.52-4.55 (2H, m), 5.17 (2H, s), 6.79 (2H, dt, J=9.2, 2.4 Hz), 7.06 (2H, d, J=8.1 Hz), 7.12 (1H, d, J=9.0 Hz), 7.30 (1H, d, J=15.4 Hz), 7.39-7.66 (11H, m), 7.84-7.85 (2H, m), 11.02 (11H, brs).
1H-NMR (DMSO-d6) δ: 1.20 (3H, d, J=6.1 Hz), 2.10 (3H, s), 2.21 (3H, s), 2.30 (3H, s), 2.85-3.59 (6H, m), 2.87 (1H, dd, J=13.7, 5.6 Hz), 2.98 (1H, dd, J=13.7, 6.6 Hz), 4.31 (2H, brs), 4.51-4.54 (2H, m), 4.61-4.68 (1H, m), 5.05 (2H, s), 6.80 (2H, dt, J=9.0, 2.4 Hz), 7.05 (2H, d, J=8.1 Hz), 7.08 (1H, d, J=8.9 Hz), 7.20 (2H, d, J=7.8 Hz), 7.27-7.52 (8H, m), 7.59 (1H, dd, J=8.9, 3.1 Hz), 7.62 (1H, d, J=1.7 Hz), 7.79 (1H, d, J=3.1 Hz), 7.83 (1H, d, J=1.7 Hz), 11.14 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.32 (3H, d, J=7.1 Hz), 2.10 (3H, s), 2.21 (3H, s), 2.30 (3H, s), 3.06-3.56 (7H, m), 4.02 (1H, dd, J=9.6, 6.8 Hz), 4.07 (1H, dd, J=9.6, 7.0 Hz), 4.33 (2H, brs), 4.52-4.55 (2H, m), 5.05 (2H, s), 6.79 (2H, dt, J=9.3, 2.5 Hz), 7.05-7.10 (3H, m), 7.20 (2H, d, J=7.8 Hz), 7.29 (1H, d, J=15.6 Hz), 7.33 (2H, d, J=8.1 Hz), 7.43-7.53 (5H, m), 7.59 (1H, dd, J=8.9, 3.2 Hz), 7.62 (1H, d, J=1.7 Hz), 7.78 (1H, d, J=3.2 Hz), 7.84 (1H, d, J=1.7 Hz), 10.82 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.00-3.39 (7H, m), 3.63 (1H, brs), 4.32 (2H, brs), 4.48-4.55 (4H, m), 5.24 (2H, s), 6.81 (1H, d, J=8.3 Hz), 6.97-6.99 (1H, m), 7.12 (1H, d, J=9.0 Hz), 7.30 (1H, d, J=15.4 Hz), 7.39-7.56 (5H, m), 7.62-7.73 (5H, m), 7.77 (2H, d, J=8.3 Hz), 7.82-7.85 (2H, m), 8.16 (1H, dd, J=5.0, 1.3 Hz), 11.41 (1H, brs).
1H-NMR (DMSO-d6) δ: 0.53-0.57 (2H, m), 0.84-0.88 (2H, m), 1.80-1.87 (1H, m), 2.11 (3H, s), 3.00-3.07 (5H, m), 3.38-3.63 (3H, m), 4.17 (2H, t, J=6.6 Hz), 4.33 (2H, brs), 4.51-4.53 (2H, m), 5.24 (2H, s), 6.80-6.83 (2H, m), 6.97-6.99 (2H, m), 7.12 (1H, d, J=9.3 Hz), 7.30 (1H, d, J=15.4 Hz), 7.43-7.51 (5H, m), 7.62-7.68 (4H, m), 7.77 (2H, d, J=8.1 Hz), 7.83 (1H, d, J=2.7 Hz), 7.84 (1H, d, J=2.0 Hz), 10.87 (1H, brs).
mp: 219.4-221.0° C.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.22 (3H, s), 2.98-3.13 (5H, m), 3.35-3.41 (2H, m), 3.52-3.54 (1H, m), 4.17 (2H, t, J=6.6 Hz), 4.32-4.34 (2H, m), 4.53-4.55 (2H, m), 5.23 (2H, s), 6.81 (2H, d, J=8.3 Hz), 7.09 (3H, dd, J=18.9, 8.7 Hz), 7.29 (1H, d, J=15.1 Hz), 7.42-7.51 (5H, m), 7.62-7.66 (4H, m), 7.81-7.84 (2H, m), 7.88 (2H, d, J=8.3 Hz), 10.64 (1H, s).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.01-3.08 (4H, m), 3.32-3.47 (3H, m), 3.58 (1H, brs), 4.21 (2H, t, J=6.6 Hz), 4.33 (2H, brs), 4.51-4.53 (2H, m), 5.24 (2H, s), 6.89-6.93 (2H, m), 7.12 (1H, d, J=9.0 Hz), 7.30 (1H, d, J=15.4 Hz), 7.42-7.53 (7H, m), 7.62-7.69 (4H, m), 7.77 (2H, d, J=8.1 Hz), 7.83 (1H, d, J=2.9 Hz), 7.84 (1H, d, J=2.0 Hz), 10.97 (1H, brs).
mp: 198.1-199.8° C.
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=7.1 Hz), 2.81 (1H, septet, J=7.1 Hz), 3.05 (2H, t, J=6.7 Hz), 3.14-3.16 (2H, m), 3.24-3.70 (4H, m), 3.71-4.88 (2H, m), 4.17 (2H, t, J=6.6 Hz), 4.29-4.35 (2H, m), 5.26 (2H, s), 6.81-6.85 (2H, m), 7.10-7.15 (3H, m), 7.24-7.30 (1H, m), 7.36-7.55 (8H, m), 7.60 (1H, d, J=2.4 Hz), 7.68 (1H, dd, J=9.0, 3.2 Hz), 7.94 (1H, d, J=8.5 Hz), 8.00 (1H, dd, J=3.2, 0.5 Hz), 8.04 (2H, d, J=9.0 Hz), 10.83 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.32 (3H, d, J=7.1 Hz), 2.03 (6H, s), 2.21 (3H, s), 3.04-3.60 (7H, m), 3.75 (3H, s), 4.02 (1H, dd, J=9.5, 6.8 Hz), 4.07 (1H, dd, J=9.5, 6.8 Hz), 4.32 (2H, brs), 4.53 (2H, brs), 5.01 (2H, s), 6.79 (2H, dt, J=9.2, 2.4 Hz), 6.94 (2H, dt, J=9.2, 2.4 Hz), 6.99 (1H, d, J=9.1 Hz), 7.06 (2H, d, J=8.3 Hz), 7.19 (1H, d, J=15.4 Hz), 7.37 (2H, dt, J=9.1, 2.9 Hz), 7.42-7.50 (5H, m), 7.54-7.57 (3H, m), 7.78 (1H, d, J=2.9 Hz), 11.19 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.32 (3H, d, J=7.1 Hz), 2.03 (6H, s), 2.21 (3H, s), 3.03-3.60 (7H, m), 4.02 (1H, dd, J=9.4, 6.7 Hz), 4.07 (1H, dd, J=9.4, 6.7 Hz), 4.32 (2H, brs), 4.53 (2H, brs), 5.08 (2H, s), 6.79 (2H, dt, J=9.3, 2.5 Hz), 7.00 (1H, d, J=9.0 Hz), 7.06 (2H, d, J=8.1 Hz), 7.17-7.25 (3H, m), 7.42-7.60 (10H, m), 7.80 (1H, d, J=2.7 Hz), 11.15 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.20 (3H, s), 2.30 (3H, s), 3.01-3.08 (4H, m), 3.33-3.58 (4H, m), 4.32 (2H, brs), 4.44 (2H, t, J=6.8 Hz), 4.51-4.53 (2H, m), 5.06 (2H, s), 6.69 (1H, d, J=8.3 Hz), 7.09 (1H, d, J=9.0 Hz), 7.20 (2H, d, J=7.8 Hz), 7.27-7.34 (3H, m), 7.40 (2H, d, J=7.6 Hz), 7.47-7.53 (4H, m), 7.58-7.63 (2H, m), 7.79 (1H, d, J=3.2 Hz), 7.84 (1H, s), 7.96 (1H, s), 10.80 (1H, brs).
mp: 196.3-196.9° C.
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 3.05-4.53 (14H, m), 5.16 (2H, s), 6.95 (2H, dd, J=7.3, 4.4 Hz), 7.02 (1H, d, J=9.0 Hz), 7.10 (2H, t, J=8.3 Hz), 7.19 (1H, d, J=15.4 Hz), 7.39-7.43 (4H, m), 7.46-7.53 (6H, m), 7.61-7.63 (2H, m), 7.84 (1H, brs), 11.24 (1H, brs).
mp: 212.1-212.5° C.
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.30 (3H, s), 3.03-4.53 (17H, m), 5.04 (2H, s), 6.82-6.88 (4H, m), 6.99 (1H, d, J=8.8 Hz), 7.17-7.20 (3H, m), 7.32 (2H, d, J=7.8 Hz), 7.42 (2H, d, J=7.6 Hz), 7.47 (2H, d, J=7.6 Hz), 7.49 (2H, d, J=7.6 Hz), 7.52 (1H, d, J=7.6 Hz), 7.55-7.58 (1H, m), 7.79 (1H, d, J=2.4 Hz), 10.90 (1H, s).
mp: 221.1-221.5° C.
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.30 (3H, s), 3.05-4.53 (14H, m), 5.04 (2H, s), 6.94 (2H, dd, J=9.0, 4.4 Hz), 6.99 (1H, d, J=9.0 Hz), 7.10 (2H, t, J=8.8 Hz), 7.17-7.20 (3H, m), 7.32 (2H, d, J=7.8 Hz), 7.43 (2H, d, J=7.6 Hz), 7.47 (2H, d, J=7.6 Hz), 7.49 (2H, d, J=7.6 Hz), 7.51-7.58 (3H, m), 7.79 (1H, d, J=2.9 Hz), 10.95 (1H, s).
mp: 172.6-173.8° C.
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 3.03-4.53 (17H, m), 5.16 (2H, s), 6.84 (2H, d, J=9.8 Hz), 6.87 (2H, d, J=9.8 Hz), 7.02 (1H, d, J=9.0 Hz), 7.19 (1H, d, J=15.4 Hz), 7.39-7.43 (4H, m), 7.46-7.55 (6H, m), 7.61-7.62 (2H, m), 7.84 (1H, d, J=2.2 Hz), 11.23 (1H, s).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 3.03-3.15 (5H, m), 3.30-3.48 (2H, m), 3.58 (1H, brs), 4.30-4.34 (4H, m), 4.52-4.55 (2H, m), 5.05 (2H, s), 7.09 (1H, d, J=9.0 Hz), 7.20 (2H, d, J=7.8 Hz), 7.27-7.34 (3H, m), 7.41-7.54 (7H, m), 7.59 (1H, dd, J=8.9, 3.1 Hz), 7.63 (1H, s), 7.79 (1H, d, J=3.2 Hz), 7.84 (1H, d, J=1.5 Hz), 8.11 (1H, d, J=3.2 Hz), 11.01 (1H, brs).
mp: 218.2-219.3° C.
mp: 179.6-180.7° C.
mp: 211.1-212.3° C.
mp: 187.3-189.2° C.
1H-NMR (DMSO-d6) δ: 1.21 (6H, d, J=5.9 Hz), 2.10 (3H, s), 2.30 (3H, s), 3.04-4.52 (14H, m), 5.05 (2H, s), 6.83 (4H, brs), 7.09 (1H, d, J=9.0 Hz), 7.20 (2H, d, J=7.8 Hz), 7.27-7.34 (3H, m), 7.42 (2H, d, J=7.8 Hz), 7.47-7.51 (3H, m), 7.59 (1H, dd, J=9.0, 2.9 Hz), 7.63 (1H, brs), 7.79 (1H, d, J=2.9 Hz), 7.84 (1H, brs), 10.83 (1H, brs).
mp: 168.5-169.2° C.
1H-NMR (DMSO-d6) δ: 1.21 (6H, d, J=5.9 Hz), 2.03 (6H, s), 2.30 (3H, s), 3.04-4.52 (15H, m), 5.04 (2H, s), 6.83 (4H, brs), 6.99 (1H, d, J=8.8 Hz), 7.16-7.20 (3H, m), 7.32 (2H, d, J=7.6 Hz), 7.42 (2H, d, J=7.6 Hz), 7.46-7.57 (6H, m), 7.78 (1H, brs), 11.00 (1H, brs).
mp: 184.2-187.5° C.
1H-NMR (DMSO-d6) δ: 1.21 (6H, d, J=6.1 Hz), 2.04 (6H, s), 3.03-4.52 (15H, m), 5.16 (2H, s), 6.83 (4H, brs), 7.02 (1H, d, J=8.8 Hz), 7.19 (1H, d, J=15.4 Hz), 7.39-7.43 (4H, m), 7.46-7.51 (4H, m), 7.54 (2H, d, J=8.5 Hz), 7.60-7.63 (2H, m), 7.84 (1H, d, J=2.9 Hz), 11.23 (1H, brs).
mp: 163.2-163.9° C.
1H-NMR (DMSO-d6) δ: 1.21 (6H, d, J=5.9 Hz), 2.11 (3H, s), 3.03-4.52 (15H, m), 5.17 (2H, s), 6.83 (4H, brs), 7.12 (1H, d, J=8.8 Hz), 7.30 (1H, d, J=15.4 Hz), 7.39-7.43 (4H, m), 7.47-7.53 (4H, m), 7.60-7.67 (3H, m), 7.84 (2H, brs), 11.02 (1H, brs).
mp: 219.7-220.7° C.
mp: 217.3-219.0° C.
mp: 186.1-187.6° C.
mp: 213.2-214.6° C.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 2.59 (3H, s), 3.04-3.56 (8H, m), 4.32-4.43 (4H, m), 4.51-4.54 (2H, m), 5.06 (2H, s), 7.09 (1H, d, J=9.0 Hz), 7.20 (2H, d, J=7.6 Hz), 7.28-7.34 (3H, m), 7.43-7.49 (3H, m), 7.55-7.68 (5H, m), 7.79 (1H, d, J=2.9 Hz), 7.84 (1H, d, J=1.5 Hz), 7.95 (1H, brs), 8.45 (1H, s), 11.33 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 3.00-3.09 (4H, m), 3.38-3.47 (3H, m), 3.58 (1H, brs), 4.32 (2H, brs), 4.45-4.52 (4H, m), 5.06 (2H, s), 6.80 (1H, dd, J=8.8, 0.5 Hz), 7.09 (1H, d, J=8.8 Hz), 7.20 (2H, d, J=7.8 Hz), 7.28-7.34 (3H, m), 7.40 (2H, d, J=8.1 Hz), 7.47-7.53 (3H, m), 7.59 (1H, dd, J=8.9, 3.1 Hz), 7.63 (1H, s), 7.79 (1H, d, J=2.9 Hz), 7.84 (1H, d, J=2.0 Hz), 7.89 (1H, dd, J=8.8, 2.4 Hz), 8.28 (1H, dd, J=2.6, 0.6 Hz), 11.00 (1H, brs).
mp: 209.6-210.0° C.
mp: 194.2-195.2° C.
mp: 182.8-182.9° C.
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.21 (6H, s), 3.04-3.06 (4H, m), 3.19-3.21 (1H, m), 3.33-3.36 (2H, m), 3.61-3.63 (1H, m), 4.16 (2H, t, J=6.6 Hz), 4.31-4.33 (2H, m), 4.51-4.54 (2H, m), 5.22 (2H, s), 6.54-6.55 (3H, m), 7.01 (1H, d, J=9.0 Hz), 7.19 (1H, d, J=15.4 Hz), 7.41-7.43 (2H, m), 7.47-7.49 (3H, m), 7.54-7.56 (2H, m), 7.60 (1H, dd, J=9.0, 3.2 Hz), 7.64 (2H, d, J=8.3 Hz), 7.82 (1H, d, J=2.9 Hz), 7.87 (2H, d, J=8.3 Hz), 11.37 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 3.02-3.04 (2H, m), 3.18-3.20 (3H, m), 3.32-3.35 (2H, m), 3.63-3.65 (1H, m), 4.31-4.34 (2H, m), 4.41 (21, t, J=6.6 Hz), 4.51-4.54 (2H, m), 5.22 (2H, s), 7.01 (1H, d, J=9.0 Hz), 7.19 (1H, d, J=15.4 Hz), 7.47-7.49 (5H, m), 7.56-7.65 (7H, m), 7.77 (1H, s), 7.82 (1H, d, J=2.9 Hz), 7.87 (2H, d, J=8.3 Hz), 8.12 (1H, d, J=8.3 Hz), 8.64 (1H, s), 8.94 (1H, s), 11.30 (1H, s).
mp: 136.8-140.2° C.
1H-NMR (DMSO-d6) δ: 1.17 (6H, d, J=6.8 Hz), 2.80-2.87 (1H, m), 3.05-4.57 (20H, m), 5.22 (2H, s), 6.73-6.75 (1H, m), 6.77 (1H, s), 6.80 (1H, d, J=7.8 Hz), 6.93 (1H, d, J=9.0 Hz), 7.13 (2H, s), 7.18 (1H, t, J=7.8 Hz), 7.25 (1H, d, J=15.4 Hz), 7.43 (2H, d, J=7.8 Hz), 7.51-7.57 (4H, m), 7.64 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz), 7.87 (2H, d, J=8.3 Hz), 11.23 (1H, s).
mp: 154.9-157.7° C.
1H-NMR (DMSO-d6) δ: 1.17 (6H, d, J=7.1 Hz), 2.80-2.87 (1H, m), 3.05-4.57 (20H, m), 5.24 (2H, s), 6.74 (1H, d, J=8.1 Hz), 6.77 (1H, s), 6.80 (1H, d, J=7.8 Hz), 6.95 (1H, d, J=9.0 Hz), 7.14 (2H, s), 7.18 (1H, t, J=7.8 Hz), 7.26 (1H, d, J=15.4 Hz), 7.43 (2H, d, J=7.8 Hz), 7.54-7.60 (5H, m), 7.72-7.78 (2H, m), 7.81 (1H, d, J=2.9 Hz), 7.92 (1H, d, J=7.8 Hz), 11.30 (1H, s).
mp: 136.8-137.1° C.
1H-NMR (DMSO-d6) δ: 3.05-4.57 (20H, m), 5.24 (2H, s), 6.93-6.96 (3H, m), 7.10 (2H, t, J=8.8 Hz), 7.14 (2H, s), 7.26 (1H, d, J=15.4 Hz), 7.42 (2H, d, J=7.8 Hz), 7.54-7.61 (5H, m), 7.72-7.78 (2H, m), 7.81 (1H, d, J=2.9 Hz), 7.92 (1H, d, J=7.6 Hz), 11.29 (1H, s).
mp: 142.0-143.6° C.
1H-NMR (DMSO-d6) δ: 3.05-4.57 (20H, m), 5.22 (2H, s), 6.92-6.96 (3H, m), 7.08-7.13 (4H, m), 7.25 (1H, d, J=15.4 Hz), 7.42 (2H, d, J=7.8 Hz), 7.51-7.57 (4H, m), 7.64 (2H, d, J=8.1 Hz), 7.77 (1H, d, J=2.9 Hz), 7.87 (2H, d, J=8.1 Hz), 11.31 (1H, s).
mp: 178.3-180.6° C.
mp: 186.7-189.5° C.
mp: 186.9-189.4° C.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.22 (3H, s), 2.30 (3H, s), 2.35 (3H, s), 3.00-3.58 (6H, m), 3.05 (2H, t, J=6.8 Hz), 4.15 (2H, t, J=6.8 Hz), 4.28 (2H, brs), 4.52-4.55 (2H, m), 5.06 (2H, s), 6.82 (2H, dt, J=9.2, 2.6 Hz), 7.06-7.10 (3H, m), 7.20 (2H, d, J=7.6 Hz), 7.28-7.39 (6H, m), 7.49 (1H, d, J=15.4 Hz), 7.59 (1H, dd, J=8.9, 3.2 Hz), 7.63 (1H, d, J=2.0 Hz), 7.79 (1H, dd, J=3.2, 0.5 Hz), 7.84 (1H, d, J=2.0 Hz), 10.99 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.22 (3H, s), 2.35 (3H, s), 3.00-3.57 (6H, m), 3.05 (2H, t, J=6.8 Hz), 4.15 (2H, t, J=6.8 Hz), 4.28 (2H, brs), 4.53 (2H, brs), 5.08 (2H, s), 6.82 (2H, dt, J=9.3, 2.6 Hz), 7.00 (1H, dd, J=9.0, 0.5 Hz), 7.06-7.08 (2H, m), 7.17-7.25 (3H, m), 7.33-7.39 (3H, m), 7.46-7.52 (5H, m), 7.58 (1H, dd, J=9.0, 3.2 Hz), 7.80 (1H, dd, J=3.2, 0.5 Hz), 10.96 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 2.28 (3H, s), 2.88 (2H, t, J=6.6 Hz), 3.01-3.03 (2H, m), 3.30-3.32 (3H, m), 3.63-3.65 (3H, m), 4.29-4.32 (2H, m), 4.44 (2H, s), 4.50-4.52 (2H, m), 5.44 (2H, s), 7.06 (1H, d, J=9.0 Hz), 7.14-7.20 (5H, m), 7.33 (2H, d, J=7.8 Hz), 7.46-7.50 (3H, m), 7.54 (2H, d, J=8.1 Hz), 7.66 (1H, dd, J=9.0, 3.2 Hz), 7.87 (1H, d, J=2.9 Hz), 7.98 (2H, d, J=6.1 Hz), 8.88 (2H, d, J=6.1 Hz), 11.67 (1H, s).
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 3.06-3.08 (4H, m), 3.31-3.33 (3H, m), 3.64-3.66 (1H, m), 4.25 (2H, t, J=6.6 Hz), 4.30-4.33 (2H, m), 4.51-4.53 (2H, m), 5.44 (2H, s), 6.92 (1H, dd, J=8.3, 1.7 Hz), 6.98-7.08 (3H, m), 7.20 (1H, d, J=15.4 Hz), 7.29 (1H, t, J=8.1 Hz), 7.43-7.48 (5H, m), 7.57 (2H, d, J=8.1 Hz), 7.65 (1H, dd, J=8.9, 3.1 Hz), 7.87 (1H, d, J=2.9 Hz), 7.96 (2H, d, J=6.1 Hz), 8.87 (2H, d, J=6.3 Hz), 11.63 (1H, s).
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 2.90 (2H, t, J=6.6 Hz), 2.94-3.01 (2H, m), 3.16-3.19 (1H, m), 3.31-3.34 (2H, m), 3.61-3.68 (3H, m), 4.30-4.32 (2H, m), 4.47 (2H, s), 4.50-4.53 (2H, m), 5.40 (2H, s), 7.05 (1H, d, J=9.0 Hz), 7.15-7.20 (3H, m), 7.30-7.35 (4H, m), 7.48-7.51 (5H, m), 7.64 (1H, dd, J=9.0, 2.9 Hz), 7.86-7.89 (3H, m), 8.82-8.85 (2H, m), 11.23 (1H, s).
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 2.90 (2H, t, J=6.5 Hz), 3.01-3.03 (2H, m), 3.17-3.19 (1H, m), 3.31-3.34 (2H, m), 3.61-3.69 (3H, m), 4.30-4.32 (2H, m), 4.47-4.55 (4H, m), 5.40 (2H, s), 7.05 (1H, d, J=8.8 Hz), 7.19 (1H, d, J=15.4 Hz), 7.28-7.52 (11H, m), 7.64 (1H, dd, J=9.0, 2.9 Hz), 7.86-7.89 (3H, m), 8.83 (2H, d, J=5.9 Hz), 11.20 (1H, s).
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 2.63 (3H, s), 3.01-3.04 (2H, m), 3.11 (2H, t, J=6.5 Hz), 3.19-3.21 (1H, m), 3.33-3.35 (2H, m), 3.60-3.62 (1H, m), 4.28-4.31 (4H, m), 4.51-4.53 (2H, m), 5.30 (2H, s), 6.94 (1H, t, J=7.1 Hz), 7.04 (1H, d, J=9.0 Hz), 7.17-7.20 (2H, m), 7.26-7.30 (1H, m), 7.40 (1H, dd, J=7.9, 1.3 Hz), 7.46-7.48 (5H, m), 7.55-7.57 (3H, m), 7.65 (2H, dd, J=8.9, 3.1 Hz), 7.85 (1H, d, J=2.9 Hz), 8.10 (1H, s), 11.39 (1H, s).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 3.00-3.17 (5H, m), 3.34-3.47 (2H, m), 3.57 (1H, brs), 3.78 (3H, s), 4.23 (2H, t, J=6.6 Hz), 4.33 (2H, brs), 4.51-4.53 (2H, m), 5.06 (2H, s), 6.75 (1H, d, J=8.8 Hz), 7.09 (1H, d, J=9.0 Hz), 7.20 (2H, d, J=7.8 Hz), 7.27-7.32 (3H, m), 7.38 (1H, dd, J=9.0, 3.2 Hz), 7.42-7.53 (5H, m), 7.59 (1H, dd, J=8.9, 3.1 Hz), 7.63 (1H, s), 7.79 (1H, d, J=3.2 Hz), 7.84-7.85 (2H, m), 10.92 (1H, brs).
mp: 133.1-134.4° C.
1H-NMR (DMSO-d6) δ: 3.05-4.57 (20H, m), 5.26 (2H, s), 6.92-6.96 (3H, m), 7.10 (2H, t, J=8.8 Hz), 7.12 (2H, s), 7.25 (1H, d, J=15.4 Hz), 7.43 (2H, d, J=7.6 Hz), 7.53-7.57 (4H, m), 7.61 (1H, d, J=8.3 Hz), 7.80 (1H, d, J=2.9 Hz), 8.10 (1H, d, J=8.3 Hz), 8.26 (1H, s), 9.41 (1H, s), 11.12 (1H, s).
mp: 133.4-135.1° C.
1H-NMR (DMSO-d6) δ: 1.21 (6H, d, J=5.9 Hz), 3.03-4.57 (2H, m), 5.26 (2H, s), 6.82 (2H, d, J=9.8 Hz), 6.84 (2H, d, J=9.8 Hz), 6.92 (1H, d, J=9.0 Hz), 7.13 (2H, s), 7.25 (1H, d, J=15.4 Hz), 7.42 (2H, d, J=7.8 Hz), 7.53-7.57 (4H, m), 7.62 (1H, d, J=7.3 Hz), 7.80 (1H, d, J=2.9 Hz), 8.10 (1H, d, J=8.3 Hz), 8.26 (1H, s), 9.41 (1H, s), 11.23 (1H, s).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.36 (3H, s), 3.04-3.57 (6H, m), 3.06 (2H, t, J=6.8 Hz), 4.17 (2H, t, J=6.8 Hz), 4.28 (2H, brs), 4.53 (2H, brs), 5.08 (2H, s), 6.92-6.97 (2H, m), 7.00 (1H, d, J=8.9 Hz), 7.07-7.14 (2H, m), 7.17-7.25 (3H, m), 7.36-7.38 (3H, m), 7.46-7.52 (5H, m), 7.58 (1H, dd, J=8.9, 3.1 Hz), 7.80 (1H, d, J=3.1 Hz), 10.91 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 2.36 (3H, s), 3.06 (2H, t, J=6.8 Hz), 3.06-3.55 (6H, m), 4.17 (2H, t, J=6.8 Hz), 4.29 (2H, brs), 4.52-4.56 (2H, m), 5.05 (2H, s), 6.92-6.97 (2H, m), 7.08-7.14 (3H, m), 7.20 (2H, d, J=7.8 Hz), 7.28-7.37 (6H, m), 7.49 (1H, d, J=15.4 Hz), 7.59 (1H, dd, J=8.9, 3.1 Hz), 7.63 (1H, d, J=1.7 Hz), 7.79 (1H, d, J=3.1 Hz), 7.84 (1H, d, J=1.7 Hz), 10.81 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 3.03-3.37 (6H, m), 3.41-3.56 (2H, m), 4.09 (2H, t, J=6.8 Hz), 4.30 (2H, brs), 4.50-4.53 (2H, m), 5.05 (2H, s), 7.09 (1H, d, J=9.3 Hz), 7.17-7.22 (4H, m), 7.29-7.33 (5H, m), 7.45-7.51 (4H, m), 7.59 (1H, dd, J=9.0, 3.2 Hz), 7.63 (1H, d, J=2.0 Hz), 7.79 (1H, d, J=2.7 Hz), 7.84 (1H, d, J=2.0 Hz), 10.87 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.24 (9H, d, J=3.9 Hz), 2.90-3.45 (7H, m), 3.52 (1H, s), 4.18 (2H, t, J=6.6 Hz), 4.33 (2H, brs), 4.53 (2H, brs), 5.12 (2H, s), 6.82-6.86 (2H, m), 7.13 (1H, d, J=9.3 Hz), 7.26-7.33 (5H, m), 7.43-7.57 (8H, m), 7.63 (1H, dd, J=8.9, 3.1 Hz), 7.83 (1H, dd, J=12.0, 2.0 Hz), 7.87 (1H, d, J=2.4 Hz), 10.58 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.37 (3H, s), 3.05-3.07 (4H, m), 3.15-3.18 (1H, m), 3.34-3.36 (2H, m), 3.58-3.60 (1H, m), 4.31-4.34 (2H, m), 4.45 (2H, t, J=6.7 Hz), 4.51-4.54 (2H, m), 5.22 (2H, s), 6.57 (1H, d, J=8.1 Hz), 6.82 (1H, d, J=7.1 Hz), 7.01 (1H, d, J=9.0 Hz), 7.19 (1H, d, J=15.4 Hz), 7.41 (2H, d, J=7.6 Hz), 7.51-7.61 (9H, m), 7.82 (1H, d, J=2.9 Hz), 7.87 (2H, d, J=8.1 Hz), 11.14 (1H, s).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 2.23 (3H, s), 2.90-3.70 (7H, m), 4.47-4.54 (3H, m), 5.17 (2H, s), 5.53 (2H, s), 6.84-6.88 (2H, m), 7.07-7.13 (3H, m), 7.31 (1H, d, J=15.4 Hz), 7.37-7.44 (2H, m), 7.48-7.54 (2H, m), 7.60-7.67 (3H, m), 7.77 (2H, d, J=5.9 Hz), 7.84-7.86 (2H, m), 8.11 (2H, d, J=8.1 Hz), 11.07 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.36 (3H, s), 3.06 (2H, t, J=6.8 Hz), 3.06-3.51 (6H, m), 3.75 (3H, s), 4.17 (2H, t, J=6.8 Hz), 4.28 (2H, brs), 4.53 (2H, brs), 5.01 (2H, s), 6.92-7.00 (5H, m), 7.07-7.14 (2H, m), 7.19 (1H, d, J=15.4 Hz), 7.35-7.38 (5H, m), 7.46-7.50 (3H, m), 7.56 (1H, dd, J=9.0, 3.2 Hz), 7.78 (1H, d, J=3.2 Hz), 10.82 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=6.8 Hz), 2.81 (1H, septet, J=7.1 Hz), 2.90-3.65 (8H, m), 4.18 (2H, t, J=6.7 Hz), 4.33 (2H, brs), 4.53 (2H, brs), 5.26 (2H, s), 6.82-6.86 (2H, m), 7.11-7.15 (3H, m), 7.27-7.32 (2H, m), 7.42-7.58 (6H, m), 7.62-7.66 (3H, m), 7.83 (1H, dd, J=12.2, 2.0 Hz), 7.87-7.89 (3H, m), 10.71 (1H, brs).
mp: 190.4-191.8° C.
mp: 199.2-200.9° C.
mp: 207.0-207.2° C.
mp: 216.7-216.9° C.
mp: 177.7-178.6° C.
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 3.04-3.58 (8H, m), 4.19 (2H, t, J=6.8 Hz), 4.32 (2H, brs), 4.52 (2H, brs), 5.22 (2H, s), 6.91-6.97 (2H, m), 7.00 (1H, d, J=9.0 Hz), 7.07-7.14 (2H, m), 7.19 (1H, d, J=15.4 Hz), 7.41-7.56 (7H, m), 7.62 (1H, dd, J=9.0, 3.2 Hz), 7.81 (1H, d, J=2.0 Hz), 7.83 (1H, d, J=3.2 Hz), 8.13 (1H, d, J=2.0 Hz), 10.97 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=6.8 Hz), 2.03 (6H, s), 2.81 (1H, septet, J=6.8 Hz), 3.04-3.60 (8H, m), 4.17 (2H, t, J=6.8 Hz), 4.32 (2H, brs), 4.52 (2H, brs), 5.22 (2H, s), 6.82-6.87 (2H, m), 7.00 (1H, d, J=9.0 Hz), 7.11-7.15 (2H, m), 7.19 (1H, d, J=15.4 Hz), 7.41-7.55 (7H, m), 7.62 (1H, dd, J=8.8, 3.2 Hz), 7.81 (1H, d, J=2.0 Hz), 7.84 (1H, d, J=3.2 Hz), 9.13 (1H, d, J=2.0 Hz), 11.16 (1H, brs).
1H-NMR (DSMO-d6) δ: 2.03 (6H, s), 2.21 (3H, s), 3.03-3.61 (8H, m), 4.16 (2H, t, J=6.8 Hz), 4.32 (2H, brs), 4.52 (2H, brs), 5.22 (2H, s), 6.79-6.84 (2H, m), 7.00 (1H, d, J=8.8 Hz), 7.06 (2H, d, J=8.3 Hz), 7.14 (1H, d, J=15.6 Hz), 7.40-7.56 (7H, m), 7.62 (1H, dd, J=8.8, 2.9 Hz), 7.81 (1H, d, J=2.0 Hz), 7.84 (1H, d, J=2.9 Hz), 9.13 (1H, d, J=2.0 Hz), 11.25 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.30 (3H, s), 2.95-3.03 (4H, m), 3.17-3.58 (4H, m), 4.20 (2H, t, J=7.1 Hz), 4.29 (2H, brs), 4.52 (2H, brs), 5.05 (2H, s), 7.09 (1H, d, J=9.0 Hz), 7.15-7.21 (3H, m), 7.28-7.34 (7H, m), 7.44-7.46 (2H, m), 7.50 (1H, d, J=15.4 Hz), 7.58-7.64 (3H, m), 7.79 (1H, d, J=3.2 Hz), 7.85 (1H, d, J=2.0 Hz), 10.97 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 2.76 (3H, s), 3.11-3.13 (5H, m), 3.36-3.57 (3H, m), 4.29-4.33 (4H, m), 4.52-4.55 (2H, m), 5.05 (2H, s), 7.02 (1H, dd, J=8.7, 2.6 Hz), 7.09 (1H, d, J=9.0 Hz), 7.20 (2H, d, J=7.8 Hz), 7.28-7.34 (3H, m), 7.45-7.55 (6H, m), 7.59 (1H, dd, J=8.9, 3.1 Hz), 7.63 (1H, s), 7.79 (1H, d, J=3.2 Hz), 7.84 (1H, d, J=1.7 Hz), 7.87 (1H, d, J=8.8 Hz), 10.98 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=7.1 Hz), 2.11 (3H, s), 2.30 (3H, s), 2.33-2.47 (2H, m), 2.61 (3H, s), 2.78-2.85 (1H, m), 3.07 (2H, t, J=6.7 Hz), 3.35-3.44 (1H, m), 3.72-3.99 (4H, m), 4.16-4.20 (3H, m), 4.42-4.49 (1H, m), 5.05 (2H, s), 6.84-6.85 (2H, m), 7.05-7.12 (4H, m), 7.20 (2H, d, J=7.8 Hz), 7.33 (2H, d, J=7.3 Hz), 7.48-7.65 (7H, m), 7.79 (1H, d, J=3.2 Hz), 7.81-7.83 (1H, m), 10.75 (0.511, brs), 10.96 (0.5H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.36 (3H, s), 3.00-3.56 (6H, m), 3.06 (2H, t, J=6.8 Hz), 4.17 (2H, t, J=6.8 Hz), 4.28 (2H, brs), 4.53 (2H, brs), 5.22 (2H, s), 6.92-6.97 (2H, m), 7.02 (1H, d, J=9.3 Hz), 7.07-7.14 (2H, m), 7.19 (1H, d, J=15.4 Hz), 7.36-7.38 (3H, m), 7.46-7.50 (3H, m), 7.60 (1H, dd, J=9.3, 3.2 Hz), 7.64 (2H, d, J=8.3 Hz), 7.82 (1H, dd, J=3.2, 0.5 Hz), 7.88 (2H, dt, J=8.3, 1.8 Hz), 10.90 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.22 (3H, s), 2.35 (3H, s), 3.01-3.57 (6H, m), 3.05 (2H, t, J=6.8 Hz), 3.75 (3H, s), 4.15 (2H, t, J=6.8 Hz), 4.28 (2H, brs), 4.53 (2H, brs), 5.01 (2H, s), 6.82 (2H, dt, J=9.3, 2.5 Hz), 6.94 (2H, dt, J=9.3, 2.5 Hz), 6.99 (1H, d, J=9.0 Hz), 7.07 (2H, d, J=8.1 Hz), 7.19 (1H, d, J=15.4 Hz), 7.35-7.38 (5H, m), 7.46-7.50 (3H, m), 7.56 (1H, dd, J=9.0, 3.2 Hz), 7.78 (1H, d, J=3.2 Hz), 10.92 (1H, brs).
mp: 206.1-206.4° C.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.22 (3H, s), 3.04-4.55 (14H, m), 5.10 (2H, s), 6.80-7.41 (1H, m), 6.82 (2H, d, J=8.2 Hz), 7.07 (2H, d, J=8.2 Hz), 7.10 (1H, d, J=9.0 Hz), 7.20 (2H, d, J=8.5 Hz), 7.30 (1H, d, J=15.4 Hz), 7.43-7.52 (7H, m), 7.61 (1H, dd, J=9.0, 2.9 Hz), 7.63 (1H, brs), 7.80 (1H, d, J=2.9 Hz), 7.84 (1H, brs), 11.04 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=6.9 Hz), 2.12 (3H, s), 2.81 (1H, septet, J=6.9 Hz), 2.90-3.18 (4H, m), 3.20-3.47 (3H, m), 3.60-3.80 (1H, m), 4.18 (2H, t, J=6.9 Hz), 4.34 (2H, brs), 4.56 (2H, d, J=13.7 Hz), 5.18 (2H, s), 6.82-6.88 (2H, m), 7.09-7.16 (3H, m), 7.33 (1H, d, J=15.6 Hz), 7.36-7.45 (4H, m), 7.47-7.55 (2H, m), 7.57-7.68 (5H, m), 7.86 (2H, d, J=2.7 Hz), 11.89 (1H, brs).
1H-NMR (DMSO-d6) δ: 0.53-0.57 (2H, m), 0.84-0.88 (2H, m), 1.80-1.87 (1H, m), 2.10 (3H, s), 2.30 (3H, s), 3.00-3.16 (5H, m), 3.31-3.75 (3H, m), 4.17 (2H, t, J=6.6 Hz), 4.32 (2H, brs), 4.52-4.54 (2H, m), 5.05 (2H, s), 6.80-6.83 (2H, m), 6.96-6.99 (2H, m), 7.09 (1H, dd, J=8.8, 0.5 Hz), 7.20 (2H, d, J=7.8 Hz), 7.29-7.32 (3H, m), 7.41-7.43 (2H, m), 7.47-7.52 (3H, m), 7.59 (1H, dd, J=9.0, 2.9 Hz), 7.63 (1H, d, J=2.0 Hz), 7.78 (1H, d, J=3.4 Hz), 7.84 (1H, d, J=2.0 Hz), 10.81 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 2.22 (3H, s), 2.42 (3H, s), 3.01 (2H, t, J=6.8 Hz), 3.19-3.63 (6H, m), 4.16 (2H, t, J=6.8 Hz), 4.34 (2H, brs), 4.54 (2H, brs), 5.08 (2H, s), 6.82 (2H, dt, J=9.3, 2.6 Hz), 7.00 (1H, d, J=9.3 Hz), 7.07 (2H, d, J=8.1 Hz), 7.18-7.26 (5H, m), 7.47-7.53 (5H, m), 7.55 (1H, d, J=7.8 Hz), 7.58 (1H, dd, J=9.3, 3.2 Hz), 7.80 (1H, d, J=3.2 Hz), 10.52 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 2.22 (3H, s), 2.42 (3H, s), 3.01 (2H, t, J=6.8 Hz), 3.18-3.62 (6H, m), 3.75 (3H, s), 4.16 (2H, t, J=6.8 Hz), 4.34 (2H, brs), 4.54 (2H, brs), 5.01 (2H, s), 6.82 (2H, dt, J=9.3, 2.5 Hz), 6.94 (2H, dt, J=9.3, 2.5 Hz), 6.99 (1H, d, J=9.0 Hz), 7.07 (2H, d, J=8.1 Hz), 7.18-7.26 (3H, m), 7.37 (2H, dt, J=9.0, 2.3 Hz), 7.47-7.58 (5H, m), 7.78 (1H, d, J=2.9 Hz), 10.59 (1H, brs).
mp: 198.5-198.8° C.
mp: 193.7-194.2° C.
mp: 240.5-243.5° C.
mp: 161.0-163.1° C.
1H-NMR (DMSO-d6) δ: 1.28 (3H, t, J=6.8 Hz), 2.11 (3H, s), 3.03-4.56 (16H, m), 5.17 (2H, s), 6.82 (2H, d, J=9.5 Hz), 6.85 (2H, d, J=9.5 Hz), 7.12 (1H, d, J=9.0 Hz), 7.30 (1H, d, J=15.4 Hz), 7.39-7.43 (4H, m), 7.47-7.51 (4H, m), 7.60-7.67 (3H, m), 7.84-7.85 (2H, m), 10.87 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 3.05-3.20 (4H, m), 3.40-3.43 (3H, m), 3.61-3.63 (1H, m), 4.33-4.37 (4H, m), 4.53-4.56 (2H, m), 5.22 (2H, s), 7.01 (1H, d, J=8.8 Hz), 7.14-7.20 (3H, m), 7.31-7.35 (2H, m), 7.46-7.49 (3H, m), 7.60-7.64 (5H, m), 7.70-7.73 (1H, m), 7.82 (1H, d, J=2.9 Hz), 7.88 (2H, d, J=8.1 Hz), 11.34 (1H, s).
1H-NMR (CDCl3) δ: 2.11 (2H, tt, J=6.9, 6.9 Hz), 2.19 (3H, s), 2.72 (2H, brs), 2.85 (2H, t, J=6.9 Hz), 3.46 (2H, brs), 3.67 (1H, brs), 3.97 (2H, t, J=6.9 Hz), 4.15-4.23 (4H, m), 4.78 (1H, brs), 5.09 (2H, s), 6.70 (1H, d, J=15.3 Hz), 6.89 (2H, d, J=8.1 Hz), 6.93-6.98 (2H, m), 7.26-7.32 (5H, m), 7.38 (1H, dd, J=8.9, 3.1 Hz), 7.45 (1H, s), 7.52 (4H, d, J=7.8 Hz), 7.60 (1H, d, J=15.3 Hz), 7.68 (2H, d, J=7.8 Hz), 7.75 (1H, d, J=2.9 Hz), 13.52 (1H, brs).
mp: 166.2-166.7° C.
mp: 168.5-170.0° C.
1H-NMR (DMSO-d6) δ: 2.04-2.10 (5H, m), 2.59 (3H, s), 2.79 (2H, t, J=7.6 Hz), 3.38 (6H, brs), 4.16 (2H, t, J=6.2 Hz), 4.31 (2H, brs), 4.53 (2H, brs), 5.23 (2H, s), 7.12 (1H, d, J=9.0 Hz), 7.30 (1H, d, J=15.4 Hz), 7.35 (2H, d, J=8.1 Hz), 7.47-7.53 (3H, m), 7.62-7.69 (5H, m), 7.82 (1H, d, J=2.9 Hz), 7.84 (1H, d, J=2.0 Hz), 7.88 (2H, dt, J=8.3, 1.8 Hz), 7.93 (1H, d, J=8.5 Hz), 8.43 (1H, d, J=2.9 Hz), 11.24 (1H, brs).
mp: 193.0-194.8° C.
mp: 197.8-198.7° C.
mp: 204.9-206.2° C.
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 2.80-3.80 (6H, m), 3.69 (3H, s), 4.25-4.45 (2H, m), 4.46-4.62 (2H, m), 5.08 (2H, s), 5.17 (2H, s), 6.83-6.90 (2H, m), 6.92-6.99 (2H, m), 7.12 (1H, d, J=9.0 Hz), 7.27-7.57 (7H, m), 7.59-7.69 (5H, m), 7.82-7.89 (2H, m), 11.28 (1H, brs).
mp: 194.7-197.0° C.
mp: 203.8-204.4° C.
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.9 Hz), 2.10 (3H, s), 2.30 (3H, s), 2.82 (1H, septet, J=6.9 Hz), 3.11-3.57 (6H, m), 4.36-4.57 (4H, m), 5.05 (2H, s), 5.11 (2H, s), 6.91-6.96 (2H, m), 7.07-7.34 (8H, m), 7.46-7.63 (7H, m), 7.78 (1H, d, J=3.0 Hz), 7.84 (1H, d, J=1.6 Hz), 10.98 (1H, brs).
mp: 209.6-212.0° C.
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 2.11 (3H, s), 2.82 (1H, septet, J=6.8 Hz), 3.02-3.59 (6H, m), 4.35-4.38 (2H, m), 4.53-4.57 (2H, m), 5.11 (2H, s), 5.17 (2H, s), 6.93 (2H, d, J=7.8 Hz), 7.11-7.17 (3H, m), 7.29-7.67 (12H, m), 7.84-7.85 (2H, m), 11.06 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.22 (6H, d, J=5.9 Hz), 2.90-3.60 (6H, m), 4.37 (2H, s), 4.44-4.50 (1H, m), 4.54 (2H, s), 5.07 (2H, s), 5.19 (2H, s), 6.83-6.87 (2H, m), 6.91-6.95 (2H, m), 7.15 (1H, d, J=8.8 Hz), 7.28-7.34 (2H, m), 7.38-7.44 (2H, m), 7.52-7.63 (8H, m), 7.66 (1H, dd, J=8.9, 3.1 Hz), 7.85 (1H, dd, J=12.1, 1.8 Hz), 7.91 (1H, d, J=2.9 Hz), 10.76 (1H, s).
mp: 207.7-208.0° C.
mp: 199.9-201.6° C.
mp: 196.2-196.4° C.
mp: 182.5-183.2° C.
1H-NMR (DMSO-d6) δ: 1.22 (6H, d, J=6.2 Hz), 2.36 (3H, s), 3.04-3.59 (6H, m), 4.35-4.51 (5H, m), 5.07 (2H, s), 5.20 (2H, s), 6.82-6.96 (6H, m), 7.04-7.14 (2H, m), 7.37-7.66 (9H, m), 7.72-7.83 (2H, m), 7.99 (1H, d, J=3.0 Hz), 11.11 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 2.79-2.86 (1H, m), 3.03-3.56 (6H, m), 4.36 (2H, brs), 4.53 (2H, brs), 5.11 (2H, s), 5.21 (2H, s), 6.93 (2H, dt, J=9.4, 2.5 Hz), 7.07-7.12 (3H, m), 7.16 (2H, dt, J=9.4, 2.5 Hz), 7.21 (1H, d, J=15.4 Hz), 7.38-7.45 (2H, m), 7.51-7.67 (8H, m), 7.75 (2H, d, J=8.5 Hz), 8.00 (1H, d, J=3.2 Hz), 10.91 (1H, brs).
mp: 189.6-190.9° C. (dec.)
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 2.31 (3H, s), 2.35 (3H, s), 2.82 (1H, septet, J=6.8 Hz), 3.09-3.52 (6H, m), 4.36 (2H, brs), 4.53 (2H, brs), 5.09 (2H, s), 5.11 (2H, s), 6.92-6.94 (4H, m), 7.03 (1H, d, J=8.8 Hz), 7.10 (1H, d, J=15.1 Hz), 7.15 (2H, d, J=8.5 Hz), 7.20 (2H, d, J=8.3 Hz), 7.34 (2H, d, J=8.3 Hz), 7.53-7.60 (5H, m), 7.74 (1H, d, J=15.1 Hz), 7.79-7.81 (1H, m), 7.94 (1H, d, J=3.2 Hz), 10.73 (1H, brs).
mp: 181.4-182.3° C.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 2.97-3.62 (6H, m), 4.34-4.36 (2H, m), 4.52-5.57 (6H, m), 5.05 (2H, s), 7.09 (1H, d, J=9.0 Hz), 7.17-7.22 (4H, m), 7.28-7.34 (3H, m), 7.38-7.51 (5H, m), 7.57-7.63 (4H, m), 7.78 (1H, d, J=2.9 Hz), 7.84 (1H, d, J=1.7 Hz), 11.08 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.97-3.65 (6H, m), 4.34-4.36 (2H, m), 4.52-4.57 (6H, m), 5.17 (2H, s), 7.12 (1H, d, J=8.8 Hz), 7.16-7.22 (2H, m), 7.31 (1H, d, J=15.4 Hz), 7.37-7.54 (8H, m), 7.58-7.67 (5H, m), 7.84-7.86 (2H, m), 11.28 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.09-3.22 (3H, m), 3.41-3.46 (2H, m), 3.60-3.62 (1H, m), 4.40-4.42 (2H, m), 4.54-4.56 (2H, m), 5.15 (2H, s), 5.23 (2H, s), 7.03-7.06 (2H, m), 7.10-7.17 (3H, m), 7.31 (1H, d, J=15.4 Hz), 7.38-7.43 (2H, m), 7.49 (1H, d, J=15.4 Hz), 7.62-7.67 (4H, m), 7.76-7.90 (5H, m), 11.29 (1H, s).
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 3.12-3.14 (2H, m), 3.43-3.46 (2H, m), 3.54-3.56 (2H, m), 4.41-4.43 (2H, m), 4.55-4.57 (2H, m), 5.05 (2H, s), 5.15 (2H, s), 7.02-7.21 (7H, m), 7.28-7.32 (2H, m), 7.34 (1H, s), 7.39-7.44 (2H, m), 7.49 (1H, d, J=15.4 Hz), 7.59 (1H, dd, J=8.9, 3.1 Hz), 7.63 (1H, s), 7.71 (1H, s), 7.79 (1H, d, J=2.9 Hz), 7.84 (1H, s), 10.78 (1H, s).
mp: 141.8-141.9° C.
mp: 218.0-220.5° C.
mp: 176.7-176.9° C.
1H-NMR (DMSO-d6) δ: 0.87 (3H, t, J=7.2 Hz), 1.53-1.56 (2H, m), 2.10 (3H, s), 3.09-3.12 (3H, m), 3.35-3.57 (5H, m), 4.39-4.41 (2H, m), 4.53-4.55 (2H, m), 5.13 (2H, s), 5.23 (2H, s), 6.94 (2H, d, J=8.5 Hz), 7.12 (3H, d, J=8.5 Hz), 7.30 (1H, d, J=15.4 Hz), 7.39-7.54 (3H, m), 7.62-7.67 (5H, m), 7.82 (1H, d, J=2.9 Hz), 7.84 (1H, s), 7.88 (2H, d, J=8.1 Hz), 10.71 (1H, s).
1H-NMR (DMSO-d6) δ: 2.12 (3H, s), 3.00-3.18 (3H, m), 3.35-3.60 (3H, m), 4.38-4.40 (2H, m), 4.53-4.57 (2H, m), 5.15 (2H, s), 5.17 (2H, s), 7.04-7.08 (2H, m), 7.10-7.17 (3H, m), 7.30 (1H, d, J=15.4 Hz), 7.38-7.53 (6H, m), 7.60-7.67 (4H, m), 7.83-7.86 (2H, m), 11.01 (1H, s).
1H-NMR (DMSO-d6) δ: 0.87 (3H, t, J=7.3 Hz), 1.50-1.60 (2H, m), 2.10 (3H, s), 2.30 (3H, s), 3.03-3.09 (2H, m), 3.20-3.23 (1H, m), 3.37-3.47 (3H, m), 3.62-3.65 (2H, m), 4.37-4.40 (2H, m), 4.53-4.56 (2H, m), 5.06 (2H, s), 5.13 (2H, s), 6.94 (2H, d, J=8.3 Hz), 7.07-7.15 (3H, m), 7.20 (2H, d, J=7.8 Hz), 7.28-7.35 (3H, m), 7.45-7.52 (2H, m), 7.58-7.63 (4H, m), 7.79 (1H, d, J=2.9 Hz), 7.84 (1H, s), 11.52 (1H, s).
mp: 213.9-214.8° C.
mp: 216.2-219.2° C.
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 2.04 (6H, s), 2.82 (1H, septet, J=6.8 Hz), 3.04-3.60 (6H, m), 4.36 (2H, brs), 4.53 (2H, brs), 5.11 (2H, s), 5.22 (2H, s), 6.91-6.95 (2H, m), 7.00 (1H, d, J=8.8 Hz), 7.14-7.22 (3H, m), 7.46-7.55 (5H, m), 7.60-7.64 (3H, m), 7.81 (1H, d, J=2.0 Hz), 7.84 (1H, d, J=2.9 Hz), 9.13 (1H, d, J=2.0 Hz), 11.23 (1H, brs).
mp: 207.4-207.6° C.
1H-NMR (CDCl3) δ: 2.12 (6H, s), 2.72 (2H, brs), 3.45-3.66 (3H, m), 4.15 (4H, brs), 4.72-4.78 (3H, m), 5.09 (2H, s), 6.48 (1H, dt, J=16.1, 5.5 Hz), 6.68 (1H, d, J=15.1 Hz), 6.75 (1H, d, J=16.1 Hz), 6.86 (1H, d, J=9.0 Hz), 6.95-7.00 (3H, m), 7.25-7.36 (5H, m), 7.47-7.70 (9H, m), 7.78 (1H, d, J=2.7 Hz), 13.58 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.23 (3H, s), 2.33 (3H, s), 3.07-3.52 (6H, m), 4.30 (2H, brs), 4.53 (2H, brs), 4.73 (2H, dd, J=5.7, 1.1 Hz), 5.08 (2H, s), 6.43 (1H, dt, J=15.9, 5.7 Hz), 6.89 (2H, dt, J=9.3, 2.5 Hz), 6.98 (1H, d, J=15.9 Hz), 7.00 (1H, d, J=9.0 Hz), 7.10 (2H, dd, J=8.7, 0.6 Hz), 7.17-7.25 (3H, m), 7.37 (2H, brs), 7.46-7.52 (5H, m), 7.58 (1H, dd, J=9.0, 3.2 Hz), 7.63 (1H, d, J=8.3 Hz), 7.80 (1H, dd, J=3.2, 0.5 Hz), 10.59 (1H, brs).
mp: 188.2-189.1° C.
mp: 210.4-212.2° C.
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 2.23 (3H, s), 2.43 (3H, s), 3.15-3.57 (6H, m), 3.75 (3H, s), 4.36 (2H, brs), 4.55 (2H, brs), 4.70 (2H, d, J=5.4 Hz), 5.01 (2H, s), 6.57 (1H, dt, J=15.6, 5.4 Hz), 6.73 (1H, d, J=15.6 Hz), 6.88 (2H, dt, J=9.2, 2.4 Hz), 6.94 (2H, dt, J=9.2, 2.4 Hz), 6.99 (1H, d, J=9.0 Hz), 7.09 (2H, d, J=8.1 Hz), 7.20 (1H, d, J=15.6 Hz), 7.35-7.38 (2H, m), 7.48-7.51 (5H, m), 7.56 (2H, dd, J=9.0, 3.1 Hz), 7.78 (1H, d, J=3.1 Hz), 10.34 (1H, brs).
mp: 204.7-206.2° C.
mp: 162.7-163.3° C.
mp: 145.0-145.8° C.
mp: 169.5-170.0° C.
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 2.12 (3H, s), 2.23 (3H, s), 3.04-3.60 (6H, m), 4.35 (2H, brs), 4.53 (2H, brs), 4.75 (2H, d, J=6.3 Hz), 5.08 (2H, s), 6.10 (1H, t, J=6.3 Hz), 6.88 (2H, dt, J=9.2, 2.4 Hz), 7.00 (1H, d, J=9.0 Hz), 7.09 (2H, d, J=8.3 Hz), 7.17-7.25 (3H, m), 7.46-7.52 (5H, m), 7.55-7.60 (5H, m), 7.80 (1H, d, J=3.2 Hz), 11.21 (1H, s).
1H-NMR (DMSO-d6) δ: 1.93 (3H, s), 2.03 (6H, s), 2.23 (3H, s), 3.06-3.57 (6H, m), 4.35 (2H, brs), 4.53 (2H, brs), 4.58 (2H, s), 5.08 (2H, s), 6.64 (1H, brs), 6.90 (2H, dt, J=9.2, 2.4 Hz), 7.00 (1H, d, J=8.8 Hz), 7.09 (2H, d, J=8.3 Hz), 7.17-7.24 (3H, m), 7.40 (2H, d, J=8.1 Hz), 7.46-7.52 (5H, m), 7.56-7.60 (3H, m), 7.80 (1H, d, J=2.9 Hz), 10.95 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.19 (6H, d, J=6.8 Hz), 2.10 (3H, s), 2.30 (3H, s), 2.70-4.00 (13H, m), 4.20-4.40 (2H, m), 4.45-4.62 (2H, m), 5.56 (2H, s), 7.08 (1H, dd, J=8.8, 0.5 Hz), 7.19 (2H, d, J=7.8 Hz), 7.25-7.35 (7H, m), 7.37 (2H, d, J=8.1 Hz), 7.48 (1H, d, J=15.4 Hz), 7.54-7.62 (3H, m), 7.63 (1H, d, J=2.0 Hz), 7.78 (1H, dd, J=3.1, 0.5 Hz), 7.84 (1H, d, J=2.0 Hz), 11.59 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.19 (6H, d, J=6.8 Hz), 2.11 (3H, s), 2.70-4.00 (13H, m), 4.24-4.40 (2H, m), 4.45-4.61 (2H, m), 5.17 (2H, s), 7.11 (1H, d, J=9.5 Hz), 7.25-7.69 (16H, m), 7.82-7.88 (2H, m), 11.57 (1H, brs).
mp: 184.2-186.2° C.
mp: 204.6-208.5° C.
mp: 206.3-207.8° C.
mp: 200.3-202.4° C.
mp: 193.7-194.9° C.
mp: 211.2-211.9° C.
mp: 219.5-222.3° C.
mp: 219.5-221.3° C.
mp: 217.5-218.4° C.
mp: 191.3-192.5° C.
1H-NMR (DMSO-d6) δ: 1.19 (6H, d, J=6.8 Hz), 1.45-1.71 (2H, m), 1.90-2.06 (2H, m), 2.10 (3H, s), 2.30 (3H, s), 2.72 (1H, t, J=12.0 Hz), 2.91 (1H, septet, J=6.8 Hz), 2.98-3.07 (2H, m), 3.13 (1H, t, J=12.2 Hz), 3.30-4.00 (7H, m), 4.32-4.58 (2H, m), 5.06 (2H, s), 7.08 (1H, dd, J=9.0, 0.5 Hz), 7.19 (2H, d, J=7.8 Hz), 7.28-7.47 (12H, m), 7.59 (1H, dd, J=9.0, 3.2 Hz), 7.63 (1H, d, J=2.0 Hz), 7.79 (1H, dd, J=3.2, 0.5 Hz), 7.83 (1H, d, J=2.0 Hz).
mp: 171.7-174.5° C.
mp: 228.0-228.9° C.
1H-NMR (DMSO-d6) δ: 1.25 (6H, d, J=6.8 Hz), 2.11 (3H, s), 2.96 (1H, septet, J=6.8 Hz), 3.00-3.80 (6H, m), 4.42-4.64 (4H, m), 5.17 (2H, s), 7.12 (1H, d, J=8.8 Hz), 7.15-7.20 (2H, m), 7.25-7.55 (8H, m), 7.59-7.69 (3H, m), 7.72 (1H, d, J=8.8 Hz), 7.82-7.90 (3H, m), 8.12 (1H, brs), 8.43 (1H, d, J=8.8 Hz), 11.22 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.23 (3H, s), 2.99-3.13 (3H, m), 3.40-3.54 (3H, m), 4.28-4.33 (6H, m), 4.53-4.56 (2H, m), 5.24 (2H, s), 6.87 (2H, d, J=8.5 Hz), 7.07-7.14 (5H, m), 7.31 (1H, d, J=15.4 Hz), 7.49-7.52 (3H, m), 7.64-7.67 (4H, m), 7.78 (2H, d, J=8.1 Hz), 7.83 (1H, d, J=3.2 Hz), 7.85 (1H, s), 10.99 (1H, brs).
mp: 190.3-191.9° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.02-3.14 (3H, m), 3.34-3.55 (3H, m), 4.30-4.34 (6H, m), 4.52-4.56 (2H, m), 5.24 (2H, s), 7.00-7.04 (2H, m), 7.07-7.12 (3H, m), 7.28-7.37 (3H, m), 7.47-7.51 (3H, m), 7.62-7.68 (4H, m), 7.77 (2H, d, J=8.3 Hz), 7.82 (1H, d, J=2.9 Hz), 7.84 (1H, d, J=1.5 Hz), 10.80 (1H, brs).
mp: 232.0-234.1° C.
mp: 178.9-181.1° C.
mp: 227.6-228.9° C.
mp: 227.1-228.0° C.
mp: 221.4-221.6° C.
mp: 228.3-230.2° C.
mp: 225.0-227.1° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.27 (3H, s), 3.00-3.14 (5H, m), 3.39-3.55 (3H, m), 4.19 (2H, t, J=6.8 Hz), 4.27 (2H, brs), 4.52-4.55 (2H, m), 5.24 (2H, s), 7.02 (2H, d, J=8.5 Hz), 7.12 (3H, d, J=8.8 Hz), 7.21 (2H, d, J=7.8 Hz), 7.29 (1H, d, J=15.6 Hz), 7.47-7.51 (3H, m), 7.62-7.68 (4H, m), 7.77 (2H, d, J=8.3 Hz), 7.82 (1H, d, J=2.9 Hz), 7.84 (1H, d, J=1.7 Hz), 10.80 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.97-3.12 (5H, m), 3.33-3.54 (3H, m), 3.72 (3H, s), 4.17 (2H, t, J=6.8 Hz), 4.28 (2H, brs), 4.52-4.55 (2H, m), 5.24 (2H, s), 6.86-6.89 (2H, m), 7.02 (2H, d, J=8.5 Hz), 7.12 (1H, d, J=8.8 Hz), 7.23-7.27 (2H, m), 7.29 (1H, d, J=15.4 Hz), 7.45-7.51 (3H, m), 7.62-7.68 (4H, m), 7.77 (2H, d, J=8.3 Hz), 7.82 (1H, d, J=2.9 Hz), 7.84 (1H, d, J=2.0 Hz), 10.71 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.21 (6H, d, J=6.8 Hz), 2.11 (3H, s), 2.87-2.94 (1H, m), 3.01-3.17 (2H, m), 3.36-3.39 (2H, m), 3.55-3.58 (2H, m), 4.31-4.34 (2H, m), 4.53-4.56 (2H, m), 5.23 (2H, s), 6.99 (2H, d, J=8.5 Hz), 7.05 (2H, d, J=8.3 Hz), 7.12 (1H, d, J=9.0 Hz), 7.28-7.33 (3H, m), 7.49 (1H, d, J=15.4 Hz), 7.56 (2H, d, J=8.3 Hz), 7.62-7.66 (4H, m), 7.81-7.89 (4H, m), 10.90 (1H, s).
mp: 196.5-197.4° C.
mp: 195.2-198.7° C.
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 2.82 (1H, septet, J=6.8 Hz), 2.90-3.65 (8H, m), 4.18 (2H, t, J=6.7 Hz), 4.32 (2H, brs), 4.52 (2H, brs), 5.14 (2H, s), 6.84 (2H, d, J=8.8 Hz), 7.12-7.17 (4H, m), 7.27-7.34 (3H, m), 7.43 (2H, d, J=7.8 Hz), 7.50-7.56 (4H, m), 7.60-7.66 (2H, m), 7.83 (1H, dd, J=12.1, 1.8 Hz), 7.89 (1H, d, J=3.2 Hz), 10.76 (1H, brs).
mp: 231.9-233.7° C.
mp: 231.3-231.5° C.
mp: 200.2-200.3° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.96-4.55 (17H, m), 5.17 (2H, s), 6.87 (2H, d, J=8.5 Hz), 7.02 (2H, d, J=8.1 Hz), 7.12 (1H, d, J=8.8 Hz), 7.24 (2H, d, J=8.5 Hz), 7.30 (1H, d, J=15.4 Hz), 7.39-7.42 (2H, m), 7.46-7.53 (4H, m), 7.60-7.67 (3H, m), 7.84-7.84 (2H, m), 10.83 (1H, brs).
mp: 224.8-225.5° C. (dec.)
mp: 222.2-224.2° C. (dec.)
mp: 218.3-218.5° C.
mp: 152.0-152.1° C.
mp: 223.7-223.8° C.
1H-NMR (DMSO-d6) δ: 2.10 (3H, s), 2.30 (3H, s), 3.06-3.57 (6H, m), 3.29 (3H, s), 4.06 (2H, dd, J=5.5, 1.3 Hz), 4.34 (2H, brs), 4.52-4.55 (2H, m), 5.05 (2H, s), 6.45 (1H, dt, J=16.1, 5.5 Hz), 6.64 (1H, d, J=16.1 Hz), 7.09 (1H, d, J=9.3 Hz), 7.20 (2H, d, J=7.8 Hz), 7.28-7.34 (3H, m), 7.49 (1H, d, J=15.4 Hz), 7.52-7.57 (4H, m), 7.59 (1H, dd, J=9.3, 3.2 Hz), 7.63 (1H, d, J=2.0 Hz), 7.79 (1H, d, J=3.2 Hz), 7.84 (1H, d, J=2.0 Hz), 10.93 (1H, brs).
mp: 224.7-226.0° C.
mp: 216.1-216.5° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.34 (3H, s), 3.05-4.56 (10H, m), 5.11 (2H, s), 7.10 (1H, d, J=8.8 Hz), 7.21 (2H, d, J=7.8 Hz), 7.26 (1H, t, J=74.0 Hz), 7.26-7.33 (3H, m), 7.48-7.53 (5H, m), 7.60-7.64 (2H, m), 7.81 (1H, brs), 7.85 (1H, brs), 11.62 (1H, brs).
mp: 191.6-193.1° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 3.04-3.61 (6H, m), 4.15 (2H, dd, J=4.6, 1.5 Hz), 4.32 (2H, brs), 4.54 (2H, brs), 5.23 (2H, s), 6.48 (1H, dt, J=16.0, 4.8 Hz), 6.60 (1H, dt, J=16.0, 1.5 Hz), 7.12 (1H, dd, J=9.0, 0.5 Hz), 7.30 (1H, d, J=15.4 Hz), 7.47-7.56 (5H, m), 7.62-7.66 (4H, m), 7.82 (1H, dd, J=3.2, 0.5 Hz), 7.84 (1H, d, J=2.0 Hz), 7.88 (2H, dt, J=8.3, 1.7 Hz), 11.12 (1H, brs).
mp: 170.2-170.5° C.
mp: 205.5-206.5° C.
mp: 147.6-149.7° C.
mp: 156.5-158.2° C.
mp: 197.8-198.4° C.
mp: 196.4-197.6° C.
mp: 155.5-157.0° C.
mp: 142.2-144.1° C.
mp: 144.3-145.8° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.51 (3H, s), 3.05-3.44 (8H, m), 4.31-4.57 (6H, m), 5.17 (2H, s), 7.03 (2H, d, J=8.8 Hz), 7.12 (1H, d, J=9.0 Hz), 7.29-7.53 (9H, m), 7.60-7.67 (3H, m), 7.83-7.85 (2H, m), 7.92 (2H, d, J=8.8 Hz), 9.87 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.21 (3H, d, J=6.1 Hz), 2.12 (3H, s), 2.21 (3H, s), 2.89 (1H, dd, J=13.9, 5.4 Hz), 2.98 (1H, dd, J=13.9, 6.6 Hz), 3.05-3.46 (6H, m), 4.35 (2H, brs), 4.54-4.56 (2H, m), 4.61-4.69 (1H, m), 5.17 (2H, s), 6.79 (2H, dt, J=9.2, 2.4 Hz), 7.05 (2H, d, J=8.1 Hz), 7.12 (1H, d, J=9.5 Hz), 7.30 (1H, d, J=15.4 Hz), 7.37-7.53 (8H, m), 7.60-7.67 (3H, m), 7.84 (1H, d, J=3.2 Hz), 7.85 (1H, d, J=2.0 Hz), 9.85 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.21 (3H, d, J=6.1 Hz), 2.03 (6H, s), 2.21 (3H, s), 2.89 (1H, dd, J=13.8, 5.7 Hz), 2.99 (1H, dd, J=13.8, 6.6 Hz), 3.05-3.39 (6H, m), 3.76 (3H, s), 4.35 (2H, brs), 4.55 (2H, brs), 4.62-4.67 (1H, m), 5.01 (2H, s), 6.79 (2H, dt, J=9.3, 2.6 Hz), 6.94 (2H, dt, J=9.3, 2.6 Hz), 6.99 (1H, d, J=9.0 Hz), 7.05 (2H, d, J=8.3 Hz), 7.19 (1H, d, J=15.4 Hz), 7.35-7.50 (9H, m), 7.56 (1H, dd, J=9.0, 3.2 Hz), 7.78 (1H, d, J=3.2 Hz), 9.87 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.21 (3H, d, J=6.1 Hz), 2.04 (6H, s), 2.21 (3H, s), 2.89 (1H, dd, J=13.8, 5.7 Hz), 2.99 (1H, dd, J=13.8, 6.7 Hz), 3.06-3.47 (6H, m), 4.35 (2H, brs), 4.53-4.56 (2H, m), 4.61-4.69 (1H, m), 5.08 (2H, s), 6.79 (2H, dt, J=9.0, 2.4 Hz), 7.00 (1H, d, J=9.3 Hz), 7.05 (2H, d, J=8.1 Hz), 7.17-7.25 (3H, m), 7.39 (2H, d, J=8.3 Hz), 7.44-7.52 (7H, m), 7.58 (1H, dd, J=9.3, 3.2 Hz), 7.80 (1H, d, J=3.2 Hz), 9.90 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.34 (3H, s), 3.05-3.41 (8H, m), 4.20 (2H, t, J=6.4 Hz), 4.37 (2H, brs), 4.55-4.58 (2H, m), 5.19 (2H, s), 6.92-6.95 (2H, m), 7.08-7.14 (4H, m), 7.24 (1H, d, J=15.1 Hz), 7.38-7.53 (7H, m), 7.61-7.70 (3H, m), 7.91-7.92 (1H, m), 8.02 (1H, s), 9.92 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=6.8 Hz), 2.30 (3H, s), 2.33 (3H, s), 2.81 (1H, septet, J=6.8 Hz), 3.05-3.63 (8H, m), 4.18 (2H, t, J=6.6 Hz), 4.37 (2H, brs), 4.55-4.58 (2H, m), 5.08 (2H, s), 6.82-6.85 (2H, m), 7.07-7.14 (4H, m), 7.19-7.25 (3H, m), 7.33 (2H, d, J=8.1 Hz), 7.43-7.48 (4H, m), 7.59 (1H, dd, J=9.0, 3.2 Hz), 7.68 (1H, d, J=15.1 Hz), 7.86 (1H, d, J=3.2 Hz), 8.01 (1H, s), 9.93 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.21 (3H, s), 2.30 (3H, s), 2.33 (3H, s), 3.04-3.60 (8H, m), 4.17 (2H, t, J=6.6 Hz), 4.36 (2H, brs), 4.55-4.58 (2H, m), 5.08 (2H, s), 6.79-6.83 (2H, m), 7.06-7.12 (4H, m), 7.19-7.25 (3H, m), 7.33 (2H, d, J=7.8 Hz), 7.43-7.48 (4H, m), 7.59 (1H, dd, J=9.0, 3.2 Hz), 7.67 (1H, d, J=15.4 Hz), 7.86 (1H, d, J=3.2 Hz), 8.01 (1H, s), 9.93 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.15 (3H, s), 2.21 (3H, s), 3.04-3.42 (8H, m), 4.17 (2H, t, J=6.6 Hz), 4.35 (2H, brs), 4.55 (2H, brs), 5.20 (2H, s), 6.80-6.82 (2H, m), 7.08 (2H, d, J=8.1 Hz), 7.11 (1H, d, J=9.3 Hz), 7.16 (1H, s), 7.29 (1H, d, J=15.1 Hz), 7.36-7.44 (6H, m), 7.51-7.53 (1H, m), 7.61-7.67 (2H, m), 7.80 (1H, d, J=15.1 Hz), 7.95-7.96 (2H, m), 9.83 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=7.1 Hz), 2.14 (3H, s), 2.30 (3H, s), 2.81 (1H, septet, J=7.1 Hz), 3.05-3.56 (8H, m), 4.18 (2H, t, J=6.6 Hz), 4.36-4.55 (4H, m), 5.09 (2H, s), 6.82-6.85 (2H, m), 7.08 (1H, d, J=8.8 Hz), 7.11-7.14 (3H, m), 7.20 (2H, d, J=7.8 Hz), 7.29 (1H, d, J=15.1 Hz), 7.33 (2H, d, J=7.8 Hz), 7.45 (4H, brs), 7.60 (1H, dd, J=8.8, 2.9 Hz), 7.80 (1H, d, J=15.1 Hz), 7.90-7.91 (1H, m), 7.96 (1H, s), 9.86 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.15 (6H, d, J=6.8 Hz), 2.15 (3H, s), 2.81 (1H, septet, J=6.8 Hz), 3.05-3.38 (8H, m), 4.18 (2H, t, J=6.4 Hz), 4.36-4.55 (4H, m), 5.20 (2H, s), 6.82-6.84 (2H, m), 7.10-7.16 (4H, m), 7.29 (1H, d, J=15.4 Hz), 7.38-7.54 (7H, m), 7.61-7.67 (2H, m), 7.80 (1H, d, J=15.4 Hz), 7.95-7.96 (2H, m), 9.84 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.15 (3H, s), 3.05-3.48 (8H, m), 4.20 (2H, t, J=6.6 Hz), 4.36-4.55 (4H, m), 5.20 (2H, s), 6.92-6.96 (2H, m), 7.07-7.16 (4H, m), 7.29 (1H, d, J=15.1 Hz), 7.37-7.54 (7H, m), 7.61-7.68 (2H, m), 7.80 (1H, d, J=15.1 Hz), 7.95-7.96 (2H, m), 9.87 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.22 (3H, d, J=5.9 Hz), 2.03 (6H, s), 2.90 (1H, dd, J=13.9, 5.4 Hz), 2.99 (1H, dd, J=13.9, 6.6 Hz), 3.05-3.38 (6H, m), 3.76 (3H, s), 4.35 (2H, brs), 4.56 (2H, brs), 4.62-4.71 (1H, m), 5.01 (2H, s), 6.90-6.96 (4H, m), 6.99 (1H, d, J=9.3 Hz), 7.05-7.12 (2H, m), 7.19 (1H, d, J=15.4 Hz), 7.35-7.50 (9H, m), 7.57 (1H, dd, J=9.3, 3.2 Hz), 7.78 (1H, d, J=3.2 Hz), 9.88 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.22 (3H, d, J=6.1 Hz), 2.03 (6H, s), 2.90 (1H, dd, J=13.9, 5.6 Hz), 2.99 (1H, dd, J=13.9, 6.7 Hz), 3.04-3.39 (6H, m), 4.35 (2H, brs), 4.55 (2H, brs), 4.62-4.70 (1H, m), 5.08 (2H, s), 6.89-6.94 (2H, m), 7.01 (1H, d, J=9.0 Hz), 7.05-7.11 (2H, m), 7.17-7.26 (3H, m), 7.39-7.52 (9H, m), 7.59 (1H, dd, J=9.0, 3.2 Hz), 7.80 (1H, d, J=3.2 Hz), 9.85 (1H, brs).
mp: 197.0-199.1° C.
mp: 166.7-168.8° C.
mp: 211.3-211.9° C.
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 1.99-2.05 (2H, m), 2.11 (3H, s), 2.76-3.48 (9H, m), 3.94 (2H, t, J=6.4 Hz), 4.36 (2H, brs), 4.54-4.57 (2H, m), 5.17 (2H, s), 6.82-6.85 (2H, m), 7.11-7.14 (3H, m), 7.29-7.53 (9H, m), 7.59-7.67 (3H, m), 7.83-7.86 (2H, m), 9.88-9.96 (1H, m).
mp: 200.5-202.1° C.
mp: 167.3-168.9° C.
1H-NMR (DMSO-d6) δ: 1.19 (6H, d, J=6.8 Hz), 2.10 (3H, s), 2.30 (3H, s), 2.85-3.48 (7H, m), 4.38 (2H, brs), 4.52-4.56 (6H, m), 5.05 (2H, s), 7.08 (1H, d, J=9.0 Hz), 7.18-7.24 (4H, m), 7.27-7.33 (5H, m), 7.46-7.51 (5H, m), 7.58-7.62 (2H, m), 7.78 (1H, d, J=2.9 Hz), 7.84 (1H, d, J=1.7 Hz), 9.89 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.19 (6H, d, J=6.8 Hz), 2.11 (3H, s), 2.85-3.54 (7H, m), 4.39 (2H, brs), 4.52-4.56 (6H, m), 5.17 (2H, s), 7.12 (1H, d, J=9.0 Hz), 7.22-7.32 (5H, m), 7.37-7.32 (8H, m), 7.60-7.66 (3H, m), 7.83-7.85 (2H, m), 9.93 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 2.34 (3H, s), 2.83 (1H, septet, J=6.8 Hz), 3.06-3.60 (6H, m), 4.40 (2H, brs), 4.55-4.58 (2H, m), 5.12 (2H, s), 5.19 (2H, s), 6.91-6.95 (2H, m), 7.11-7.17 (4H, m), 7.24 (1H, d, J=15.1 Hz), 7.37-7.44 (2H, m), 7.50-7.70 (8H, m), 7.91-7.92 (1H, m), 8.02 (1H, s), 9.92 (1H, brs).
mp: 194.9-196.6° C.
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 2.30 (3H, s), 2.33 (3H, s), 2.83 (1H, septet, J=6.8 Hz), 3.07-3.40 (6H, m), 4.40-4.58 (4H, m), 5.08 (2H, s), 5.12 (2H, s), 6.91-6.95 (2H, m), 7.07-7.25 (7H, m), 7.33 (2H, d, J=8.1 Hz), 7.53-7.61 (5H, m), 7.68 (1H, d, J=15.1 Hz), 7.86-7.87 (1H, m), 8.01 (1H, s), 9.91 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 2.15 (3H, s), 2.83 (1H, septet, J=6.8 Hz), 3.09-3.58 (6H, m), 4.41-4.57 (4H, m), 5.12 (2H, s), 5.20 (2H, s), 6.93 (2H, d, J=8.6 Hz), 7.10-7.17 (4H, m), 7.31 (1H, d, J=15.4 Hz), 7.38-7.44 (2H, m), 7.50-7.68 (7H, m), 7.81 (1H, d, J=15.4 Hz), 7.95 (1H, d, J=3.2 Hz), 7.98 (1H, s), 9.97 (1H, brs).
1H-NMR (DMSO-d6) δ: 1.16 (6H, d, J=6.8 Hz), 2.34 (3H, s), 2.83 (1H, septet, J=6.8 Hz), 3.06-3.63 (6H, m), 4.41-4.58 (4H, m), 5.12 (2H, s), 5.26 (2H, s), 6.91-6.95 (2H, m), 7.10-7.18 (4H, m), 7.24 (1H, d, J=15.1 Hz), 7.56 (4H, s), 7.61-7.70 (4H, m), 7.87-7.90 (3H, m), 8.02 (1H, s), 10.00 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 3.05-3.52 (6H, m), 3.30 (3H, s), 4.06 (2H, dd, J=5.5, 1.3 Hz), 4.37 (2H, brs), 4.55 (2H, brs), 5.08 (2H, s), 6.46 (1H, dt, J=16.4, 5.5 Hz), 6.65 (1H, d, J=16.4 Hz), 7.01 (1H, d, J=8.8 Hz), 7.18-7.25 (3H, m), 7.46-7.52 (7H, m), 7.57-7.60 (3H, m), 7.80 (1H, d, J=3.2 Hz), 9.87 (1H, brs).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 2.77 (2H, t, J=7.0 Hz), 3.05-3.07 (3H, m), 3.39-3.41 (3H, m), 3.63 (2H, t, J=7.0 Hz), 4.34-4.37 (2H, m), 4.55-4.57 (2H, m), 5.22 (2H, s), 7.02 (1H, d, J=8.8 Hz), 7.20 (1H, d, J=15.4 Hz), 7.34 (2H, d, J=7.8 Hz), 7.43-7.50 (5H, m), 7.60-7.64 (3H, m), 7.82-7.88 (3H, m), 9.90 (1H, s).
1H-NMR (DMSO-d6) δ: 2.04 (6H, s), 2.77 (2H, t, J=6.8 Hz), 3.08-3.10 (3H, m), 3.38-3.41 (3H, m), 3.63 (2H, t, J=6.8 Hz), 4.36-4.38 (2H, m), 4.54-4.56 (2H, m), 5.45 (2H, s), 7.06 (1H, d, J=9.0 Hz), 7.21 (1H, d, J=15.4 Hz), 7.34 (2H, d, J=8.1 Hz), 7.46-7.49 (5H, m), 7.66 (1H, dd, J=8.9, 2.9 Hz), 7.87 (1H, d, J=2.9 Hz), 7.98 (2H, d, J=6.3 Hz), 8.89 (2H, d, J=6.3 Hz), 10.03 (1H, s).
1H-NMR (DMSO-d6) δ: 2.03 (6H, s), 3.06-3.42 (6H, m), 3.30 (3H, s), 3.75 (3H, s), 4.06 (2H, dd, J=5.6, 1.2 Hz), 4.37 (2H, brs), 4.56 (2H, brs), 5.01 (2H, s), 6.46 (1H, dt, J=15.9, 5.6 Hz), 6.65 (1H, d, J=15.9 Hz), 6.94 (2H, dt, J=9.4, 2.6 Hz), 6.99 (1H, d, J=9.0 Hz), 7.20 (1H, d, J=15.4 Hz), 7.37 (2H, dt, J=9.4, 2.6 Hz), 7.47-7.50 (5H, m), 7.55-7.59 (3H, m), 7.78 (1H, d, J=3.2 Hz), 9.91 (1H, brs).
mp: 206.8-207.6° C.
mp: 176.7-178.2° C.
1H-NMR (DMSO-d6) δ: 1.28 (6H, d, J=6.1 Hz), 2.11 (3H, s), 3.03-4.57 (10H, m), 4.66 (1H, septet, J=6.1 Hz), 5.10 (2H, s), 7.01 (2H, d, J=8.5 Hz), 7.11 (1H, d, J=8.8 Hz), 7.20 (2H, d, J=8.3 Hz), 7.24 (1H, t, J=74.0 Hz), 7.30 (1H, d, J=15.1 Hz), 7.41-7.52 (5H, m), 7.60-7.63 (2H, m), 7.80 (1H, d, J=2.9 Hz), 7.84 (1H, brs), 9.75 (1H, brs).
mp: 211.3-211.7° C.
mp: 196.8-197.0° C.
mp: 198.6-198.8° C.
mp: 201.4-201.6° C.
mp: 199.2-199.6° C.
mp: 236.1-236.6° C.
mp: 234.4-235.2° C.
mp: 233.5-233.9° C.
mp: 174.1-175.0° C.
mp: 167.3-169.4° C.
1H-NMR (DMSO-d6) δ: 2.11 (3H, s), 2.93-4.05 (10H, m), 5.17 (2H, s), 5.31 (1H, d, J=11.0 Hz), 5.88 (1H, d, J=17.6 Hz), 6.11 (2H, s), 6.76 (1H, dd, J=17.6, 11.0 Hz), 7.11 (1H, d, J=9.0 Hz), 7.29 (1H, d, J=15.4 Hz), 7.37-7.55 (8H, m), 7.60-7.66 (3H, m), 7.83-7.85 (2H, m).
To a solution of (E)-3-[3-chloro-4-({5-[(4-fluorobenzyl)oxy]pyridin-2-yl}oxy)phenyl]prop-2-enoic acid (212 mg) in DMF (7.0 mL) were added 1-{4-[2-(3-methoxyphenoxy)ethyl]benzyl}piperazine (190 mg), HOBT (89 mg) and WSC (112 mg) at room temperature, then the reaction mixture was stirred over night. The reaction mixture was basified with saturated aqueous NaHCO3, extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/4 to 0/1 and then MeOH/AcOEt=1/9) to afford (E)-3-[3-chloro-4-({5-[(4-fluorobenzyl)oxy]pyridin-2-yl}oxy)phenyl]-1-(4-{4-[2-(3-methoxyphenoxy)ethyl]benzyl}-piperazin-1-yl)prop-2-en-1-one (387 mg) as a colorless amorphous. To a solution of that amorphous (387 mg) in AcOEt (7.0 mL) was added 6 M aqueous HCl (0.088 mL) at room temperature, and then the reaction mixture was stirred for 30 minutes. The reaction mixture was filtered off, and the crude crystal was recrystallized from EtOH—H2O to afford (E)-3-[3-chloro-4-({5-[(4-fluorobenzyl)oxy]pyridin-2-yl}oxy)phenyl]-1-(4-{4-[2-(3-methoxyphenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one hydrochloride as a colorless powder (333 mg).
mp: 201.5-202.0° C.
The following compounds were produced in the same manner as in Example 757 using appropriate starting materials.
mp: 193.3-193.5° C.
mp: 212.4-213.0° C.
mp: 188.2-188.5° C.
mp: 194.5-195.2° C.
mp: 217.7-218.4° C.
mp: 192.9-193.4° C.
mp: 202.4-203.2° C.
mp: 220.0-220.9° C.
mp: 219.7-220.0° C.
mp: 208.3-209.7° C.
mp: 194.2-195.0° C.
mp: 205.8-205.9° C.
mp: 209.3-209.6° C.
mp: 228.2-228.5° C.
mp: 227.5-228.3° C.
mp: 242.4-243.1° C.
mp: 240.4-240.9° C.
mp: 205.8-206.5° C.
mp: 156.4-158.6° C.
To a solution of (E)-3-{3-chloro-4-[(5-hydroxypyridin-2-yl)oxy]-5-methylphenyl}-1-(4-{4-[2-(4-methylphenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one (479 mg) and p-chlorobenzyl chloride (129 mg) in DMF (5.0 mL) was added NaH (41.6 mg, 60% in mineral oil) at 0° C. Then the reaction mixture was stirred over night at room temperature. The reaction mixture was quenched by addition of saturated aqueous NH4Cl, and extracted with AcOEt. The organic layer was washed with water and saturated aqueous NaCl, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane/AcOEt=1/0 to 9/1) to afford (E)-3-[3-chloro-4-({5-[(4-chlorobenzyl)oxy]pyridin-2-yl}oxy)-5-methylphenyl]-1-(4-{4-[2-(4-methylphenoxy)-ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one (507 mg) as a colorless amorphous. To a solution of that amorphous (507 mg) in EtOH (10 mL) was added 6 M aqueous HCl (0.129 mL) at room temperature, then the reaction mixture was stirred for 3 hours. The reaction mixture was filtered off, and the precipitate was dried at 50° C. under reduced pressure to afford (E)-3-[3-chloro-4-({5-[(4-chlorobenzyl)oxy]pyridin-2-yl}oxy)-5-methylphenyl]-1-(4-{4-[2-(4-methylphenoxy)ethyl]benzyl}piperazin-1-yl)prop-2-en-1-one hydrochloride (486 mg) as a colorless crystal.
mp: 220.1-220.3° C.
The following compounds were produced in the same manner as in Example 777 using appropriate starting materials.
mp: 227.1-228.2° C.
mp: 223.9-224.5° C.
mp: 218.7-220.1° C.
mp: 223.1-224.0° C.
Pharmacological Test
Antiproliferative Effect on Cancer Cell (in vitro)
The growth inhibition on a bicalutamide resistant human prostate cancer cell line established from LNCaP.FGC (LNCaP-Bic) (Hobisch A, et al. Prostate. 2006; 66(4):413-20.) was determined by a WST-8 assay according to the method of Singh A K, et al. (Cancer Lett. 1996 Oct. 1; 107(1): 109-15.). In this method, LNCaP-Bic cells were seeded in RPMI 1640 medium containing 10% fetal bovine serum in a 96-well microplate and incubated at 37° C. for 24 hours in the presence of 5% carbon dioxide. Then, the test compound was added and the cells were incubated for another 5 days. After incubation, a 15-μL volume of WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfenyl)-2H-tetrazolium, monosodium salt) was added. After the incubation for the time, the color reaction was stopped by adding 15 μL of 1% SDS (sodium dodecyl sulfate) solution and the optical density was determined at the measurement wavelength of 450 nm and the reference wavelength of 630 nm, and the difference was calculated. The cell growth activity in each well was defined as the value determined by subtracting the OD in the control well not containing cells (the difference in absorbance between 450 nm and 630 nm) from that in the test well.
The 50% inhibitory concentration (IC50 (nM)) of the test compound was determined by comparing the cell growth activity in the well containing the test compound with that of the control not containing the test compound.
The growth inhibition on a human prostate (carcinoma) cell line (LNCaP.FGC) (van Bokhoven A, et al. Prostate. 2003; 57(3):205-25.) was also determined by the above method.
The growth inhibition on a human prostate (adenocarcinoma) cell line (VcaP) (Korenchuk S, et al. In Vivo. 2001; 15(2):163-8.) was also determined by the above method.
The growth inhibition on a human prostate (carcinoma) cell line (DU 145) (van Bokhoven A, et al. Prostate. 2003; 57(3):205-25.) was also determined by the above method.
The growth inhibition on a human prostate (adenocarcinoma) cell line (PC-3) (van Bokhoven A, et al. Prostate. 2003; 57(3):205-25.) was also determined by the above method.
The results are shown in Table 2.
Growth inhibition of a human breast cancer cell line (MDA-MB-468) was determined by the sulforhodamine B method based on the method of Skehan P. et al. (J Natl Cancer Inst. 1990 Jul. 4; 82(13): 1107-12). In the study, MDA-MB-468 cells were seeded on DMEM medium containing 10% fetal bovine serum in a 96-well microplate. After 24-h incubation at 37° C. in the presence of 5% carbon dioxide, the test compound was added and the cells were incubated for another 5 days. After incubation, a trichloroacetic acid solution was added to yield the final concentration of 10% and the cells were left to stand at 4° C. for 1 hour to fix. Then, the cells were washed with water to remove the medium and trichloroacetic acid and dried in the air. The dried cells were stored at 4° C. until they were stained with sulforhodamine B. To each well, 1% acetic acid solution containing 0.4% sulforhodamine B was added and left to stand for 20 to 30 minutes at room temperature. After discarding the supernatant, each well was washed with 1% acetic acid solution, and 10 mM Tris(tris-hydroxyaminomethane) solution was added while stirring to elute the dye taken into the cells. Then, the optical density was determined at the measurement wavelength of 492 nm and the reference wavelength of 690 nm, and the difference was calculated. The cell growth activity in each well was defined as the value determined by subtracting the OD in the control well not containing cells (the difference in absorbance between 492 nm and 690 nm) from that in the test well.
The 50% inhibitory concentration (IC50 (nM)) of the test compound was determined by comparing the cell growth activity in the well containing the test compound with that of the control not containing the test compound.
The results are shown in Table 3.
The growth inhibition on a human hepatic cancer cell line (HuH-7) was also determined by the above method.
The results are shown in Table 4.
Antitumor Effect on Prostate Cancer Cells, LNCaP-Bic (in vivo)
Human prostate cancer cells (LNCaP-Bic) were transplanted in nude mice (6 males/group) and the inhibitory effect of the invention on their growth was examined. In the study, the tumor cell suspension with matrigel was inoculated at 0.12 mL/body (2.4×106 cells/body) into the subcutaneous space of the right axillary region to prepare tumor bearing mice. When the tumor diameter became 5 mm or more, the animals were allocated to groups based on the tumor volume. The test compound was administered orally as a suspension in 5% gum arabic, once daily, for 14 consecutive days. The control group received 5% gum arabic. Tumor volumes were measured on the following day of the last administration. Tumors were removed and the wet weight of the tumor was measured using an electronic balance. The ratio of the tumor weight in the treated group to that in the control group (T/C %) was calculated as the index for the effect.
T/C %=(Mean tumor weight in the treatment group/Mean tumor weight in the control group)×100.
The results are shown in Table 5.
The heparinized blood was collected from the postcava under diethylether anesthesia. The plasma levels of PSA were measured using ELISA. The ratio of the plasma levels of PSA in the treated group to that in the control group (T/C %) was calculated as the index for the effect.
T/C %=(Mean plasma levels of PSA in the treatment group/Mean plasma levels of PSA in the control group)×100.
The results are shown in Table 6.
This application is a national phase application based on PCT/JP2011/052302, filed Jan. 28, 2011, which claims the benefit of U.S. Provisional Application No. 61/299,631, filed Jan. 29, 2010 and U.S. Provisional Application No. 61/359,729, filed Jun. 29, 2010; the content of all of which is incorporated herein by reference.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/JP2011/052302 | 1/28/2011 | WO | 00 | 1/6/2012 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2011/093524 | 8/4/2011 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 20100261720 | Sumida et al. | Oct 2010 | A1 |
| Number | Date | Country |
|---|---|---|
| 20 2009 007 345 | Oct 2009 | DE |
| WO 2006014012 | Feb 2006 | WO |
| WO 2007066784 | Jun 2007 | WO |
| WO 2008044667 | Apr 2008 | WO |
| WO 2009057811 | May 2009 | WO |
| Entry |
|---|
| Cancer Drug Design and Discovery, Neidle, Stephen,ed. (Elsevier/Academic Press), pp. 427-431 (2008). |
| International Search Report from the European Patent Office in International Application No. PCT/JP2011/052302 mailed May 2, 2011. |
| Number | Date | Country | |
|---|---|---|---|
| 20120283242 A1 | Nov 2012 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61359729 | Jun 2010 | US | |
| 61299631 | Jan 2010 | US |
